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Abstract 
 
 
Shared decision making (SDM) is a collaborative process that allows patients and their 
providers to make health care decisions together, taking into account scientific evidence 
and the patient’s values and preferences. The thesis shifts the explanatory framework of 
SDM from current literature, which evaluates the concept of SDM, to a qualitative critical 
health psychology approach, which explores SDM in terms of its meaning and experiences 
for individuals. The thesis explores the experience of SDM for the treatment of breast 
cancer, and theoretically draws on phenomenology (Husserl, 1970) and symbolic 
interactionism (Blumer, 1969).  
 The thesis comprises three separate studies to investigate patient experiences of 
SDM, based on a triangulation of in-depth qualitative methods, which explore patient 
perceptions and interactions. Study one, a semi-structured interview design with post-
treatment patients, identifies themes in accounts of SDM by means of a thematic analysis. 
Study two, explores SDM further through a thematic analysis on patient interaction within 
Internet breast cancer support forums. Study three, discusses the experience of SDM 
through a conversation analysis on doctor-patient interaction during adjuvant treatment 
consultations.  
 Results indicate that for most patients, SDM is understood in accordance with the 
NICE guidelines (2004 & 2012), and is experienced through the characteristics of two-way 
interaction, information exchange (‘sharing information’), and sharing of views and 
preferences (‘sharing decisions’), in respect to individual differences. SDM is also 
experienced during online interaction. The forums make patients aware of SDM, and 
encourage it to occur during consultations. However, the construction of power, as a 
clinical problem, results in problematic experiences of SDM. A perceived discrepancy in 
clinician-patient roles and discursive practices creates an issue of unbalanced doctor-
patient power-relations. This deters patient participation and patients’ recognition and 
response to SDM. The research contributes to qualitative research and critical health 
psychology. It has implications for medical professionals to understand patient experience 
of SDM, and to improve doctor-patient communication skills for SDM, for the 
development of breast cancer services to promote patient good health and well-being. 
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 Chapter 1 
 
Breast cancer and SDM: introducing the research question 
 
 
1.1 Introduction  
At some point in our lives, we may encounter the task of making a decision. Not so long 
ago, I was faced with a scenario which involved me talking to a friend who was 
deliberating about a personal dilemma, regarding health issues. She had to make a 
confusing decision. My response to her was, “just decide…it’s not like it’s a matter of life 
or death”.  This is a phrase we may commonly use after patiently listening to a person 
describing their problem. We say this, presumably, as a well-intentioned way of 
encouraging the troubled problem solver to feel a little less anxious, a little more hopeful 
that life will go on, and that the future will be better.  But was I right? Are all health-
related decisions really not a matter of life or death? For example, there are many 
individuals who are diagnosed with life threatening illnesses, and are subsequently faced 
with the complex dilemma of making an appropriate treatment decision. For some people, 
the task of decision-making may be non-existent, as they might believe that a treatment 
choice should be ultimately decided by medical professionals. For others, the responsibility 
for the decision may be more personal and, perhaps, fuelled by fears of recurrence, feelings 
of anxiety, distress over side-effects, and the effects on loved ones. All of these are 
concerns which further add to the complexity of the decision-making task.  
 It was during my Masters Research project, which involved exploring levels of 
distress amongst cancer patients, that I became more aware of the heightened emotional 
distress and decision-making complexities surrounding cancer. Subsequently, this inspired 
my further research ambitions, which were to take a more focused examination of the 
decision-making processes, encountered by the cancer patients during treatment. Although 
much of my previous research had been conducted among patients with a range of cancer 
types, I decided to focus specifically on breast cancer for the purpose of a PhD thesis. 
During my Masters, I began to learn about the many difficulties that breast cancer patients 
face regarding treatment choices, such as worrying about body disfigurement and 
heightened levels of distress regarding treatment. This became a personal motive for 
focusing on decision-making relating to breast cancer. With existing collaborations already 
in place between the Cancer Centre at the University teaching hospital and the School of 
Chapter One 
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Psychology at Keele University, this provided an appropriate opportunity for this research 
to take place.  
 At the outset, it is important to gain a better understanding of the disease in 
question and a clearer scientific rationale for the research project. In order to facilitate a 
reading of this thesis, a glossary of terms and a dictionary of abbreviations are given in 
Appendix A. 
 
1.2 Breast cancer 
Breast cancer is a disease in which malignant (cancer) cells form in the tissues of the 
breast. Although the disease occurs amongst men, it is, however, most commonly found in 
women over the age of 35 (Office for Cancer Statistics, 2007). The precise reasons why 
women develop breast cancer are still unknown. Neither socio-economic status nor 
demographics such as age, gender, and ethnicity have been shown to provide a normative 
basis for causation. It is thought to be a combination of genetic, environmental, and 
lifestyle factors (National Institute of Environmental Health Science, 2010). The National 
Health Service (NHS) referral system indicates that all patients, suspected of having breast 
cancer, must be seen by a hospital specialist within two weeks of an urgent referral by their 
general practitioner (GP) (Department of Health, DOH, 2010a). The treatment process is 
under rigid time constraints as, according to guidelines, clinicians have a 31 day timescale 
from diagnosis to completing treatment (DOH, 2010b). It is during this narrow time frame 
where information and supportive care is consistently provided by external support groups 
and educational material, and communicated by medical professionals to guide the patient 
through queries, emotions, and treatment decision-making. 
 Effective doctor-patient communication skills are increasingly considered as an 
important factor in helping patients cope with breast cancer (Cassileth, 1980; Coulter, 
1998; Ford, Fallowfield & Lewis, 1995; Fallowfield, Ford & Lewis, 1995; Meredith et al, 
1996). Breast cancer patients value effective communication, because they recognise it as 
central to a therapeutic doctor-patient relationship (Back, Arnold, Tulsky, Baile, Fryer-
Edwards, 2003). However, doctor-patient communication in breast cancer care can be 
particularly challenging, due to fear and stigma associated with the illness, complexity of 
medical information, and uncertainty about the course of the disease (Siminoff, 1992). 
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Therefore, clinicians need to acquire the right skills to adapt communication, which takes 
contextual, cognitive, and emotional barriers into account; and offers patients information 
and choice (Tattersall, Butow & Clayton, 2002). Regular attendances of communication 
skills training programmes, which are largely influenced by ideas arising from patient-
centred medicine, psychotherapeutic communication, informed consent, and shared 
decision-making (SDM), are now a necessary part of breast cancer care (Makoul, 2001).  
 As with most cancers, the key to successful treatment requires early diagnosis. The 
NHS Breast Screening Programme (NHSBSP, 2009) in the UK allows for the early 
detection of breast cancer at an early stage, before symptoms or signs develop, such as a 
lump. The programme invites all women aged between 47 and 73 for screening every 3 
years, through the use of mammograms (low-dose x-rays) to each breast. This has shown 
to lower mortality rates in breast cancer in the 55-69 age group.  
Following detection of breast cancer, management and treatment of the diagnosis requires 
a team effort, provided by a number of specialists, surgeons, oncologists, and breast care 
nurses. Although there is no single treatment for breast cancer, the treatment path still 
remains very specific, with options depending on several factors, such as the stage of the 
tumour (how far it has spread) and whether there is secondary cancer; the receptor status of 
the breast cancer; the patient’s fitness and well-being; and the patient’s own wishes 
regarding treatments. According to the National Institute for Health and Care Excellence 
(NICE, 2009), the first treatment for most women with breast cancer is usually surgery, 
and depending on the size of the breast lump, patients will have either a lumpectomy or a 
mastectomy. With new technologies, it is possible to restore the appearance of the breast 
with reconstructive surgery during a mastectomy. The advice of the NICE guidelines for 
early and advanced breast cancer (2009), states that after surgery for breast cancer, all 
women should be advised to undertake follow-up adjuvant treatments, which consist of 
either radiotherapy, chemotherapy, hormone treatment, or a combination of all three. These 
treatments can help to reduce the chance of the cancer cells reoccurring or spreading. The 
treatment or combination of treatments that patients choose, not only depends on their 
diagnosis and type of surgery, but could also be influenced by the roles that they and their 
clinician take during consultations for treatment decision-making. On completion of all 
treatments, patients are required to undergo regular check-ups and mammograms to 
monitor the breast and the cancer cells (NHS Breast Screening Program, 2009). 
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1.3 Breast cancer and medical decision-making 
During the diagnosis and treatment for breast cancer, women may often be faced with 
making complex decisions about surgical and adjuvant treatments. Information describing 
treatment options can be complex, and the decision comes at an emotionally charged time 
when communication and thought processing can be difficult to structure. Despite being 
presented with choices for treatment, many patients believe they have little control over 
their decisions and find it difficult to manage health decisions (Fallowfield, Baum, & 
Maguire, 1986; Royak-Schaler, 1991). For example, it can be difficult for some patients to 
make a decision about something that is very important to them, in respect to the physical 
side-effects which may come as result of that treatment choice. Patients may feel 
overwhelmed with all the information given, and possibly feel pressured by the opinions of 
relatives and friends over their decision. There may also be a degree of uncertainty which 
comes with the task of making decisions about treatment, as patients could feel anxious, 
angry, irritable, or frightened about making the right decision. Subsequently, treatment 
decision-making for breast cancer patients is recognised to be an inherently stressful 
process (Wainstock, 1991), which can impact patients’ psychological well-being (Degner, 
Kristjanson & Bowman, 1997; Moyer & Salovey, 1998), and result in psychological 
diagnoses such as distress and anxiety (Akechi, Okuyama, Imoto, Yamawaki & Uchitomi, 
2001; Burgess et al, 2005; Grabsch et al, 2006; Okamura, Watanabe, & Narabayashi, 
2000). These negative psychological consequences are reportedly severe enough to also 
affect subsequent quality of life (QOL) (Montazeri, 2008; Skarstein, Aass, Fossa, 
Skovlund & Dahl 2000), cause poorer adherence to treatment recommendations (Kennard 
et al, 2004), and result in poorer survival (Steel, Geller, Gamblin, Olek & Carr, 2007).  
 As a result of such findings on the psychological burden of medical decision-
making, research within the field of health psychology has taken a growing interest in 
exploring the process of decision-making and associated health behaviours. This had led to 
the development of many normative and descriptive models and theories of decision-
making (discussed in Chapter Two), which focus on describing strategies to explain how 
patients look at choice and decision-making in the medical context. These models have 
been recognised through an exploration of the patient role and patient levels of 
participation in decision-making, which illustrate a medical shift from thinking about 
patient care and treatment decisions in terms of disease and pathology, towards thinking in 
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terms of people and their problems through established relationships (Emanuel & Emanuel 
1992). 
 Patients are slowly being regarded as consumers, who expect to be involved in their 
medical care (Coulter & Jenkinson, 2005; Degner et al, 1997; Magee, Davis & Coulter 
2003).  This is evident in various NHS reports by the DOH on patient centred-care (DOH, 
2008 & 2010c), which focus on the need for more active patient participatory roles, 
without the expense of depleted emotions and psychological well-being. Good doctor-
patient communication and accurate information during a consultation, is regarded as 
highly fundamental to the delivery of high quality cancer care, and an important 
prerequisite for a successful move towards increased involvement in decision-making 
(Brennan, 1997; Fallowfield & Jenkins, 1999; Katz, 1984; Scott et al, 2003; Simpson, 
1981). As a result, the preferred model of medical decision-making is moving away from 
approaches which perceive patients as passive spectators in their own healing process 
(Charles, Gafni & Whelan, 1997), and towards a more shared approach (Elwyn & Charles, 
2009). Subsequently, this has given rise to the practice of SDM, which is incorporated into 
many government policy documents. Such documents highlight SDM as ‘standard 
practice’ by all medical practitioners, across all hospitals and GPs in England for all 
treatments (DOH, 2010; NHS constitution, 2013; NICE, 2004).  
 SDM is a dynamic process in which patients and doctors influence each other 
through two-way interaction (Fochsen, Deshpande & Thorson, 2006). SDM involves a 
partnership between doctor and patient that is based on a division of labour, whereby the 
clinician provides enough knowledge and information for the patient to make an informed 
decision (Beaver et al, 1996; Charles et al, 1997; Elwyn & Charles, 2001 cited in Edwards 
& Elwyn, 2001; Towle & Godolphin, 1999). SDM is increasingly recognised as an ideal 
model of treatment decision-making in the medical encounter (Brock & Wartman, 1990; 
Deber, 1994; Emanuel and Emanuel, 1992). Regarding the treatment of breast cancer, this 
involves ‘preference-sensitive’ care. The term ‘preference-sensitive’ care implies that 
legitimate treatment options exist, and that decisions about these interventions should 
reflect patients’ personal values and preferences, and should be made only after patients 
have enough information to make an informed choice, in partnership with the clinician. 
Consequently, as a result of the nature of breast cancer care, the NICE guidelines (2004 & 
2012) state that it is essential that decision-making approaches, during treatment choice, 
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acknowledge patients’ informed values and support their involvement in ways which 
sustain psychological well-being and health outcomes. A review of the literature reveals 
that SDM has become the preferred approach to treatment decisions for breast cancer, 
between patients and clinicians (Fallowfield, Hall, Maguire, & Baum, 1990; Gafni, 
Charles, & Whelan 1998; Guadagnoli & Ward 1998; Moyer, 1997; Silliman, Dukes, 
Sullivan, & Kaplan, 1998; Street & Voigt, 1997). This will be discussed in more detail in 
the next section (1.4) of this chapter.  
 
1.4 Breast cancer and SDM: what is already known about research in this area? 
There is a substantial amount of existing literature on SDM and breast cancer. This 
research focuses largely on exploring breast cancer patients’ levels of involvement in 
decision-making (Dominick, Frosch, Robert & Kaplan, 1999; Guadagnoli & Ward, 1998; 
Hawley et al, 2007; Street, Voigt, Geyer, Manning & Swanson, 1995), and the long-term 
effects that treatment decision-making can have on women’s QOL (Andersen, Bowen, 
Morea, Stein & Baker, 2008; Katz et al, 2005). These and other studies have highlighted 
factors which can impact decision-making and patient participation (Degner & Sloan, 
1992; Lerman et al, 1990). For instance, one of the main obstacles to patient participation 
is due to a lack of patient knowledge about their illness (Coulter & Ellins, 2006). 
Therefore, it has been suggested that the quality of information provided by clinicians, is 
important in helping women cope with breast cancer (Degner et al, 1997). A second factor 
suggested by authors is good doctor-patient communication skills during a consultation, as 
this has been demonstrated to be fundamental to the delivery of high quality cancer care, 
and in enabling patient involvement in decision-making (Fallowfield & Jenkins, 1999; 
Katz, 1984; Simpson, 1981). These findings, therefore, suggest the importance of 
conversation, as a method to further explore health-related decision-making. Finally, there 
are arguments that support the impact of patients’ participatory roles; for example, if they 
are ‘active’ or ‘passive’ in their care, on levels of participation which take place for 
treatment decision-making (Cahill, 1996; Caress, 1997; Greenfield, Kaplan, & Ware, 1985; 
Guadagnoli & Ward, 1998; Sutherland, Llewellyn-Thomas, Lockwood, Tritchler, & Till, 
1989).  
 Although research illustrates that most patients desire participation in treatment 
decisions, (Benbassat, Pilpel & Tidhar, 1998;  Blanchard, Labrecque, Ruckdeschel, & 
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Blanchard, 1988; Deber, Kraetschmer & Irvine, 1996; Ende, Kazis, Ash & Moskowitz, 
1989; Sutherland et al, 1989), and have shown improved medical outcomes by maintaining 
an ‘active’ role in their health care (Frosch & Kaplan, 1999; Kaplan, Greenfield & Ware, 
1989; Stewart, 1995; Waterworth & Luker, 1990), a contrary argument is that not everyone 
wants to participate to the same degree. There are proposed arguments which indicate that 
patients, with a variety of chronic illnesses, prefer a ‘passive’ or collaborative role to an 
‘active’ role in making treatment decisions (Arora & McHorney, 2000; Beaver et al, 1996; 
Blanchard et al, 1988; Degner & Sloan, 1992; Degner et al, 1997; Sutherland et al, 1989). 
This finding has also been observed in breast cancer patients (Beaver et al, 1996). These 
findings, therefore, suggest the importance of exploring patient perceptions and views, as a 
method to further explore health-related decision-making. 
 In exploring the health literature, in relation to breast cancer and SDM, research 
demonstrates attempts to provide greater descriptions of SDM between the patient and 
clinician (Charles et al, 1998; Elwyn, Edwards, Kinnersley, 1999b; Frosch & Kaplan, 
1999; Gattellari, Butow, Tattersall, 2001; Towle, 1997). These studies and others, have 
focused on evaluating the benefits of SDM for breast care patients such as, improved  
health outcomes (Hack, Degner, Watson & Sihna, 2006; Janz et al, 2004; Mandelblatt, 
Kreling, Figeuroedo & Feng, 2006; Moyer, 1997; Silliman et al, 1998; Street & Voigt, 
1997); adherence to treatment (Desroches, Lapointe & Deschenes, 2011); enhanced coping 
strategies (Vodermaier et al, 2001); improved patient satisfaction with care (Scheibler, 
Janssen & Pfaff, 2003; Swanson, Bastani, Rubenstein, Mereditch & Ford, 2007); an 
increase in patient autonomy and confidence (Joosten, De Jong, de Weert-van, Sensky & 
van der Staak, 2011); and improved satisfaction with care for partners and family members 
(Zeliadt et al, 2011).  
 There is also evidence of research which explores barriers and facilitators to 
implementing SDM within breast cancer care. Such research tends to focus on evaluating 
specific tools or competencies, such as information aids to help patients and professionals 
interact more effectively; or structured checklists to support a SDM process (Loh, Simon, 
Hennig, Harter & Elwyn, 2006; O’Connor, Llewellyn-Thomas, & Flood, 2004). The 
purpose of such research is to introduce initiatives which can train professionals on their 
knowledge and practice of SDM, and to try and improve breast cancer services. However, 
not all research on SDM with breast cancer care is positive, as studies have also revealed 
barriers to the implementation of SDM in practice. It has been suggested that this is due to 
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patients lacking adequate information, poor interactive relationships between patients and 
clinicians, and time/resource pressures (Barry & Edgman-Levitan, 2012; Elwyn, Frosch, 
Thomson, Joseph-Williams, & Lloyd et al, 2012; Kleeberg, Feyer, Günther, & Behrens, 
2008; Légaré, Ratté, Gravel & Graham, 2008; Légaré & Witteman, 2013). These findings, 
once more, indicate the importance of conversation, as a method to explore health-related 
decision-making. 
 The existing literature on SDM and breast cancer, as outlined above, shows that the 
topic is an explored area of health research. However, these studies often only focus on 
evaluating and describing characteristics of SDM, through methods which often forget to 
ask the most basic questions such as, what does the concept of SDM actually mean to the 
patients, and how is it experienced by patients? We know that every patient has the right to 
take part in his or her care and the related decision-making (Act on the status and rights of 
patient 1992), but to what extent is the realisation of this right meaningful, or even known 
to patients? No existing research has examined this directly in relation to breast cancer 
care. There is also no literature devoted to exploring the real meaning, role, and process of 
SDM, through investigation of patients’ encounters and perceptions; and through the 
conversations that patients engage in regarding decision-making for treatment. As 
discussed above, the existing literature provides awareness of what SDM is and how it 
operates within breast cancer care. However, to fully understand the processes involved, an 
enquiry into how SDM is encountered by breast cancer patients, using methods which aim 
to capture and explore the patients’ perspectives, experiences, and interactions across their 
treatment trajectory, is required. This is an area of research which is limited within the 
decision-making and breast cancer health literature. With demands for new strategies and 
increasing guidelines within the cancer care systems, there is a gap in the literature on 
SDM for breast cancer patients. 
 
1.5 What is the remit of this thesis? 
This thesis aims to explore how women with breast cancer experience SDM through their 
treatment journey. In addition to the general research question, there are additional 
questions: 
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 What does the concept of SDM mean to women with breast cancer, and what are 
the characteristics of SDM? 
 How is the experience of SDM influenced (hindered or facilitated) for women with 
breast cancer? 
 Can SDM for breast cancer be explored qualitatively, through examining patient 
perceptions and conversations? 
Patient experience of SDM is explored in two ways: through an exploration of breast 
cancer patient encounters and perceptions; and an exploration of breast cancer patients’ 
interactions (conversations with clinician, and with other patients). The research questions 
are explored through a theoretical framework informed by phenomenology and symbolic 
interactionism (discussed in Chapter Three). Subsequently, this deploys to qualitative 
research, which is the methodology used throughout the thesis. Figure 1.1 provides an 
illustration of how the research questions will be explored. The thesis aims to answer the 
research question through a triangulation of methods, in three distinct qualitative studies. 
This qualitative method of exploring patient experiences and SDM is the first to be 
accounted for within the health literature for the treatment of breast cancer. The first study 
aims to retrospectively explore individual patients’ perspectives, understanding, and 
encounters of SDM within their treatment, through semi-structured interviews. This will 
provide a comprehensive insight into patient experience of SDM, from the viewpoint of 
patients who are post-treatment completion. The second study further explores SDM, 
however, from patient interaction. Through a method of examining the conversations that 
patients have with other breast cancer patients, during online forum interaction, a thorough 
insight into patients’ experience of SDM will be provided. The final study explores SDM 
and encounters on part of the patient, through an analysis of the interactions and 
conversations which take place between doctor and patient, during breast cancer 
consultations. The exploration of doctor-patient communication will provide additional 
knowledge about the presence of SDM and how it is displayed through talk. All three of 
the studies will aim to uncover insight into the additional questions raised about the 
meaning and characteristics of SDM; and how patient experience of SDM can be influence 
(hinder or facilitate).  
 All three of these methods of investigation on the topic of SDM for breast cancer 
have not been documented in any of the existing literature. Therefore, an overall distinctive 
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feature of this thesis is that it looks at SDM for the medical treatment of breast cancer, 
from the patients’ experience and interactions. As outlined in the questions above, one of 
the aims of this thesis is not only to explore the research topic, but to examine how this can 
be achieved through various qualitative methods and theoretical frameworks. Therefore, 
the research question is investigated through three different qualitative methods, as shown 
in Figure 1.1, which focus on exploring SDM from both patient viewpoint and interactions. 
 
 
Research question: How women with breast cancer experience SDM 
   Methodology:    QUALITATIVE  
 
    Thesis design:    Patient experiences / perceptions              Conversations 
 
    Theoretical  
    Frameworks:  (Phenomenology)        (Symbolic interactionism)     
                                                  
  
 
     Method 
          & 
    Analysis:  
 
 
 
 
  
 
 
Figure 1.1 Diagram to explain the thesis research questions and how it will be examined 
 
The content of the thesis is as follows: 
Chapter Two reviews the literature in health psychology regarding medical decision-
making and SDM. The aim of the literature review is to provide an understanding of the 
concept of SDM in relation to medical models of decision-making. 
Study 2: Internet forum 
interaction: peer to peer 
communication  
Written BC forum data  
Thematic Analysis 
Study 3: Consultation 
interaction: doctor-patient 
communication 
Audio-recordings of BC 
consultations 
Conversation Analysis 
Study 1: Semi-
structured interviews  
BC patients’ interview 
transcripts 
Thematic Analysis 
*note ‘BC’ stands for breast cancer 
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 Chapter Three identifies the theoretical underpinnings of the thesis, and provides a 
justification for exploring both the general and additional questions raised. Phenomenology 
and symbolic interactionism are introduced as theoretical frameworks, and discussed in 
relation to qualitative research and previous literature on SDM, and breast cancer 
 Chapter Four opens with a literature review which introduces the qualitative 
method of interviews, as a way to explore patient perceptions and experiences, to further 
understand about patient experience of SDM. The literature review also provides the 
rationale for study one. This study aims to explore retrospective accounts of patients’ 
views and experiences of SDM during the course of their treatment for breast cancer. 
Following the literature review, the chapter describes the methods used for data collection, 
which consisted of qualitative semi-structured interviews with patients who were two years 
post-treatment. The interviews offered an opportunity for participants to reflect and to talk 
about their views and experiences of SDM, and to describe their understanding of SDM. 
The procedure used for participant recruitment, data collection, and data analysis are 
described in the chapter. The findings from the interview transcripts are then presented 
using a thematic analysis (TA). The chapter outlines the key themes derived from the 
analysis, supported with interview extracts to illustrate them. The chapter concludes with a 
discussion of the findings. 
 Chapter Five opens with a literature review which introduces the potential of 
Internet/ online research, as a way to explore patient conversations, to further understand 
about patient experience of SDM. The literature review also provides the rationale for 
study two. This study aims to explore SDM through investigating the interactions that take 
place between patients, within online breast cancer forums. Following the literature review, 
the chapter describes the methods used for data collection. Data collection of written posts 
from online breast cancer support forums, offered an opportunity to explore SDM within 
an online patient membership community. Exploring interaction within the forums allowed 
for further insight into how SDM is experienced and understood, in both clinical and non-
clinical settings. The findings from the forum discussion threads are then presented using 
TA. The chapter outlines the key themes derived from the analysis, supported with online 
forum extracts. The chapter concludes with a discussion of the findings.  
 Chapter Six opens with a literature review which introduces the potential of doctor-
patient communication research and conversation analysis (CA), as a way to explore 
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patient conversations, to further understand about the concept of SDM. The literature 
review also provides the rationale for study three. This study aims to explore SDM through 
investigating the conversations which take place, between patient and clinician, during a 
breast cancer consultation. Following the literature review, the chapter describes the 
methods used for data collection which consist of tape recordings of adjuvant treatment 
consultations. Exploring interaction from the audio-recordings offered an opportunity to 
gain deeper understanding about the characteristics and presence of SDM, during clinical 
interactions. This provided an opportunity to explore whether factors, such as conversation 
techniques and doctor-patient relationships, facilitate or hinder patient encounters of SDM. 
By means of a CA, the findings from the tape recordings are accounted for in terms of 
linguistic practices, which impacted upon shared conversations, and are supported by 
extracts from the recordings. The chapter concludes with a discussion of the findings.  
 Chapter Seven combines all three studies to discuss how the findings, from all three 
stages of data collection, can contribute to understanding how SDM is experienced by 
breast cancer patients. The discussion also reviews the additional questions to answer what 
the concept of SDM means to patients, and what the characteristics of SDM are; how 
patient experience of SDM can be influenced (hindered or facilitated); and whether SDM 
for breast cancer should be explored qualitatively, through examining patient perceptions 
and conversations. The findings and the use of qualitative research are discussed in relation 
to their contributions and implications for future health research and cancer care.  
 This provides an introductory overview of this thesis, but now it is important to 
consider the questions that have been raised. The first step is to review the literature in 
more detail to consider what is already known about medical decision-making, and to see 
what existing literature can contribute to understanding how women with breast cancer 
experience SDM. The next chapter provides a literature review on the psychology of 
decision-making and health-related decision-making, in association with SDM. 
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Chapter 2 
Breast cancer and medical decision-making: from a paternalistic model  
to a patient-centred approach 
 
2.1 Introduction 
The previous chapter provided an overall introduction to the thesis, and outlined the 
rationale as to why it is important to further explore SDM within breast cancer care. As 
emphasised in Chapter One, this thesis is primarily concerned with exploring how women 
with breast cancer experience SDM during their treatment. As the underlying topic under 
investigation is associated with health-related decision-making, it is important to explore 
the literature surrounding the psychology of decision-making. This chapter will explore 
research on decision-making in the medical setting, in relation to theoretical models of 
decision making. 
 
2.2 Decision-making theories and models 
Decision-making is a process which involves the selection of a preferred option or a course 
of actions from a set of alternatives (Wang, Wang, Patel & Patel, 2004; Wilson & Keil, 
2001). Research on decision-making concentrates on explaining how people make choices, 
and describes the cognitive processes that underlie the choices. Decision theories and 
existing research on choice is widely applied in many disciplines such as, computer 
science, economics, sociology, psychology, political science, and statistics. For the purpose 
of this thesis and chapter, exploration of the existing research will be based on decision-
making in the discipline of health psychology.  
 
 Understanding the types of decisions made and the factors that influence an 
individual’s decision-making process, is an important area of exploration.  Within the 
discipline of psychology, strategies have been described to explain the process of decision-
making for individuals when faced with having to make a choice between several options. 
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Decision research has traditionally been categorised across two paradigms: normative and 
descriptive theories. 
 
2.2.1 Normative models  
Normative issues focus on how decisions be made best. It explores theories of formal logic 
and probability through the implementation of decision analysis, such as cost-effectiveness 
analysis. This is a particular type of decision analysis in which economic outcomes are 
analysed in addition to health outcomes, and the cost of achieving those additional health 
benefits is determined.  
 There are typical examples of normative theories. One is the Expected Utility 
Theory (EUT) (Bernoulli, 1738) which states that decision-making is achieved through a 
process of balancing risk versus rewards, using a mathematical function. Another is the 
Bayesian Theory (Bayes, 1763), which provides a mathematical framework for performing 
inference, or reasoning, using probability. The Decision Theory involves mathematical 
strategies for optimal decision-making between options involving different risks or 
expectations of gain depending on the outcome. Finally, the Games Theory (Von Neumann 
& Morgenstern, 1947) is a mathematical method of decision-making in a competitive 
situation, where the outcome of choice crucially depends on other participants’ actions. 
Within these normative theories, the mathematical model of decision-making is 
highlighted and widely used in determining rational, heuristic, and intuitive selections in 
complex situations, as well as in daily life procedures. 
 
2.2.2 Descriptive models 
Where normative theories consist of rationalistic components that indicate how decisions 
should be made, the descriptive theories alternatively study the psychological or social 
processes of decision-making (i.e. how are decisions actually made). The model is based 
on empirical observation and on experimental studies of choice behaviours. Descriptive 
models use cognition to explain decision-making, and use decision-making models to 
illustrate how decision makers analyse a number of possible alternatives from different 
scenarios before selecting a choice. Stein and Welch (1997) argued that cognitive 
psychology is useful in that it provides tools for analysing simple rules people use in the 
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process of reacting to complex dilemmas. As a result, research on cognitive decision-
making aims to understand the cognitive processes which underlie human judgment.  
 Cognitive theories of decision-making are attentive to individual variances and 
methods of simplification, through which people process information and interpret their 
surrounding environments. An important approach in cognitive psychology is the 
Information Processing Theory (Miller, 1956). Research in cognitive psychology initially 
focused on the information processing approach to decision-making, which is primarily 
concerned with understanding controllable conscious processes. This model of decision-
making can be traced back to Simon (1955) and the notion of bounded rationality, that is, 
humans are constrained by the environment (e.g. information costs), and in the mind (e.g. 
limited memory); these constraints shape people's behaviour. Over the years, newer 
cognitive models of decision-making were introduced such as, the Attribution Theory 
(Heider, 1958) which highlights the importance of schemata in determining how people 
interpret new information based on their pre-existing beliefs. There is also the Adaptive 
Decision Maker Framework (cited in Broder, 2003), which is concerned with preferential 
choice problems. This framework focuses on how individuals choose between different 
courses of action, in particular, in choice situations where no single alternative is best for 
all attributes. The framework argues that preferential choice problems are generally solved 
through a process of information acquisition and evaluation about the alternatives and their 
attributes.  
 
 Cognitive theories within psychology have also explored the relationship between 
attitudes and behaviour in the task of decision-making. This has led to the Theory of 
Reasoned Action (TRA) (Ajzen & Fishbein, 1980), which is particularly influential in the 
field of decision-making regarding health-related behaviour and social influence. This is a 
model based on behavioural intention, and highlights that the primary determinant of 
behaviour is the person’s intention (as well as attitudes towards the behaviour and 
perceived social norm regarding the behaviour). Ajzen (1988) proposed an extension of 
TRA which was the Theory of Planned Behaviour (TPB). According to Ajzen, a person’s 
perceived behavioural control (skills, ability, information, and emotions) reflects their 
beliefs about factors that may inhibit or promote the performance of the behaviour. TRA 
and TPB have been applied to a wide range of decisions about health-related behaviours, 
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for example, smoking initiation, condom use, oral contraception, and participation in 
exercise.  
 Similar to normative models of decision-making, an important element of cognitive 
theories of decision-making is heuristics (Kahaneman, Slovic & Tversky, 1982). Cognitive 
theorists argue that there are ranges of simple strategies (heuristics) that can save on 
cognitive effort and assist decision-making.  According to Gigerenzer (2004), heuristics 
are simple relative to human capacities; allow fast and frugal judgements; can be easily 
understood and taught to a novice; and can be generalised to new situations.  There are 
certain models to explain this approach. One is the Single-Feature Model or Lexographic 
Strategy, which requires ignoring other variables and focuses purely on a single important 
attribute. Another is the Additive Feature Model (Simon, 1955), which takes all the 
important features of the possible choices into account, and then systematically evaluates 
each option to determine which option has the highest rating. Finally, the Elimination by 
Aspect Model (Tversky, 1972), evaluates each option one characteristic at a time, 
beginning with whatever feature you believe is the most important, until you cross all 
possible items off and eventually arrive at just one alternative. These models have been 
suggested to be useful techniques in helping individuals to determine the best option 
amongst a variety of choices, and minor everyday decisions (Broder, 2000 & 2003; Payne, 
Bettman & Johnson, 1993). This argument is further supported by Simon (1957) who 
stated that heuristics are satisfying procedures for making inferences and decisions, and 
that being satisfied allows for more optimism and higher life satisfaction  (Schwartz et al , 
2002).  
 Descriptive theories have explored decision-making in relation to risky and 
uncertain choices. Risky decisions are those where the probabilities of the various possible 
outcomes are objective or unknown. Uncertainty occurs when the decision-maker has to 
estimate the probabilities of the various outcomes happening. The Prospect Theory 
(Kahneman & Tversky, 1979) provides an analysis of probabilistic decision under risk.  It 
is known as a prescriptive approach, as it is concerned with how to get people to act more 
normatively. This area of work is called decision-analysis.  Similar to the EUT, the 
Prospect Theory states that people make decisions based on the potential value of losses 
and gains, using certain heuristics. However, it provides a more accurate description of 
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decision-making in comparison to the EUT, and it tries to model real-life choices rather 
than optimal decisions.  
 Many of the existing descriptive models of decision-making, outlined above, 
assume there is a single system of thought that produces preferences. However, research 
also signifies that preferences are formed from a dual process/system of reasoning 
(Damasio, 1994; Sanfey, Loewenstein, McClure & Cohen, 2006). Dual-process Theory 
(Mukherjee, 2010) postulates that there are two fundamentally different systems that can 
process information. One system is described as automatic, intuitive, fast, and experiential. 
The other is labelled as deliberative, analytical, slow, and rational. Both systems are 
identified as having functionally distinct roles that differ according to the type of 
information encoded, and vary according to the level of expressible knowledge, which 
results in different responses. Research has shown that dual-process accounts are often 
more successful at explaining behavioural phenomena than unitary approaches 
(Kahneman, 2003). 
 It is therefore apparent that choice represents the core characteristics of decision-
making, and that decision-making involves the processes of thinking, reacting, 
comprehending expectations, and evaluation. Descriptive and normative theories are 
evident within the health psychology literature, and aim to explain, conceptualise and 
discuss the meanings of values, beliefs, and behaviours for decision-making amongst 
individuals.  For example, normative theories for cognition aim to tell us how we, ideally, 
should reason, make judgments, and make decisions. They give us rules to follow that 
supposedly make our thought rational. Descriptive theories in psychology try to describe 
how people actually think. Descriptive results, which show that people are out of line with 
a suggested normative rule, conclude that their thinking is fallacious or biased. The next 
stage of the chapter discusses decision-making in relation to health-related research and 
medical decision-making. 
 
2.3 Models of medical decision-making 
 
Within the context of health, decision-making can be a complex and essential part of 
medical care for both the medical professional and the patient. Medical professionals need 
to understand what is wrong with the patient, and then suggest the most appropriate form 
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of treatment. Patients need to decide whether they wish to seek medical care, and to 
consent to having the treatment the medical expert has recommended. In the context of 
breast cancer, many treatment recommendations are based on increasingly complicated 
clinical algorithms. For example, adjuvant treatments are commonly given to women with 
breast cancer following breast surgery, as results of clinical trials having shown that 
treatments, such as chemotherapy, decrease cancer recurrence (Abe et al, 2005; Early 
Breast Cancer Trialists’ Collaborative Group-EBCTCG, 2005). For many patients, the 
decision to opt for such treatment, or to opt out, can possibly be a challenge and may create 
a dilemma. On the one hand, opting in means that the risk of cancer recurrence may 
become small; conversely, undergoing adjuvant chemotherapy can have large adverse side-
effects on the patient’s QOL during treatment (Levine, Gafni, Markham & MacFarelane, 
1992; Shapiro & Recht, 2001). In a given scenario like this, there is no right or wrong 
answer in treatment choice. However, the process of deciding should involve the act of 
deliberation, similar to the EUT, whereby potential morbidity and negative side-effects are 
weighed up against the potential reduction, in both morbidity and inconvenience (NICE, 
2009). Research indicates that patients are often faced with different options and decisions 
about the type of surgery they receive (Lantz, Janz, Fagerlin, Schwartz & Liu, 2005); the 
use or avoidance of radiation (Jansen, Otten, van de Velde, Nortier & Stiggelbout, 2004); 
and the use of follow-up care (Andersen & Urban, 1999).  
 The burden of involvement in decision-making has been described to likely cause 
patients to experience decisional conflict. For example, 66% of women with early-stage 
breast cancer reported feeling uncertain about whether to choose a mastectomy or a 
lumpectomy with radiation therapy (Collins et al, 2007). Another study indicated that 43% 
of patients, with advanced breast cancer, were uncertain about whether to receive end-of-
life care at home or in a health care institution (Murray, O’Connor, Fiset & Viola, 2003).  
There are arguments that support patients choosing their own treatments (Longtin et al, 
2010); however, a cancer patient’s ability to make the appropriate decisions about their 
treatment choices has arguably been described as limited, due to several factors that 
contribute to patients’ decisional conflict. For example, patients can feel a lack of clinician 
support for decision-making (Entwistle, Carter, Cribb, & McCaffery, 2010; Leo, 1999); 
have insufficient knowledge of the likely outcomes of their disease (Renzi et al, 2006); or 
lack information concerning the effects of alternative strategies on health outcomes (Leo, 
1999). Research also supports that some patients may be too ill, or too overwhelmed 
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emotionally to play a major role in deciding the right therapy (Heyland, Tranmer, 
O’Callaghan, & Gafni, 2003; Weeks et al, 1998). Furthermore, factors such as past health 
experience (Juliusson, Karlsson & Garling, 2005); cognitive biases (Stanovich & West, 
2008); age and individual differences (Bruin, Parker & Fischoff, 2007); belief in personal 
relevance (Acevedo & Krueger, 2004); and an escalation of commitment, can influence 
what choices people make, and add further difficulty in making decisions. Patients require 
a lot of time, effort, and mental energy to reach a conclusion. 
 
2.3.1 The application of normative and descriptive models of medical decision-making 
Across both descriptive and normative theories outlined previously, the components of 
these theories have provided a number of implications for how we look at choice and 
decision-making in the medical context. The application of decision-making theories to 
medical treatment decision-making often requires the measurement of health values 
(referred to as ‘utilities’) for health outcomes. These measurements have been explored in 
the medical context through normative methods. For example, the Game Theory has been 
used in research to provide an insight into the possible underlying dynamics of the doctor-
patient interaction (Tarrant, Stokes & Colman, 2004). The application of this theory to 
medical decision-making has provided a supplementary means to explain optimal rational 
strategies, in situations where the actual outcome depends on the choices of both the 
patient and the clinician (Diamond, Rozanski & Steuer, 1986).   
 The use of heuristics has also been applied to health-related decision-making. This 
allows health research to question the processes by which service users and carers make 
choices; to explore what important strategies used; and to examine what happens if the 
strategies used by the patient and professionals differ.  For example, Green and Mehr
 
(1997) illustrated the use of heuristics to medical decision-making, by developing the Fast-
and-frugal Tree for treatment allocation of coronary care. The resulting heuristic is shown 
in Figure 2.1 in the form of the fast and frugal decision tree for coronary care. This 
method is designed to ignore calculating all probabilities, and instead asks only a few yes-
or-no questions to help patients establish mental short cuts in reaching a decision. The 
model relies on three simple building blocks of heuristics: ordered search for information, 
a fast stopping rule, and one reason decision-making (Gigerenzer & Goldstein, 1996; 
Gigerenzer, Todd & the ABC research group, 1999). The model is ‘fast’ because it does 
Chapter Two 
 
22 
 
not involve much computation, and ‘frugal’ because it only searches for part of the 
information. Evaluation of the Fast-and-frugal Tree has shown that it is more accurate in 
classifying and correctly assigning heart disease patients to the appropriate coronary care, 
than both the clinicians’ intuition and the Heart Disease Predictive Instrument (HDPI) 
(Gigerenzer & Kurzenhauser, 2005). Furthermore, some medical researchers see the model 
as a powerful alternative to the prescription of classical Decision Theory for patient care 
(Elwyn, Edwards, Eccles & Rover, 2001).  Another model that has been increasingly used 
to address complex decision-making problems in health care is the EUT. Research by both 
Cohen (1996), and Ubel and Lownstein (1997), identified many strengths of this model in 
that, it allows for the integration of patient values with medical facts; it uses both 
information that only a patient possesses and probabilistic information; it closely resembles 
linear models, which have proven to be successful in judging and prediction; and the 
model can accommodate two conflicting probabilities by using one piece of information 
and then the other.  
Figure 2.1 Fast and frugal decision tree for coronary care (Green & Mehr, 
1997). Source: Gigerenzer & Kurzenhauser (2005), page 8 
 
 Descriptive models have also been applied to the study of medical decision-
making. For example, in a study by Gurmankin and Baron (2005), the Prospect Theory 
was illustrated to explain why subjects are more affected by differences among high 
probabilities than small ones, with regards to medical risk. Many scholars argue that the 
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Prospect Theory provides a framework, by which studies have been able to understand 
how patients assign values to health status, and seemingly make rational or irrational 
treatment decisions (Treadwell & Lenert, 1999). There are also arguments to support that 
the Prospect Theory is becoming a preferred and more utilised approach, to improve the 
prescriptive use of EUT for medical decision-making under uncertainty and risk 
(Bleichrodt, Pinto & Wakker, 2001).  
 The concept of perceived social norms, from the TRA, can be seen as relevant to 
many instances of health-related decision-making, where the attitudes of key people, such 
as medical professionals, are likely to influence decisions (Ajzen & Fishbein, 2008). 
Similarly, the TPB raises attention to individuals’ beliefs, values, and perceived control 
and explores how these affect choice making (Cote, Gagnon, Houme, Abdeljelil & 
Gagnon, 2011; Kasper et al, 2012). Consequently, both of these models have, therefore, 
been shown as relevant to medical decision-making. 
 Other descriptive theories such as the Information Processing Theory and the 
Attribution Theory, which emphasise the role of information in decision-making, may raise 
issues about access to information in a health setting. For example, the way information is 
provided and how that may facilitate or hinder a decision; how much information do 
patients have and actually use in making the decision; and supporting patient involvement 
in decision-making, by changing the amount of information received and the way it is 
provided. These areas of enquiry regarding information based from both theories, have 
subsequently provoked an increase in health research to focus on exploring the impact of 
information and communication in medical decision-making (Blanchard et al, 1988; 
Coulter, 1998; Degner et al, 1997; Robinson & Thomson, 2001; Strull, Lo & Charles, 
1984;). Finally, the Dual-processing Model has also been applied to medical decision-
making to shed better understanding of treatment decision-making, and to explain the 
widespread variation in treatments observed in clinical practice (Djulbegovic, Hozo, 
Beckstead, Tsalatsanis & Pauker, 2012). The model has also been used to identify 
individual differences in the cognitive processing between doctors that could inform 
strategies to change practice (Sladek, Phillips & Bond, 2006). 
 
 Although the models described provide a normative and descriptive theory for 
medical decision-making, it is important to note that deviance from these models is very 
common in medical decision-making. Patients’ values may not always conform to a 
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normative theory. For example, when considering risky options, people may not weigh the 
possible outcomes exactly according to their respective probabilities. The typical finding in 
support of this suggestion is that people overestimate low probabilities, and underestimate 
moderate and high probabilities (Dietrich, 2010). Therefore, measured health values may 
need to be adjusted prior to inclusion in a normative model. Furthermore, Fischhoff (2006) 
argued that systematic discrepancies from the normative model can result in biases and, as 
a result, elicit flawed conclusions about the treatment decision. Similarly, although 
descriptive models are useful when dealing with uncertainty, heuristics often lead to 
systematic errors that affect the quality and/or ethics of medical decisions (Thompson & 
Dowding, 2002). Hastie and Dawes (2001) suggest that good decisions are those in which 
the process follows the laws of logic and probability theory. Others have argued that it is 
not possible to identify, assign relative probabilistic weight to, and account for all aspects 
of risk, particularly in medicine and health care (Hammond, 2000). Attempts to do so 
provide an analysis that is only valid for one point in time with significant, unrepresented, 
and unaccounted bias. This has, therefore, led to the criticism of models of decision-
making which are based on a fixed universe of possibilities, whereby the ‘known’ is only 
considered and focus on expected variations, not on unforeseen events. For example, 
normative theories of decision-making rely on the quantification of risk in complete and 
known ways. Thompson and Dowding (2002) argue that this is not always possible, 
especially in health care decision situations that are characterised by incomplete 
knowledge of all available alternatives and there consequences; and have limited 
techniques for measuring patient utility (Thompson & Dowding, 2001). Chapman and 
Sonnenberg (2000) supports this argument further by suggesting that decision making, 
through the use of simplifying strategies such as heuristics and decision trees may not fit 
well in chaotic worlds, uncontrolled environments, or critical situations, and therefore, 
have an outsized impact during medical decision-making and for significant health-care 
events which must be considered. This line of argument, called the ludic fallacy, is that 
there are inevitable imperfections in modelling the real world by particular models, and 
that unquestioning reliance on models blinds one to their limits. 
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2.3.2 Models of medical decision-making 
 
With the growth in research aimed at exploring health-related decision-making, a number 
of medical decision-making models have been identified to describe treatment decision-
making. These models were developed through an exploration of doctor-patient 
relationships and communication. Existing research on patient participatory roles outlines 
that there is an asymmetry of information between the doctor and the patient (Fudge, 
Wolfe & McKevitt, 2008; Woolf et al, 2005). Such studies signify that the clinician can 
possess technical knowledge about the disease and the expected outcome of each course of 
action, compared to the patient who does not. As a result of such findings, research in the 
field of medical decision-making has subsequently focused on identifying a number of 
theoretical models of decision-making, which describe patient and clinician roles, as well 
as doctor-patient partnership in medical decision-making. These models of medical 
decision-making will now be explored individually. 
 
 
2.3.2.1 Paternalistic model 
 
Historically, it was regarded that medical practitioners were the keepers of medical 
information and the sole decision makers. Supporting this argument, it has been shown that 
in many cultures the relationship between the patient and the doctor follows a paternalistic 
approach (Charles et al, 1997), which looks upon the patient as a passive spectator in his or 
her own healing process (Emanuel & Emanuel, 1992). This is known as the paternalistic 
model of decision-making, in which the patient passively consents to professional authority 
by agreeing to the doctor’s choice of treatment. Within this model, there are no trade-offs 
for the patient and no sharing of any of the decision-making steps. This model arguably 
places the patient in a passive, dependent role, compared to the clinician as the expert. 
Clinicians are seen as someone who dominates the medical encounter, and using their 
skills to diagnose and recommend tests and treatments, to restore patients’ good health. In 
the extreme case, “the physician authoritatively informs the patient when the intervention 
will be initiated” (Emanuel & Emanuel, 1992, p.2221). In a less extreme scenario, the 
clinician will give the patient selected information, and will encourage the patient to 
consent to what the physician considers best (Emanuel & Emanuel, 1992). The role of the 
clinician, depicted in this model, is to act as the patient’s guardian and to implement what 
is best for the patient. Patient involvement is limited to providing consent to the treatment 
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advocated by the clinician (Emanuel & Emanuel, 1992), and the concept of patient 
autonomy is patient assent to the clinician’s determination of what is best. Table 2.2 
describes the paternalistic model of medical decision-making. 
 
 
Table 2.2  
The paternalistic model of medical decision-making 
 
 
 The extent to which this approach is currently practised by clinicians is an 
empirical question. In emergency situations, for example, it may still be widely accepted 
and might, in practice, be the only feasible model for the task. However, efforts to 
formulate alternative treatment decision-making models have risen, in reaction to the 
perceived prevalence of the paternalistic approach, which is viewed as inappropriate for 
current treatment decision-making contexts (Levine et al, 1992). Subsequently, over the 
years, there has been a medical shift from thinking about patient care in terms of disease 
and pathology, towards thinking in terms of people and their problems. With the evolving 
health care climate, research reveals a shift as patients are slowly becoming regarded as 
consumers, who are expected to be involved in their medical care (Stacey, Samant, & 
Bennett, 2008).  
 Several factors may have contributed to this change. It could be argued that as 
communities in Western society have become better educated and informed about health 
care issues, a fundamental shift in society’s expectations of the appropriate role for 
clinicians, and increased emphasis on patient rights, has occurred. This notion is supported 
by humanist considerations, which state that every human being is endowed with will and 
with a right to self-determination (Gillon, 1994). Therefore, by participating in the 
decision-making process, the patient exercises his or her most fundamental rights. It could 
Gathering the 
information 
Communicating the 
information 
Understanding and applying 
the information 
 
-The clinician acquires the 
scientific information on 
risks and benefits of 
different treatment options. 
 
-The clinician in clinical 
practice communicates the 
scientific information to the 
patient. 
 
-Deliberation occurs with 
clinician alone, with limited or 
no input from the patient. 
-The clinician makes the final 
treatment choice. 
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also be suggested that such movement has risen as a result of the rapid expansion in 
medical knowledge and the evolution of improved access to health information for 
patients. Increased accessibility of the internet has become an influential source for 
patients to obtain information about medical problems and treatments, alternatives to 
traditional medicine, as well as to receive social support (Eysenbach, 2000; Hardy, 2001). 
Such wider availability of information for patients forces clinicians to have to be more 
comprehensive in discussing available treatment options and, therefore, helps to empower 
patients (Sharf, 1997). Another proposed argument is that consumerism has contributed to 
the modification of the patient’s role in the treatment process (Kizer, 2001). Like any 
consumer, patients are beginning to demand and expect quality services (Coulter & Ellins, 
2006). By patients continuously evaluating the service, the patient-consumer can improve 
the health care system (Kizer, 2001), and advocate new patient vision into official medical 
documents and governmental policies. For example, the Department of Health (1999) 
recognised the necessity of encouraging an active and participatory role for patients to 
improve their well-being and increase the efficiency of the health care system. 
 From the early 1990’s research highlights how the terms ‘patient participation’ and 
‘patient-centred care’ are understood and placed in the context of medical decision-making 
(Avis, 1994; Biley, 1992; Llewellyn-Thomas, McGreal, & Thiel, 1995; McWhinney, 1989; 
Siminoff & Fetting, 1991). The concept of patient-centred care is described as an approach 
where the physician tries to enter the patient’s world, to see the illness through the patient's 
eyes. It is a practice which focuses on ensuring the patient participates by putting their 
experience foremost, and the practice is at the heart of quality improvement. Table 2.3 
describes the core principles and implications of the patient-centred care approach.  In 
today’s medical practice, research draws attention to the significance of patient-centred 
care, as a quality benchmark for establishing increased patient satisfaction by delivering 
dignified care (Bauman, Fardy & Harris, 2003; Lewin, Skea, Entwistle, Zwarenstein & 
Dick, 2002). With this new concept taking form, an increased number of health care 
studies are demonstrating a growth in patient expectations to participate in medical care, 
and the importance of informed choice in treatment decision-making (Balint, 1996; Charles 
& DeMaio, 1993; Charles et al, 1997; Feste & Anderson, 1995). Across many different 
health conditions, research identifies that patients want to be responsible for their health 
and well-being, and also expect to be well informed and involved in making health 
decisions (Coulter & Jenkinson, 2005; Degner et al, 1997; Magee et al, 2003).  
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Table 2.3  
The core principles and implications of patient-centred care 
 
 Patient-centred care is important for improved patient health outcomes (Crawford, 
et al, 2002). For example, it allows for greater perceptions of control and self-responsibility 
(Lerman et al, 1990); less functional disability (Greenfield et al, 1985); increased 
adherence to medical regimens (Ceichanowski, Katon, Russo & Walker, 2001; DiMatteo, 
Hays & Sherbourne, 1992; Ley, 1982); and reduced anxiety (Fogerty, Curbow, Wingard, 
McDonnell, & Somerfield, 1999; Macleod, 1991), and depression (Hack et al, 2006). 
These improved health outcomes have also shown and to result in good recovery (Selfe, 
Matthews, & Stones, 1998), and better management of health (Heisler, Bouknight, 
Hayward, Smith, & Kerr, 2002). More importantly, the impact of patient involvement on 
improved health outcomes is especially true of breast cancer patients. A mixed method 
study by Street and Voigt (1997) examined recordings of doctor-patient breast cancer 
consultations and assessed patient surveys post-operatively. Results illustrated that women 
who were actively involved in the decision-making process regarding their treatment, 
tended to be more satisfied with the care they received and had higher overall QOL. These 
findings are also reflected by Hack et al (2006), who showed similar findings through 
analysis of breast cancer patient surveys, using the decision role preference scale.  
 
 Due to the perceived shortcomings of the paternalistic model to patient decision-
making, Charles et al (1997) argued the need for a consumer model in health-related 
decision-making that provided options to patients, and allowed them to make decisions. 
Principles Implications 
 
-Working with patients beliefs and values 
-Providing Holistic Care 
-Having sympathetic presence 
-Enabling patients and offering engagement 
-Shared decision making 
-Offering coordinated care, treatment and 
support 
-Offering personalised care, treatment and 
support 
-Affording people with dignity and respect 
-Power sharing 
 
 
 
 
- Improves clinical outcomes 
- Satisfaction with care 
- Involvement with care 
- Creating a therapeutic culture 
- People take more responsibility for their 
own care 
- Improves healthcare performance 
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Supporting this, Levine et al (1992) suggested that in order to make treatment decisions, 
which are based on the clinician’s knowledge and the patient's preferences, there is a need 
for a model which combines the two components. To accomplish this, two key treatment 
decision-making models have been outlined, which originate from recognition of 
informational asymmetry between patient and clinician. These models are known as the 
‘physician as the perfect agent model’ and the ‘informed decision-making model’. 
 
 
2.3.2.2 Physician as a perfect agent model 
 
The physician as a perfect agent model, also referred to as the interpretative model, aims 
to elucidate the patient’s preferences and values to the clinician. Similar to normative 
models of decision-making and the Prospect Theory, treatment decisions have also been 
identified in terms of ‘trade-offs’ of cost versus benefits. In order for a patient to carry out 
a trade-off, two components are required: first, having full knowledge about the risks, 
costs, and benefits of each course of action or treatment; and second being able to 
formulate single measure utility functions (i.e. preferences) for each attribute. However, 
regarding treatment decision-making, it could be argued that both components are not 
found in the same person, and often the clinician may have the knowledge while the patient 
has the preference mapping system. Subsequently, for the clinician to act as a ‘perfect 
agent’, the clinician needs to know the patient’s values and preferences. To facilitate this 
process, the clinician provides the patient with the information on the nature of the 
condition, and the risks and benefits of possible interventions. The clinician then assists the 
patient in clarifying these values, and determining which medical intervention best 
supports their values and preferences. According to this model, the patient’s preferences 
are not always fixed, understood, or even known to the patient. To do this, the method of a 
‘decision tree’ type of analysis, at a clinical level, is practiced by the clinician to elicit 
patient preferences. Through use of a decision tree, similar to one described above by 
Green and Mehr (1997), the clinician not only offers knowledge, but the patient can also 
provide preferences in the form of utility scores assigned to various potential outcomes. 
The clinician can then use the input made by the patient to subsequently refer it back to 
their knowledge (i.e. the decision tree), and identify the best treatment option in 
accordance with the patient’s perspective and highest score utility. As a result, in this 
model, the clinician makes the treatment decision, having elicited the patient’s preference. 
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Therefore, both components (information and preferences) reside with the clinician, rather 
than with the patient, and the former becomes the sole decision maker, while the patient 
provides informed consent. However, it is important to stress that the clinician does not 
dictate to the patient or judge the patient’s values. They instead help the patient to 
understand and realise their preferences, by providing them with relevant information, and 
then use those preferences in the medical situation of decision-making. In accordance to 
the concept of patient autonomy, this model helps patients to better understand who they 
are and how the various medical options bear on their identity. Health research shows that 
this type of doctor-patient interaction, for medical decision-making, is highly 
recommended by clinicians (Bensing, 2000; Robinson & Thomson, 2001).  Table 2.4 
provides a description of the physician as a perfect agent model of medical decision-
making. 
 
 
Table 2.4  
The physician as a perfect agent model of medical decision-making 
 
 However, some issues about this model have been raised. For example, empirical 
studies have found that people do not necessarily behave in a manner consistent with their 
values, and in such cases, the clinician might recommend a treatment option which the 
Gathering the 
information 
Communicating 
the information 
Making the facts 
personally meaningful 
Understanding and applying 
the information 
 
-The clinician 
acquires the 
scientific 
information on 
risks and 
benefits of 
different 
treatment 
options. 
 
-The clinician in 
clinical practice 
communicates 
the scientific 
information to 
the patient, with 
the help of 
decision aids. 
 
-The patient interprets the 
information provided and 
tries to make it 
meaningful to their 
preferences. 
-The patient’s 
preferences/interpretations 
are influenced by their 
beliefs and values. 
- The patient provides the 
clinician information 
about their preferences. 
 
-The patient’s interpretation of 
the scientific information is 
what gives the information 
personal meaning. 
-The patient’s interpretation 
and voiced preferences may 
result in them feeling more 
informed and participate in 
decision-making. 
-The clinician uses the 
patient’s 
interpretation/preferences to 
deliberate and make an 
appropriate decision.  
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patient sees as inferior (Fishburn, 1988; Karnie & Schmiedler, 1991). Regarding breast 
cancer care, some critics argue that because there is no optimal treatment for all breast 
cancer patients this, therefore, disables the process of trade-offs between the clinician and 
patient (Mooney & Ryan, 1993). Charles et al (1997) elaborated on this notion, explaining 
that the model is therefore not necessarily one of shared decision-making between the 
patient and clinician, and that decision-making is still seen as one sided. According to such 
arguments, by definition, in this model the clinician’s treatment preferences are excluded, 
and the only treatment preferences that matter are those of the patient. Consequently, it can 
be suggested that although the model might be useful theoretically, it is, however, limited 
in its use in practice and in particular to decision-making for the treatment of breast cancer. 
 
 
2.3.2.3 Informed decision model 
It has been argued that one of the most important preconditions for participation in 
decision-making is that the patient must have access to adequate and accurate information 
(Brennan, 1997). Ubel and Lowenstein (1997) emphasised that the provision of 
information has to be grounded in patients’ own values, and that this is crucial in enabling 
patients to choose the medical option that were most consistent with their values. Since the 
1970s, increasing recognition, that patients needed to be better informed about their 
medical care, led to the introduction of informed consent (General Medical Council, 1999), 
and alternative models of decision-making, such as the informed decision-making model, 
also referred to as the consumer model. Where the physician as a perfect agent model 
concentrates on the transfer of patients’ preferences to the clinician, the informed decision-
making model, similarly incorporates the idea of information sharing, however, focuses on 
the transfer of technical knowledge from the clinician to the patient. The aim of the 
clinician is to provide the patient with all of the relevant information, for the patient to 
select the medical intervention that they want, and for the clinician to execute the selected 
intervention. To achieve this, the process involves a partnership between doctor and patient 
that is based on a division of labour, whereby the clinician provides enough knowledge and 
information in order for the patient to make an informed decision. This is accomplished by 
increasing the patient’s knowledge of the possible risks of alternative therapeutic options, 
and about the clinical effectiveness of each treatment option. The informed decision-
making model, therefore, assumes a clear distinction between facts and values, as the 
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patient values are well defined and known to the patient, but what the patient lacks is facts. 
Information transfer is, therefore, seen as key to the decision-making process. According to 
Hurley, Birch and Eyles (1992), it is a process that allows patients to make decisions that 
reflect both their preferences and the best scientific knowledge available. Table 2.5 
describes the informed decision making model of medical decision making. 
 
Table 2.5  
The informed decision model of medical decision-making 
 
 
This model assumes that the deliberation and decision-making steps are the sole 
prerogative of the patient. The doctor is accorded no legitimate claim for involvement in 
these phases, or has any legitimate investment in the treatment decision that the patient 
makes. It is solely the preference of the patient that counts, and the clinician is 
consequently a purveyor of technical expertise, providing the patient with the means to 
exercise control. Charles et al (1997) argued that “the informed model is premised on the 
assumption that information is an enabling strategy, ‘empowering’ the patient to become a 
more autonomous decision maker” (p. 683). Therefore, the concept of patient autonomy is 
control over medical decision-making.  
 
 According to Charles, Gafni, and Whelan (2004), such a model of decision-making 
is in line with the move towards patient-centred care, and towards an ideal in which patient 
autonomy and appropriate involvement in treatment decision-making is highly valued. 
This notion is further emphasised by Feste and Anderson (1995), as they argued that the 
Gathering the 
information 
Communicating the 
information 
Understanding and applying the information 
 
-The clinician 
acquires the 
scientific 
information on 
risks and benefits 
of different 
treatment options. 
 
-The clinician in 
clinical practice 
communicates the 
scientific information 
to the patient, with 
the help of decision 
aids. 
 
-The patient increases their knowledge of 
treatment options, and the benefits and risks of 
each. 
-The patient feels more ‘informed’ and 
‘empowered’. 
-Deliberation occurs with the patient alone. 
-The patient increases their involvement in 
treatment decision-making, and makes the final 
treatment choice. 
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term ‘informed consent’, which largely rests on the physician as a perfect agent model, is 
slowly becoming revised to ‘informed decision-making’ with this improved model. There 
are arguments that support such evolved notion of informed consent (Charles, Gafni, & 
Whelan, 1999b; Emanuel & Emanuel, 1992; Quill & Brody, 1996). These studies illustrate 
how informed consent, which once essentially demoted the patient’s role to agreeing with 
the decisions arrived by the doctor, has now moulded into a practice which instead 
emphasises an open exchange of information and sharing of values and preferences, 
through patient participation. It can be argued that this model promotes participation in 
medical decision-making for patients, as it allows patients to possess both components 
(information and preferences), which are viewed as essential to the task (Levine et al, 
1992). Studies have shown that in this model, treatment decision-making control is clearly 
seen to be in the patient’s hands (Eddy, 1990) and the clinician’s role is limited to that of 
information exchange and communication of scientific knowledge to the patient (Mooney 
& Ryan, 1993; Williams, 1988). Consequently, there are arguments that suggest that the 
model works on the assumption that information is an empowering strategy, which allows 
the patient to become a more autonomous decision maker and take a more active 
participatory role (Charles, Whelan, Gafni, Reyno & Redko, 1998; Charles et al, 1999b; 
Frosch & Kaplan, 1999; Guadagnoli & Ward, 1998).   
 
 The informed decision model limits the role of the clinician to one of transferring 
information. In the extreme case, information transfer can be done without the presence of 
any health care worker, for example, through the use of decision aids. Recently, the issue 
of transferring adequate information, to enable patients to make an informed treatment 
choice, has received much attention within health psychology literature. Many different 
methods to inform patients, known as decision aids, have been systematically reviewed and 
highlighted as effective in informing patients about available treatment (O’Connor et al, 
2009), especially regarding interactive web videos (Deber, 1994; Deber et al, 1996) and 
decision boards (Levine et al, 1992). Figures 2.6 and 2.7 illustrate an example of an 
interactive web video and a decision board for breast cancer. These decision aids include a 
clear description of treatment options, information based on clinical trials, and the 
associated benefits and risks of recurrence with or without the treatment. They are 
designed to help patients make specific and deliberative choices, among different options, 
and to voice their treatment preference.  
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Figure 2.6 Screenshot of an interactive video web-based decision aid for patients 
diagnosed with early breast cancer, who are about to decide their surgical treatment.  
 
 
Figure 2.7 A section from the take-home version of the decision board for breast cancer 
patients, who are having to make adjuvant treatment decisions. 
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Waitzkin (1991) suggested that clinicians, who adopt the paternalistic approach, are 
unlikely to use such decision aids, as they can help overcome traditional professional 
dominance over interactions regarding medical treatment decisions. However, the informed 
decision model enables the clinicians to provide patients with decision aids and, therefore, 
to transfer the medical information and knowledge needed for patients to make a treatment 
decision.  
 
 Decision aids, decision boards in particular, are predominantly used within breast 
cancer care. Research has shown that within the treatment of cancer, doctor-patient 
communication is a major problem (Mackillop, Stewart, Ginsberg & Stewart, 1988; 
Siminoff et al, 1989). As a result of this breakdown, aids, such as decision boards, are 
being introduced into cancer care to encourage and improve doctor-patient communication. 
Furthermore, randomised tests have demonstrated that the decision boards improve breast 
cancer patients’ knowledge about their disease and risk of recurrence, and increases their 
satisfaction and confidence with decision-making (Whelan et al, 2003 & 2004). Whelan et 
al (1995), for example, reported in a quantitative survey study that 97% of women with 
breast cancer who were assigned to a group, in which the clinician used a treatment 
decision board with information about the risks and benefits of breast irradiation following 
lumpectomy, felt that they were offered a treatment choice compared with 70% of women 
in the no decision board group. However, Charles et al (1997) stated that a limitation to the 
informed decision model is that there are time costs involved, in the process of transferring 
information. Moreover, it could be argued that there may be a possibility of bias, as the 
clinician might present decision aids and the information in a way to convince the patient 
to choose a treatment that the clinician prefers. 
 
 In an ideal world of doctor-patient partnership, where both clinicians and patients 
share the goal of a treatment decision by transferring both knowledge and preferences to 
one another, it could be suggested that there should be no difference between the informed 
decision-making model and the physician as a perfect agent model. However, in reality, the 
implementation of each approach is far from perfect and easy. This view is supported by 
existing research which argues that, while both represent two normative models of 
treatment decision-making, the patients’ actual preferences, for the role they want to play 
in the decision-making process, are problematic in both models. For example, in the field 
of cancer care, a high number of quantitative cross sectional survey and questionnaire 
studies, using instruments and scale which measure patient satisfaction, participatory roles, 
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and informational needs, have been conducted. These studies suggest that while most 
patients have high preferences for information about their disease, treatment alternatives, 
and prognosis, they have low preferences for participation in the treatment decision-
making process (Beisecker & Beisecker, 1990; Blanchard et al, 1988; Cassileth, 1980; 
Deber, 1994; Degner & Sloan, 1992; Ende et al, 1989; Sutherland et al, 1989). In other 
words, patients may want information about their medical condition and treatment options, 
without necessarily being responsible for making treatment decisions. There are other 
arguments that support that patients want to be ‘active’ in discussing treatment options and 
receiving information, but ultimately rely on their clinician when it comes to making 
decisions (Blanchard et al, 1988; Frosch & Kaplan, 1999; Deber, 1994; Quill, 1989; 
Robinson & Thomson, 2001; Strull et al, 1984). These findings are based on systematic 
reviews, and utilise self-administered questionnaires to measure the degree of patient 
participation.  Subsequently, what is clear from the findings is that limiting the 
conceptualisation of clinician-patient treatment decision-making to any one model of 
decision-making, does not reflect the current realities of clinical practice. This is especially 
true of breast cancer care; Ong, Haes, Hoos and Lammes (1995) stated, through a 
systematic review of doctor-patient communication literature, that there is a need for an 
approach which can amalgamate the process of information exchange and the patient 
values, beliefs, and preferences in one model that better reflects the current cancer care 
practice.  
 
 In summary, several models of treatment decision-making have been developed, 
partially in reaction to the paternalistic model. A closer examination of each model reveals 
that none of these explicitly describes a process in which both the clinician and patient 
share in decision-making, no matter how much information is shared. The notion that 
information sharing and treatment decision-making are two separate goals, in the medical 
encounter, is recognised in the literature on doctor-patient communication (Ong et al, 
1995). This consequently led to the introduction of the ‘shared model’ for treatment 
decision-making. This suggests that for shared treatment decision-making to occur, there 
needs to be a two-way exchange, not only of information, but also of treatment 
preferences, by both the clinician and the patient. The next section describes the concept of 
medical SDM and the extent to which it is practiced in health care.  
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2.3.2.4 The shared model and concept of SDM 
 
With the NHS cultural shift towards a patient-centred service over the years, treatment 
decisions should ideally result in the most desirable outcome for the patient. According to 
Eddy (1990), to meet this goal there is a need for ‘active’ participation and engagement by 
both the clinician and the patient. Policy guidelines, such as the White Paper Equity, 
Liberating the NHS: equality and excellence (DOH, 2010c), were established to give 
everyone a more integrated and equal voice concerning their care and treatment; and to 
allow for more patient opportunities to make choices, with shared information, and 
collective support structures. This guideline was enforced as a means of securing 
appropriate treatment decisions and better health outcomes. None of the models outlined 
above, explicitly describe a process in which both clinician and patients necessarily share 
in decision-making, no matter how much information they exchange between themselves. 
This introduces the third theoretical approach to medical decision-making, between 
clinicians and patients, which is the shared model. The characteristics of this model are 
grounded in two-way interaction and exchange of information, and involve complex trade-
offs between risks and benefits. Table 2.8 describes the shared model of medical decision-
making. The doctor and patient share all stages of the decision-making process 
simultaneously. Both the clinician and patient reveal their treatment preferences, and both 
agree on a chosen treatment plan.  
 
Table 2.8  
The shared decision model of medical decision-making 
 
Gathering the 
information 
Communicating the 
information 
Understanding and applying the 
information 
 
-The clinician 
acquires the 
scientific 
information on risks 
and benefits of 
different treatment. 
options. 
 
-The clinician in clinical 
practice communicates the 
scientific information to the 
patient, with the help of 
decision aids. 
- The patient provides the 
clinician information about 
their preferences. 
 
 
-The roles in decision-making processes 
are defined during the task of 
information exchange. 
- The clinician and patient deliberate 
treatment choice together. 
-Both clinician and patient make the 
final treatment choice together. 
. 
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Wirtz, Cribb and Barber (2006) criticised the shared model for being nothing more than an 
alternative name for the informed decision model, or a model of the doctor-patient 
relationship. However, this critique misses the essence of a shared approach towards 
decision-making. This approach assumes that both the patient and the clinician have a 
legitimate investment in the treatment decision; hence, both declare treatment preferences 
and their rationale, while trying to build a consensus on the appropriate treatment to 
implement. To achieve this, Brennan (1997) suggested that a sense of trust between the 
patient and the clinician is required, so that the patient can be assured that the information 
given is credible and in their best interests. Consequently, it could be argued that there is now 
an established system which incorporates a combined process of patient participation and 
informed consent, as well as facilitating an individualised patient-centred approach.  
 The SDM approach, towards medical treatment decision, has been introduced into 
NICE medical guidelines (2004 & 2012) and termed as the preferred practice for all 
treatments, by all medical practitioners across hospitals and GPs. The character of SDM in 
clinical consultations is co-determined by patients and professionals (Thompson, 2007). 
Good communication is essential for SDM (Moumjid, Gafni, Brémond & Carrère, 2007). 
During doctor-patient communication, the acquisition of health information is shown to be 
important in allowing patients to construct stable beliefs about self-interest, and in helping 
patients to choose a course of action (Hibbard, Slovic & Jewett, 1997). However, sharing 
information and sharing decisions are not identical processes, as they are separate goals 
within the consultation and require different skills (Ong et al, 1995). While it is possible 
for the sharing of information to occur alone, the process of SDM cannot occur unless 
preceded by the sharing of information (Ong et al, 1995). Subsequently, the way 
information is provided by the clinician during interaction, and combined with other skills 
for SDM, is crucial in assisting patients to construct their preferences and make their 
decisions.  
 Elwyn and Charles (2009) explained that to achieve an SDM approach in clinical 
practice, the model has to encompass three stages, which fundamentally rely on both the 
patient and clinician playing reciprocal roles. The first stage consists of ‘information 
exchange’, whereby the patient identifies their beliefs, values, and preferences and the 
clinician informs the patient of their treatment/management options and explains the risks 
and benefits of each option. The second stage involves ‘deliberation’, whereby the pros 
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and cons of the available treatment options are discussed in light of the evidence and 
patient preferences. The final stage consists of ‘implementation’, whereby both the patient 
and clinician work together to attempt to achieve a consensus, and the clinician may offer a 
specific recommendation which contributes to the decision-making.  
 
 SDM sits between an authoritarian approach, where clinicians make medical 
decisions for patients, and a consumer approach, where clinicians provide information to 
patients to make their own decisions. In comparison with the notion of patient 
participation, aspects of SDM expanded from a simple concept of patient engagement, 
towards advocating a more bipartisan approach. SDM has been extensively and 
systematically reviewed within medical decision-making literature. It has been described 
as a framework whereby both parties involved are required to communicate and exchange 
information together, about possible attributes and consequences of options. They should 
also share their informed preferences for treatment, in order to negotiate a mutually 
acceptable decision, which respects patient autonomy and is also desired, ethical, and legal 
(Beaver et al, 1996; Charles et al, 1997; Elwyn & Charles, 2001; Towle & Godolphin, 
1999).  
 Unlike the paternalistic model and informed decision model, SDM recognises two 
experts: the clinician is an expert in defining the clinically appropriate options, including 
the risks and benefits of each option, based on the latest medical evidence; and the patient 
is an expert in their own values, preferences and concerns. However, SDM is not all about 
mutual agreement on a matter. There are also arguments, which support the view that it is 
also suitable for both parties to agree to disagree, as an acceptable outcome of SDM 
(Elwyn et al, 1999b). It is also important to note that SDM should not be confused with the 
informed decision model or obtaining ‘informed consent’ from a patient. The historical 
concept of informed consent can be interpreted as a legal rather than an ethical obligation 
of doctors, in order to preserve patient sovereignty. Obtaining information of the clinician 
and informed consent does not necessarily mean that patients are involved in making 
medical decisions; rather, the signature indicates that they have agreed to the treatment, 
which may, more or less, have been recommended by their clinician. However, SDM is a 
process which goes several steps further.   
 Increasingly, SDM is emphasised for preference-sensitive care. For example, 
Wennberg (2002) argued that SDM is particularly valuable for decisions about cancer 
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treatment trajectories, or care situations in which there are two or more treatment options 
that are medically justified.  Research supports this argument by highlighting the concept 
of SDM as a prevailing approach for patient involvement in breast care decision-making. 
Hack et al (2006) illustrated this finding in a quantitative study, using the decisional role 
preference scale and QOL measures. Similarly, in a self-administered survey study by 
Bruera, Willey, Palmer and Rosales (2002), approximately 89% of women with breast 
cancer preferred a SDM process during their treatment. Research evaluating the benefits of 
SDM, through the use of systematic review, illustrate a promotion in both psychological 
and physical well-being (Joosten, DeFuentes-Merillas, de Weert, Sensky, van der Staak, & 
de Jong, 2008). Evaluation studies which explore patients’ perceived involvement in care, 
through the use of self-report questionnaires, also demonstrated how SDM provides 
patients with a greater sense of control over their health care (Adams & Drake, 2006; 
Joosten et al, 2008). According to a systematic review on SDM and doctor-patient 
relationships (Charles et al, 1997), the concept of sharing medical decisions is 
advantageous, as it allows for better data collection on the part of the clinician, as well as 
the patient; and it forces the clinician to present and consider all treatment alternatives. In 
later research, Charles et al (1999a) revisit and add elements to their earlier conceptual 
framework on shared treatment decision-making, by stating that the process of sharing 
decisions can enhance the quality of decisions made, and increase satisfaction with medical 
treatment, as patients feel that they have participated in the decision-making process. 
 
 Specifically regarding breast cancer, the NICE guidelines (2007) specify that 
“treatment and care should take into account patients’ needs and preferences” (p.6). 
Therefore, patients with advanced breast cancer should have the opportunity to participate 
in making informed decisions about their care and treatment, in collaboration with their 
healthcare professional. According to the NICE guidelines (2004), due to the complexity of 
cancer treatment choice, breast care services must allow for substantial patient-centred care 
through the use of the shared model, embedded within its services. A relevant example of 
this is demonstrated within cancer treatment paths, which aim to join a range of high 
quality experts in breast cancer diagnosis, surgery, medication, treatment/therapy, and 
support services. Different health professionals are trained to work together in a single 
clinic, with the patient being the centre of attention, surrounded by shared information and 
discussions, to reach a mutual agreement. Importantly, in support of these adjustments, 
quantitative and mixed method research has also illustrated SDM as a preferred approach 
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to breast cancer treatment decision-making, and has been linked to positive patient 
outcomes (Moyer, 1997; Silliman et al, 1998; Street & Voigt, 1997). A number of 
interventions promoting SDM in breast cancer treatment have been evaluated, all showing 
that women who have actively been involved in SDM for their treatment, tend to be more 
satisfied with the care they receive and have a higher overall QOL (Street & Voigt, 1997); 
show treatment adherence (Sepucha, Belkora, Tripahty & Esserman, 2000); obtain higher 
physical and social functioning (Whelan et al, 1999); and report fewer side effects (Hack et 
al, 2006). Concurrently, from these findings, the Registered Nurses’ Association (2006) 
has placed greater emphasis on motivating providers and the health care system within 
oncology, to increase more ‘active’ participatory roles for patients, and to include the 
routine practice of patient involvement in making informed health decisions. 
 
 
2.3.2.4.1 To what extent is there a shared approach in medical decision-making? 
 
A central question about the shared model is whether it actually describes what takes place 
within particular treatment decision-making settings. Several studies have explored this 
through examinations of certain mediating factors, such as age and educational difference. 
For example, previous research has found that younger and more educated patients, 
generally prefer more egalitarian relationships with providers, ask more questions, offer 
more opinions, and believe more strongly in participating in decision-making than older 
and less educated patients (Roter, Hall & Katz, 1988; Street, 1991).  
 Within doctor-patient relationship research, it has been shown that SDM is sparsely 
implemented and practiced in health care (Holmes-Rovner et al, 2000; Stevenson, Barry, 
Britten, Barber & Bradley, 2000). Clinicians can lack self-efficacy to implement SDM 
(Keefe, Thompson & Noel, 2002; Thistlethwaite & van der Vleuten, 2004), and can be 
reluctant to disclose information relevant to making uncertain choices, especially when 
these choices involve trade-offs among risk, disability, and death (Eraker & Politser, 
1982). There are also arguments outlining why clinicians may discourage patient 
participation. For example, research has shown that clinicians can show unwillingness to 
share power between doctor and patient (Ford, Schofield & Hope, 2003). Earlier research 
supports this (Katz, 1984) and argued that some clinicians may feel threatened by patient 
empowerment. Other authors suggest that clinicians are reluctant to encourage patient 
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participation, because either they refuse to delegate power or control, or they are afraid to 
lose their identity (O’Flynn & Britten, 2006), even though they may not be openly negative 
about the concept of SDM (O’Flynn & Britten, 2006; Stevenson, 2003).  
 A primary obstacle to patient participation in decision-making is low health literacy 
and lack of knowledge on the subject (Coulter & Ellins, 2006). The most common 
complaints made by cancer patients are about poor communication and inadequate 
information (Jenkins, Fallowfield & Saul, 2001). Research suggests that clinicians lack the 
appropriate communications skills to engage patients in the medical SDM process 
(Auerbach, 2000; Gwyn & Elwyn, 1999; Marvel, Epstein, Flowers & Beckman, 1999). 
This is further supported by Charles et al (2004), who stated that clinicians lack the 
necessary communication skills needed to ‘share’ and ‘involve’ patients in decision-
making. Subsequently, this can inhibit patients from acquiring the knowledge and 
understanding they need regarding treatment options, to make informed decisions 
(Fallowfield & Jenkins, 1999; Maquire, 1999). It can also result in patients’ lack of 
awareness and familiarity with SDM (Cabana et al, 1999; Davis et al, 2003).  
 According to Thorne (1999), problems with staff communication such as their 
failure to provide all the information the patient needs, or the assumption that the patient is 
unable to understand medical information, will deter patient participation. This is 
supported by the earlier work of Waitzkin (1985) who operationalised a multivariate 
research model, to assess associations between information giving and the characteristics 
of doctors, patients, and the clinical situations in which they interact. From this study, 
Waitzkin (1985) argued that patients were more likely to be more responsive when the 
clinician provided efficient communication which encourages patient participation, and 
shows interest in the patient’s questions, feelings, and beliefs. However, if the patient 
perceived that the clinician wished to be in charge of the consultation, did most of the 
talking, and made decisions for treatment, then many patients assumed the traditionally 
‘passive’ role in the encounter. The above studies suggest that the inherently unequal 
power dynamic within consultations, may prevent a successful provision of information 
and communication about treatment options and risk (Gafni et al. 1998; Schneider 1998). 
This, consequently, suggests that SDM probably requires an attitudinal shift by clinicians, 
as well as the conventional communication skills training currently taught within medical 
education (Skelton, 2005). The importance of doctor-patient interaction and 
communication skills on SDM will be explored more thoroughly in Chapter Six.  
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 Historically, research shows another obstacle to patient participation which is an 
imbalance in the patient-clinician relationship. Studies suggest that an imbalance in 
perceived roles is created, since the patient is the person who is regarded as sick and the 
clinician has the expert knowledge to address this issue (Emanuel & Emanuel, 1992; Haug 
& Lavin, 1981). Studies revealed that for some patients, the aspect of being faced with the 
life-threatening diseases and having to challenge the psychological emotions, can result in 
them taking a more ‘passive’ role (Richards et al, 1995), and leaving treatment decisions to 
their clinician to make (Degner & Sloan, 1992). As explained by Degner and Sloan (1992), 
when severely ill patients feel physically vulnerable and distressed, they appear to show a 
decrease in information seeking, thus allowing for a degree of paternalism by the clinician 
in decision-making. Research suggests that patients are more likely to be involved in 
decisions that do not require medical knowledge than those that require clinical expertise 
(Thompson, Pitts & Schwankovsky, 1993). In a study which explored barriers to patient 
participation in decision-making, through observations across several hospitals, Lidz et al 
(1983) reported that although patients want information about treatment, they generally 
believed that treatment decisions should be primarily left to clinicians, due to their 
technical expertise and commitment to the best interests of the patients.  
 To explain such perceived discrepancies in doctor-patient relationships, Henderson 
(2003) described that certain situations are referred to as ‘problem solving situations’ 
(requiring medical expertise) and, therefore, do not present themselves well to patient 
participation. In contrast, most ‘decision-making situations’ (involving values and 
preferences)  require an analysis of the value (utility) of potential outcomes to the 
individual, which is something only the patient can determine. Further research on this 
notion has illustrated, that patients instinctively make the distinction between these two 
types of decisions, and prefer to be involved in the latter rather than the former 
(Thompson, Pitts & Schwankovsky, 1993). This is also supported by Deber (1996) who 
asserted that patients, who do not appear to want to participate, may have simply rejected a 
role in the ‘problem-solving aspect’ and, therefore, would rather pass on elements of 
responsibility to their clinician. On the other hand, research also shows that some may still 
participate in the decision-making aspect, by sharing their values and beliefs, and believe 
that the ‘decision-making situation’ should be shared (Frosch, & Kaplan, 1999; Robinson 
& Thomson, 2001; Strull et al, 1984; Waterworth & Luker, 1990).  
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 A central question to the SDM paradigm is whether patients actually want to 
participate in medical decision-making and be ‘active’ in aspects of information seeking. 
Several studies have addressed this question, and results of these studies have been mixed. 
For example, the research predominantly reveals, through quantitative questionnaire 
studies, that most patients desire participation in treatment decisions (Benbassat et al 1998; 
Blanchard et al, 1988; Cassileth et al, 1989). A qualitative example of this is also 
demonstrated by Mazur and Hickam (1997), who used structured interviews to examine 
the extent to which patients desired SDM, when faced with the possibility of an invasive 
medical procedure such as surgery. The findings showed that most participants (68%) 
indicated a preference for SDM. However, there are also further quantitative survey studies 
which propose alternative arguments. These suggest that a proportion of patients do not 
accept the ‘active’ patient role, and instead prefer a ‘passive’ or collaborative role in 
making treatment decisions (Beaver et al, 1996; Deber et al, 1996; Ende et al, 1989; Lidz 
et al, 1983; Strull et al 1984). This has been shown to be especially true for patients who 
are faced with a life-threatening disease (Deber et al, 1996; Ende et al, 1989; Richards et 
al, 1993).  
 Regarding the shared model and cancer/breast cancer research, the findings within 
this area of health care also appear to be mixed. For example, a systematic review both for 
and against patient participation in decision-making by Guadagnoli and Ward (1998), 
highlighted that patient preference for an ‘active’ role can range from 48% for women 
recently diagnosed with breast cancer, to 80% for patients with cancer who had been 
offered an experimental treatment. Waterworth and Luker (1990), demonstrated through 
the use of qualitative in-depth interviews with 12 cancer patients, that patients are more 
concerned about doing what is right, that is, pleasing the medical professional, than 
participating in decisions concerning care. Yet, in a cross-sectional survey study on 
treatment decision-making amongst breast cancer patients, it was confirmed that 22% 
desired to select their own cancer treatment, 44% desired to select their treatment 
collaboratively with their clinician, and 34% desired to delegate this decision to their 
clinician (Degner et al, 1997). Within this study, Degner et al (1997) also drew attention to 
the importance of assessing both the preferred and actual levels of patient participation, as 
only 42% of women had achieved their desired level of participation in making decisions 
about their breast surgical treatment. A similar finding was also demonstrated by Keating, 
Guadagnoli, Landrum, Borbas and Weeks (2002), as only 49% of women reported an 
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actual role that matched the desired role they had reported. As a result, by the early 1990s, 
more established arguments grew for the importance of matching patients’ preferred level 
for participation with actual level of participation, as an important outcome for decision 
researchers (Beaver et al, 1996; Bilodeau & Degner, 1996; Degner & Sloan, 1992).  
 Schain (1990) proposed that ideal clinician communication with breast cancer 
patients, should be tailored to the patients’ needs or coping styles, to reduce patient 
distress; and clinicians need to practice achieving a balance between under-informing and 
overloading the patient. Differentiating strategies to foster patient involvement in treatment 
decisions have been identified for clinicians’ use. For example, Pierce’s (1993) study, 
which described the decision-making process of women facing early stage breast cancer, 
classified three types of decision makers: ‘delayers’, who consider at least two options, but 
their deliberation is perfunctory and they immediately prefer one option; ‘deferrers’, who 
accept their doctor’s recommendation; and ‘deliberators’, who weigh the pros and cons of 
each treatment, and do not make a choice until they have considered the relevant 
information and have found an alternative that satisfies them. These findings were derived 
from a qualitative analysis on a convenience sample of 48 women, who completed an 
open-ended interview while they were making a decision. With these classifications, it is 
proposed that clinicians should modify their style to accommodate the different types of 
patients. For example, a paternalistic style with a  patient who is a ‘deferrer’; a more 
informative style with a ‘delayer’ patient; and a shared approach with a patient who is 
classified as a ‘deliberator’. Although such strategy is useful in assessing initial 
preferences, a limitation to such an approach could be that it assumes that some patients 
are incapable of participating and, therefore, little is done to encourage those who may be 
initially reluctant to participate.  
 The NICE guidelines (2006), advises that clinicians should regularly assess the 
quality of doctor-patient communication skills, to ensure information quantity and levels of 
involvement are personalised to suit individuals’ needs and preferences. This is supported 
by Shaller (2007), who suggested that clinicians need to create an atmosphere that is 
conducive to patients’ desired level of participation, which includes making the patients 
feel that their contributions, preferences, and goals are valued. This argument is further 
supported by the NICE guidelines (2009), which emphasise the need to achieve higher 
quality decisions, by balancing patient autonomy with clinician expertise; encouraging 
open communication and information between patients and their oncology team; and 
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sharing the responsibility for these decisions. According to Politi, Dizon, Frosch, 
Kuzemchak and Stiggelbout (2013), by endeavouring to engage all patients, according to 
their desired needs, this can overcome some of the known barriers to SDM (Gravel et al, 
2006).  
 In conclusion, given the findings from the above studies, there are a number of 
unresolved questions related to the implementation of SDM.  It is not clear whether the 
SDM paradigm is, in fact, feasible for all patients. As discussed above, the evidence 
regarding breast cancer patients’ interest in decision-making is somewhat mixed. While the 
evidence suggests that many prefer SDM and control over treatment decisions, it remains 
unclear why some women with breast cancer prefer clinicians to make decisions for them. 
Moreover, there is currently little known knowledge about patients’ lived experience of 
SDM during treatment for breast cancer.  
 Empirically measuring if and how patients deliberate over treatment choices, and 
the process they use to arrive at a decision, is an area within the SDM literature which is 
heavily dominated by quantitative methods. Observation techniques are frequently used to 
measure doctor-patient relationships. However, observations have limitations when trying 
to understand the subjective experiences of patients. A key method, as outlined previously, 
is to measure patient preferences for participation in treatment decision-making through 
the use of quantitative self-report questionnaires, Likert scales, and surveys. Such 
quantitative measures also have limitations, as they simplify and structure the measurement 
process to such a degree, that little information is gleaned about the dynamics of SDM, 
encountered experiences, or the interactional processes involved. To answer some of the 
mixed findings on SDM, particularly within cancer care and breast cancer, it is necessary 
to undertake more in-depth exploration of these complex processes: how patients think 
about decision-making and SDM; why patients hold different perspectives and preferences 
for treatment involvement; and to explore the meanings patients ascribe to views and 
experiences.  
 By taking the view that SDM is a subjective interaction between two people, 
understanding such complex processes is therefore beyond quantitative methods. In order 
to access patient experience, there is a need to adopt a research method that originates from 
a person centred paradigm. Therefore, this research moves towards a more critical health 
psychology perspective, which challenges many mainstream health psychologists’ 
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assumptions and practices that take a ‘scientific’ approach. In contrast, a critical health 
approach argues that people are far more complex than just fixed objects that can be 
studied ‘scientifically’. It seeks understanding and insight into human behaviour by means 
of a more social constructionist position, which assumes that knowledge is variable and a 
product of the social and cultural context, within which it is located.  Subsequently, by 
taking such a critical health approach, the thesis introduces interests in qualitative research 
as a method of enquiry to explore breast cancer patients’ experiences of SDM; and 
introduces the theoretical frameworks of phenomenology and symbolic interactionism, 
which will be discussed thoroughly in the next chapter. 
 
 
2.3.2.4.2 A qualitative approach towards exploring SDM and breast cancer 
 
It is important to review the existing research to explore the extent to which medical 
decision-making for breast cancer has been researched qualitatively. The literature review 
in this chapter has demonstrated that health-related decision-making, amongst women with 
breast cancer, is an area of research which is predominantly explored by means of 
quantitative measure, such as surveys and questionnaires. As outlined in this chapter, much 
of this research devotes attention to interpreting breast cancer patients’ attitudes and their 
preferences towards decision-making, in relation to doctor-patient communication, impact 
of illness on QOL, and levels of patient participatory roles.  
 However, research also reveals some evidence of qualitative methods used to 
explore medical decisions for breast cancer. The qualitative method of inquiry employed in 
these studies focuses on fully understanding patients’ experiences of the decision process, 
and their preferences for participation in treatment decisions. This is achieved by methods 
which aim to explore and understand how they interpret their individual worlds, by 
producing rich and in depth information, and opening clarity and transparency to the 
dimensions of reality, to both the patient and the researcher. A key study illustrating this is 
by Hack, Degner and Dyck (1994), who examined relationships between cancer patients’ 
preference for involvement in making treatment decisions, and preferences for information 
about diagnosis, treatment, side-effects, and prognosis. Semi-structured interviews were 
conducted with 35 women with stage one and two breast cancer, to provide patients with 
an opportunity to elaborate on their role preferences and health care experiences. Results 
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showed that patients who desired an ‘active’ role in treatment decision-making also desired 
detailed information and explanations of their diagnosis, treatment alternatives, and 
treatment procedures. In a similar study, Grunfield et al (2006) used semi-structured 
interviews on 102 women with advanced breast cancer, who were offered chemotherapy, 
to examine their perceptions of the information they had received, and their involvement in 
the decision-making process. Grunfield et al (2006) showed that compassionate and good 
doctor communication skills about prognosis and likelihood of benefit from treatment, 
helped to enable patients to make fully informed decisions about palliative chemotherapy.  
 Yet, qualitative studies have also shown that patient participation in breast cancer 
treatment decision-making is a more complex issue, than simply giving patients 
information and choices. This was shown in a study, which aimed to assess how women 
treated for early stage breast cancer perceived the treatment selection process, using semi-
structured interviews and thematically analysing the transcripts (Kenny, Quine, Shiell & 
Cameron, 1999). Although these qualitative studies shed valuable light on medical 
decision-making from breast cancer patients’ perspectives they, however, are aimed at 
examining issues which are intrinsic to breast cancer and decision-making, largely at a 
clinical level. Therefore, it is implied that they only focus on evaluating and assessing 
(Moyer, 1997; Silliman et al, 1998; Street & Voigt, 1997), rather than describing the 
meanings and the lived experiences of treatment decision-making.  
 
 While every effort has been made by research to qualitatively explore breast cancer 
patients’ accounts of decision-making, the concept of SDM is lacking from a qualitative 
stand point in the critical health psychology literature. There are some examples of 
qualitative studies carried out to distinguish the processes of SDM and to evaluate SDM 
with patients and clinicians, which will be explored in thorough detail in Chapter Four 
(Davis et al, 2003; Edwards & Glyn, 2006; Stevenson et al, 2000). However, the health 
psychology literature fails to demonstrate any qualitative research conducted, which is 
concerned with breast cancer patients’ meanings and experiences of SDM.  
 Currently, the majority of research on SDM has been systematically reviewed 
amongst patients with wide-ranging chronic illnesses (Charles et al, 1997; Coulter, 
Entwistle, & Gilbert, 1999; Gwyn & Elwyn, 1999), and has been evaluated and defined 
amongst breast cancer patients by means of quantitative measures, such as patient 
questionnaires, self-report surveys, and health scales. Much of these evaluative studies are 
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far from being able to provide an in-depth understanding of the concept and process of 
SDM within breast cancer care, from the patients’ perspectives, experiences, and actions. 
An understanding of SDM amongst women with breast cancer is yet to be explored 
qualitatively and comprehensively. Within the existing breast cancer and SDM literature, 
there are no studies which have adopted an interpretative approach to exploring cancer 
patients’ experiences of SDM. By employing a phenomenological and symbolic 
interactionist approach to qualitatively exploring SDM, this would subsequently allow for 
a more in depth and thorough understanding of concept, from the service users’ personal 
encounters, views, and interactions.  It adds to the existing decision-making health 
literature and fills the gap on SDM research, by providing a qualitative study which 
explores how SDM is characterised; and examines patients’ experiences and meanings of 
SDM.  
 
2.4 Conclusion 
This chapter has taken a broad approach to understanding medical decision-making. It 
initially reviews several cognitive and psychological theories of decision-making, and then 
explores these theories in relation to decision-making in the context of health care. 
Reviews of normative and descriptive theories of decision-making outlined several useful 
models, which illustrate how decisions are made by individuals, and how they can be made 
better. Within the health psychology literature, these models of decision-making have also 
been shown to be applicable and useful in explaining and evaluating medical decision-
making by patients and clinicians. 
  In reviewing health-related decision-making, several approaches to treatment 
decision-making were highlighted. Importantly, these models illustrate the overall 
progression in models of medical decision-making, from a paternalistic approach to a 
method which integrates the patient within the decision-making task. With this move 
towards patient-centred care, the concept of the shared model and SDM was introduced 
and discussed.  
 However, the available evidence suggests that participation can mean different 
things to different people. Although these models are useful in understanding how people 
make treatment decisions, in the real world of everyday practice, it could also be argued 
that many clinical decision-making interactions reflect a form of hybrid model. As this 
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chapter illustrates, it is not always possible to categorise patients into ‘passive’ or ‘active’ 
participatory types. A review of the extent to which SDM occurs, demonstrated some 
mixed findings and several mediating factors. It was suggested that given the dynamic, 
complex, and personal nature of the doctor-patient relationships, the type of decision-
making model adopted at the beginning of the consultation may not operate accordingly to 
the patients’ ideal form. For example, a clinician who favours a shared model and takes an 
SDM approach during consultations, may find, through the course of interaction and 
information exchange, that the patient has gained enough confidence and gathered enough 
information to make the decision on his or her own. At this point, the process might shift 
from a shared model to an informed decision-making model, as a result of the learning that 
has occurred in the interaction itself. As a result, research suggests that medical decision-
making needs to be modified to reflect the needs of patients.  Furthermore, the literature 
review highlighted the lack of qualitative enquiry and subjective experience concerning 
SDM for breast cancer patients, and in addition to the issues stated above, cemented the 
rationale for this thesis. 
 As outlined in Chapter One, there is no research which has explored SDM through 
the patients’ experiences, as the health psychology literature remains largely medical, and 
SDM has been studied largely through examination of patient health outcomes. This, 
therefore, instigates whether a qualitative enquiry, through exploring patient perspectives 
and interactions, has more significance in assisting our understanding of SDM. To truly 
understand the actual processes involved in SDM for the treatment breast cancer, a more 
comprehensive exploration of the lived experience of the patient is required. To find this 
undocumented experience and method of enquiry, Chapter Three discusses the theoretical 
frameworks and research methodology of this thesis. 
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 Chapter 3 
 
Exploring patient experiences: theoretical and methodological framework 
 
3.1 Introduction 
The previous chapters outlined the research questions which this thesis aims to address. 
They also reviewed the literature on models of decision-making, paying particular attention 
to decision-making in the context of health care. Chapter One outlined the thesis aim, 
which is to explore breast cancer patients’ experience of SDM, through three distinct 
studies. The first being a semi-structured interview study, which aims to capture the 
patients’ experience of SDM from their perspectives and encounters. The second study is 
an online forum study, which explores the patients’ experience of SDM from analysis of 
peer interactions within breast cancer forums. The final study is an audio-recorded study, 
which seeks and interprets how patients might experience SDM from analysis of the 
conversations which take place between patients and clinicians during a medical 
consultation.   
 To understand why SDM needs to be explored qualitatively through patient 
experiences, and to understand how an insight into patient experience can be obtained, it is 
important to outline the chosen methodology and theoretical framework of the thesis as a 
whole. In this chapter, phenomenology and symbolic interactionism as theoretical 
frameworks, and qualitative research, are discussed in relation to health psychology and 
the research questions.  
 
 
3.2 Theoretical approach 
 
What is decision-making? Although this may sound like a simple question, especially since 
most people can apparently provide everyday examples of decision-making, the answer, 
however, is by no means clear. According to Owens (2001) the topics that are studied by 
health psychologists, such as health behaviours (e.g. decision-making), experience of 
disease and suffering, and the meaning of illness, “must be open to question and critical 
examination (p.263). As biomedicine and health psychology are ideological and 
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ethnocentric in nature (Stainton Rogers, 2002), critical perspectives within health 
psychology have gathered momentum in the past few years.  
 The discipline of critical health psychology “aims to analyse how power, 
economics and macro-social processes influence and/or structure health, health care, health 
psychology, and society at large” (Mark, 2002a, p. 15). The approach provides diverse and 
conflicting views about the direction and shape of the field of health and illness (Mark, 
2002b). The thesis is situated in the realm of critical health psychology, in an attempt to 
develop new psychological ways of conceptualising medical SDM for the treatment of 
breast cancer. It is also in line with the four inter-related areas of the critical health 
approach, in that is has: 1) theory that is typically reflexive, relational, moral and 
experiential; 2) a focus on contexts that take into account social justice and an appreciation 
of the meanings of culture as transitional; 3) research methods that are critical, qualitative 
and ethical; and 4) practice that is enabling, community-based and empowering for 
participants (Murray, 2004). Critical health psychology research focuses on experience and 
meaning, and giving a voice to the ill. It also asks questions that bring to the fore issues of 
power-relations. Such basic principles of critical health psychology are related to the 
underlying aims of this thesis, which focus on exploring patients’ experiences and 
understandings on SDM in the medical context of breast cancer. Furthermore critical 
health psychologist focus on the use of various qualitative research methods, based on 
social constructionist epistemology, and interpretivisit perspectives (e.g. phenomenology 
and symbolic interactionism) and methodologies (e.g. phenomenological research, 
discourse/conversation analysis) (Hepworth, 2006). These principles provide greater 
insight into the experience of health and illness (Chamberlain, Stevenson, Lyons, 1997; 
Murray & Chamberlain, 1999), which therefore further situates the topic of this thesis and 
the research questions proposed within the domain of critical health psychology.  
 The thesis emphasises the underlying philosophical assumptions and 
methodological approaches of phenomenology and symbolic interactionism, both as useful 
theoretical frameworks for gaining a deeper understanding surrounding the experience and 
meaning of SDM, amongst women undergoing treatment for breast cancer.  These two 
methodological frameworks will now be explored more thoroughly. 
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3.2.1 Phenomenology  
Since Strauss and Glaser’s (1975) pioneering work on the use of grounded theory to 
understand the meaning and experience of chronic illness, from both sufferers and their 
families’ own perspectives, interest in studying the meanings and experience of chronic 
illness has grown (Anderson & Bury 1988; Bury 1991; Williams, 2000). The past decade 
has brought an increasing focus on understanding how patients experience illness and 
health care. Arguably, this is due to an increasing growth in the number of people who 
expect to be involved in their care, and want to be sure that the received services are of the 
highest quality and safety (Holme, 2009). Patients offer a complementary perspective to 
that of clinicians, providing unique information and insights into both the humanity of care 
and the effectiveness of health care. Subsequently, it is suggested that the experiences of 
patients are a key component of the quality of healthcare, and as a result it is suggested that 
research should increasingly focus on understanding and improving patient experience 
(National Clinical Guideline Centre- NCGC, 2012).  
 Phenomenology, is a field of inquiry which argues that human beings are not 
passive perceivers of an objective reality, but rather that they come to interpret and 
understand their world by actively engaging with it (Sokolowski, 2000). The 
phenomenological perspective assumes that human action depends upon the meanings that 
people ascribe to their situations and actions. It has been suggested that such a perspective 
involves the use of detailed description and close analysis of individuals lived experiences, 
to understand how meaning is created through embodied perception (Sokolowski, 2000). 
Through close examination of individuals’ experiences, phenomenological analysts seek to 
capture the meaning and common features, or essences, of an experience or event. As a 
theoretical framework, it is rooted within the principle that the most basic human ‘truths’, 
are only accessible through the subjective view of the individual experiencing reality 
(Merleau-Ponty, 2012). This notion is consistent with a phenomenological life-world 
approach. According to Schutz (1966), this approach is defined as the world in which we 
as humans among other fellow humans, experience culture and society, take a stand 
regarding objects, are influenced by them, and act on them. Drew (1989) argued that the 
life-world consists of “social, practical, experiential, and taken for granted dimensions” 
(p.6). Howitt (2010) states that taking a life-world approach, involves a systematic inquiry 
and understanding of conscious experience from the person experiencing it. 
Phenomenology is, therefore, argued to be a critical reflection on conscious experience, 
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rather than subconscious motivation, and is designed to uncover the essential invariant 
features of that experience (Jopling, 1996).  
 Researchers suggest that a persons’ experience is seen as unfixed and enriched with 
meaning, which only emerges when consciousness engages with it (Crotty, 1998; Raphael, 
2000). As the aim of this thesis, as a whole, is to explore patient experience of SDM from 
the patient’s perspective, a phenomenological perspective is employed for the purpose of 
the first study. This is a semi-structured interview study aimed at exploring patients’ 
encounters and understandings of SDM from their perspectives. This will allow for greater 
understanding about the concept of SDM, as well as what it means to patients and how it is 
experienced. In addition, by examining of how SDM is perceived, from the point of view 
of patients having experienced it, this allows for a greater insight into the presence of 
SDM, and to explore how factors can influence (hinder or facilitate) patient experience of 
SDM. In order to apply this phenomenological approach to the first study of this thesis, it 
is important to determine which phenomenological framework is most appropriate.  
 The two approaches that guide phenomenological investigations are descriptive 
phenomenology (Husserlian, 1970) and interpretive phenomenology (Heideggerian, 1962). 
In both the interpretive and descriptive methods, the aim is to capture the descriptions of 
the lived experiences, as described by the participants. Kleiman (2004) suggested that in 
the interpretive method, the researcher uses prior knowledge and insights to interpret 
hidden meanings, with the goal of producing a vivid textual representation of the 
phenomenon described.  This achieved through interpretative phenomenological analysis 
(IPA), which is tied to a Heideggerian phenomenological epistemology (Smith, Jarman, & 
Osborn, 1999; Smith & Osborn, 2003), and is theoretically rooted in critical realism and 
contextualism (Larkin, Watts & Clifton, 2006). IPA is phenomenological in that it seeks an 
insider perspective on the lived experiences of individuals (Holloway & Todres, 2003), and 
interpretative in that it acknowledges the researcher’s personal beliefs and standpoint and 
embraces the view that understanding requires interpretation (McLeod, 2001). In contrast, 
in descriptive phenomenology, the researcher analyses the descriptions given by 
participants and divides them into meaning-laden statements, which are essential to the 
phenomenon being studied. For the purpose of this thesis, a descriptive phenomenological 
approach is regarded as appropriate for study one and two. By employing a descriptive 
phenomenological approach, this would allow for deeper exploration of phenomena, at the 
descriptive semantic level, setting aside any researcher preconceptions or subjectivity. 
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Therefore, the lived experience itself, as described by patients, is used to provide 
description of their experiences of SDM.  
 
 Descriptive phenomenology is achievable through qualitative data collection, and 
analysis which focuses on scrutinising the text for ‘meaning units’. These are then 
synthesised, to provide a general description of the whole central aspect of patient 
experience of SDM. It is important to note that there are numerous methodological 
approaches within descriptive phenomenology.  The steps consistently outlined as essential 
in the descriptive phenomenology method of inquiry include: bracketing, analysing, 
intuiting, and describing (Colaizzi, 1978; Giorgi, 1997). Figure 3.1 illustrates the steps 
within the process of descriptive phenomenological data analysis, created by Colaizzi 
(1978).   
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 A summary of Colaizzi's (1978) strategy for the process of descriptive 
phenomenological data analysis. Source: Shosha (2012), pg 34 
 
Chapter Three 
57 
 
According to Shosha (2012), the accurate application of Colaizzi's process of descriptive 
phenomenology provides an exhaustive description about human experience, as it includes 
understanding the data and identifying significant statements, which in turn are converted 
into formulated meanings. This strategy will be employed within the data analysis of study 
one and two by means of a thematic analysis (TA). Similar to IPA, TA is characterised by 
theories such as critical realism and can be underpinned by phenomenology, as its 
analytical procedures acknowledge the ways individuals make meaning of their 
experience, and, in turn, the ways the broader social context impinges on those meanings 
(Willig, 1999). This makes it a useful method of analysis for this thesis, in exploring the 
how women with breast cancer experience SDM. However, unlike IPA, the hallmark of 
TA is its theoretical freedom and flexibility, as it can be essentially independent of theory 
and epistemology, and can be applied across a range of theoretical and epistemological 
approaches. This makes it a suited analytical method for study one and two, as a 
phenomenologically-informed TA can be applied to Colaizzi’s process of descriptive 
phenomenology, which also fits both studies epistemological approach of inductive-
realism. TA can also be used to provide rich and detailed analysis from a range of 
qualitative data (e.g. focus groups, diaries, qualitative surveys, secondary sources, and 
story completion tasks), other than qualitative interviews, which is how IPA ideally 
collects data (Smith, Flowers & Larkin, 2009), and, therefore, makes it applicable to the 
online forum data in study two. Moreover, as both studies one and two involve working 
with larger samples, which do not require IPA’s ideographic focus, and focus on the 
patterning of meaning across participants and the data-set, this, therefore, further supports 
the use of TA. 
 The thesis as a whole also deals with exploring SDM through conversations, which 
requires another theoretical perspective. The second study in this thesis focuses on 
exploring SDM through the analysis of interactions, between peers, within online breast 
cancer forums. The third study explores SDM through the conversations that take place 
between patient and clinician, during medical consultations. Subsequently, this introduces 
symbolic interactionism as the second theoretical framework deemed appropriate for this 
thesis. 
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3.2.2 Symbolic interactionism 
 
The second theoretical framework applicable to this project is symbolic interactionism. 
Symbolic interactionism is a major framework of sociological theory. It was formulated by 
Blumer (1969) and its perspective relies on the symbolic meanings that people develop and 
rely upon in the process of social interaction. For symbolic interactionists, ‘meaning’ is 
one of the major elements in understanding human behaviour, interactions and social 
processes within particular contexts. In this regard, Osborne (1994) stated that symbolic 
interactionists have much in common with phenomenologists, in their emphasis on the 
individual’s lived experience, the inner world of human behaviour, the notion of meaning 
perceived by the participant, and understanding a situation from the participant’s point of 
view.  
 The symbolic interactionist theory consists of three core principles: ‘meaning’, 
which states that humans act toward people and situations based upon the meanings they 
ascribe to those people or situations; ‘language’, which allows humans to negotiate 
meaning through symbols during speech with others; and ‘thought’, which modifies each 
individual’s interpretation of symbols (Griffin, 1997). According to Griffin (1997), these 
core principles lead to conclusions about the creation of a person’s self and socialisation 
into a larger community. For example, social interactionists state that people behave on the 
basis of what they believe and not just on what is objectively true. Therefore, society is 
thought to be socially constructed through human interpretation. People interpret one 
another’s behaviour, and it is these interpretations that form social bonds. Regarding the 
notion of ‘self’, social interactionists assert that the person and the world cannot be 
understood in isolation, because the ‘self’ is being continually developed through 
interaction with other human beings and participation in society (Cooley, 1964; Mead, 
1933). This process is often referred to as the ‘looking-glass self’, which means that 
individuals have the capacity to reflect upon oneself through the process of taking the role 
of the other, and imagining how they would look to another person (Cooley, 1964). As a 
result of such skill, it has subsequently been argued that the looking-glass self enables 
human beings to develop the sense of ‘social self’ (Morris, 1977).  
 
 Symbolic interactionism can be considered as a second theoretical approach in this 
thesis, suited for studying how breast cancer patients might experience SDM. According to 
Boden (1990) the ordinary or important talk of people in their everyday world, is the very 
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sinew of social interaction. Boden (1990) further argues that one way of characterising talk 
is as ‘language-in-action’, and it is here, as thought becomes action through language, that 
conversation analysis meets symbolic interaction. Symbolic interactionists have long been 
concerned with language, thought, meaning, shared symbols, and social acts. These 
concepts hold relevance to the research question, for example, as this facilitates exploration 
the subjective experience of SDM constructed through patient interaction, and how 
language can be interpreted to give meaning to patients’ personal encounters of SDM.  
 
 The methodological position for symbolic interactionism proposes that to 
understand the meaning and experience of SDM, research needs to look into the 
interpretations and meanings that patients ascribe to their actions, interactions, and 
situations. This subsequently makes language a central medium for transmitting meaning 
to such interactions and the object of experience. The meaning of a word is taken to be 
what it references, corresponds with, or stands for in the real world. This is based on the 
premise that the essential task of language is to convey information and describe ‘reality’. 
Therefore, research must be able to see things from a patient’s point of view, and in their 
natural context. This is of particular relevance to breast cancer research, as the life 
threatening chronic illness presents and reflects a deeply personal existential crisis (Frank, 
1995). Therefore, an approach which offers an insight into the suffering as it is lived 
during the cancer journey, and narrates the role and range of cancer beliefs and attitudes 
following life threatening diagnosis, is of importance (Frank, 2000). Subsequently, through 
exploring the symbolic meanings attached to personal experiences of breast cancer, this 
helps to construct the realities of breast cancer and decision-making behaviour, through the 
strategic health-seeking choices and beliefs patients make during social interaction. 
  According to Charles et al (1999a) decision-making, and SDM in particular, 
involves some form of partnership and interaction between the patient and significant 
others (i.e. medical professionals, family, support group member). Therefore, the study of 
social interactions, and the meanings ascribed to those interactions, becomes important to 
this thesis. It allows for greater understanding about the concept of SDM, how it is 
encountered, and what it means to patients. In addition, by examining of how SDM is 
verbalised or exchanged, this allows for a greater insight into the presence of SDM, to 
explore how patient experience of SDM can be influenced (hindered or facilitated). 
Consequently, for the purpose of this thesis, a symbolic interactionist approach is used in 
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two separate studies: in study two, to explore the social interactions amongst breast cancer 
patients within online forums; and in study three, to examine interactions between the 
patient and clinician, during breast cancer consultations. This will produce a deeper 
understanding of the relationship between breast cancer care, patient experience, and SDM. 
 In conclusion, as the aim of the thesis is to explore SDM through patients’ lived 
experiences, i.e. their perspectives and interactions, for the purpose of this thesis, symbolic 
interactionism and phenomenology will serve as the theoretical frameworks to examine 
breast cancer patients’ experience of SDM. The relevance of these two approaches will 
now be discussed in more detail in relation to the discipline of health psychology, research 
in the field of cancer, and the existing research on SDM. 
 
 
 
3.2.3 The relevance of phenomenology and symbolic interactionism to health psychology 
 
 
Phenomenology and symbolic interactionism, both as philosophical and methodological 
approaches, have been used in organisational and consumer research in order to develop an 
understanding of complex issues that may not be immediately explicit. It has been 
suggested that both of the theoretical frameworks have particular relevance for health 
psychology (Smith, Jarman & Osborn, 1999). Health psychology assumes a connection 
between physical condition, cognition, and verbal response. As research moves away from 
the biomedical model of disease, where observations of biological processes are seen as 
predictable illness experiences, there is, therefore, increasing recognition of understanding 
patients’ perceptions and interpretation of their bodily experiences, and the constructed 
nature of illness (Leventhal, Nerenz & Steele, 1984).  
 Schutz (1966) argues that chronically ill people experience their constructions 
(‘beliefs’) as reality, and their constructions reflect their understandings of their 
experiences as well as the diverse situations in which they have them. Some patients 
struggle to make their constructions plausible or negotiable. Others may use their 
constructions to challenge or contradict medical professionals. What interpretivist 
approaches, like phenomenology and symbolic interactionism, do is subsequently provide 
an alternative understanding of patients’ beliefs and actions than those readily available in 
clinical settings.  According to Beck (1994), through interacting with patients and focusing 
on people’s interpretations of the meaning of the phenomena they encounter, a deeper 
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understanding of their perceptions, experiences, and needs is developed.  As a result, 
medical professionals and health care establishments may use these understandings to 
improve medical communications and to act on problems defined by patients.  
 There is a significant amount of work in health psychology, which use 
phenomenology or symbolic interactionism to understand and explore chronic illness 
(Åsbring & Närvänen, 2002; Fox & Chesla, 2008; Karp, 1996; Ohman, Soderberg & 
Lundman, 2003; Woodgate, 1998). Studies adopting a phenomenological framework 
acquire a common goal, which is to understand the complex world of lived experience and 
the meaning of chronic illness, from the point of view of patients living it. Understanding 
of the phenomenon is gained through patients’ accounts and interpretations of their 
experiences or actions.  Such a phenomenological method of enquiry has been 
predominantly used to explore topics, such as the impact of chronic illness on QOL 
(Holmes, Coyle, & Thomson, 1997; Michael, 1996), and health care relationships during 
chronic illness (Fox & Chesla, 2008; Thorne & Robinson, 1988). Alternatively, studies 
employing a symbolic interactionist approach are concerned with examining the interaction 
between the different role players in health and illness. The focus is on how illness and the 
subjective experience of being sick are constructed through the doctor-patient exchange. 
The argument here is that health and illness are social constructions (Lorber & Moore, 
2002). This means that various physical and mental conditions have little or no objective 
reality, but instead are considered healthy or ill conditions, only if they are defined as such 
by a society and its members. Clinicians ‘manage the situation’ to display their authority 
and medical knowledge. Subsequently, the symbolic interactionist approach informs that 
health and illness can have a subjective as well as an objective reality. This approach is 
predominantly present within the nursing and women’s health literature to explore patient-
nurse interactions (Benzies & Allen, 2000; Shattell, 1997). It is also used to understand 
topics about stigma attached to illness (Åsbring & Närvänen, 2002; Stevens & Hall, 2007), 
and the role of illness on body and identity (Charmaz, 1983 & 1995; Thoits, 2013; Waskul 
& Vannini, 2006). 
 Consequently, both phenomenology and symbolic interactionism allows research, 
within the health psychology field, to explore subjective experiences, as a participant’s 
account will provide an entrée to that perceptual process. For both theoretical frameworks, 
emphasis is on interpretivism and on inductive logic (also known as ‘bottom-up’ research), 
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as they seek participants’ opinions, subjective accounts, and interpretations to guide the 
research to understand how illness affects the lived experiences. According to Raimundas 
and Darulis (2007) in order to provide meaningful evidence-based health research, 
attention needs to be given to patients’ lived experiences; patients’ understanding of 
health-related issues and situations; and the social interactions within which patients gain 
meaning and insight about their situation and illness.  
 
 
 
3.2.3.1 The relevance of phenomenology and symbolic interactionism to cancer research 
 
With specific attention to cancer research within the field of health psychology, 
phenomenology and symbolic interactionism have been widely used approaches to explore 
the lived experience of cancer for patients. Topics on the screening, diagnosis, treatment, 
and survival of cancer have been explored phenomenologically (Lyons, Jacobson, Prescott 
& Oswalt, 2002; Potter, 2004; Pascal 2010; Phillips & Cohen, 2011). The method used 
within these phenomenological enquiries consisted of qualitative semi-structured 
interviews with cancer patients, to acquire an insight into patients’ meanings and 
encounters of their illness. In relation to breast cancer, phenomenology has also been 
applied to elicit the experience of breast cancer (Cohen, Kahn & Steeves, 1998; Coward, 
1990; Luoma & Hakamies-Blomqvist, 2004; Moch, 1990); the meaning of breast cancer 
(Allen, 2002); breast cancer survival (Cater, 1993; Thibodeau & MacRae, 1997); and 
doctor-patient working relations (McWilliam, Brown & Stewart, 2000).  
 More relevantly, phenomenology has also been applied to research aimed at 
understanding the phenomenon of making decisions during the experience of breast cancer. 
For example, in a study by Hack et al (1994), semi-structured interviews were conducted 
with 35 breast cancer patients to examine their preferences for decision-making, based 
upon their breast care experiences and meanings ascribed to the concept of patient-
involvement. In another similar, recent study, in-depth interviews were conducted with 18 
breast cancer patients who had completed treatment, to phenomenologically provide an 
understanding of the broad range of decisions with which women may be faced, and 
present an interpretation of what the experience of making decisions is like for women 
diagnosed with breast cancer (Halkett, Arbon, Scutter & Borg, 2007).  Phenomenology 
within both of these studies played a useful role in advancing health researchers and 
professionals understanding of the decision-making process, from the patients’ 
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perspectives. This in turn enabled medical professionals to improve their therapeutic 
relationships with patients, and further assisted women as they worked through their 
experience of breast cancer. 
 
 Similarly, research exploring patient experiences of cancer has also been carried 
out with a symbolic interactionist approach. For example, topics such as the impact of 
cancer on the self (Fife & Erc, 2000; McClement, 2005; Wilson &Luker, 2006), and 
relationships between the patient and medical professionals, families members, and group 
therapy participants (Cline et al, 2006; Rustøen & Hanestad, 1998) have been explored 
from a symbolic interactionism theoretical framework. These focused on studying patient 
perceptions of social interaction, and exploring language to access cancer patients’ 
experience and understanding of their illness. Methods used in these studies tended to 
consist of qualitative recorded observations, conversation analysis (CA), and semi-
structured interviews. With specific attention to breast cancer, a symbolic interactionist 
approach has also been applied to elicit meaning and experience in the context of breast 
cancer (Chalmer & Thomson, 1996; Ching, Martinson & Wong, 2009; Collie & Long, 
2005; Degner, Hack, O'Neil & Kristjanson, 2003; Halstead & Hull, 2001; Suh, 2008; 
Taleghani, Yekta, Nasrabadi & Käppeli, 2008; Zebrack, 2000), and to explore the lived 
experience of breast cancer treatments and side-effects (Collins, Nash, Round & Newman, 
2004; Halkett, Kristjanson & Lobb, 2008).  
 A study by Balneaves, Truant, Kelly, Verhoef and Davison (2007), is more relevant 
to decision-making and breast cancer research, and contained a theoretical assumption of 
symbolic interactionism, to explore the social and personal processes that breast cancer 
patients engage in when making treatment decisions. The method of in-depth semi-
structured interviews was conducted to explore how decisions are made and the challenges 
experienced by patients. The role of symbolic interactionism in this study was to access the 
patients meaning of ‘treatment choice’ and ‘patient involvement’, and their interpretations 
of decision-making situations during their cancer journey. Symbolic interactionism within 
this study played a useful role in providing a conceptual framework for enhancing future 
decision support interventions and strategies, needed to ensure breast cancer patients make 
informed decisions. 
 In conclusion, the health psychology literature, as outlined above, indicates the 
growth of interpretative approaches in informing knowledge on diverse subjects, such as 
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cancer, and breast cancer in particular, within the more general field of health psychology. 
Subsequently, this promotes attention to an area of health research, where the priority is to 
understand the patients’ subjective experience of health and illness; and the patients’ 
meanings and interpretations of these experiences, from their unique perspectives and 
interactions with others and the environment. Due to medical treatment being a science, 
concerned with human responses to actual and potential health problems, medical 
professionals, therefore, must acquire specialist knowledge which reflects the lived and 
contextual realities, and the concerns of the patients (Meleis, 1996). Meleis (1996) further 
stated that it is important for medical scholars to develop knowledge that is culturally 
relevant, and respectful of the social realities of those living within the situation. Symbolic 
interactionism and phenomenology, therefore, can play an important role in allowing 
medical researchers to achieve the specialist knowledge required. 
 
 
3.2.3.2 Has SDM been previously explored through a phenomenological or symbolic 
interactionist approach? 
The nursing and medical literature reveals little research on SDM within these 
philosophical approaches. What has been predominantly written about SDM tends to 
reinforce the biomedical or bio-psychological view of health and illness, which focuses on 
physical processes that affect and improve health. This, therefore, loses sight of the 
concept of SDM as a whole process, as the ways in which patients experience illness and 
SDM, based on environmental and societal factors, are not accounted for. Instead, as 
outlined in Chapter Two, research on SDM and breast cancer in particular aims to evaluate 
the process of SDM on improving patient physical and psychological health outcomes. 
These health studies are frequently conducted through a positivist theoretical framework, 
with a deductive approach which employs quantitative research methods. These studies 
evaluate the bio-medical effectiveness of the process of SDM, through the use of surveys 
and questionnaires, to measure improved patient health (Moyer, 1997; Silliman et al, 1998; 
Street & Voigt, 1997); higher physical functioning and emotional well-being (Greenfield et 
al, 1985; Kaplan et al, 1989; Whelan et al, 1999); treatment adherence (Sepucha et al, 
2000); and reduced side-effects (Hack et al, 2006).  
 As a result, there is limited research on SDM which takes an interpretivist 
approach. Arguably, to be able to thoroughly explore the process and experience of SDM 
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for cancer patients’, a need exists to study the phenomenon from the perspective and 
interaction of the patient. This thesis subsequently seeks to fill the gap in the literature, by 
employing theoretical frameworks, based on the interpretivist approaches of 
phenomenology and symbolic interactionism, to exploring the experience of SDM from the 
patients’ perspective, interaction with peers, and communication with consultations. Its 
aim is to uncover the nature of SDM, experienced by patients, through listening to the 
accounts of women with breast cancer, exploring their lived experiences in their 
conversations with other breast cancer patients, and assessing the interactions which take 
place for decision-making between patient and clinician.  
 
3.3 Qualitative methods 
As with all research endeavours, choosing the method that is best suited to the line of 
inquiry is vital in obtaining the desired results. A judicious choice of method guides the 
research toward the intended aims, and helps to ensure that its products are useful and well 
received. For many social scientists, the choice of a particular research method is also 
inextricably linked to a particular theoretical perspective. It is important for research to 
discuss methods in relation to philosophical foundations. For the purpose of this thesis, 
both of the outlined theoretical frameworks above will now be examined and rationalised 
in relation to qualitative research. 
 
 Qualitative research methods enable the researcher to delve into questions of 
meaning, examine practices and processes, identify barriers and facilitators to change, and 
discover the reasons for the success or failure of interventions. Denzin and Lincoln (1994) 
broadly define qualitative research:  
“Qualitative research is multi-method in focus, involving an interpretive, naturalistic 
approach to its subject matter. This means that qualitative researchers study things in 
their natural settings, attempting to make sense of, or interpret, phenomena in terms 
of the meanings people bring to them. Qualitative research involves the studied use 
and collection of a variety of empirical materials- case study, personal experience, 
introspective, life story, interview, observational, historical, interactional, and visual 
texts- that describe routine and problematic moments and meanings in individuals’ 
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lives. Accordingly, qualitative research deploys wide range of interconnected 
methods, hoping always to get a better fix on the subject matter at hand”. (p. 2)  
 
From the quote above, it is understood that qualitative research embraces an ontology and 
epistemic foundation that values participant’s own interpretations of reality and, therefore, 
assumes that reality is socially constructed by individuals, from within their own unique 
contextual interpretation. Denzin and Lincoln (2005) suggested that since the qualitative 
researcher embraces an ‘internal reality’, qualitative research cannot embrace an objective 
epistemology and, therefore, knowledge comes from a deep understanding of the meanings 
people attach to their experiences, and interpretations of the social world. Qualitative 
methods, therefore, try to interpret social phenomena in terms of the meanings people 
bring to them, and because of this, it is often referred to as interpretative research. 
According to Bauman (1990), qualitative research refers to a process of  ‘de-familiarising’, 
whereby rather than simply accepting the concepts and explanations used in everyday life, 
qualitative research asks fundamental and searching questions about the nature of social 
phenomena. Qualitative research, therefore, focuses on studying people in their natural 
setting and, therefore, largely depends on watching people in their own territory, and 
interacting with them in their own language.   
 
 Due to different theoretical positions, qualitative research is neither unified nor well 
defined. The distinctions between the various theoretical stances are frequently presented 
as clear-cut, but in practice the contrasts are often less apparent. Therefore, there is 
considerable debate about what constitutes the central tenet of qualitative research. For the 
purpose of this thesis, the choice of method of enquiry and how it is used is informed by 
the theoretical underpinning of the project.  
 Both phenomenology and symbolic interactionism fit into the qualitative paradigm 
and, therefore, this was the method chosen throughout the thesis. It is apparent that the 
symbolic interactionist’s view of meanings, and the notion of socially constructed realities, 
blends well with the ontological and epistemological assumptions of qualitative research. 
As discussed above, symbolic interactionists believe that meanings are socially constructed 
creations, and it is through our interactions with the social world that we create meaning. 
Similar to symbolic interactionism, phenomenology also embraces an internal ontology, 
which assumes the only reality that exists is the one we interpret, through our interactions 
with symbols, culture and ourselves (Lindlof, 1995).  Phenomenological methods are 
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particularly effective at showing the experiences and perceptions of individuals’ from their 
own perspectives and, therefore, effective at challenging structural or normative 
assumptions. Pure phenomenological research seeks, essentially, to describe rather than 
explain, and to start from a perspective free from hypotheses or preconceptions (Husserl, 
1980). The purpose of the approach is to illuminate the specific, to identify phenomena 
through how they are perceived by the actors in a situation. In the human sphere this 
normally translates into gathering ‘deep’ information and perceptions through inductive 
methods, such as interviews, focus group discussions, and participant observation, and 
representing it from the perspective of the research participants. As such, phenomenology 
embraces qualitative methods. 
 
3.3.1 Qualitative methods and health psychology 
With the growth in interpretative approaches to researching health issues, research has seen 
an increase in the use of qualitative methods to explore phenomenological issues. Rather 
than more quantitative research of the clinical practice, focus has turned to exploring 
patients’ lived experience during illness, through qualitative approaches. Barbour (1999) 
stated that the growth of qualitative health research, implies that qualitative research is not 
only useful as the first stage of quantitative research, as it also has a role to play in 
validating quantitative research or in providing a different perspective on the same social 
phenomena. Therefore, it can force a major reinterpretation of quantitative data.  
Subsequently, with the development of qualitative methods within health research, the 
field of health psychology is now beginning to see an expansion in independent qualitative 
studies, used to uncover a range of health topics and to access areas of health-related 
quality of life (HRQOL) that are not open or amenable to quantitative research. These 
topics include constructions of disease, prevention, treatment, and risk (Charmaz, 1990; 
Pound et al, 2005; Walter, Emery, Braithwaite & Marteau, 2004; Young, Woods, 
Windridge & Heney, 2002); living with and managing the physical, psychological, and 
social effects of diseases and their treatments (Murray et al, 2007; Murray et al, 2010; 
O’Reilly, Finnan, Smith, Allwright & Shlomo, 1996); and factors enhancing or inhibiting 
quality care, and the promotion of good health (Davis, Jacklin, Savdalis & Vincent, 2007; 
Hagbaghery, Salsali & Ahmadi, 2004; Shiner, Whitley, Van Citters, Pratt & Bartels, 2008). 
It has been argued that qualitative methods can be used to considerable effect in evaluating 
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organisational reforms, and to provide changes to health service provision, from the 
viewpoint of patients, health professionals, and managers (Pollitt, Harrison, Hunter & 
Marnoch, 1991).  
 
 Many different qualitative methods are available to explore a patient’s 
understanding and experience of illness: these can be heard, seen, read; and/or can be told, 
performed, or written. Research reveals excellent examples of a variety of qualitative 
methods used in health psychology research. For example, clinical observations, focus 
groups, audio/written diaries, conversational data, online written data, and interviews are 
all used to engage patients in discussing in-depth information about their health 
experience, their perceptions, opinions, beliefs, and attitudes. Such qualitative methods are 
often known as a reflective intervention (retrospective methods) in clinical situations, as 
they can help patients reflect on their experiences, daily activities, and hidden aspects of 
their thoughts and feelings. Within all these qualitative methods, the pragmatic is that 
experience is shared and storied, and focus is on talk and action, rather than on number.  
 The process of either writing or speaking has been suggested to encourage 
participants to focus on daily activities and reflections that they value; and highlights 
hidden aspects of their thoughts and feelings (Campbell, 1992; Rancour & Brauer, 2003). 
As a result, narratives can provide a context that encompasses and inter-relates both the 
illness event and surrounding life events. In health research, the method of collecting 
patient stories of their care journey has gained importance in the study of chronic illness. 
For instance, Williams (1984) stated that chronic illness alters the relationship between the 
patient’s body, self, and surrounding world and, therefore, the reconstruction of a patient’s 
own story of their lived experience is of central importance, and makes it possible to give 
meaning to events that have occurred during that person’s health journey. Subsequently, 
Williams (1984) suggested that it is through the process of capturing the individuals’ story 
of illness, which enables research to comment on the narrative and to offer new 
interpretations and suggestions. Further exploration of specific qualitative methods (semi- 
structured interviews, online written analysis, and CA) in relation to theoretical 
frameworks of this thesis (phenomenology and symbolic interactionism) and SDM for 
breast cancer, will be outlined in more detail within the literature review at the start of  
Chapters Four to Six.  
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3.4 Conclusion 
This chapter outlined the theoretical framework of the thesis. Phenomenology and 
symbolic interactionism have been discussed in relation to its philosophical assumptions, 
and has been explored in relation to research within the field of health psychology, cancer 
research, and breast cancer. The SDM literature also highlights a lack of research which 
explores SDM through these theoretical approaches. The chapter also introduces the 
importance of qualitative research to this thesis, and ties it to phenomenology, symbolic 
interactionism, and medical decision-making in health research. Existing research on SDM 
reveals a deficiency in qualitative methods to explore the concept and practice of SDM. 
 This thesis sets out to explore SDM through a phenomenological and symbolic 
interactionist approach, and considers qualitative research as the appropriate method to 
conduct such an inquiry. To address the qualitative phenomenological side of the inquiry, a 
semi-structured interview study will be conducted with post-treatment breast cancer 
patients (Chapter Four). The study aims to take a phenomenological approach to capture 
patients’ perspectives and lived experiences of SDM, from their personal accounts, during 
their breast cancer journey. To address the symbolic interactionist framework of the 
inquiry by means of qualitative research, two additional distinct studies are presented to 
explore SDM. The first is an online breast cancer forum study (Chapter Five), which aims 
to explore patients’ experiences of SDM, though a study of the interactions which take 
place between patients online. The second study is an audio-recording study of breast 
cancer consultations (Chapter Six), which aims to explore the concept and presence of 
SDM, through the interactions which take place between doctor and patient during a 
medical consultation.  
 The next chapter will introduce the first of the three qualitative studies, which is a 
semi-structured interview study. Within the next chapter, a small literature review will 
introduce the study, followed by the method, results, and discussion. 
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Chapter 4 
 
Study 1: retrospective accounts of breast cancer and SDM 
 
4.1 Introduction 
The previous chapter explored theoretical frameworks and qualitative methodology, and 
drew attention to the increased recognition and importance of patients’ perceptions, 
experiences, and interactions within health psychology and research on illness. 
The previous chapter also introduced the roles of phenomenology and symbolic 
interactionism, as two theoretical bases, for an in depth exploration of breast cancer 
patients’ experiences of SDM, as this has been largely ignored in the existing health 
literature. These frameworks govern the ideology held within qualitative methodology, 
which is embedded in the three studies of this thesis.  
 This chapter introduces the first of three qualitative studies, which investigates 
patients’ experience of SDM through semi-structured interviews. In this chapter, a short 
literature review is provided which focuses on exploring the use of semi-structured 
interviews within health research, and as a qualitative method to access patients’ health 
experiences. Semi-structured interviews will also be discussed in relation to existing SDM 
research and their applicability in exploring SDM amongst breast cancer patients. 
Following the literature review, the method is described. This is then followed by a 
detailed explanation of the findings achieved through a TA of the interview data. The 
chapter is finally concluded with a discussion of the findings. 
 
4.2. Literature Review 
 
4.2.1 Accessing patient experience through interviews 
Interviews, explained by Britten (1997) are verbal interchanges, where one person, the 
interviewer, attempts to elicit information from another person, the interviewee. Watt 
(2011) stresses the importance of the retrospective conduct of qualitative interviews, as this 
is not only less intrusive, but it also recognises the cognitive and affective dimensions of a 
patient’s experience.  
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 There are three fundamental types of interviews that can be placed along a 
continuum. Structured interviews are, essentially, verbally administered questionnaires, in 
which predetermined questions are asked, with little or no variation, and with no scope for 
follow-up questions to responses that warrant further elaboration. Conversely, unstructured 
interviews do not reflect any preconceived theories or ideas, and have no obvious 
organisation to their structure (Silverman, 2010). Semi-structured interviews lie in the 
middle of this continuum, as they have some predetermined order, but still allow flexibility 
in the way issues are addressed by the informant. It has been suggested that semi-
structured interviews are a key qualitative method of data collection, which account for 
capturing patients’ lived health experiences, as they offer biographical narratives or general 
opinions (Pavis, Masters & Cunningham-Burley, 1996; Williams, 1984).  Centrally, semi-
structured interviews consist of open-ended questions to past experiences. This permits the 
individual to retell their personal story and experiences using their own spontaneous 
language. The desired minimal influence from the interviewer inhibits the presence of a 
questions-response-type interview, and instead leans more towards an everyday 
communicative interaction, namely personal story telling and listening. This allows areas 
to be explored, and from which the interviewer may divert in order to pursue an idea in 
more detail, which may not have been possible with more structured questionnaire surveys.  
 Across all three types of interviews, the key purpose of the research interview is to 
explore the views, experiences, beliefs and/or motivations of individuals on specific 
matters. Interviews are believed to provide a deeper understanding of social phenomena 
(Silverman, 2000). Therefore, they are most appropriate where little is already known 
about the study phenomenon, or where detailed insights are required from individual 
participants. They are also particularly appropriate for exploring sensitive topics, where 
participants may not want to talk about such issues in a group environment. Subsequently, 
the method has become popular amongst qualitative research and widely used in 
psychology. 
 
 
4.2.2 Qualitative interviews as a medium for phenomenology in health research  
 
Health researchers initially led the way for the use of interviews in social action research, 
particularly to identify problems in clinical practice and to develop potential solutions in 
order to improve practice (Hart & Bond, 1995). Research on health-related topics 
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continues to be a major area of interview research today. Medical advances, increasing 
specialisation, rising patient expectations, and the sheer size and diversity of health service 
provision mean that today’s health professionals work in an increasingly complex arena. 
The wide range of research questions generated by this complexity has encouraged the 
search for alternative ways of conducting research, which move away from quantitative 
research.  
 As mentioned in the previous chapters, the rapid expansion of research about health 
and the interest towards participants’ own meanings of health and illness, introduced the 
integration of qualitative methods into clinical research in the 1970s and 1980s. Williams 
and Popay (1994) suggested that “understanding the nature of lay knowledge requires an 
approach to data collection that is, in a sense, egalitarian, and most certainly 
phenomenologically open” (p.123). Therefore, for health researchers with an interest in 
accessing participants’ own meanings, interviews have been suggested to offer a valuable 
way forward (DiCicco-Bloom & Crabtree, 2006).  According to Warren and Karner 
(2005), the purpose of a qualitative interview is to contribute rich or in depth data to a body 
of knowledge that is conceptual and theoretical; and is based on the meanings that life 
experiences hold for the interviewees. Interviews are therefore a major source of data 
collection for phenomenologist and health research underpinned by phenomenology, and 
has an established position within critical health psychology, which makes its relevant to 
the research questions of this thesis. 
 
 For health researchers concerned with eliciting meanings, it is argued that 
qualitative one-to-one interviews are most often the method of choice (O’Connor, Wicker 
& Germino, 1990). Despite this assertion, some may use questionnaires (Harding & 
O’Looney, 1984), written accounts (Robinson, 1990), focus groups (Brody, 1990), and 
scales (Fife, 1995) to explore experience and meaning. However, interviews are most 
commonly illustrated as an ideal method of data collection, to those researchers concerned 
with the patients’ views, or those approaching health-related research from a theoretical 
perspective.  
 The words used to describe what is elicited from interviews can vary across 
research topics and with the theoretical bent of the researcher. For example, some 
researchers such as Fielding (1993) suggested that participants’ talk provides interviewers 
with information about their experiences; whereas other researchers use terms such as 
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‘understandings’ (Rubin &Rubin, 1995), ‘lay representations’ or ‘common sense beliefs’ 
(Williams & Popay, 1994), and ‘participant’s meanings’ (O’Connor et al, 1990). 
Regardless of which term used, it is understood from all these terms that the information 
gathered from interviews, tries to reflect and embody the meanings attributed by the 
participants themselves to their own experience. Subsequently, for health psychology 
researchers, the use of qualitative interviews allow for detailed exploration of individuals’ 
lived experiences of specific disorders and diseases, and the experience of living with 
chronic illness or disability.  
 In specific relation to breast cancer, semi-structured interviews are a popular 
qualitative method used for data collection. Research demonstrates the use of semi 
structured interviews as a key tool for breast cancer health assessment and service 
evaluations, through exploring patient experiences of doctor-patient communication 
(Roberts, Cox, Reintgen, Baile & Gibertini, 2009; Siminoff, Ravdin, Colabianchi & Strum, 
2000; Wright, Holcombe & Salmon, 2004), and patient preferences (Degner et al,1997; 
Keating et al 2002; Leydon et al, 2000; Simes & Coates, 2001). Semi-structured interviews 
have also been illustrated as an ideal tool for eliciting breast cancer patients’ meanings and 
understanding of health, through exploring experiences of psychological distress to cancer 
(Fallowfield et al, 1986; Fallowfield et al, 1990; Ganz et al, 1996; Spiegel, Kraemer, 
Bloom, Gottheil, 1989). Other studies have used in-depth interviews to explore patient 
perceptions of cancer (Woods, 1993), and the meaning of breast cancer on QOL (Luoma & 
Hakamies‐Blomqvist, 2004; Payne, 1992). Topics such as long term survivorship of breast 
cancer (Carter, 1993; Johnson, 2001) and the impact of breast cancer on relatives 
(Harrison, Haddad & Maguire, 1995) have also been explored through the method of semi-
structured interviews.  
 
 It is apparent that qualitative interviews are a method used within research on 
medical decision-making. Much of this literature focuses on exploring patients’ 
preferences for involvement in treatment decision-making, through semi-structured 
interviews (Beaver et al, 2005; Doherty & Doherty, 2005; Ende, Kazis, Ash & Moskowitz, 
1989; Ford et al, 2003; Hack et al, 1994; Say, Murtagh, Thomson, 2006); and to determine 
barriers and facilitators for patient involvement in decision-making (Wetzels et al, 2006; 
Wirrmann & Askham 2006). A more specific literature review on decision-making and 
breast cancer, also reveals the use of qualitative semi-structured interviews to explore 
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barriers to patient participation during treatment decision-making (Mills et al, 2006); 
patient perceptions of decision-making (Grunfeld et al, 2006); and to examine decision-
making styles (Harcourt & Rumsey, 2004).  
 
4.2.3 Exploring SDM through interviews 
Patients’ perspectives and experiences of medical decision-making can be explored 
through the method of semi-structured interviews, particularly amongst breast cancer 
patients. Research identifies the benefits of using qualitative methods to investigate 
patients’ experiences of treatment decision-making, and patients’ meaning of participation 
in medical decision-making. However, is this method of investigation also applicable to 
SDM research?  
 SDM is an area of research which has been explored by means of qualitative 
interviews. The focus of these studies was not to explore patients’ meanings about the 
concept, but to describe SDM and to evaluate its effectiveness as a tool in establishing 
patient involvement and partnership in health care. For example, studies have been carried 
out to distinguish the definition and processes of SDM through semi-structured interviews, 
carried out with patients and clinicians (Davis et al, 2003; Edwards & Glyn, 2006; 
Stevenson et al, 2000). Other qualitative studies have aimed to explore clinicians’ attitudes 
towards sharing decisions, through semi-structured interviews (McGuire, McCullough, 
Weller & Whitney, 2005; Thistlewait & van der Vleuten, 2004). Research has examined 
barriers to SDM by means of semi-structured interviews with clinicians (Suurmond & 
Seeleman 2006). These studies demonstrate that qualitative interviews are a well suited 
method for acquiring understanding about the concept of SDM, through individuals’ views 
and experiences. However, they fail to demonstrate, through the use of interviews, 
patients’ meanings and experiences of SDM through a theoretical perspective of 
phenomenology. Furthermore, none of the above qualitative interview studies on SDM 
have been conducted amongst breast cancer populations. Given the ‘preference-sensitive’ 
nature of breast cancer care, which implies that treatment options exist and decisions about 
interventions should be made by the patient in partnership with their clinician, an 
opportunity exists to design a qualitative interview study to explore breast cancer patients’ 
understandings of SDM and experiences during their treatment. 
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 There is little doubt that patients’ health experiences can be explored through 
qualitative methods. The literature review has outlined the benefits and use of semi-
structured interviews, as a method to capture and explore patients’ health experiences, and 
in relation to decision-making and breast cancer.  Although qualitative methods such as 
semi-structured interviews are shown to have been used to assess and evaluate the concept 
of SDM, the SDM literature, however, lacks examples of qualitative research which aim to 
explore the characteristics, meanings, presence, and experience of SDM for patients, 
through a phenomenological approach (i.e. through their perspectives and encounters). 
This, therefore, provides a rationale for the first study of this thesis. To elicit breast cancer 
patients’ ‘lay knowledge’ and ‘meanings’, the qualitative method of semi-structured 
interview, retrospectively, captures breast cancer patients’ health beliefs and experiences 
during their cancer journey. The next section of this chapter introduces the first study of 
this thesis, which, in line with the Heideggerian phenomenology (Heidegger, 1962), 
utilises a thematic analysis (TA) to provide an in-depth insight about what SDM means to 
breast cancer patients and how it is encountered.  
 
4.3 Methods 
4.3.1 Study design 
 
Semi-structured interviews were selected as a qualitative method of data collection with 
breast cancer patients, as they are suggested to be well suited for the exploration of the 
perceptions and opinions of respondents, regarding complex and sometimes sensitive 
issues; and enable probing for more information and clarification of answers (Barriball & 
While, 1994). The one to one semi-structured design of the interviews, allowed each 
participant unrestricted time to thoroughly reflect on their breast cancer journey. It also 
meant that participants could freely share their personal stories and accounts, with some 
questions asked by the interviewer to structure the flow and content of the interview. 
Therefore, it was important that each interview did not restrict the participants in their 
accounts, and instead allowed participants to share their experiences and perspectives in 
relation to SDM in more detail.  
 
 
Chapter Four 
77 
 
4.3.2 Pre data collection preparations 
Before collecting interview data on breast cancer patients’ experiences of SDM, it was 
important to explore specific aspects of medical assessments for breast cancer. This 
permitted greater understanding of the participants’ accounts of their cancer journey. In 
order to build a thorough understanding of the terminology and practice of SDM, in the 
clinical practice for breast cancer, it was essential to find out about the complete medical 
process and treatments from diagnosis to completion, and post-treatment. This also 
avoided assumptions about SDM based upon existing literature. While study one aims to 
explore individuals’ personal experiences of SDM relating to their clinical treatment, it is 
also equally important to become familiar clinical practicalities and situations, to 
understand more about the practice of breast cancer and the concept of SDM. To achieve 
this, on-going observation took place at breast cancer clinics and multi-disciplinary team 
(MDT) meetings. The observations were not intended as an independent observational 
study, and instead were utilised as an opportunity to become acquainted with medical 
practices, clinical procedures, and increase awareness of terminology related to breast 
cancer. 
 
4.3.2.1 Clinic observations: initial diagnosis clinic and post-surgery monitoring clinic 
Regular visits were made to two different types of breast cancer clinics for observation. 
These were an initial diagnosis clinic and a post-surgery monitoring clinic, which were 
observed weekly, over a four month period. Both clinics took place at the University 
teaching hospital’s Cancer Centre, once a week, by the same clinician who was an 
oncology surgeon. The aim of the observations was to gain an extensive understanding of 
breast cancer, and to observe the different types of consultations that take place during a 
patient’s treatment path. Attendance at these clinics provided the first opportunity to see 
patients talk about their illness, and to perceive the clinician’s and patients’ roles and 
duties within the consultations. The observations provided suitable insight into the 
phraseology, medical terms, procedures, and systems involved during breast cancer care. 
 
 The first clinic observed was an initial diagnosis clinic. Patients attended the clinic 
with a family member, partner, or friend for support. A breast care nurse was also present 
in the consultation room for additional support. Following a physical examination of the 
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breast by the clinician, patients were then informed about the outcomes of their test results 
and the next stages of the treatment process. Little interaction took place during 
consultation, as patients spent the majority of the consultation time listening to the 
clinician’s suggestions. Dialogue regarding diagnosis and proposed treatment was led by 
the clinician in terms of description, explanation and justification. Patient involvement was 
limited to asking the clinician questions about their treatment. The nurse remained inactive 
during the consultation and during the clinician’s interaction with the patient. However, at 
times when the patients showed emotions, the nurse provided verbal support for them and 
whoever else had attended the consultation. A more active part of the breast care nurse’s 
role was evident outside of the consultations, during one to one sessions with patients. The 
session took place immediately after the diagnosis consultation, in a room designed like a 
home living room. With comfortable sofas, plants, TV, and a kitchenette area for 
refreshments, the room was designed to give a sense of relaxation and ease. Patients and 
their partners/family members were invited to come to this room with the breast care nurse, 
after the initial diagnosis clinic. The time spent there, with the breast care nurse, generally 
allowed patients some personal time to reflect on their diagnosis and the information given 
by the clinician, outside of the clinic room. The nurse once more informed them 
thoroughly about their diagnosis and treatment plan, allowing them another opportunity to 
express any queries or doubts. This period allowed the nurse time to provide the patient 
with information packs, and to guide them with reading material.  
 
 The second clinic observed was a post-surgery monitoring clinic. On entering the 
clinic, a physical examination of the patient’s breast was conducted by the clinician. 
Patients were then informed about their progress in their treatment. These consultations 
were much more patient-led, in that they were focused on reviewing the patients’ health, 
QOL, emotional well-being, and any other concerns or issues with the treatment. 
Therefore, the clinician asked the patients regular questions and invited them to participate 
in talk, to check their health status. During the clinician’s talk, positive language and 
reassurance was used throughout the consultation, and adequate time was devoted to 
describing and explaining the next stages of treatment. More interaction between the 
clinician and patients took place, with patients frequently asking questions about their 
health status and treatment plan. A breast care nurse was present during these interactions 
to take medical notes, but did not interact in order to allow for focussed interaction 
between the clinician and patient. Upon completion of the examination, patients were taken 
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to another clinic consultation room, by the breast care nurse who had been present during 
the consultation, and given the opportunity to ask further questions. Information and 
treatments outlined by the clinician were once again explained by the nurse, and further 
support was given to patients. 
 
4.3.2.2 Multi-disciplinary (MDT) team meetings 
An opportunity to observe MDT meetings, revealed more details about the diagnosis of 
breast cancer, and how appropriate treatment choices were discussed by medical 
professionals. The MDT meetings took place weekly, at the University teaching hospital’s 
Cancer Centre, among all the breast care nurses, oncologists, and oncology surgeons. This 
was a collaborative period when discussions and confirmations focused on each patient’s 
diagnosis, prognosis, and treatment plan. During this time, it became clear how medical 
professionals deliberated over the appropriate treatment plan and decided whether, and at 
which stage of the treatment, SDM is appropriate for each patient. Based on the nature of 
each patient’s illness, decisions about whether surgical treatment was required, and which 
adjuvant follow-up treatments were of value, and related options were considered based on 
test results and statistical percentages, devised by scientific measures. Depending on the 
cancer grade, tumour size, and whether the cancer had travelled to the lymph nodes, the 
team identified whether a patient required a mastectomy or a lumpectomy, and whether 
SDM would be suited. Adjuvant treatments, such as chemotherapy, radiotherapy and 
hormone therapy, were also dependent on the nature of the diagnosis, and decisions 
relating to whether SDM is appropriate for the adjuvant stages of treatment were discussed. 
The task of decision-making during these MDT meetings rested heavily on scientific and 
medical guidelines.  The breast care nurses’ role during these meetings was to voice patient 
concerns. As patients do not attend these MDT meetings, the nurses ensured that patients’ 
views and opinions were expressed with respect to their treatment plan. The nurses also 
used this time to share additional information to the clinicians about the patients’ 
emotional well-being. By the end of the meeting, a consensus on treatment options and the 
role of SDM was reached by the surgeons, oncologists and breast care nurses for each 
patient.  
 
 Observation of the MDT meetings posed an interesting philosophical point, as it 
demonstrated that the presence and experience of SDM for each patient is dependent on the 
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severity and nature of their diagnosis and illness. Decisions as to whether a SDM 
consultation would be appropriate are made in advance during these MDT meetings. This, 
therefore, raises an interesting question, which is, do all patients experience SDM and at 
what point does the process of a shared model occur for patients? As a result, the 
observations of the MDT meetings helped to further rationalise this thesis and show why it 
is important to further explore the characteristics, meanings, and experiences of SDM from 
the patients’ perspectives and interactions. 
 The opportunity to observe both initial diagnosis clinics, post-surgical monitoring 
clinics; and the MDT meetings, provided a better understanding of breast cancer medical 
terms and stages of treatment, and revealed how a treatment plan is devised and negotiated. 
Such access to clinical practices and expansion of knowledge subsequently helped to 
facilitate the development of the study design and methods of data collection. 
 
4.3.3 Participants 
Breast cancer is widespread and occurs across different ages, genders, social classes, and 
races. Fifteen women aged 18 years and above, and diagnosed with breast cancer, were 
interviewed for the study. The majority (six women) of the participants interviewed were 
between 60-69 years old. All 15 participants were from a white British ethnic background. 
Table 4.1 below provides additional information on treatment profiles. Eight of the 
participants had indicated a family history of breast cancer. In reference to the discovery of 
the lump, nine participants had found the lump themselves, while the remaining six 
participants had the lump detected by means of routine mammograms. 
 All 15 participants had completed all breast cancer treatments two years prior to 
being recruited into the study.  The two year time frame was considered by the outpatient 
oncology breast surgeon as a suitable length of time for the participant to have adjusted 
from the emotional distress of the disease, whilst not being too distant from the onset of the 
disease to prevent recollection of events. This is an important consideration for ethical and 
data collection purposes. It allowed the women to participate in the interviews at a time of 
relative physical and emotional stability, rather than soon after diagnosis. 
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Table 4.1  
Participant demographic 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: M- Mastectomy, L- Lumpectomy, C- Chemotherapy, R- Radiotherapy, T- Tamoxifen 
 
Patients, who had opted for breast reconstruction following a mastectomy, were not 
included in the sample criteria. It was advised by the Oncology surgeons, as part of the 
research team, that reconstructive surgery entails its own dimension of decision-making 
and, therefore, is arguably a project in its own entity.  Focus was maintained on recruiting 
patients who only had to make surgical and adjuvant treatment decisions that related to the 
excision and management of disease. Whether individuals had had a specific breast cancer 
treatment (e.g. having had a mastectomy or a lumpectomy, or undertaking chemotherapy 
or radiotherapy) was not a criterion of consideration.  
 
4.3.3.1 Participant recruitment 
All participants were registered patients of the Oncology Department, at the University 
teaching hospital outpatient clinic. Following ethical approval and access from the 
P 
No’ 
Age  
 
Surgery Adjuvant 
treatment 
Other 
conditions 
Employment 
Status 
Marital 
status 
 
1 
 
40-49 
 
L 
 
C 
 
None 
 
Employed 
 
Married 
2 50-59 M C & T None Employed Married 
3 60-69 M C None Retired Married 
4 60-69 M None None Unable to work Married 
5 60-69 M C Diabetes Retired Married 
6 70+ M C None Retired Married 
7 60-69 L R Diabetes Retired Married 
8 60-69 L R & C None Retired Married 
9 40-49 M R, C &T  Depression Out of work Married 
10 40-49 L R & C None Employed Married 
11 60-69 M None None Retired Single 
12 50-59 L R & C None  Employed Married 
13 70+ M None Arthritis  Retired Married 
14 40-49 M C & T None Employed Single 
15 50-59 L R &T Arthritis Unable to work Married 
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Research and Development Department (R&D) at the hospital (section 4.3.7), the senior 
oncology breast surgeon granted access to his patient records. The patient list was filtered 
to identify patients who met the inclusion criteria. This resulted in 46 individuals, who 
were all sent a study invitation letter (appendix B)  by the clinician to take part in the 
study, along with a patient information leaflet (appendix C) and an agreement form 
(appendix D), which indicated their wish for participation. From the purposive sample, 15 
responded positively, nine declined, and the remaining 22 did not respond.  The sample 
size of 15 was agreed on and approved upon extensive discussions amongst the research 
team, taking into account the capacity and detailed nature of the research question. The 
practical guidelines for interviews recommended for qualitative research (Howitt, 2010; 
Smith, 2008) was also accounted for. 
 
4.3.4 Interview development 
The interview schedule was primarily used to ensure that the wording and sequence of all 
the questions in the interview were exactly the same for each participant, so that the 
interviewer can be sure that any differences in the answers are due to differences amongst 
the respondents, rather than in the questions. It is noteworthy that the interview schedule 
was to be used to guide the interview only, and not to direct it in any way. According to 
Pattron (2002), the primary aim of a semi-structured interview is to enable participants to 
talk openly about their views and experiences in their own words. Therefore, considerable 
flexibility was permitted with the interview schedule during the interviews, to ensure that 
data collection was largely participant-led. Where the interviewer contributed to the 
participants talk, they were encouraged to elaborate on their accounts and provide specific 
examples of their views and experiences through the use of interviewer probes, such as 
‘how did that make you feel?’ Such probes were proven to be a valuable tool for ensuring 
reliability of the data, as they allow for the clarification of interesting and relevant issues 
raised by the respondents (Hutchinson & Skodal-Wilson 1992). They also provided further 
opportunities to explore sensitive issues (Nay-Brock 1984, Treece & Treece 1986), and 
helped respondents recall information for questions involving memory (Smith 1992). The 
latter was particularly relevant to this sample of participants, as the retrospective nature of 
the interviews depended on participants’ ability to recall memories of their experiences and 
perceptions, from two years ago. However, caution was exercised as to the excessive use 
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of probes, as according to Howitt (2010), this can disrupt participants and create unhelpful 
diversions. 
 The focus of the interview schedule was to maintain a balance between disease-
related and decision-making material, to allow for an exploration of SDM to take place 
during the analysis; rather than an analysis of patient experiences and meaning of breast 
cancer. Therefore, it was important to develop a schedule which was both exploratory in 
order to elicit abstract concepts, such as perceptions and experiences, and sufficiently 
standardised to facilitate access to different views of SDM between respondents during 
analysis. To achieve this, the questions started broadly and then became more detailed. For 
example, the interviews invited sequential story from self lump discovery, to diagnosis of 
breast cancer, and then took a more in-depth approach to exploring decision-making. This 
structure was drawn from the initial clinic observations at the hospital (section 4.3.2.1), 
and mirrored the structure of a consultation, which starts broadly about the diagnosis and 
then becomes more detailed about treatment selection. This structure was also based on the 
guidance of Howitt (2010), who described how it takes time to build up trust and rapport 
with participants and, therefore, it is important to move slowly towards the main area of 
interest during an interview.  
 The interviews started with basic background information questions, such as ‘how 
long ago were you diagnosed?’, and ‘what treatment(s) did you undertake?’ These 
questions were taken from the initial clinic observations made, and were included in the 
interview schedule to establish a clear account about the participants’ medical history, in 
relation to their breast cancer.  The interview then went on to asking participants questions 
surrounding their knowledge on breast cancer treatments, and whether these changed over 
time.  For example, questions such as, ‘can you describe how much you knew about breast 
cancer and treatments before you were diagnosed?’, were asked, to explore the type and 
frequency of information and communication style they received, as well as to discuss any 
information seeking behaviour.  These questions were drawn from an engagement with the 
existing literature on doctor-patient communication and patient participation, to acquire an 
insight into how patients were informed and whether this had an impact on their decision-
making.  To avoid the data becoming too disease-orientated, the next stage of the interview 
schedule focused on specific questions which directed the interview towards the topic of 
decision-making. For instance, participants were asked questions, such as ‘to what extent 
did you feel involved in choices of treatment /care offered to you?’, so they could recall 
Chapter Four 
84 
 
aspects of SDM which were experienced during course of their treatment. Such aspects 
included: their degree of involvement and participation; their levels of control; whether 
they had treatment choices; their experience of doctor-patient relationship; and finally what 
their understanding of SDM was. These questions were drawn from both the existing 
literature on patient participation, and from the observations made at clinics and MDT 
meetings. These questions were designed to highlight the patients’ experience of SDM, 
their understanding of SDM and its characteristics, and to explore the presence of SDM 
(i.e. if any factors hindered of facilitated patient encounters of SDM). The final stage of the 
interview progressed to exploring participants’ experience of SDM on their subsequent 
QOL, post-treatment completion.  These questions were drawn from pilot interviews 
conducted at another University teaching hospital (section 4.3.4.1). Questions such as, 
‘how would you say your life has changed since completing your treatment?’ were asked, 
which required participants to describe their current QOL in relation to aspects, such as 
body image, relationships, social skills, careers, self- control, and emotional well-being. 
The interview concluded with some short summary questions relating to evaluation of their 
overall experiences and care received.  The full interview schedule can be seen in 
Appendix E. 
 
4.3.4.1 Pilot interviews 
Prior to devising the interview schedule, regular weekly attendance, for a period of three 
months was made at a breast cancer support group, which took place at a different 
University teaching hospital to the one where the sample were recruited. Taking part in the 
support group allowed for an opportunity to talk with some breast cancer patients, and gain 
insight into their cancer journey. This helped to build a profile of the important issues 
which could be included in the interview schedule and explored in study one.  
 
 According to Barriball and While (1993), the success of the semi-structured 
interview method, clearly relies upon the skills of each interviewer in making a number of 
difficult field decisions. Before commencing the main study interviews, three pilot 
interviews with the designed schedule were conducted with women at the breast cancer 
support group. These women were post-treatment for breast cancer, or were undergoing 
treatments at that time. There were two main purposes for the pilot interviews, which were: 
establishing competent use and understanding of the specific interview schedule being 
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used in the study; and developing an awareness of the errors or bias which can arise with 
interview technique. The exercise was extremely useful, as it enabled the practice of 
interview techniques, such as prompting, language, and listening skills, as well as 
establishing the appropriate setting and types of questions to consider. The pilot was also a 
means to build knowledge and gain more familiarity with the specifics of breast cancer. A 
group discussion took place afterwards with the three women who engaged in the 
interviews, to gain feedback on the interview schedule and the interviewing skills 
deployed. All three women were happy with the clarity and type of questions asked, and 
the manner or sensitivity of the interviewer. Comments were expressed that the interview 
consisted of questions which were free of technical jargon and leading content or 
assumptions, which may have led to biased responses. There were no feelings of distress or 
emotional discomfort reported by the women.  Subsequently, no alterations were made to 
the interview schedule for the main data collection in study one. The audio-tapes of these 
practice runs were used only by the interviewer, as a self-evaluation tool, so that questions 
and queries could be raised and discussed with the research team. Identified features from 
the pilot interviews raised the need for the interviewer to balance flexibility and 
consistency between each interview, and also highlighted the use of leading questions and 
inappropriate probing which needed to be eliminated by the interviewer. 
 
 
4.3.5 Procedure 
 
As mention in section 4.3.3.1 (‘participant recruitment’), participants who met inclusion 
requirements were sent a study pack, which included an invitation letter, study information 
leaflet, and agreement form. Participants, who agreed to take part, signed and sent the 
agreement form back to the research team, who then contacted them by phone to discuss 
the next stages of the study. Participants were allocated a convenient interview date and 
time by the interviewer, and were informed about the interview location. The telephone 
call also provided an opportunity for participants to ask any questions, and have their 
queries addressed before the interview day. Once arriving at the hospital, participants were 
once more issued with the information leaflet to read, and were given another opportunity 
to ask any questions and to clarify any concerns. They were then asked to sign an interview 
consent form (appendix F) prior to the interview. Participants were also asked to complete 
a demographic questionnaire (appendix G), for data collection on participant profiles. On 
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completion of the interview, participants were fully debriefed and once more given the 
time to ask any questions or provide any additional comments. This procedure was 
repeated for all 15 participants, who were interviewed by the same interviewer each time. 
 
4.3.5.1 Interview setting 
Given the sensitive nature of the topic, it was seen as appropriate to invite the participant 
for interview at the teaching hospital’s Cancer Centre, which was an area with which they 
were familiar. With the interview being focused on past events, the choice to conduct the 
interviews in a clinical environment was also a technique to facilitate the participants’ 
memory and recall experiences of events. The location added extra security and 
confidentiality to the participants’ personal disclosure, with the absence of others. 
Participants were allowed to bring a companion for support or assistance on the day. 
However, only the participant who had consented to take part was solely interviewed. This 
was to allow for an adequate self-reflection by the participant, and also to avoid 
interference with the structure of the interview and interviewees’ relationship with the 
interviewer. 
 
4.3.5.2 Data collection and transcription 
The interviews were recorded on a hand held digital recorder. The use of audio-tapes 
ensured that an identical replication of the contents of each interview was available for 
analysis. Audio-recordings provided a detailed insight into the performance of both the 
respondent and the interviewer, which helped validate the accuracy and completeness of 
the information collected. Barriball and While (1993) suggested that audio taping also 
reduces the potential for interviewer error by, for example, recording data incorrectly or 
cheating by logging an answer to a question that was not asked. 
 At no point during the interviews was the recorder paused or stopped, until the 
interview had reached an end, or unless the participant indicated so. There were no time 
constraints for each interview, as it was important to allow each participant to talk freely 
for as long as they wanted, and at the required speed. However, on average, each interview 
lasted approximately 45 minutes. Once all the data had been gathered from the 15 
participants, these were reviewed and fully transcribed on a verbatim basis. Each 
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participant’s recording and transcription was listened to and reviewed several times to 
ensure full understanding and familiarity of content, and accuracy of transcription. 
 
 
4.3.6 Data analysis 
 
With the first study being underpinned by phenomenology, a TA was considered as the 
appropriate analytical strategy. TA was regarded as suitable, as it aims to identify, analyse, 
and report patterns (themes), laterally across an entire data set (Braun & Clark, 2006). It, 
also, minimally organises and describes the data set in rich detail. Boyatzis (1998) further 
proposed that TA frequently goes further than this, and interprets various aspects of the 
research topic. Therefore, it provides a complex account of the data. As a result, TA can be 
a particularly useful method when investigating an under-researched area (Braun & Clark, 
2006), such as SDM and breast cancer, or with participants whose views on the topic are 
not known. One of the advantages of TA, which made it suited to this study, is that it is 
theoretically-flexible. This means it does not require the detailed theoretical and 
technological knowledge of approaches, or connection to any pre-existing theoretical 
framework. Therefore, it can offer a more accessible form of analysis, and be used within 
different frameworks to answer different types of research question. TA can be an 
essentialist or realist method, which interprets and reports individuals’ subjective 
experiences, meanings, and the reality of participants. Therefore, it suits questions related 
to people’s experiences, views, and perceptions, such as ‘what are breast cancer patients 
experience of SDM?’; or it suits questions related to understanding and representation, 
such as ‘how do women with breast cancer understand SDM?’ This subsequently made 
TA, well suited to the phenomenological ‘life-world’ approach of this thesis, and the first 
study. 
 Thematic data analysis was achieved manually without the use of any qualitative 
data analysis software. In conducting a TA, the procedure and stages described by Braun 
and Clarke (2006) were followed. First, several readings of each transcript were conducted 
to achieve familiarity with the data. Specific attention was made to listing patterns of 
experiences that occurred in the text. Each transcript was systematically examined, line by 
line, and bits of data embedded within the material were de-contextualised to facilitate a 
micro analysis of the data. Key points and extracts were highlighted, to indicate potential 
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patterns. Initial notes were made on the transcript to identify segments of data which 
appeared to be important or significant, as defined by the researcher, to decision-making, 
patient participation, views and perceptions, and spoken experiences. Table 4.2 provides an 
example of notes applied to a short segment of data. Appendix H illustrates a table charting 
all the notes made across the 15 transcripts. 
 
Table 4.2  
Data extract, with initial notes applied 
 
 The second stage involved a process of data reduction and organising the data into 
meaningful groups. Therefore, all of the talk (initial notes) that fitted under a specific 
category was identified and placed under an initial code. At this stage, keeping the codes as 
simple as possible assisted flexibility in the categorisation process, and helped create and 
re-define the initial themes. A description of what the codes meant and a source of the code 
were noted. Table 4.3 illustrates an example of how notes were classified into codes.  
 
Table 4.3 
How notes were classified into codes 
  
 
 
 
 
 
 
 
 
Data Extract Initial Notes 
 
I didn’t want to read anything. I didn’t want to absorb any 
knowledge about it. I just wanted to just do it, get on with it, and 
forget about it. I still don’t think it even hit me then. I just wanted 
it to go away. (Lucy, lines 74-76) 
 
Block learning/acquiring 
health information 
 
In denial over diagnosis 
Initial Notes/ Patterns Lines (name) Initial Codes 
Block learning information  
In denial over diagnosis 
Fear of increasing knowledge 
Pass responsibility of decision-making 
Want no control over health care 
View that SDM does not exist 
Little awareness of what SDM is 
69-77 (Elaine) 
 58-62 (Debbie) 
170-182 (Sarah) 
 96-99 (Lucy) 
101-114 (Debbie) 
74-81(Helen) 
44-50 (Charlotte) 
Submissive 
patients 
 
Passive  
participatory role 
 
Hindered 
experience of SDM 
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 The next step was to analyse all of the codes, which involved searching for 
connections, and considering how the different codes combined to form over-arching sub-
themes. The focus was on identifying broader patterns in the data and emerging sub-
themes, which identified what the data meant. At this stage, visual representations were 
used to help sort the different codes in to sub-themes. Therefore, each code, with a brief 
description, was written on a separate piece of paper, and they were played around with 
until they were organised into sub-theme-piles. The sub-themes were identified by bringing 
together components or fragments of ideas or experiences (codes), which often were 
meaningless when viewed alone and, therefore, pieced together to form a comprehensive 
picture of participants collective experience (proposed sub-theme). Table 4.4 illustrates an 
example of how this was achieved. At this stage, a number of initial codes had to be 
abandoned, as upon review there was little original data to support them. Key phrases from 
the participants’ transcripts that supported the sub-themes were also identified at this stage. 
Appendix H provides a full table of all sub-themes produced from the analysis. 
 
Table 4.4  
How codes were combined to form sub-themes 
Initial codes Sub-themes 
 
Involved patient 
Active participatory role 
Facilitated experience of SDM 
 
 
Individual difference 
 
Submissive patient 
Passive participatory role 
Hindered experience of SDM 
 
Varying types of information 
Clinician’s communication skills 
Quality of information 
 
                  
                  
                 Learning styles 
 
Knowledge restrictions 
Quantity of information 
 
 
Isolation 
Self-support 
Distress management 
 
 
 
Coping Strategies 
 
Identification process 
Support structure 
Inclusion 
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The final stage involved a process whereby sub-themes were examined amongst 
each other and combined to form main themes. This was the stage of the analysis where 
the relationship between codes, between sub-themes, and the main overall themes were 
examined. A provisional name and flexible definition was then created for each emerging 
theme. Table 4.5 illustrates an example of a final theme with the sub-themes included in 
that theme. Each theme was then taken separately and re-examined against the original 
extracts, for each theme, and the entire data set. This was to check the validity of 
individual themes in relation to the data set; to consider whether they formed a coherent 
pattern; and to assess what aspects of the data were being captured, and how the theme 
contributed to understanding the data. This stage of re-contextualisation focused on the 
underlying meaning of each theme. Each finalised theme was given a name, and illustrated 
with a few quotations from the original text to help communicate its meaning.  
 
 
Table 4.5  
An example of a final theme and sub-themes within 
 
Provisional named theme Final theme Sub-themes 
Individualised experiences of 
SDM- SDM is experienced in 
different ways by different 
people  
 
Personalising and adapting 
                     SDM 
Individual differences 
Learning styles 
Coping strategies 
 
 
 Once the procedure had been carried out for the first transcript, the exact same 
procedure was carried out for the others. Each transcript was analysed as new. Similar 
themes between different transcripts were identified, as well as those that were different 
and exclusive to a particular participant. A final table was constructed containing all of the 
initial codes, sub-themes, and themes for all of the transcripts (Appendix H).  
 As a methodological approach, phenomenology and qualitative research 
acknowledges that the researcher’s knowledge, experiences, emotions, and position can 
influences the research process (Willig, 2001). Therefore, the ongoing completion of 
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personal reflections, and the adoption of reflexive subjectivity were important during data 
analysis. Such epistemological reflexivity recognises the importance of the need to 
continually reflect on the ways in which the researcher may influence the data and 
analysis, and the ways in which meaning and interpretations are assigned to data (Finlay & 
Gough 2003). This was undertaken through the use of a reflexive diary, maintained 
throughout study one, as a measure of quality assurance. Journaling is identified as a good 
method to use to ensure that the researcher undertakes “an acceptable form of honest self-
assessment, and are critically reflective of their performances” (Grbich, 1999, p.89). 
Therefore, reflexive commentary was maintained during the analytical procedures. The 
diaries focused on recording key events and habitual practices, what the researcher felt 
about the data extracts, the reasons for the decisions that were made by the researcher, and 
the researcher’s thoughts and attitudes towards the research itself and the information that 
was arising. Any presuppositions, choices, experiences, and actions during the analytical 
process were included in the diary. An evaluation of the researcher’s performance of a TA 
was also recorded. In turn, the commentary notes in the diary were an effective way of 
confronting the researcher’s thoughts and perceptions, and to see whether they influenced 
the data analysis. The process of reflexivity will be discussed further in the discussion 
section (section 4.5.1) of this chapter.  
 
4.3.7 Ethical submission  
Application for ethical approval was submitted to the local NHS Research Ethics 
Committee (REC), and to the R&D Department at Keele University (Appendix Ia). 
Approval was also sought from the R&D Department at the University teaching hospital, 
from which the participants were recruited (Appendix Ib). The Research Institute for 
Social Sciences at Keele University, together with the supervisor team in Psychology 
Department, also certified full peer review of study one and the thesis as a whole. The 
researcher had clearance from the Disclosure and Barring Services (DBS), and was given 
access to patients, subject to the award of an honorary contract and research passport by 
the NHS trust, which was granted by the R&D Department at the University teaching 
hospital. The research also received full Good Clinical Practice (GCP) training, by the 
NHS trust, to ensure that research was conducted to ethical and practical standards.  
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 All ethical procedures were adhered to during the conduct, analysis, and write-up of 
data collection. All of the participants were informed that their participation was 
completely voluntary, and informed of their rights to withdraw; refusal to answer 
questions; and ability to stop the recording at any point without giving a reason. All 
participants provided their written informed consent.  Participants were also informed that 
they could request copies of the transcription, and could also receive a copy of the final 
report, if they wished. For the purpose of anonymity, participants were given identification 
numbers only. Where extracts from the transcripts are used within this thesis, participants 
were given a pseudonym, and no information is displayed to show their identity or to 
identify any medical professionals. 
 
 
4.4 Results 
The first study aimed to explore breast cancer patients’ experiences of SDM, by means of a 
phenomenological approach to explore patient perceptions. Each transcript was examined 
in great detail through a TA, before moving on to more nomothetic general claims across 
all 15 transcripts. The focus of such detailed analysis, aimed to explore the relationships 
between the individual and the experience of SDM for breast cancer. A narrative account 
and interpretation of themes that emerged from the analysis follows, encompassing clear 
illustrative extracts from the participants’ transcripts (a false name, interview number and 
line numbers will be provided for each quote in the parentheses). Whilst these quotes 
exemplify the theme that is being discussed, the inter-connections between the themes may 
result in the quotes being illustrative of more than one theme. The interpretative role of the 
researcher played an integral part in the analysis process and, therefore, it is important that 
the narrative and description of themes are considered as a product of interpretative 
engagement with the data. Several sub-themes emerged from the analyses which included: 
active and/or passive positioning, learning styles, coping strategies, doctor-patient 
knowledge discrepancy, roles and duties, being informed, information exchange, and two-
way processes. Upon clustering these sub-themes together, three key themes were formed 
which encapsulated the experience of SDM for participants during treatment of breast 
cancer. These three themes were, 1) personalising and adapting SDM, 2) power imbalance 
and SDM, and 3) features of SDM. These three themes will now be illustrated and 
discussed in thorough detail. 
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4.4.1 Theme one: personalising and adapting SDM 
This theme encompassed three sub-themes (active and/or passive positioning, learning 
styles, coping strategies), all associated with how participants are subjected to personal 
preferences and participatory roles, which influence their decision-making process during 
their treatment. More specifically, the degree they choose to be involved in their care, and 
obtain elements of control over their health, negotiated their understanding and experience 
of SDM. The three sub-themes raised a range of concerns. However, for the purpose of 
staying close to the research question and ensuring that focus was maintained on exploring 
patients’ understandings and experiences of SDM, the sub-themes learning styles and 
coping strategies were chosen not to be reported in the results. The sub-theme active 
and/or passive positioning will be examined in relation to the theme.  
 This theme is concerned with the impact of patient participatory roles and 
preferences of involvement, which led to the adoption of modifying behaviours, and 
resulted in differing encounters (hindered or facilitated) and meanings of SDM, portrayed 
by participants.  For instance, in relation to patient participation in decision-making, some 
participants demonstrated an enthusiastic attitude towards their treatment decision-making 
(‘active patients’), whereby their involvement and acquired knowledge was essential to 
their decision-making process. This resulted in a facilitated experience and understanding 
of SDM, and allowed patients to manage their emotional well-being. Alternatively, some 
participants showed a defensive approach (‘passive patients’) towards being informed and 
participating in decision-making, as a coping strategy, whereby avoidance and 
disengagement resulted in a hindered understanding and encounters of SDM. Both of these 
patient characteristics will now be illustrated, through the sub-theme active and/or passive 
positioning, in more detail with extracts, and interpreted in relation to how SDM is 
experienced and understood. 
 
4.4.1.1 Sub-theme one: active and/or passive positioning 
In this sub-theme, the analysis showed that some participants emphasised an active and 
working role in their health care. Extract one illustrates this personal preference and 
participatory role, and how it subsequently shapes and facilitates involvement in treatment 
decision-making. 
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EXT 1. Judy. Interview 10. Lines 51-58 
Oh my goodness. Well after I had had the biopsy and they had 
told me it was highly unlikely not to be breast cancer, you 
get on the Internet don’t you [LAUGHTER]. I did everything. I 
did loads of research, looked at all the websites, like 
McMillan and Breakthrough Breast Cancer, and researched all 
of those. I looked at some papers and medical journals, but 
only what was available on the Internet. I also looked at 
some clinical guidelines because I kind of wanted to be 
prepared for them to tell me yes it was cancer. I wanted to 
have a bit more of background knowledge of what to be 
expected in terms of treatment. So it could make the 
decision-making process easier for me.  
 
Judy’s account exemplifies a participant who is clearly motivated and concerned about 
their health. Judy’s ‘active’ personality is demonstrated through their eagerness to enhance 
their knowledge on breast cancer. With the Internet being a common accessible means of 
information, half of the participants, similar to Judy, who also illustrated ‘active’ 
personalities, stated that they utilised the Internet as an immediate reference for further 
enquires. For older and less computer literate participants, the NHS resource packs and 
charity leaflets were commonly used to gain further information. It is interesting to note 
that Judy mentions medical journals and clinical guidelines, which was entirely due to her 
familiarity through working as a physiotherapist. This was also evident with another 
participant who practiced as a GP nurse. Therefore, this indicates that demographic factors 
such as education and employment may facilitate and encourage an ‘active’ participatory 
role. For Judy, having an active role in her treatment is seen as vital for preparing her for 
receiving bad news. In a sense the preparation acts as a shield, to protect her from shock or 
emotional distress once given the result of her biopsy. However, her ‘active’ stance also 
helped to provide her with the ability to organise her thoughts and the capability to 
confidently participate in the consultation. It also equipped her with enough information to 
feel educated enough to participate in her treatment decision-making. 
 For some of the ‘active’ participants, acquiring information and advancing their 
knowledge, by means of direct interaction and verbal dialogue with the professionals, was 
seen as greater advantage to their understanding and decision-making process. All 
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participants received verbal explanations regarding their diagnosis and treatment. They 
also all received regular face-to-face or private telephone conversations with the breast 
care nurse about issues and concerns. The analysis revealed that ‘active’ patients utilised 
those opportunities, by frequently engaging in decision-making conversations. Extract two 
illustrates this. 
EXT 2. Tina. Interview 13. Lines 43-46 
That was a really heavy morning, because you’re in bits about 
your test results. It’s a very anxious time, but I still 
wanted to know all information. So regardless, I was asking 
loads of questions. It wasn’t over whelming for me or 
exhausting at the end. It was in fact reassuring and made me 
feel in control. Maybe everyone isn’t like that, but it’s 
just that I had those questions to ask and wanted to hear the 
answers to help me make important decisions. 
Much of the doctor-patient communication is standard routine practice, whereby a full 
patient history is explored and diagnoses of results are outlined. However, in Tina’s case, 
and those participants who chose to take a more ‘active’ role in their care, the level of 
discussion and the amount of information exchange was greater. As Tina explains, it was 
important for her to discuss matters further with the clinician, and to ask questions about 
uncertain areas. For Tina, not only was this a healing process and one which enabled 
reassurance, but it also gave her an element of control over her health care and decision-
making process. Subsequently, her ‘active’ participatory role was seen to facilitate and 
contribute towards her decision-making experience.  
 Patient preferences for being ‘active’ and involved in medical decision-making 
were not only unique to a medical setting. For many women, as shown in extract three, 
participation in support groups and discussion, with other breast cancer patients, about 
their health care and treatment decisions, were also regarded as necessary to their decision-
making process. This in turn was interpreted to facilitate their decision-making experience. 
Ext 3. Helen. Interview 3. Lines 42-47 
I joined this support group, which consisted of this group of 
old ladies who had all experienced breast cancer in different 
ways. I enjoyed attending this group, as we would sit down, 
have discussion and share information and knowledge about 
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issues or worries. We would ask questions to one another, and 
try to inform and advise each other. I learnt so many 
additional things that I didn’t know. Things which aren’t in 
the patient hand book, and things that the consultants don’t 
necessarily tell you. This helped to put my mind and distress 
at ease. So it was another extra source of information to 
help me make decisions.  
Many women like Helen, who preferred to be involved in their health care and decision-
making process, also talked about the significance of attending support group sessions. 
These sessions, brought women with the same problems and issues together, where they 
could engage in discussions and share experiences or ideas. For Helen, the support groups 
enabled her to acquire information differently, compared to the standard NHS reading 
material. Here, Helen could learn from others’ personal experiences, and engage in real life 
material, which she describes as an important facilitator in aiding decision-making, as well 
as acting as a useful coping strategy. Most importantly, the extract illustrates that for 
individuals with ‘active’ characteristics, by participating in discussions with others and 
sharing knowledge and information, the task of decision-making can also be encountered 
outside of the clinical setting and with non-medical individuals. 
 Within this sub-theme, the analysis also revealed some participants who showed 
opposite traits to involved patient. These participants instead retained ‘passive’ and 
submissive behaviours and were, therefore, inert to involvement in their care and did not 
want to participate in decision-making. Extract four by Debbie illustrates this trait in 
relation to her treatment for a mastectomy. She highlighted, in her account, that sharing 
decisions and being involved in her health care was not a priority, and instead preferred to 
refuse information and decline engagement, due to the fear of increased knowledge about 
her breast cancer. 
EXT 4. Debbie. Interview 4. Lines 47-53 
When I got diagnosed I got given a big information booklet, 
which I didn’t look at. I didn’t want to read anything. I 
didn’t want to absorb any knowledge about it. I just wanted 
to just do it, get on with it, and forget about it. I still 
don’t think it even hit me then. I just wanted it to go away. 
My husband would look up stuff on the laptop to read more 
about breast cancer. But I rather not, as it’s finding out 
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about what you didn’t originally know, that ends up worrying 
you in your mind. So I preferred to not know [LAUGHTER]. I 
think you can know too much sometimes, and I didn’t want 
that. I didn’t want that emotional weight to have to carry. I 
wouldn’t even watch certain programmes on TV as I wasn’t 
brave enough to deal with some of the cancer related 
storylines. 
 
Debbie’s response demonstrates signs of ‘passive’ behaviour, which appear to be rooted in 
her feelings of denial and apprehension to engage in any forms of written information, 
which might cause further distress. She states that she ‘wanted it to go away’ and, 
therefore, by taking a preventative approach and being avoidant, this became a great way 
of escaping the issue and realisation of her breast cancer diagnosis. Despite her husband’s 
‘active’ role, acquiring knowledge appeared daunting and could expose her to feelings of 
anxiety and distress. Debbie refers to this as an ‘emotional weight’ or burden to have to 
carry. Therefore, ignorance was regarded as bliss, and by putting up an unconscious barrier 
or a defence mechanism, which restricted the quantity of information acquired, this 
stopped her thinking about further health worries and fears. For the other ‘passive’ 
participants in the analysis, like Debbie, attaining knowledge was what opened realisation 
and fear of their cancer and, therefore, many chose to remain in denial by pushing the 
treatment out of sight and mind, and rejecting all participation in their care. Consequently, 
the definition of cancer is understood to be labelled as a pessimistic fear, which is fuelled 
by thoughts of disbelief. As Debbie’s interview progressed, a clearer demonstration of how 
her ‘passive’ personality and portrayed fear of cancer influenced her involvement in 
decision-making. Extract five by Debbie, illustrates this further. 
EXT 5. Debbie. Interview 4. Lines 24-28 
Until this day I still haven’t looked at the scar. It’s like 
as if it all never happened, which is why I’m so ignorant 
towards my treatment. On the day I was diagnosed, we came out 
of the consultation and went in a room. Then the breast care 
nurse was trying to tell me things, but it never sank in. I 
didn’t want to know or decide anything. All I could remember 
at that time was seeing the doctor face and hearing this word 
‘cancer’. I just couldn’t stare at him, it was just that 
word.  
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Debbie’s second extract shows that a great association is made between the word ‘cancer’ 
and fear. For Debbie, such association subsequently resulted in feelings of denial over her 
diagnosis, and caused her to avoid the disease and its management. For such patients, their 
encounters of decision-making are almost non-existent and shadowed by their fear of the 
disease, which subsequently hinders their involvement in any decisions for treatment 
choice.  
 In reviewing this sub-theme in relation to this theme, the analysis revealed that 
these two types of participatory roles appear to impact how SDM is understood and 
experienced. Extract six illustrates this with a participant who exerts ‘active’ 
characteristics. 
EXT 6. Judy. Interview 10. Lines 60-66 
I think I went prepared to ask them questions, because I had 
done so much reading. I had a list of questions that I used, 
taken from things that I had found on the internet, and I 
wanted to ask them specifically around that. They were very 
receptive to doing that. I think perhaps they gave me their 
spiel and then I had time to ask them questions specific to 
what I wanted to know. Perhaps maybe if I hadn’t of asked any 
questions, then they would think that the information they 
gave would have been ok or enough. But for me I was keen to 
have a lot of discussion about the benefits and risks of all 
the treatments. That’s what shared decision-making is. For me 
I needed to know the evidence behind everything, and it was 
extremely important that I understood the reasons behind what 
they were suggesting. I had to understand why I was going 
through something that was potentially quite a risky 
procedure, and I needed to understand what the risks and 
benefits were to make an informed decision. I think it’s 
really important to be involved and how I experienced shared 
decision-making, I think, is probably due to the way I am.  
 
Judy highlights her continual desire for participation in treatment knowledge and 
procedures. Her extract is a substantial example of ‘active’ participation within a 
consultation, as Judy is keen to form interactive dialogue with the clinician to acquire 
further information and understanding. For a patient with an ‘active’ personality, it is 
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noticeable that being part of the decision-making process is vital for them. We appreciate 
the importance of open discussions, which entail a two way process of questioning and 
answering, as this helps to shed light on ambiguities and iron out any anxieties or doubts. 
What is noteworthy from Judy’s account is that she referenced a standard clinical practice. 
This was defined by Judy as a process which involved the doctor giving ‘their spiel’, 
providing explanations, and then giving the patient an opportunity to ask questions. From 
Judy’s account it is evident that this practice is not sufficient for all patients, especially 
those who like to play an ‘active’ role in their care. Therefore, in Judy’s case, more sharing 
of dialogue was encouraged, to enhance her knowledge further, as this was viewed as 
essential to her ability to make an informed decision, and for her to experience SDM. 
Judy’s extract shows that patient participation is important, and can be achieved by means 
of an active participatory role. By acquiring an ‘active’ stance, this can impact the 
relationship between clinician and patient, the types of conversations within a consultation, 
and amount of information seeking. As a result, the patient demands and expects more two-
way interaction, information, and the opportunity for involvement. This in turn is 
interpreted and described by Judy to result in the process of SDM to take place, and to be, 
therefore, experienced during the consultation.  
 Extract seven below demonstrates that the ‘passive’ participatory role can also have 
an impact on how a patient perceives and experiences SDM. The analysis revealed that due 
to submissive actions towards patient participation, this subsequently resulted in an inactive 
experience of SDM for some participants. 
EXT 7. Lucy. Interview 5. Lines 170-180 
I was happy to place a lot of the decision-making in the 
hands of the doctor. I didn’t want any control really because 
he knew what he was doing, and I just wanted to get on with 
it. I felt confident with him. He was nice, had a nice manner 
and he explained everything to me. I got involved as much as 
I wanted to get involved. I could have had control over my 
treatment if I wanted to, but I chose to put it one side and 
give that control to someone else. I was more than happy to 
pass on that responsibility over to an expert, and put it all 
to one side of my mind. So I don’t really know what shared 
decision-making is. Even if it did exist or even if I was 
given the option to have it, I wouldn’t want it. Like I said, 
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I didn’t want to know, share, or decide nothing. Just wanted 
to let the doctor do what was right.  
 
From Lucy’s extract, it is understood that her ‘passive’ personality influenced her 
experience of decision-making and any encounters of SDM. In her account, she emphasised 
the need to reject involvement or control over her health care. Arguably, this is because, for 
a ‘passive’ patient, responsibility and participation are seen as an emotional weight, as 
supported by Debbie’s extract. Some patients, therefore, preferred not to engage in such 
complex and emotive task of making a decision. As Lucy states, although she could have 
been involved and have control over her treatment plan, she felt safer if the clinician, with 
high expertise, was accountable for the decisions made. Therefore, similar to Debbie, it 
allowed her to avoid the topic and protected her from any feelings of distress, such as worry 
or anxiety. The reason why Lucy was able to exercise such passivity is explained and 
justified through her trust in the clinician, and expectation for him to deliver quality of care. 
Such confidence and trust is described to be established as a result of the clinician’s 
enhanced knowledge and skills in the field, which subsequently places the clinician at a 
superior level. Therefore, for a patient like Lucy, there was no personal desire to be in 
control and involved in decision-making. This was especially due to the clinician being 
open to explain everything to her, to enable informed consent. As a result of such a 
‘passive’ attitude and behaviour towards decision-making, extract seven shows that SDM 
appears to be limited. As Lucy explains, she had very little awareness of what the process 
of SDM is and, therefore, did not encounter it. Due to her personal requirements, this 
inhibited the process of SDM to occur with the clinician. This was, however, satisfactory 
for her and in accordance to her needs and personal preferences for involvement. 
 
4.4.2 Theme two: power imbalance and SDM 
This theme encompassed two sub-themes, associated with issues which influenced the 
degree to which participants encountered and experienced SDM. Sub-themes included 
doctor-patient knowledge discrepancy, and medical professional roles and duties. 
Associations between these two sub-themes will be discussed in relation to a perceived 
discrepancy in power between the clinician and patient, as this appeared to play an 
influencing role on how and whether SDM was encountered by participants. Interpretation 
of this theme revealed how and where participants positioned themselves regarding the 
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SDM process. For example, many participants perceived the clinician’s role and expertise 
at a higher position compared to theirs, and as a result, this allowed the clinician greater 
control and superiority to make decisions. Subsequently, an experience of SDM became 
somewhat regulated and hindered by a hierarchal influence and enhanced skills of the 
clinician. The breast care nurses emerged to play an important role in facilitating patient 
encounters of SDM, and attempting to find solutions.  This theme will now be discussed in 
more detail in light of each one of the two sub-themes. 
 
 
4.4.2.1 Sub-theme one: doctor-patient knowledge discrepancy 
This sub-theme revealed, that participants described an inconsistency between the 
clinicians’ knowledge and experiences, in comparison to patients’. This in turn was 
explained to influence patient experience of SDM. Participants argued in their accounts that 
in order to be able to make appropriate decisions, a certain degree of experience and 
knowledge in the field of breast cancer is needed. As the clinician is a key individual who 
is fully experienced and trained, with the relevant skills to handle and manage breast 
cancer, participants subsequently stated that this helped to raise the clinician’s hierarchal 
status and, therefore, obtain a higher level of control or discretion over treatment decisions, 
above the patient. Participants agreed that a lack of SDM during consultations is a result of 
the patient not acquiring high levels of expertise. This discrepancy in professional skill, 
subsequently, became the product of patient detachment from decision-making and 
treatment involvement. Extracts eight and nine both illustrate this matter further. 
 EXT 8. Charlotte. Interview 13. Lines 101-109 
I had no control over decision-making. How could I?! How 
could I say ‘no I don’t want this, yes I do want that’ when I 
didn’t know exactly how the options worked or operated. Even 
if I was a bit more informed, I don’t know how I could have 
been more in control, because I read and asked about whatever 
I could at the time. Cancer isn’t like a cold, which is an 
everyday occurrence which you have more control over. Cancer 
is out of the blue, happens very quickly. Unless you are 
actually involved in day to day care with people with breast 
cancer, I don’t think you have enough experience to make any 
big decision yourself. So I guess that can affect the task of 
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sharing a decision with a clinician, as you don’t have the 
necessary skills to engage in that task with him.  
 
Charlotte’s account brings attention to the aspect of patient control within decision-making. 
In her description, it is demonstrated that control is very much dependent on a level of 
obtained experience, which is something that she lacked compared to a clinician. She 
explains that no matter how much she tried to seek involvement in her care, by asking 
questions or engaging in medical literature, this did not equip her with the same amount of 
experience required to make a decision, compared to a clinician in the field. She uses the 
concept of ‘having a cold’ as a great example to elaborate on this. For example, a cold is an 
illness which patients are all capable of independently controlling and managing, as a result 
of our repeated encounter of the illness over years. However, for many, cancer is an 
unanticipated illness and one which patients lack experience of, unless their diagnosis is 
secondary cancer. Therefore, in the face of making a treatment decision, or engaging in 
SDM, for Charlotte, it felt like she was powerless and unqualified to experience it or take 
control of such a task. Conversely, she explains that a clinician, through practice and 
everyday encounters, acquires the appropriate skills and expertise and, therefore, can be 
viewed as more appropriately suited for such responsibility. 
             Another similar example which supports this issue of power imbalance, as outlined 
by Charlotte, is also illustrated in extract nine by Sophie. However, in Sophie’s account, 
she associated the issue of doctor-patient knowledge discrepancy with negative feelings of 
intimidation and withdrawal, which resulted in a hindered process of SDM.  
 EXT 9. Sophie. Interview 13. Lines 139-141 
I am an ordinary house wife with general academic knowledge. 
Nothing on their level of skills. So you can feel a little 
bit that they can be a bit overshadowing and unapproachable 
because of their professional knowledge. So you choose to not 
get involved as much. So half of the time you sat there in 
the consultation thinking, should I say that? Will they think 
I’m being a bit silly for asking that? So you end up just 
doing as they say because they know more. 
Similar to Charlotte, Sophie’s account demonstrates how participants view the clinician on 
a completely superior level compared to them. However, Sophie’s account further shows 
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how the perceived issue of unequal power between the clinician and patient, can hinder 
patient experience of SDM. Sophie initially outlines a clear distinction in statuses, as she 
labels herself as an ordinary housewife who lacks the expertise of a medical professional. It 
is understood from her account that she felt intimidated and perhaps embarrassed to 
confront the clinician, due to such a knowledge discrepancy. This distracted her from 
wanting to get involved in the decision-making process and deterred her from the process 
of SDM.  As a result, she became highly reliant on the clinician, which is evident in her 
comment ‘so you end up doing as they say’. 
 Within the next two extracts (extracts 10 and 11), it is observable that the clinician’s 
level of knowledge not only creates a boundary between the patient and clinician, in terms 
of interaction and decision-making participation, but it also enhances the clinician’s 
position. As a result of such perceived power imbalance, participants indicated that this 
rationalised for patient compliance and the lack of SDM within a consultation. 
EXT 10. Louise. Interview 8. Lines 102-107 
Personally, I just left it to the people who knew what they 
were doing. There was not much control out there for me to 
have, because if you have a problem that you can’t solve, then 
you go to the doctor who solves it for you. I don’t mean that 
in a derogatory way…I meant it in the sense that your doctor 
has the knowledge and skills to know what needs to be done, 
tells you what can be done, and you go ahead with it. So at no 
point did I feel like I was in control or had to chance to make 
any decisions.  
 
Some women, similar to Louise, were forced to take a submissive route, as they believed 
that control, treatment options, and decision-making were out of their hands due to the 
logicality of the clinician’s professional status of knowledge. For Louise, the clinician was 
seen as an authoritarian figure, due to his assigned role as a medical problem solver. As she 
truly believed that she was unable to treat herself she, therefore, knew the decision-making 
task was one which should be in the hands of the experts. As a result of adhering to this 
mentality, Louise began to show a compliant attitude and behaviour towards the treatment 
plan, as suggested by the clinician. This consequently left very little room for patient 
participation and the concept of SDM to operate. 
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             Extract 11 by Katherine illustrates similar findings to Louise’s account, however, 
Katherine account relates the impact of doctor-patient knowledge discrepancy and the issue 
of power inequality to the experience of SDM further. 
EXT 11. Katherine. Interview 1. Lines 160-172 
At the end of the day, it was ultimately my decision, but I 
just really left it to him basically. He’s the expert! I use to 
say to him “you’re the expert so you do what you feel the need 
to do”. I don’t think you’re informed enough to gain that 
control yourself. Lay people don’t have access to the latest 
medical research. They can only read what they are given, or 
know from what they see or hear in the media. I’m a believer 
that if you’re the professional then you obviously know your 
job. Who am I to tell you what you should or shouldn’t do? If 
you think that you can help me by going down that road, then 
I’m quite happy to go down that road. So I would say decision-
making is a 70/30 spilt. The doctor has more power because he 
is the expert. He would say “right this is the kind of 
treatment you going to have, this is why we think you should 
have this treatment, these are the side effects”. Then he would 
finally ask “how do you feel about that?” If it means saving 
your live, then having less power than the clinician is a small 
price to pay. So as far as I’m concerned, the clinician is in 
the driving seat which makes shared decision-making harder to 
take place. 
 
Although Katherine begins her account by reaffirming patient rights in treatment decision-
making she, however, indicates that she chose to discard her entitled involvement. Her 
rejection of patient participation in decision-making was justified by her understanding that 
the clinician retains more superior knowledge. This is illustrated by her ability to label the 
clinician as ‘an expert’. However, Katherine showed no dissatisfaction towards there being 
a chain of command, as she indicated that patients do not have access to the right 
professional knowledge or resources, to have control over decision-making. What is of 
interest, further in her account, is that Katherine makes a statement which marks patient 
inferiority, and raises the issue of a power imbalance between patient and clinician. She 
expresses ‘who am I to tell you’, and presents an understanding that the patient is of no 
impact or importance to have the power and control to make treatment decisions. This, 
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therefore, reinforces the clinician’s position of authority and highlights the impact of 
imbalanced power-relations. As a result, the participant’s concept of SDM is provoked due 
to the clinician’s position of educational superiority. Consequently, the practice of making 
an equal shared decision is hindered, as the clinician is perceived as a key figure that holds 
the decision-making power. It is evident in Katherine’s account that there is a perceived 
power imbalance, due to the clinician’s position of expertise, which can inhibit a patient’s 
experience of SDM and their participation in the decision-making. However, the presence 
of such a power imbalance is not frowned upon or protested, as it is explained by 
participants, similar to Katherine, to be a small sacrifice made for an increase their survival 
rate. 
 
4.4.2.2 Sub-theme two: roles and duties 
This sub-theme highlights an issue raised by participants, which was the issue of the 
clinician’s professional role and duty of care. In examining where the participants 
positioned themselves in relation to the clinician and their treatment, analysis revealed that 
the clinician is categorised as a trusted responsible figure, with a duty of care. This view is 
consistent with traditional concepts which labelled the clinician as a medical healer. For 
participants who obtained this belief, it subsequently became evident that the idea of 
participating or challenging the clinician was just not possible. Many women felt that they 
had to conform and respect the doctor due to his professional role, which they greatly 
trusted. This subsequently resulted in a heightened issue of imbalanced power-relations 
between the clinician and patient, which had negative effects on participants’ experience of 
SDM. However, participants displayed no dissatisfaction, as they believed that the presence 
of a power imbalance and the resulting compliance was normal behaviour, and justified 
through the trust in which patients have towards the clinicians’ role and duty of care. 
Extract 12 illustrates how levels of patient trust in the clinicians’ role, can subsequently 
facilitate an imbalance in power-relations and submissive behaviours, and result in a 
hindered encounter of SDM. 
EXT 12. Louise. Interview 8. Lines 102-108 
I think you don’t have control and you can’t really 
participate in decision-making. I mean, how can there really 
be a shared decision-making process? Because everyone knows 
that if there is something medically wrong with you, it’s the 
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doctor’s role to put you right. I don’t think it’s an equal 
weighted relationship or shared process as you know that the 
cancer could kill you, and you want what is medically 
appropriate. So you turn to the people who know will do that. 
Like I say, I was involved as much as I needed to be. Just 
because I didn’t want to be involved or didn’t want a shared 
experience, it doesn’t mean that I wasn’t fighting it. It 
just meant that I had a lot of confidence in the people who 
were dealing with me. It’s just putting your trust in other 
people [LAUGHTER]. 
 
The portrayal of the clinician, based upon Louise’s account, is one which shows his 
position of responsibility. Great emphasis is given to the importance of trust within doctor-
patient relationship and treatment decision-making. Louise explains that trust is an 
instinctive response felt, as a result of people’s learnt understanding of whom and what a 
clinician’s role is. For example, Louise explains that in the face of health problems, it is 
natural to initially place your treatment and health in the hands of a doctor, as she/he is 
regarded as the person to turn to and can give medical advice and care. With the clinician 
being granted such liability for managing and being responsible for individuals’ healthcare, 
this subsequently meant that participants automatically associated the power and control of 
decision-making to the clinician. For Louise, control, treatment options, and decision-
making was something which was out of her hands due to the logicality of the doctors’ role 
and authoritative position, as a medical problem solver. As a result of Louise’s 
preconception of the clinician’s role and duty, she described deferential behaviour towards 
the clinician and took a submissive route to decision-making. It is understood from 
Louise’s account that her understanding of patient participation was overruled by her 
deferential position, as she believed that the clinician should be in the driving seat of 
decision-making due to his given role. Consequently, she had acquired a perception that 
SDM is not plausible and cannot be experienced by patients. Yet, she states that regardless 
of choosing to sit in the passenger seat, this did not mean that she felt helpless or 
disadvantaged in any way, as it was her personal belief to comply with and trust those 
above her.  
 Extract 13 is another similar example of how patient perceptions of the clinician’s 
role and responsibility, can impact feelings of compliance and hinder patient participation. 
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Within Jennifer’s account, it is understood that participants’ control over decision-making 
is surrendered as a result of a dominating sense of trust and belief that patients acquire 
about the clinician’s role. An observed disparity in doctor-patient roles was illustrated 
within the analysis, which subsequently resulted in a lack of understanding about the 
concept of SDM, and its experience. 
 
EXT 13. Jennifer. Interview 14. Lines 203-215 
I don’t know what shared decision-making is. I put all the 
faith and trust I had into the clinician, and had to take 
away in some respect the control from myself. I believed in 
these people and what they were doing, and because of my 
trust, I put the control in somebody else’s hands. So by 
putting my health and life in this person’s hand, I was 
therefore happy to listen and consent to what they said. I 
believe that they have worked hard to have that role and that 
why I handed over that control to somebody else who is an 
expert. I am just an ordinary patient. I remember one day the 
oncologist said to me “no, you don’t have to have chemo, but 
if you choose not to, then I wouldn’t be doing my job 
properly, especially if you come back to me in three years’ 
time with cancer somewhere else” Then all of a sudden I 
thought he is right, he has a job to do which is to look 
after me, and I have to let me carry that out. 
 
Jennifer explains that she had pure faith in the doctors and those who managed her care. As 
a result of her absolute trust, she believes that it was important for her to owe the 
responsibility of the decision-making control to the doctors. Subsequently, with the control 
being passed over to the clinician, it was therefore understood by Jennifer that she had to 
follow the clinician’s advice and suggested treatment plan. To have felt controlled by the 
doctors was not an issue for Jennifer, as she carried a mind-set which highlighted the 
clinician as a medically trained professional, who has earned the role to be responsible for 
the patient and control the patient’s health. Further in her account, Jennifer compares this 
view to her labelled status as an ‘ordinary patient’. Such a term redefines her role and 
repositions her in relation to the clinician, as someone of less expertise and superiority. As 
a result of her perceived inferior position, this subsequently helps to justify her behaviour 
of reliance on and compliance with the clinician. Therefore, the extract demonstrates how 
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participants were able to hierarchically position themselves, and the clinician, in relation to 
their treatment and decision-making processes. In Jennifer’s case, such positioning 
involved granting the clinician the power to govern her care. Jennifer provides an example, 
taken from a conversation she had during a consultation, which further emphasises the 
difference in patient-doctor roles during decision-making. The scenario she provides raises 
attention to the issue of job role, and that the clinician has a duty of care to carry out. 
However, her situation also showed that the patient too has a role, which is to enable the 
clinician to practice his skills and knowledge, in order to aid the patient. Therefore, a 
distinct division and discrepancy of roles and positions is demonstrated. The clinician is 
portrayed as a person with well-defined superior responsibilities in relation to patient 
health, whereas the patient is perceived as a person who puts their trust into the clinician 
role and, therefore, hands over control and remains passive to decision-making. As a result 
of such acquired understanding about roles and discrepancies in roles, the concept and 
experience of SDM was illustrated to be limited. This is shown in the opening line to 
Jennifer’s extract, as she noticeably states her unfamiliarity to SDM.  She is unable to 
describe knowledge or her experience of SDM, as her decision-making experience is over 
shadowed by her attitudes towards the clinician’s role. 
 
 Through exploring the sub-themes ‘roles and duties’ and ‘doctor-patient knowledge 
discrepancy, it became clear that it was not only the clinician’s role which impacted on 
patients’ experience of SDM, but that the breast care nurses also played a vital part. 
Although much reference was made to participants’ experience of SDM with the clinician, 
it was also an indicated that SDM can take place with other medical professionals for the 
treatment of breast cancer. Participants frequently related examples of the emotional care, 
decision-making support, and information and advice that the breast care nurses provided. 
They described this as not only beneficial in decreasing patient distress, but also beneficial 
in facilitating participants with the confidence and ability to engage in decision-making, 
and encounter an experience of SDM. Extract 14 illustrates how SDM was also 
experienced between patient and breast care nurse. 
EXT 14. Elaine. Interview 9. Lines 92-100 
I would see the surgeon and then see the breast care nurse 
after. The surgeon would advise you what’s best, and then the 
nurse would go over it with you. You see, you don’t really 
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listen in the consultation, due to the shock. It’s in one ear 
and out the other, so the nurse would go over it in simple 
terms. She would tell me about all the options. She played a 
big part involving me in the decision-making of my treatment, 
and helped me make the decisions. The nurse would sit down 
with me sometimes over an hour, and together we would go over 
things. You could ask all the questions you wanted to help 
you decide on your treatment. It was a very reassuring 
process which helped bring out the positives. That to me is a 
good example of shared decision-making.  
 
Elaine demonstrates how the breast care nurses played a reinforcing role in encouraging 
and allowing SDM to be experienced by the patient. She explains that due to shock and 
emotional responses, much of what is discussed in a consultation about diagnosis and 
treatment can be distorted. Therefore, the breast care nurses ensured that information and 
knowledge was attained at all stages of Elaine’s treatment, to allow her to make an 
informed choice. She explains that a large amount of nurse’s time is devoted to allowing 
two-way conversations to take place. This involved a process of information exchange, 
whereby Elaine was given the opportunity to ask questions and share her queries. This 
demonstrates that, like clinicians, the nurses reciprocate the process of information 
exchange by devoting time to explaining and clarifying matters, through sharing of 
information and their knowledge. This process was highly valued by Elaine, especially 
since information was delivered in layman terms. For example, material and conversations 
with the doctor were broken down into simpler terms, which Elaine was able to understand 
and clearly digest, without feeling over powered or overwhelmed. By having had her 
knowledge enhanced, had her worries and queries addressed, and become more aware of 
her treatment options, this type of support subsequently played an important role in 
Elaine’s decision-making. It is observable that the breast care nurses helped Elaine to feel 
involved in her care and treatment decisions, which resulted in an acquired experience of 
SDM. The sharing of information and knowledge, along with the interaction and 
discussions which took place between Elaine and the breast cancer nurses, created a similar 
encounter of SDM, of that experienced between patient and clinician. This is consistent 
with the early findings in the chapter (section 4.4.2), which also highlight the importance 
of information exchange and two-way interaction in facilitating an encounter of SDM. 
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             The breast care nurses not only allowed patients to encounter SDM themselves, but 
they also played an important role in helping to facilitate SDM between the patient and the 
clinician. The breast care nurses were seen as the middle person or a bridge that ties the 
relation between patient and doctor, to allow for SDM to occur. Extract 15 demonstrates 
how this interconnected process occurs though the breast care nurses interaction with both 
the clinician and the patient. 
EXT 15. Margaret. Interview 11. Lines 227-232 
I see it as a shared decision through a multi disciplinary 
team because if you have anxieties and queries about 
decisions and choices, then the nurses are a method of 
getting your anxieties across to the doctor. Sometimes I 
didn’t even have to come into hospital, and they would just 
ask the doctor my questions for me, and then ring me back. 
They could pass information back and forth between me and the 
doctor. They were like the middle inside people who kept me 
involved and connected with the medical team. The breast care 
nurse dealings and efforts to keep my communication with the 
doctor really helped the decision-making process. 
 
For Margaret, it becomes apparent that patients cannot always access the clinician outside 
of consultation appointments. Away from the hospital, she experienced feelings of worry 
and anxiety, which restricted her decision-making ability at home.  However, Margaret 
explains how the breast care nurses acted as a source of relief to contact any time, as they 
provide reassurance by verifying matters with the clinician. For Margaret, it was important 
to have regular contact with the clinician to discuss and address her concerns, and so she 
could make an informed decision. She believes that the breast care nurses maintained a 
supportive and encouraging role, by ensuring that the patients’ views and queries were 
persistently voiced and made aware to the clinician. Therefore, the breast care nurses help 
to maintain the patients’ participation and commitment to the SDM process. Margaret states 
that she was keen to be kept informed at all stages of her treatment and, therefore, saw the 
breast care nurses as the ‘middle inside people’, who could answer her questions and 
provide feedback from the clinician. This appeared to be a reassuring process for Margaret 
as it meant that she did not have to wait anxiously for the clinician’s availability and 
appointments. Therefore, because of the breast care nurses’ connections between the 
Chapter Four 
111 
 
clinician and Margaret, her experience of SDM was maintained and further encouraged, 
through the additional sources of information and shared communication.    
 
 
4.4.3 Theme three: features of SDM  
 
Through analysis of the patients’ accounts, an important theme emerged which 
encompassed two sub-themes: information exchange and two-way processes. Both are 
concerned with the definition and characteristics of SDM from the participants’ 
perspectives. These sub-themes brought awareness to a range of factors which influenced 
(facilitated) the degree to which SDM was experienced by participants. For participants, 
these factors were often described in relation to the process of SDM, and more specifically, 
used to describe what constitutes an experience of SDM. This in turn produced a theme 
which provided an insight into what characteristics are classified as an experience of SDM, 
how SDM is perceived by patients, and the meaning of SDM to patients. These two sub-
themes will now be explored in more detail. 
 
 
4.4.3.1 Sub-theme one: information exchange 
A predominant feature which stood out in all participants, accounts was the notion of 
‘being kept in the loop’. Regardless of the participants’ participatory role (‘active’ or 
‘passive’), all participants felt that explanation and being informed by the clinician were 
important parts of their decision-making process. Therefore, to some participants, being 
given a detailed description of their own individualistic treatment; obtaining clarity over 
processes; and understanding the reasons grounding their treatment path, produced 
subsequent feelings of involvement, and for many participants, was described as an 
experience of SDM. Extract 16 demonstrates how the role of explanation, by the clinician, 
and the sharing of information were defined as key characteristics, and facilitated a 
patient’s understanding of SDM.  
EXT 16. Vicky. Interview 14. Lines 60-72 
I saw the oncologist and he explained to me what type of 
cancer I got, how big the lump was, what I was going to have 
done. I was happy with that. I didn’t have a lot of questions 
or felt the need to discuss it, because I was explained about 
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everything I needed to know. I was happy with my involvement. 
I don’t think there was anything else they could have told 
me. You got a lump, you’re going to have it out, you’re going 
to have treatment after, and that’s all. For me shared 
decision-making was the fact that I was being explained what 
was going to happen. That’s what makes it an informed 
decision. By the doctor sharing all his knowledge with me and 
allowing me to know all I needed to know, that to me is a 
shared decision. Even If we don’t make the decision together 
and he does, it’s still a shared decision because he has 
shared everything with me. 
 
Vicky defines what is meant by information exchange to the participant. Her account 
demonstrates an appreciation of full understanding of diagnosis and how the cancer will be 
addressed. For Vicky, having a full comprehensive knowledge of her treatment path was 
necessary before consenting. Therefore, this outlines a clear example of the requirement of 
informed consent in practice, and the importance of what she refers to as ‘informed 
decision-making’. Vicky’s contentment in her level of involvement is displayed through her 
ability to acquire understanding. It is recognised, towards the end of her account, that her 
encounter of SDM is documented through her heightened gratitude towards knowing and 
being fully informed. Vicky was happy to allow the clinician to outline her appropriate 
treatment path. However, she still references to an encounter of SDM, which was 
experienced by means of this method of information and knowledge sharing. Therefore, by 
the clinician explaining each course of action, this was defined as an SDM process. 
              Extract 17 below, demonstrates another example of the impact of information 
exchange on patients’ experiences of participation in decision-making.  
EXT 17. Helen. Interview 3. Lines 60-65 
I wasn’t given a choice over surgery, chemo, or radiotherapy. 
I was told this is what you are going to have to have. I 
didn’t mind being told that, because they said to me that 
that was the best regime to give me a better prognosis. As 
long as they explained it to me properly and that I could 
understand, then I felt involved in my health care and I felt 
that it wasn’t going over my head. The doctors were really 
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good and I cannot fault their explanations, and how they 
talked me through what is going to happen to me. 
 
Helen’s account displays similarity to Vicky’s, whereby the significance of explanation is 
highlighted. Helen outlines that a matter of choice in treatment decision-making was not 
always available, due to the type of breast cancer and diagnosis received. This meant that 
shared discussion over treatment choice, between the clinician and Helen, did not take 
place. However, this was not seen as problematic to Helen, as she still felt incorporated into 
the pre-made treatment decision. Her participation in decision-making was experienced 
through the clinician’s ability to explain the decision made. From both Vicky’s and Helen’s 
extract, it is understood that as long as participants were aware of what, why, when, and 
how; and got to acquire knowledge and information from the clinician, then an 
understanding of patient involvement and participation in decision-making was achieved.  
 For some participants, the role of information exchange and being informed, did not 
only offer the clinician an opportunity to share knowledge and information. The process 
also allowed patients to voice their views and preferences and, therefore, to share 
information with the clinician about their concerns, queries, and beliefs. Subsequently, 
such reciprocal process of information exchange partially constituted an SDM experience. 
Extract 18 below, illustrates the clinician’s shared explanations and the given opportunity 
for the patient to share their views and preferences. It also shows how the process of 
information exchange, by both the patient and clinician, helped to establish an experience 
of SDM towards treatment selection. Sarah explains this in relation to her personal 
experience of having to decide between a lumpectomy and a mastectomy.  
 
EXT 18. Sarah. Interview 2. Lines 135-145 
I suppose going to get a second opinion, to discuss the type 
of surgery I was going to have, is a classic example of a 
shared decision-making. I was very much in the opinion that I 
needed a mastectomy, because I just wanted to get rid of it 
and have the breast tissue taken away, so I completely 
eliminated the risk of it ever coming back again. That’s why 
I was anxious when I was told I was going to have a 
lumpectomy. The fact that I was able to have that decision 
explained to, be told what the outcomes are if I had the 
lumpectomy, and have explained why a mastectomy was better, 
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that to me was a perfect example of shared decision-making, 
and one that I really valued. It allowed me to reflect a 
little bit more and be more logical about things. It made me 
feel less distressed, because you can be in such a state and 
not always thinking logically. So to have that extra time and 
to be able to have that explanation was handy in enable me to 
come to a mutual decision with the clinician. 
 
Sarah provides a scenario which demonstrates a difficult time that she faced in having to 
make the appropriate surgical treatment decision. Primarily, Sarah explains that’s she 
showed resistance towards decision-making, by choosing an immediate mastectomy. In her 
opinion, the option of a mastectomy eliminated all chances of the cancer returning, whilst 
increasing her survival chances. This was a reoccurring finding within the data, as all 
participants stated that when it came to surgical decision-making, patient choice and 
decision-making was not important. Participants obtained a belief that the clinical route to 
surgery should be to simply remove the cancer, as the principal aim of recovery is to 
remove the cells and increase chances of survival. Therefore, a strong attitude of ‘just get 
rid of it’ occupied the data, as illustrated in Sarah’s extract. However, to complicate 
decisions, most women similar to Sarah were encouraged by the clinician to have a 
lumpectomy, which created a state of dilemma. To ease this process, Sarah makes reference 
to the importance of explanation during the consultation, as this helped to reassure her 
confidence on the suggested surgery type. Her doubts over having a lumpectomy soon 
became diminished through a two-way process of information sharing. For example, by 
allowing Sarah to participate and share her worries, views, and preferences, through asking 
questions, this in turn also allowed the clinician to share his knowledge and information to 
address Sarah’s concerns, and inform the patient. For Sarah, this was seen as a healing 
process which enabled reassurance. Therefore, acquiring an explanation not only 
enlightened Sarah’s knowledge on the benefits of a lumpectomy and gave her a higher 
degree of optimism, but it also provided justification for the treatment, which she could 
understand and feel content with. As Sarah explains, the process of reciprocal exchange of 
information becomes associated with an experience of SDM. Sarah exemplifies high 
gratitude towards the process of SDM, as it allowed her to make and/or consent to the right 
decision, with the necessary knowledge in mind. Her experience of SDM also gave her 
some element of control over her emotions, as the discussions she shared with the clinician 
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and the information provided to her allowed her to independently rationalise and structure 
her thoughts and feelings accordingly. Therefore, the role of explanation and interaction 
here is presented to be more than just a duty in clarification. It activates patient control, and 
causes a mutual doctor-patient partnership to form, which starts an SDM process which can 
then be experienced. 
 
4.4.3.2 Sub-theme two: two-way processes 
Within the analysis, it became apparent that the role of two-way interaction ran very closely 
with the importance of information exchange. As outlined by Sarah, and by Vicky and 
Helen, much reference was made by participants about two-way conversations and 
interaction, and how this facilitated the sharing of information and knowledge; and in turn 
generated shared participation and constituted experience of SDM. The analysis revealed 
that two-way processes between the doctor and patient, such as two-way communication 
and mutual relationships, is an important characteristic of SDM during a consultation. For 
many participants, their understanding of SDM was shown to be related to their experience 
of a two-way interaction that occurred between themselves and the clinician. Within the 
data, much attention was drawn to the participants’ experience of doctor-patient 
communication. Patient experience of SDM became regarded as a collaborative and equal 
weighted task, by means of doctor-patient conversation. With the clinician ensuring equal 
interaction during a consultation, the patient was given an opportunity to have a say in their 
treatment, as opposed to having it imposed on them or being directly instructed. Opening 
up a two way discussion, invited the patients to work together with the clinician to outline 
the best route of treatment. Extract 19 demonstrates such notion of two-way interaction, 
and how this is played a constituting role in a patient’s encounter of SDM. 
Ext 19. Elaine. Interview 9. Lines 106-111 
In my experience of shared decision-making, it was a 
discussion. I would say a 50/50 process. For example, if the 
consultant was saying this would be the absolute best route 
for you to go down, but I was saying I’m actually not so 
sure about going down that route, then we would have a 
conversation together to come to an agreement. So decision-
making would have to be 50/50 process. I would ask and then 
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he explains, I would query and then he suggests, and through 
this back and forth process together we reached a decision.  
 
In Elaine’s account, her experience of SDM is shown to be linked to the notion of 
interactivity. She highlights the importance of conversation in enabling her to engage and 
take part in the decision-making process. In a hypothetical scenario, she points out in her 
account, the importance of mutual agreement between the patient and the doctor. She 
explains that this can be achievable by means of two-way communication, and a 50/50 
process. For example, the clinician’s purpose is to identify and explain, whilst the patient 
has a duty to be able to query. Both actions coinciding result in an equal weighted route 
towards making the decision, and what is defined to be, by Elaine, as an encountered 
experience of SDM. 
 In some given situations, participants were told their treatment plan directly, with 
no element of treatment choice. Yet, participants still made reference to an encounter of 
SDM, which was as a result of two-way conversations during the consultation. Extract 20 
illustrates that SDM is not only experienced or applicable to those patients who are given 
several treatments to deliberate and choose from. Rachel’s extract below, demonstrates that 
SDM can occur even when there is no choice and little scope for the patient to feel 
involved. How this alternative is achieved, is through a process of two-way interaction that 
takes place between the clinician and patient. 
EXT 20. Rachel. Interview 7. Lines 103-110 
Nothing has ever been totally imposed on me. The clinicians 
input is more than a suggestion...it is the course of action 
which is appropriate. I suppose if at any point, for example, 
if I didn’t want the lymph glands out, I could say. But I 
could see that that was a necessary medical action. I don’t 
think even if there had been a choice it would have made any 
difference to the decision-making process. I still had 
everything explain to me regardless of having no choice, 
which allowed me to see why it was necessary, and why they 
were doing everything they want to do. So it did feel mutual 
and shared in that sense. Talking it out together and sharing 
one another’s thoughts and knowledge made it feel like a 
shared decision. 
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In this recollection, it is evident that Rachel was offered no choice in her treatment 
selection. Nonetheless, she highlighted her rights, as a patient, to be able to voice any 
concerns or preferences. Rachel remained satisfied with the fact that she has no choice over 
treatment. Her contentment appeared to be due to her encounter of a characteristic of SDM, 
which was mutual interaction. Through interaction with the clinician about the treatment 
plan, this enabled Rachel to feel as if her treatment was not imposed. Having that 
opportunity to talk to the clinician to gain further knowledge, ask questions, and share her 
emotions, allowed for patient participation during the consultation. Subsequently, as Rachel 
explains, such involvement, therefore, gave a sense of SDM taking place and having been 
experienced. 
 
 
4.5 Discussion 
A TA on the semi-structured interview data identified three key themes, which provided 
valuable information and awareness about the experience of SDM for breast cancer 
patients, from their personal accounts. The first theme identified that the experience of 
SDM can mean different things, and be experienced in different ways, for different 
patients. The second theme emphasised a power imbalance between clinicians and patients, 
as an influencing factor which can hinder patient experience of SDM. The final theme 
drew attention to patients’ understanding of SDM, and highlighted certain characteristics 
which define and contribute towards an experience of SDM. This section of the chapter 
will now discuss how the three identified themes answer the research question- how do 
women with breast cancer experience SDM? The discussion concludes with the 
researcher’s personal and epistemological reflexivity, to outline certain issues and 
influences during data analysis and to outline how reflexivity has a place in the findings of 
this study. 
 The first theme titled ‘personalising and adapting SDM’, highlighted the existence 
of patient participatory roles. Supporting previous research, patients either displayed an 
‘active’ or a ‘passive’ participatory role, which influenced their levels of involvement in 
care and medical decision-making (Chewing & Sleath, 1996; Degner et, 1997; Guadagnoli 
&Ward). However, the analysis in this study moved away from showing how these traits 
impact health outcomes and decision-making in general, and instead explored and revealed 
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how the recognition of varying types of patient participatory roles influence a breast cancer 
patients’ perception, understanding, and experience of SDM.  
 The findings from the data showed that patient participatory roles are associated 
with different experiences of SDM. In extracts one to three, the patients’ enthusiasm to 
acquire information and knowledge, and eagerness to be involved in discussions was 
defined as an experience of SDM. Therefore, for an involved or ‘active’ patient, SDM was 
viewed as a process which involves the patient seeking information and knowledge. The 
task of information seeking is achieved through the patient’s own determination to acquire 
resources (Internet, support groups, and leaflets), and by means of choosing to engage in 
doctor-patient interaction (Hack et al, 1994). As supported by extract three, the ability to 
acquire an understanding about their diagnosis and the treatments available, gave patients a 
sense of control over their health care, and helped to sustain reassurance and comfort. 
Furthermore, as extracts one and six indicate, the process of seeking information helped to 
increase patients’ knowledge and confidence to engage in conversations with the clinician 
about decision-making, and to make informed decisions. As a result, the experience of 
SDM subsequently becomes largely associated with knowledge and the role of information 
transfer, achieved through a division of labour between the patient and clinician, to inform 
one another. Therefore, SDM is described as an experience which involves both parties to 
share valuable information and knowledge with one another, as this will facilitate a shared 
and mutual route towards informed decision-making. This supports the NICE guidelines 
(2004 & 2012) on SDM, and the existing literature on the definition of SDM (Beaver et al, 
1996; Charles et al, 1997; Elwyn & Charles, 2001; Emanuel & Emanuel, 1992; Towle & 
Godolphin, 1999).  
 However, this theme also revealed that clinicians cannot assume that all patients 
will volunteer to take part in SDM. Not all patients demonstrated acceptance of the new 
patient role and participated in decision-making. For unresponsive or ‘passive’ patients 
responsibility was seen as an unconscious emotional weight to carry and, therefore, 
acquiring increased knowledge, making choices, or engaging in discussions about breast 
cancer was prevented. As extracts four and five illustrate, for patients who exemplified 
such traits, their goal was to maintain good health and emotional well-being. Therefore, 
being submissive, helped to act as a defensive barrier and coping strategy to protect the 
individual from feelings of distress and/or anxiety. Subsequently, as extract seven shows, 
the task of decision-making was passed to the clinician, which resulted in a lack of 
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understanding and familiarity with the concept of SDM. ‘Passive’ patients showed an 
inability to describe their understanding of what SDM is, or to be able to provide any 
personal examples of their interpretations of an SDM experience. However, this is still an 
important finding. The fact that ‘passive’ patients had no accounted experience of SDM 
implies that SDM must be a process, which is contrary to being ‘passive’. This provides 
support and further intensifies the findings revealed by the ‘active’ patients, that SDM is a 
process of information exchange and knowledge acquisition, achieved through a patient’s 
ability to engage in further reading and participate in discussions with the clinician. 
 The second theme, titled ‘power imbalance and SDM’, drew emphasis to factors 
which can influence a patients’ encounter of SDM. These factors included the issue of 
authority and control between the clinician and patient, and the role of the breast cancer 
nurses to sustain SDM.  The theme captures the view of patients that specific power-
relations govern SDM between the clinician and patient which, therefore, creates a 
hierarchical structure that assigns power and control of decision-making to the clinician 
(Emanuel & Emanuel, 1992; Haug & Lavin, 1981). Consequently, the issue of unequal 
power-relations was described as a factor which can hinder or restrict the experience of 
SDM. However, this theme also drew attention to the role of the breast care nurses, in 
reversing the power imbalance between patient and clinician.  To explain this finding, 
patients referred to two factors: a perceived discrepancy in knowledge and expertise 
compared to the clinician; and a perceived issue of power-relations as a result of the 
clinician’s professional roles. 
 
             The former factor showed that patients acquired a view that medical expertise, 
professional knowledge, and medical experience are all skills that clinicians obtain above 
the patient. This was explained in extract nine, as a key factor which gave patients the 
feeling that they were inferior compared to the clinicians. Extract nine also shows that for 
many patients, by not acquiring the right knowledge, skills, and everyday experience of the 
illness, this resulted in a lack of confidence, belief, and ability to be involved in decision-
making (Coulter & Ellins, 2006; Thompson et al, 1993). Due to such inability to be 
involved, this left many patients stating that they lacked control over their health care, as 
supported in extracts eight and 10. Similar to the first theme, this highlights that patients’ 
understanding and experience of SDM appears to be rooted in their acquisition of 
knowledge. Therefore, for SDM to occur, a substantial amount of knowledge is not only 
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required by the clinician, but by the patient as well. By having that knowledge and 
information, this allowed patients to feel similarly equivalent to the clinician, and enabled 
them to confidently participate in discussions and take part in decision-making.  However, 
with the acquired view that ‘the clinicians knows best’ and ‘is the expert’, it was 
understood by patients that, in reality, an experience of SDM cannot take place. 
Highlighted in extract 11, patients believed that it’s not plausible to experience SDM, as 
automatic behaviour is to adhere to those who know more and are professionals in the field 
(Gafni et al, 1998; O’Flynn & Britten, 2006). The process of SDM became substituted with 
deference towards the clinician. Therefore, the meaning of SDM for patients is one which 
is perceived to be based on equal skills. However, in reality the equal split ratio is distorted 
and favours the clinician which, therefore, results in patients remaining submissive and 
compliant, and deters an experience of SDM between the clinician and patient.  
  The latter factor described by patients, which contributes towards such power 
imbalance, is the issue of the clinician’s professional role and duties. Extract 12 and 13 
revealed that patients had a tendency to describe an authoritarian system, which placed the 
clinician at the top of the ladder and the patient at the bottom, as a result of the clinicians’ 
status and role.  Patients made references to the clinician as a responsible figure, with a 
distinct role as health care manager, and who had a duty of care to improve patient health 
outcomes. For many women, this belief was subsequently driven as a result of the habitual 
trust one has in a medical professional when becoming ill. Therefore, the automatic action 
for many patients was to place the responsibility of decision-making in the hands of the 
clinician and to comply, as it was perceived to be the clinicians’ role and duty to provide 
appropriate medical assistance. As a result of such attitudes and behaviours, patients 
became oblivious to the process of SDM and this obstructed their encounter of SDM. 
Therefore, a patient’s experience and awareness of SDM was subsequently overshadowed 
by this perceived issue of hierarchical status. 
 However, within this theme it was also revealed that the breast care nurses have 
an important role to play in a patient’s encounter of SDM. Not only did the information and 
support they provide alleviate patients’ feelings of distress and anxiety, but this was 
described by patients to also allow for an encounter of SDM. Extract 14 shows that the 
breast care nurses showed substantial commitment in providing patients with the necessary 
information and knowledge needed to be able to make an informed decision. The nurses 
acted as a great source for patients to obtain and update their knowledge on treatments and 
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procedures. Many hours were devoted to the patients, as the nurses sat and engaged in two-
way discussion with them, answered their queries, and ensured that they attained 
understanding about their treatment and/or decision-making options.  This process of 
sharing information to one another, similar to that between the clinician and patient during 
a consultation, in turn, was perceived by patients as an experience of SDM. This finding is 
important as it illustrates that SDM is experienced with other member with a breast cancer 
multi-disciplinary team. Subsequently, this suggests that the concept of SDM is dynamic 
and applicable to all levels of medical professionals. 
 Further, it is observable from extract 15 that the breast care nurses not only 
encouraged the experience of SDM for patients outside of a consultation and with 
themselves, but they also played a role in facilitating and promoting further experiences of 
doctor-patient SDM. This was achieved through the nurses’ ability to position themselves 
between the clinician and patients, and, therefore, act as a bridge which passes information 
to and from one another. The nurses filled in gaps in the doctor-patient relationship outside 
of a consultation, and this consequently kept an experience of SDM going for the patients. 
Through the nurses’ efforts to maintain interaction between the clinician and patient; 
ensuring the patients’ queries are heard; and providing the patient with information and 
answers from the clinician, this helped sustain the patients’ experience of SDM, as well as 
encouraging it to take place. Once again, attention is given to the importance of acquisition 
of knowledge. The breast care nurses were able to facilitate an experience of SDM for the 
patient, through their ability to provide the patient with knowledge and information, during 
two-way interaction and discussions which took place between the patient and the breast 
care nurse; and through the link the nurses provided with the clinician.  
 The final theme titled ‘features of SDM’, raised attention to the patients’ 
understanding and meaning of SDM, through interpretations of their experiences. The 
theme illustrated the perceived characteristics of SDM for the breast cancer patients. Two 
key characteristics were perceived by patients, which were described to contribute towards 
an experience of SDM. The first characteristic which stood out within the data extracts was 
explanation. The role of verbal explanation was respected as a necessity to the decision-
making process, as highlighted in extract 16. Patients valued it as a tool which exploited 
justification, involvement, and reassurance. Regardless of how much control patients 
desired over decision-making, the process of explanation was still equally important to 
them, as it was described as a means to maintain patient involvement in their health care 
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(Elwyn & Charles, 2009). This is consistent with both of the themes discussed above, 
which shows that the acquisition knowledge, through a process of information exchange 
and two-way communication, is valuable to a patient’s experience of SDM (Elwyn & 
Charles, 2009). All patients gave clear accounts, which stated their preference and desire 
for an explanation and the transfer of information from the clinician; and to be kept 
informed about procedures. Subsequently, having that knowledge and insight about their 
treatment, through the clinicians’ ability to share information and provide thorough 
explanations, helped to produce feelings of inclusion. It allowed the patients to feel on par 
with the clinician and, therefore, informed and confident enough to engage in decision-
making conversation (Charles et al, 1999b & 2004; Hack, et al, 2006; Towle, 1997).  
 As extract 17 illustrates, not all patients were given the privilege of treatment 
choice, and were instead directed to their course of treatment. However, this was not seen 
as unethical, as long as an explanation or a rationale was not exempt from their 
consultations. This theme highlights the importance of doctor-patient relationship, with the 
role of two-way communication and shared interaction facilitating the relationship (Degner 
& Sloan, 1992; Frosch & Kaplan, 1999). This relationship is important for patients to 
establish in order to overcome any asymmetry of information between the doctor and the 
patient. As extract 18 illustrates, it was important that the clinician provided enough 
information and knowledge through explanations, as this enabled patients to feel involved 
and to contribute to the decision-making process. This, subsequently, allowed them to 
make informed decisions (Ong et al, 1995). As a result, this process of reciprocal 
information exchange was described by patients to be associated with an experience of 
SDM. It appeared that participation and feelings of membership in treatment decisions, 
were being sustained through this method of information exchange. Patients regarded this 
transfer of knowledge as a ‘sharing’ process, and one which they defined as an SDM 
experience. Subsequently, it is understood that the role of information is merely just a 
description, as it is what patients describe as an important aspect which defines SDM, and 
an important element which constitutes towards their experience of SDM.  
 The second characteristic of SDM, which coincides with the first characteristic 
discussed above, is the importance of equal interaction. The data drew particular relevance 
to the significance of verbal two-way communication during decision-making, as it 
allowed for an interaction of information and preferences to be shared between the 
clinician and patient. This was described as an important ingredient for the experience of 
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SDM (NICE, 2004 & 2012). As shown by data extracts 19 and 20, the patients’ 
experiences of SDM were defined by means of their cooperative position, alongside the 
clinician, during discussions which took place within consultations. Unlike reading 
information, the role of verbal communication allowed patients to develop rapport, and, 
therefore establish a relationship with the clinician. For the majority of the women, a dual 
process of information sharing was interpreted as an equal weighted (50/50) route, towards 
an SDM experience. By opening up a two-way discussion, which operates on a cycle of 
questions by one person followed by explanations by another person, it invites both the 
clinician and patient to work together to outline the best route of treatment (Beaver et al, 
1996; Charles et al, 1997; Towle & Godolphin, 1999; Elwyn & Charles, 2001). Therefore, 
the role of two-way interaction presented, by patients, is more than just a process of 
information exchange, as it contributes towards a shared model of decision-making, and 
subsequently enables participants to experience SDM.  
 
4.5.1 Reflexivity: the researcher’s voice 
As mention previously in this chapter (section 4.3.6- data analysis), researcher reflection 
was an integral process throughout the analysis of study, and was maintained by means of 
a reflexive diary. My intentions in being reflexive were to be transparent and describe my 
potential influences. In having reached the findings discussed above, it is important to 
explore how I, the researcher, and inter-subjective elements impinged on, and even 
transformed, these findings. 
 I had initially come from Masters Qualification background, on the psychological 
impact of cancer on patient well-being and QOL. My previous research engagements with 
cancer patients, prior to starting this PhD, focused on the psycho-social impact of cancer 
treatments. Therefore, I found myself during the analysis of the interview transcripts, 
paying significant attention to patients’ reported adverse side-effects and how this affected 
their QOL. I was emotionally interested about the devastating side-effects and horrific 
emotions, which participants experienced during their treatment trajectory. During the 
period of analysis, I also knew of a friend who was currently undergoing chemotherapy for 
breast cancer. Therefore, having spoken to her on several occasions about her treatment 
and psychological well-being, I was subsequently drawn to certain extracts about patient 
distress, hair loss, and depression, which focused me to explore decision-making 
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surrounding these topics.  Such interest in the psycho-social well-being of breast cancer 
patients further fuelled me to want to learn more about the adjuvant treatment side-effects, 
and to explore whether the prospect of depleted QOL and emotional well-being can impact 
upon how a patient makes a decision. Subsequently, this encouraged me further to want to 
explore patient interaction to gain a greater insight into the difficulties and dilemmas 
during their breast cancer treatments. Such interest therefore provided further basis for me 
to conduct the second study of this thesis 
 As I had originally engaged in clinic observations prior to the collection of data, 
this had therefore equipped me with knowledge and examples of how decision-making 
occurs between the patients and the clinician. Subsequently, in reviewing the data 
transcripts, I found myself focusing on trying to find examples and instances, which 
mirrored what I had witnessed in my observations. During the clinic observations, I 
noticed a power imbalance between the patient and clinician, as very little patient 
participation in treatment discussions took place. Such acquired knowledge, therefore 
swayed me to look for instances within the data which illustrated power differentials 
during decision-making. My preconceptions about patient experience of SDM, during 
clinic observations, had resulted in influencing the initial codes and themes I drove from 
the data. 
 Having read the NICE guidelines (2004 & 2012) on SDM, I was therefore aware of 
the clinical procedures and communication skills needed for SDM.  This made it very hard 
for me to examine the data irrespective of this. In exploring how the characteristics of 
SDM were perceived by participants, I found myself looking for key words such as 
‘information-exchange’, ‘patient involvement’, ‘active participation’ and ‘sharing 
preferences’. Therefore, in some instances I was drawn to data extracts which 
demonstrated patients’ understanding of SDM in accordance to the guidelines, and not 
necessarily from their individual perspectives. 
 My own personal experience of having to make treatment decisions also influenced 
the way I examined the data. In the first year of my PhD, I was faced with the task of 
having to make a surgical treatment decision. I recall playing a very ‘active’ role in the 
decision-making process. I wanted to know lots of information and ensured to do a lot of 
online research about my illness. To make the right decision, I had questions to ask the 
clinician, and it was important for me to be able to share my queries, worries and 
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preferences during the consultation. My personality and individual traits played a key role 
in my ability to make a decision and, therefore, during the analysis, I was keen to see if 
patients’ individual traits influenced their decision making and/or the process of SDM. 
Therefore, I was to drawn to examples in the data which indentified participatory traits, 
and I looked for examples within the data where individual differences were linked to a 
particular type of SDM experience. 
 Throughout the process of reflexivity during this study, I learnt that personal 
reflexivity can prove useful for evolving the research area. Being reflexive can help 
illuminate personal research interests, which can pave the way for future projects or 
additional studies within a project. In my case, by acknowledging my personal interests 
about the psychological impact of breast cancer on decision-making, this facilitated me to 
design the second study of this thesis, which would shed more light on the research 
question. I have also learnt, as a researcher, that during the process of reflexivity, despite 
what observations have been made previously, or the literature engaged in prior to data 
collection, it is important to keep the research question at heart of the data analysis. I 
occasionally had to remind myself what the purpose and aim of my PhD was, to ensure 
that my engagement with the data extracts, and how analytical themes were drawn, 
answered the research questions in Chapter One. In conclusion, I am aware that as a 
researcher that your personal experiences and research experiences can impact on the way 
you apply meaning and interpretation the data. Therefore, reflexivity should be noted at all 
stages, in order to provide further justification and clarity to the findings drawn from the 
data. 
 
4.6 Conclusion 
In exploring the research question, through examination of patient perceptions and 
encounters of SDM during semi-structured interviews, the three identified themes have 
yielded some important findings about the experience of SDM for breast cancer patients. 
The findings have demonstrated the impact of individual difference on a patients’ 
experience and meaning of SDM. Therefore, it is understood that SDM is not a uniform 
process, and can mean different things to different people and/or is experienced in different 
ways, due to patients’ active and/or passive positioning. A patient’s experience of SDM is 
shown to be a variable process, which is self-managed by the patient’s preferences for 
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involvement. This implies that patient encounters of SDM do not automatically occur 
throughout a patient’s treatment path. Instead its occurrence is arguably patient-led and 
controlled by the patient.  
 The findings also demonstrated the hindering impact of imbalanced power-relations 
on patient experience of SDM. As a result of a perceived discrepancy in doctor-patient 
status and levels of expertise, patients were able to emphasise their understanding and the 
meaning of SDM, which was described to involve equal acquisition of knowledge and 
equal involvement in decision-making. However, although the data has revealed signs of a 
power imbalance between the clinician and patient, which impact upon a patient’s ability 
to experience SDM, the findings also showed that an experience of SDM can take place 
outside of a consultation with the breast cancer nurses. Therefore, the process of SDM is 
illustrated to one that is latched within a multi-disciplinary team of breast cancer 
professionals. This allowed patients to encounter SDM through different people and at 
various stages of treatment. 
  Finally, in assessing patients’ experiences of SDM, the analysis has opened in 
depth recognition to meaning of SDM, through a wider knowledge of key characteristics 
which constitute towards an experience of SDM. Focus is drawn to what is regarded as 
valuable content with a conversation (i.e. sharing information, preferences, and 
explanation) and how that content should be delivered (i.e. through two-way interaction). 
Therefore, the findings elevate attention to the significance of doctor-patient relationships 
and communication during a consultation, in allowing for two-way information exchange 
and interaction to occur between clinician and patient, as this works towards a shared 
model of decision-making.  
 
 
 In conclusion, the interview data has revealed substantial awareness around the 
experience of SDM, from the patients’ perspectives. It has also revealed an insight into the 
additional questions, outlined in Chapter One. For instance, it has informed about what the 
concept of SDM means to patients, and what characteristics of SDM are. It has provided an 
insight into the factors which facilitate and hinder patients’ encounters of SDM. It has also 
showed that SDM for breast cancer be explored qualitatively, through an examination of 
patient perceptions. The main discussion chapter of this thesis (Chapter Seven) will further 
explore the findings of this study in relation to the implications it has on breast cancer care, 
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further health research, and qualitative research. Chapter Seven will also further discuss the 
findings of this study in more detail, in relation to the literature review outlined in Chapters 
One and Two, and the overall research questions.  
 The findings from this study have drawn particular attention to patient participatory 
roles, and issues of a power differential between the patient and clinician. They have also 
posed questions about the role of two-way interaction and communication within a 
patient’s experience of SDM, specifically about the surrounding discourse and interactions 
which take place for SDM, and how this further shapes patients’ experience. This 
subsequently warrants further research, underpinned by a symbolic interactionist 
methodology, which focuses on exploring patients’ experiences of SDM through 
communication and interactions with others. The next chapter introduces the second study 
of this thesis, which aims to explore patients’ experience of SDM, through the interactions 
they have online with other breast cancer patients. 
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Chapter 5 
Study 2: exploring SDM within online breast cancer forums 
 
 
5.1 Introduction 
The previous study in Chapter Four took a phenomenological approach and explored SDM 
from the patients’ perspectives by means of semi-structured interviews. Thematic analysis 
(TA) of the interview transcripts identified three themes: the role of individual differences 
on a patient’s understanding and experience of SDM; the importance of information 
exchanged and two-way interaction within doctor-patient relationships during SDM; and 
the impact of imbalanced power-relations between the clinician and patient, which 
hindered SDM taking place. From these three themes, the role of two-way communication 
stood out to be an important descriptor within participants’ experience of SDM.  The study 
provided a deeper understanding of the experience of SDM, by women with breast cancer.  
It also provided additional insight about the meaning and characteristics of SDM, as 
perceived by patients; and brought attention to how the experience of SDM can be 
influenced (hindered or facilitated) for women with breast cancer 
 In order to achieve the overall goals of this thesis, a second theoretical approach 
was introduced in Chapter Three, which focused on exploring the research question by 
means of a more interpretive perspective, by citing a symbolic interactionist approach. In 
line with critical health psychology, this theoretical framework focuses on the symbolic 
meaning that people develop and rely upon, in the process of social interaction. Attention 
is given to the way that people interact through symbols such as, words, gestures, rules, 
and roles. Understanding these symbols is important in understanding human behaviour 
(LaRossa & Reitzes, 1993).  
 The findings from study one (Chapter Four), which emphasised the importance of 
two-way communication for SDM, demands an interactionist paradigm to examine the 
research questions further. This chapter introduces the second of the three qualitative 
studies, which explores SDM through patient interaction. This is achieved by exploring 
conversations which take place between patients within online breast cancer forums. In this 
chapter, a short literature review is provided, which focuses on exploring the use of 
computer mediated communication as a method of data collection within health research, 
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and a way to access patients’ health experiences. The usage of online forum data will also 
be discussed in relation to existing SDM research, and its applicability in exploring SDM 
amongst breast cancer patients. Following the literature review, the method is described. 
This is then followed by a detailed explanation of the findings achieved through a TA on 
the online forum data. The chapter concludes with a discussion of the findings. 
 
 
5.2 Literature review 
 
5.2.1 The Internet as a medium for qualitative research 
 
The Internet, also referred to in research as ‘cyberspace’ or the ‘World Wide Web’, is used 
by many people for daily tasks, such as sending and receiving personal emails, accessing 
public information, viewing merchandise, making purchases online, and generally for 
information gathering and transmission. The Internet is also increasingly used as a social 
space where relationships, communities, and cultures emerge through the exchange of 
messages and images. Due to the expansion of use in computer mediated communication, 
over the past decade, the number of studies about the Internet has grown dramatically 
(Consalvo & Paasonen, 2002; Loader, 1998).  It has yielded new opportunity for 
psychological research, as it lowers the cost of data collection (Gaiser, 1997; Hamman, 
1996; Nosek, Banaji & Greenwald, 2002); provides data on varied phenomena (Sproull, 
1995); and makes interesting psychological phenomena -which might not exist in 
traditional settings -visible. (Sproull & Kiesler, 199; Stewart, Eckermann & Zhou, 1998). 
According to Clark (2000), the accessibility of information for analysis, and the anonymity 
of the Internet, allows researchers to analyse text and narratives on web sites, to use online 
groups as global focus groups, and to conduct interviews and surveys via e-mail and chat 
rooms, all of which are suited to qualitative research. 
 
 Qualitative inquiry is grounded in information collected from observation, text, 
talk, and interviews (Silverman, 1997, 2001). According to Barbour (2000), “qualitative 
methods seek to acknowledge the existence of and study the interplay of multiple views 
and voices- including, importantly, lay voices” (p.156). The types of communication and 
interactions made online, through Internet postings, are suitable for qualitative research. 
For example, it is possible to determine information needs and preferences of online users, 
Chapter Five 
131 
 
or to investigate how health-related information can be distributed online and best 
converted into knowledge (Eysenbach, 2000). As a medium for communication, the 
Internet provides new channels for people to communicate with each other, and for 
researchers to communicate with participants. This allows research to capitalise upon 
emerging discursive forms and practices, to study the way people use communication and 
interact.  Furthermore, as a context of social construction, the Internet is a unique 
discursive environment that facilitates analysis surrounding the structure of talk; the 
negotiation of meaning and identity; the development of relationships and communities; 
and the construction of social structures as these occur discursively. The linguistic and 
social structures that emerge through online communication, provides the opportunity for 
researchers to track and analyse how language builds and sustains social reality. 
Subsequently, the Internet offers qualitative researchers many means of observing and/or 
interacting with participants, in order to study the complexity of language and interaction. 
It can be used as a tool for research topics unrelated to the Internet, and/or it can be used as 
a specific social phenomenon. Regardless of how it used, the Internet is both a tool of 
qualitative research, and a context worthy of research. This has been demonstrated 
diversely across relevant literature.  
 Research reveals three different types of Internet based research methods 
(Eysenbach & Wyatt, 2000). The first is ‘passive analysis’, which requires studying 
information patterns on websites, or interactions on discussion groups, without the 
researchers actually involving themselves. Previous research examples of this include, the 
study of content and help seeking within online self-help groups for colorectal cancer 
(Klemm, Reppert & Visich, 1998), breast cancer (Sharf, 1997), Alzheimer's disease (White 
& Dorman, 2000), and eating disorders (Winzelberg, 1997). The second type of online 
research is through ‘active analysis’, which involves the researcher participating in 
communications (Seaboldt & Kuiper, 1997). The final type of online research is through a 
process, which requires the researcher to gather information in the form of online semi-
structured interviews, online focus groups, Internet based surveys, or to use the Internet to 
recruit participants for ‘traditional research’. These three methods illustrate the degree of 
diversity in research that can take place with the Internet, as a research tool.  
 There are a variety of examples of qualitative research contexts, conducted with the 
Internet. Examples include the use of chat rooms to examine accounts and conversations 
about rape (Dibbell, 1993), and how computer-mediated communication (CMC) users 
Chapter Five 
132 
 
compensated effectively for the absence of non-verbal and paralinguistic elements of 
conversation (Witmer & Katzman, 1998) .In relation to health research, Johnson (2003) 
used the Internet to explore anorexia, as a lifestyle rather than a disease. The study found 
that women were actively constructing a global, yet, anonymous community, which 
provided solidarity and helped to justify their choice to be anorexic. These studies not only 
demonstrate the usability of the Internet for qualitative research, but also illustrate how the 
Internet provides new tools for conducting research, and new venues for social research. 
Online research also provides new means for understanding the way social realities are 
constructed and reproduced, through discursive behaviours.  
 
 
5.2.2 Online forums as a medium for health research 
 
The emergence of online support groups in the 1990s has grown into a mass social 
phenomenon, along with individuals’ growing ease in using CMC technology (Walther, 
1996). These online groups are providing new opportunities for patients to communicate 
with health care professionals, and other patients. Online support groups can operate 
through various Internet applications such as, an email list, a chat room, or a forum 
(bulletin board). As an online support group differs from a therapy group, this can have 
certain benefits for users who do not have the desire to attend face-to-face sessions. Some 
people may find online support groups a more suitable ‘venue’ in which to discuss a 
sensitive issue. The anonymity often afforded by the Internet means that messages posted 
to one another are decontextualised, and free from physical cues to the senders’ sex, age, 
race, disability, and physical appearance. It also allows discussion of potentially 
embarrassing topics or taboo subjects, whilst minimising the fear of rejection, therefore 
arguably increasing the possibility of self-disclosure and intimacy, and encouraging 
honesty (Ferguson, 1997a; Galinsky, Schopler, Abell 1997; Klemm & Nolan, 1998; 
Madara, 1997). This is particularly useful for patients with breast cancer, as the visible 
disfiguring effects from surgery and chemotherapy are avoided (Finfgeld, 2000). Many 
forms of online support groups enable access to information, support, and emotional relief 
and are an accepted technology, as participants take advantage of their synchronicity, easy 
access, opportunity for archival search, convenient links, and friendly design (Meier, 
2004). 
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 Online support forums exist on many health topics, and have grown in numbers due 
to the expanding needs of individuals to know more and be more involved about their 
health conditions. More support forums are providing mutual aid and self-help for people 
facing chronic disease, life-threatening illness, and dependency issues (Cline, 1999). For 
those who take part in an online support forum, groups function as accountable sources of 
help, through which they transmit and obtain information, provide and receive emotional 
support, socialise and form interpersonal relationships, and experience comradeship with 
others sharing a similar distress (Bane, Haymaker & Zinchuk, 2005; Cawyer & Smith-
Dupre, 1995).   
 Internet chat rooms and support group bulletin boards provide a rich sample of 
human behaviour that can be mined for studies of communication (Galegher, Sproull, & 
Kiesler, 1998; Nardi & Whittaker, 20012). Health-related research has generally focused 
on studies that evaluate the Internet, and illustrate its impact on health care users, by 
identifying what patients use the Internet for. For example, Finn (1999) examined 718 
messages over a three month period from an online bulletin board. The postings were 
divided into two realms: socio-emotional messages (expression of feelings, provision of 
support, casual conversation, friendship, taboo topics; and task-oriented messages (asking 
for or providing information, problem solving, computer talk or group cohesion). Results 
indicated that over 50% of postings concerned socio-emotional exchanges. Subjects mostly 
discussed health and interpersonal relationships, followed by legal and political issues. 
Similarly, Braithwaite, Waldron, and Finn, (1999) examined one month's messages (1179 
postings) to a disability bulletin board and found that the most frequent category of 
postings concerned emotional support (40%), followed by information (31.7%), esteem 
support (18.6%), networking (7.1%) and tangible assistance (2.7%). These findings have 
led further research to explore the impact of Internet use, to examine specific groups of 
Internet users (e.g. the ‘self-helpers’), and to investigate the practices patients deployed 
from Internet interactions during treatment (Burrows, Nettleton, Pleace, Loader & Muncer, 
2000). Studies show that the Internet seems to be used in many different ways by people 
with serious illnesses, at various stages, and follow-up, to acquire expertise and to display 
competence in the face of serious illness (Ziebland et al, 2004). This and other studies have 
found that wider access to medical information is inevitable and likely to encourage a 
balanced encounter between patient and health professional, to increase the appropriate use 
of medicine (Grol, 2001). However, others have drawn attention to the dangers of patients 
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using the Internet for health information, due to the potential for misdiagnosis and 
exploitation (Eysenbach & Diepgen, 1998; Heathfield, Pitty & Hanka, 1998; Jadad & 
Gagliardi, 1998). It has also been suggested that Internet use can erode patients’ faith in the 
authority of health-care practitioners (Hardey, 2003). 
 Other related research has evaluated and assessed the impact of the Internet on 
patients’ health and their treatment. For example, studies have found that an increase in the 
use of the Internet for health information can result in positive shifts towards more 
equitable, or even patient-controlled, relationships between practitioners and patients 
(DOH, 2001b; Graham, Smith, Kamal, Fitzmaurice, & Hamilton, 2000; Hardey 2001; 
Ferguson, 1997b). Therefore, it is suggested that Internet use may lead to further shifts in 
the models of doctor-patient interaction, used in health care settings (Gothill & Armstrong, 
1999; Little et al, 2001). More specific studies have focused on exploring the health 
benefits of online support groups for patients. Some have shown benefits such as, 
enhanced QOL and increased survival time (Cline, 1999; Spiegal, 1994); and reduced 
depression and cancer related trauma (Housten, Cooper & Ford, 2002; Winzelberg et al, 
2003). A questionnaire study showed the significant positive impact that group forums can 
have on improving decision-making (Spiegel et al, 1989). Other suggested benefits include 
a sense of power given to forum users, through the process of writing itself, as this activity 
was argued to enable emotions to be opened and a sense of cognitive order (Pennebaker & 
Seagal, 1999, Pitts, 2004); improve interpersonal interactions and reduced feelings of 
isolation, which are established through social relationships (Braithwaite et al, 1999); and 
enable users to acquire and improve their self-confidence and reassurance (Hoybye, 
Johansen & Tjornhoj-Thomsen, 2005).  
 
 Traditional face-to-face support groups are a usual integral aspect of treatment for 
patients with cancer (Cella & Yellen, 1993; Spiegel et al, 1989). However, over the years, 
online groups for cancer support have flourished (Klemm, Hurst, Dearholt, Trone, 1999). 
Research has found that the Internet is more commonly used, in a health context, by breast 
cancer patients. Nearly half of women recently diagnosed with breast cancer turn to the 
Internet for information on health (Satterlund, McCaul, & Sandgren, 2003). The UK has 
numerous cancer support charities that provide free and accessible online support groups 
for their members, and all breast cancer patients. Discussion boards within these cancer 
support groups can vary in content, but are usually categorised according to topics related 
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to diagnosis, treatment and side-effects, QOL recurrence, and alternative therapy 
(Weinberg, Schmale, Uken & Wessel, 1996). Several randomised controlled trials, 
conducted with breast cancer patients, found women used online forums extensively 
(Gustafson et al, 1993; McTavish et al, 1995; Rolnick et al, 1999; Shaw, McTavish, 
Hawkins, Gustafson, & Pingree, 2000). Similarly, Weinberg et al (1996) studied an 
electronic bulletin board established by breast cancer patients, and found during a three 
month period, that participants used the forum significantly more than face-to-face groups.  
 Online cancer forums are a popular form of engagement amongst breast cancer 
patients (Klemm et al, 1999), and research attention has, therefore, turned to explore its 
uses. Sharf (1997) found that information requests amongst breast cancer forums were the 
most common interactions, followed by psychological and emotional support, exchanges 
of personal experiences, and humour. Topics discussed included surgical treatments, side-
effects, news items about breast cancer, doctor-patient relationships, and encouragement 
issues. This is further supported by Klemm et al (1998), who demonstrated that postings on 
breast cancer support groups could be categorised into eight groups: information giving 
and seeking (25.4% of the interactions), personal opinions (22%), encouragement and 
support (17.4%), personal experience (16.4%), thanks (7.7%), humour (4.5%), prayer 
(2.9%), and miscellaneous (3.2%). Fernsler and Manchester (1997) found that over 85% of 
the cancer members of a support forum stated that contact with others, who have 
undergone similar experiences, was the most beneficial aspect of the forum. These studies 
provide useful knowledge about the function of forums for breast cancer patients, and 
highlight the “give and take” of information as a key exercise for interaction.  
 However, this does not apply to all forum users. Not all choose to take a 
participatory role in interacting and responding, and instead choose to utilise the forums for 
more passive purposes. Researchers have noted the invisible presence of hundreds, or 
perhaps thousands, of members who read but do not participate (King & Moreggi, 1998). 
Subsequently, the phenomenon of ‘lurking’ or reading messages in an online forum 
without actively sending any messages, has also been identified as a frequent feature of 
online groups (Brennan, 1996; Brennan & Ripich, 1994; Burrows et al, 2000; Klemm & 
Nolan, 1998; White & Dorman, 2000). According to Brennan et al (1996), passive online 
members may select a low level of visibility and participation as their preferred method of 
functioning in any group situation. Both Winzelberg (1997) and Finfgeld (2000) suggested 
that shy or reserved members may choose to lurk until they understand the group’s norms 
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and style. Occasionally patients, who choose to lurk in a group discussion, write to say 
how valuable the groups are, before returning to lurking (Dickerson, Flaig & Kennedy, 
2000). 
 
 From the research outlined, it is evident that the Internet mediates interactions, and 
offers new ways of conducting qualitative research. With more attention being focused on 
the use of online support groups and forums, these forms of communication and interaction 
have been shown to be valuable to health research, particularly breast cancer. From 
research, it is evident that individuals utilise these discussion rooms to seek advice, to 
improve their QOL and levels of emotional wellbeing during the course of their treatment. 
These studies generally take an evaluative approach to assessing Internet use and its 
implications for patient health. However, it is also important to explore whether the 
Internet can be used as a tool to access patients’ lived experiences and perspectives in 
relation to their health care. As the literature review above has already outlined, the 
Internet can be used as a medium for qualitative research. There is a need to further 
explore research that takes a more interpretativist perspective, which is rooted in symbolic 
interactionism, to further understand the Internet’s contribution to qualitative health 
research. This will be explored next in relation to symbolic interactionism and breast 
cancer research. 
 
 
5.2.3 A symbolic interactionist approach to online health research 
 
The Internet has frequently been evaluated within health research, through qualitative 
methods.  According to Jones (1999), “There are no ‘traditional’ methods for studying or 
using World Wide Web or anything Internet related” (p. xi). However, the significance of 
qualitative research practices is growing in online research (Sharf, 1999). Fernback (1999) 
argued that interpretative methodologies are best suited for studying online communities, 
as it recognises the importance of language and human interaction as forms of social action 
(Atkinson & Heritage, 1984; Austin, 1962). With the amount of data already available 
online this, therefore, highlights the suitability for interpretive methodologies, which aim 
to analyse social experience in everyday, naturalistic contexts (Gill, 1993; Wetherell & 
Potter, 1988). To adopt a symbolic interactionist approach, the researcher needs to be 
actively engaged in the world of the study and, therefore, the Internet has become a good 
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source in achieving this, through its accessible archives of communication. The basic 
assumption of symbolic interactionism is that meaning is a social product made possible 
through social interaction with others (Blumer, 1969). The use of online support groups, 
therefore make the symbolic interactionist a suited approach to this type of data platform. 
 
 Previous work has shown the benefits of online research, which employs a 
symbolic interactionist approach, in studying social processes, such as personal influence 
(Cummings, Sproull & Kiesler, 2002), negotiation (Biesenbach-Lucas & Weasenforth, 
2002), and identity formation (McKenna & Bargh, 1998). This method of enquiry and 
theoretical framework is increasingly used in the studying of health and illness. There are 
examples of research which examine online groups to explore the meaning of health and 
illness (Crooks, 2001; Heilferty, 2008; Kalichman, Benotsch, Weinhardt, Austin, Luke 
2002), and to explore the Internet’s role in health information (Eysenbach & Köhler, 2000; 
Hardey, 2003; Impicciatore, Pandolfini, Casella & Bonati, 1997; Ziebland, 2004).  
 More specifically in breast cancer research, online studies that are rooted in 
symbolic interactionism have been reported. These studies aimed to use the Internet to 
acquire a better understanding of the lived experience of treatment side-effects (Holley, 
2001); exploring patient attitudes towards breast cancer (Im, Chee, Lim, Liu & Guevara, 
2007); conceptualising the meaning of breast cancer (Høybye, Johansen, & Tjornhoj-
Thomsen, 2005; Orgad, 2005); and examining cancer survivors QOL (Zebrack, 2007). A 
symbolic interactionist approach to exploring decision-making amongst breast cancer 
patients online has also been demonstrated. This was achieved by Sharf (1997), who 
explored lived experiences of breast cancer patients, through observing their 
communication within online groups. Sharf’s findings, importantly, demonstrate that an 
individual’s decision-making can be enhanced through discussions which take place within 
online forums. The discussions which took place between patients online, challenged 
patients to rethink and revaluate their prior decisions, attitudes, and courses of action 
regarding treatment choice. Online interaction, within support groups, helped patients to 
cope with the emotional, social, and practical difficulties of treatment side-effects. It also 
enabled patients to gather more information; gain a better understanding of the nature of 
their distress; and develop ways in the handling of their condition, and feel more confident 
implementing their decision. Sharf’s study also highlighted the importance of interaction in 
enhancing patient control. Becoming a member of the group offered an approach to 
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meeting cultural and social needs, which resulted in the experience of personal control, and 
facilitated decision-making (Braithwaite et al, 1999; Burrows et al, 2000).   
 With research showing that online support groups can contribute towards a breast 
cancer patients’ experience of treatment decision-making this, therefore, opens suggestions 
as to whether similar findings can be achieved with SDM. However, there is little research 
conducted with online forums to explore the concept of SDM and breast cancer patients’ 
experiences and understanding of the concept.  For instance, do online forums provide 
evidence on the extent to which patients discuss the clinical decision-making processes? 
What meaning does online participation have on patients’ experience of SDM? Can the 
definition of SDM extend beyond patient and clinician, to include others outside the 
clinical setting? These are all questions that remain unanswered in the existing SDM 
literature, and in conjunction with the findings established from study one, provide a 
rationale for exploring SDM online in breast cancer forums.  The rest of this chapter will 
outline the second study of this thesis, which explores SDM within an online community 
enterprise for breast cancer. Following a description of the study method, the chapter will 
then outline the results of the analysis, and finally present a discussion on the findings. 
 
 
5.3 Method 
 
5.3.1 Study design 
 
As interpretive approaches, such as symbolic interactionism, rely heavily on naturalistic 
methods, breast cancer Internet forums were chosen as a qualitative data source. This 
material provides an opportunity to explore breast cancer patients’ interactions with other 
patients about their illness and treatment, and their experience and understanding of SDM.  
 
5.3.2. Forum selection criteria 
 
An extensive online search was conducted on UK breast cancer forum websites. Searches 
were conducted on the ‘Google’ search engine using key words such as, ‘breast cancer’, 
‘forums’, ‘support groups’, and ‘discussion boards’. Relevant forum websites were 
selected on the basis of their topic content (in accordance to Weinberg et al, 1996), and if 
they mentioned reference to decision-making. From the search process, some of the 
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websites with these key words were reports, articles, and information pages, which 
contained no patient discussion. These websites were disregarded. The websites selected 
for analysis were: 
 Breast Cancer Care: www.breastcancercare.org.uk/community/forums/ 
 Breast Cancer.Org: www.community.breastcancer.org/ 
 Macmillan Cancer Support: 
www.community.macmillan.org.uk/cancertypes/breast-cancer/discussions.aspx 
 
All three websites are UK based organisations that provide information and practical 
support, campaigns, and bring together patients with breast cancer. Participation in forums 
requires a private non-fee membership, which subsequently allows members to post their 
topic for discussion or respond to others. However, these websites are open and accessible 
to non-forum users, who are able to read members’ stories and responses. All of the 
selected discussion forums were publicly visible and require no membership or 
subscription to view the online post content. The researcher did not contact members or 
respond to any of the posts online.  
 
5.3.3 Participants 
On the three forum websites and during a two week time frame period, from 15
th
 May 
2013 to the 29
th
 May 2013, a total of 571 subscribers posted across the three forums: 162 
women posted messages to the Breast Cancer Care website; 189 to the Breast Cancer.org 
website; and 220 to the Macmillan cancer support website. Amongst those numbers were 
women who were currently diagnosed with breast cancer; were undergoing surgical 
treatment; were undergoing adjuvant treatment, and who were post-treatment completion. 
However, women who used to have breast cancer were the most active subscribers to the 
three online groups, which represented 83%. (474 women across the three forums). The 
remaining 17% (97 women across the three forums) were family members, friends, 
concerned others, and one medical professional (who was not a cancer specialist). Only the 
83% were used for data analysis. A total of 332 posts were reviewed across all three 
websites, and amongst these there were 268 participants (some participants posted within a 
discussion thread more than once). Participants were all women, aged 37-68 years. This 
information was directly accessible online, as all the members had their age indicated in 
brackets next to their name, or they mentioned their age within a post. Different stages of 
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treatment were evident amongst the 268 participants. However, 72% (193 participants) of 
the sample represented those who were post-treatment for cancer. Amongst the remaining 
28% (75 participants) of the sample, a wide range of treatments were presented, including 
mastectomy, lumpectomy, hormone therapy, radiotherapy, and chemotherapy. However, 
chemotherapy constituted 80% (60 participants) of this sample. Information about their 
stage of treatment plan was identified through examination of the content of their posts 
online. 
 For the purpose of consistency with study one’s inclusion criteria, participants who 
had opted for breast reconstruction following a mastectomy were not included in the 
sample. As reconstructive surgery entails its own dimension of decision-making, focus was 
therefore maintained on patients who only had to make surgical and adjuvant treatment 
decisions.  
 
5.3.4 Data collection  
Having conducted the search criteria to select the forums for analysis, attention was then 
given to thoroughly exploring each website, to enable familiarity with each website’s 
structure and content. All three websites displayed posts in written English and, therefore, 
did not require any translating. Each website was structured in a similar format, as each 
forum outlined several topic discussion categories, and subcategories existed within each 
category. Figure 5.1 illustrates an example of the layout, taken from the Breast Cancer 
Care website, and how categories and subcategories are presented online. Forum users 
started interaction and discussions threads, by posting their concerns or issues under the 
relevant website subcategories, which corresponds to the discussion topic they wish to 
engage in. Across all three websites, it was noticeable that they all contained similar topic 
categories and subcategory topics. This, therefore, allowed for easier handling of data. All 
the categories and subcategories across the three websites were initially reviewed, and 
since all messages were archived, this made it easy to access the posts within each 
category, on the three websites at any time. However, due to the large number of messages 
within each website, a decision was made to introduce a data inclusion criterion. The first 
criteria was that only posts that were relevant to the topic of breast cancer and QOL, breast 
cancer treatments, and decision-making, were to be included for data analysis. This ruled 
out non-disease related conversations. For example, the forums were occasionally used by 
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women for leisure and social purposes, and to talk to others about daily interests such as, 
books, TV programmes, and films. Another criteria was that only posts, which fell within 
the two week time frame (between 15
th
 May 2013 and 29
th
 May 2013), were used to ensure 
that the data was recent and up to date.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 An example of the forum categories and subcategories taken from the Breast 
Cancer Care website 
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 Having met both inclusion criteria, a total of 332 posts where identified across the 
three websites for the purpose of a TA. Each one of the 332 posts was clearly presented 
under a title. This title was devised by the thread owner (i.e. the person who initiated the 
topic of discussion online), and gave the post a form of identity by describing to other 
forum users what the post, or topic of discussion, was about. A review of all 332 posts 
revealed that emotive language within women’s messages, was expressed through the use 
of emoticons and capital letters. The 332 posts covered a broad range of categories and 
subcategories across all three websites. Table 5.2 illustrates the category topics covered, 
and the content of discussion (subcategories) within those categories. A large number of 
the 332 posts (N=132) were concerned with psychological issues and treatment decision-
making within the category ‘going through treatment’. 
 
Table 5.2 
 Summary of categories and subcategories within the 332 post for data analysis 
Categories across 
the 332 posts 
 
N’ of 
post (%) 
Sub-categories across the 332 posts 
 
Have I got breast 
cancer? 
 
 
50 (15%) 
 
Signs and symptoms; Screenings and scans; Family history and 
genetics; Waiting for test results 
I am recently 
diagnosed 
 
103 
(31%) 
Benign breast cancer; Triple negative; Inflammatory breast 
cancer; Local recurrence or new primary diagnosis 
Going through 
treatment 
132 
(40%) 
Chemotherapy; Radiotherapy; Hormone; Surgery; Targeted 
therapies; Lymphoedema 
 
Living with and 
beyond breast 
cancer 
 
 30  
(9%) 
Recovering from treatment; Sex and relationships; Work, 
Finance, Travel; Coping with fear and anxiety; Hope and 
inspiration 
 
I have secondary 
breast cancer 
 
17  
(5%) 
Treatment and medical issues; Living with secondary cancer; 
Meet-ups; Inspiring news; End of life 
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5.3.5 Data analysis 
 
With the second study being underpinned by an interpretivist approach, a TA was 
considered an appropriate analytical strategy. A TA was regarded as suitable, as it aims to 
identify, analyse, and report patterns (themes), laterally across an entire data set (Braun & 
Clark, 2006). It also minimally organises and describes the data set in rich detail. 
Therefore, a TA allowed analysis to remain close and sensitive to the data, and enabled 
cross comparisons to be made between the three forums, in order to formulate an overall 
picture of the experiences within the different online support groups. Boyatzis (1998) 
further added that TA frequently goes further and interprets various aspects of the research 
topic. Therefore, it provides a complex account of the data. As a result, a TA can be a 
particularly useful method when investigating an under-researched area (Braun & Clark, 
2006), such as SDM and breast cancer forum interaction. A TA can be an essentialist or 
realist method, which interprets and reports individuals’ subjective meanings and realities. 
This, subsequently, makes a TA well suited to the symbolic interactionist approach of this 
thesis and the second study. 
 
 A TA was achieved manually without the use of any qualitative data analysis 
software. Similar to Chapter Four, TA was based on guidelines (Braun & Clarke, 2006), 
and adapted for use with breast cancer forum posts. An inductive approach to a TA was 
taken, in order to allow themes to emerge from the data, rather than searching for pre-
defined themes. Similar to analysis in study one, the analysis comprised four stages. The 
first stage was to gather descriptions of lived experience; the second and third stage 
required a process of reduction in reviewing the data to reveal essential themes; and the 
final stage was to determine the links and associations between the themes, and how they 
reflected the essence of SDM. These four stages will now be thoroughly described. 
 First, the 332 posts on each website were read and reviewed several times, in order 
to gain familiarity with the types of messages posted online. Specific attention was made to 
listing patterns of experiences that occurred in the post. Each post was systematically 
examined line by line, and parts of data embedded within the material were de-
contextualised to facilitate a micro analysis of the data. In this stage of analysis, statements 
and phrases pertaining to decision-making and SDM were highlighted and extracted from 
the 332 posts, to indicate potential patterns. These statements were written on separate 
sheets and coded based on their post number and line numbers. Table 5.3 provides 
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examples of the statements which were identified and extracted from the 332 posts across 
the three websites.  
 
Table 5.3 
Example of statements 
 
 
After extracting the statements, initial notes were made next to each statement to identify 
segments of data which appeared to be important or significant, as defined by the 
researcher, to decision-making, patient participation, views and perceptions, and spoken 
experiences. Table 5.4 provides an example of notes applied to a significant statement. 
Appendix J illustrates a table charting all the notes made across the 332 post. 
 
 
Significant statement Post N’            Lines 
 
I have to decide whether the distress of going through chemo and 
the risk of long term side effects is worth it. I would really like to 
hear about people's experiences that would help me reach this 
decision. 
 
I have reconciled with myself that having both removed is the 
sensible thing but I am scared about having the strength to go 
through with it and looking at myself in the mirror between 
surgery and reconstruction. I also worry how it will affect me as a 
woman and my future self image with my partner. I know there 
are plenty of others out there who have done this and could give 
some advice 
 
What have others with similar experiences decided to do about 
chemo? I'm 55. Would really appreciate some feedback on both 
points. 
 
After a lot of discussion, thought, and fear of ever dealing with 
breast cancer again, I have decided that a double mastectomy is 
the safest choice. My mother thinks I made this decision too 
quickly. Did I? Am I allowing my fear to dictate this decision, or 
am I being smart for making sure that I will live a healthy, cancer 
free life? 
 
  
           
           126                  3-4 
 
 
 
 
 
 
            298                5-8 
 
              
 
 
 
           72                11-12 
 
 
 
 
 
           312               15-17 
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Table 5.4  
Significant statement, with initial notes applied 
 
 The second stage involved a process of data reduction, and organising the data into 
meaningful groups. Therefore, all of the talk (initial notes) that fitted under a specific 
category were identified, and placed under an initial code. At this stage, keeping the codes 
as simple as possible assisted flexibility in the categorisation process, and helped create 
and re-define the initial themes. A description of what the codes meant and a source of the 
code were noted. Table 5.5 illustrates an example of how notes were classified into codes. 
A full table, charting all codes can be reviewed in appendix J. 
 
 
Table.5.5 
How notes were classified into codes 
 
  
 
 
 
 
 
 
 
 
 
 
 The next step was to analyse all of the codes, which involved searching for 
connections, and considering how the different codes combined and fitted into categories. 
The focus was on identifying broader patterns in the data and emerging theme clusters, 
Significant statement Initial notes/ Patterns 
 
Why are they saying I should have chemo but then also say  
it’s my choice. To me it’s either you need it or you don't.  
I don’t know what the right decision is, and it’s me that has to 
decide (post 101, lines 7-9) 
 
Given a choice 
Treatment decision 
I have to decide 
Can’t make up my mind 
Initial notes/ Patterns Lines (post) Initial codes 
 
Given a choice 
I have to decide 
Hair loss decisions 
QOL decisions 
Treatment decisions 
Cannot make up my mind 
Not sure if made right choice 
 
5-7 (18) 
9-15 (126) 
5-10 (220) 
13-19 (81) 
21-24 (261) 
11-18 (155) 
19-249(231) 
1-14 (190) 
 
Treatment 
decision- making 
Side-effect 
decision-making 
Problem solving 
Indecisiveness 
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which identified what the data means. At this stage, visual representations were used to 
help sort the different codes in to theme clusters. Therefore, each code, with a brief 
description, was written on a separate piece of paper, and these were played around with 
until they were organised into theme cluster piles. The theme clusters were identified by 
bringing together components or fragments of ideas or experiences (codes). These were 
subsequently pieced together to form a comprehensive picture of participants’ collective 
experience. Table 5.6 illustrates an example of how this was achieved. Appendix J 
provides a full table of all sub-themes produced from the analysis. 
 
 
Table 5.6 
How codes were combined to form sub-themes 
Initial codes Theme cluster 
 
Treatment decision-making 
 
Side-effect decision-making 
 
Problem solving 
 
Indecisiveness 
 
Types of decision-making 
 
 
 The final stage involved a process whereby groups of clusters of themes, which 
reflected a particular vision or issue, were incorporated to form a distinctive theme. This 
was the stage of the analysis where the relationships between codes, between sub-themes, 
and the main overall themes, were examined. A provisional name and flexible definition 
was then created for each emerging theme. Table 5.7 illustrates an example of a final 
theme with the theme clusters included in that theme. Each theme was then taken 
separately and re-examined against the original extracts (posts) and the entire data set. This 
was to check the validity of individual themes, in relation to the data set; to consider 
whether they formed a coherent pattern; and to assess what aspects of the data were being 
captured, and how the theme contributed to understanding the data. This stage of re-
contextualisation focused closely upon the underlying meaning of each theme. Each 
finalised theme was given a name, and illustrated with a few quotations from the original 
post, to help communicate its meaning. A final table was constructed containing all of the 
Chapter Five 
147 
 
initial codes, theme clusters, and themes for all of the 332 posts in the analysis. (Appendix 
J). 
 
Table 5.7  
An example of a final theme and the theme clusters within 
Provisional named theme Final theme Theme clusters 
Examples of SDM taking 
place/ experienced online 
Experiencing SDM  
Online 
Types of  
decision-making 
 
 For the majority of qualitative researchers, “data gathering involves engaging with 
other people’s language, the stories they tell and/or the experiences they have” (Shaw, 
2010, p.234). Therefore, it was the researcher’s job to make sense of the online stories, 
interaction, and experiences in a meaningful way, with a view to learn more about breast 
cancer patients’ encounters of SDM. With this task comes the responsibility of reflexivity. 
Similar to study one, a reflexive diary was maintained throughout as a measure of quality 
assurance. The researcher ensured to make reflexive commentary during the analytical 
procedures of the second study. The diaries focused on recording key events and habitual 
practices, what the researcher felt about the data extracts, the reasons for the decisions that 
were made by the researcher, and the researcher’s thoughts and attitudes towards the 
research itself and the information that was arising. Any presuppositions, choices, 
experiences, and actions during the analytical process were included in the diary. An 
evaluation of the researcher’s engagement with the online forum data, and performance of 
a TA was also recorded. In turn, the commentary notes in the diary were an effective way 
of confronting the researcher’s thoughts and perceptions, and to see whether they 
influenced the TA. The process of reflexivity will be discussed further in the discussion 
section (section 5.5.1) of this chapter.  
 
5.3.6. Ethical Submission 
Esyenbach (2001) argued, “whether researchers analysing chat room or forum postings 
enter a ‘public’ place (in which case obtaining informed consent was not necessary), or 
Chapter Five 
148 
 
whether the space they invade is perceived as ‘private’ (in which case obtaining informed 
consent is necessary)” (p.131). Different Internet services have different levels of 
perceived privacy. The three breast cancer forum websites used for analysis were defined 
as ‘public spaces’, as they had open access and did not require membership to read the 
messages. Membership was only required to post a message online or reply to a post. As 
all messages (i.e. the data) on the three websites were publicly available, this meant that 
informed consent was not necessary. Scholars contend that, although personal, discourses 
on the Internet are public and are not subject to human subject constraints (Sudweeks & 
Rafaeli, 1995). In practice, obtaining informed consent for this study was difficult, as it 
was not possible to post an announcement to the support groups, stating that it would be 
monitored and analysed for the next few weeks. By doing this, the results could be 
influenced, and because the mere posting of such a request may disrupt the community, 
this procedure could be considered unethical.  
 To overcome any issues of informed consent, a technique developed by Sharf 
(1997) was used, whereby analysis on communication was conducted retrospectively, and 
the participants whose comments were to be analysed or quoted, were given a new identity 
(i.e. a false name). When reporting the results, it was important to ensure that total 
anonymity of the participants was maintained. The study was presented to Research 
Review Board at Keele University and was approved. It was outlined by the board that no 
formal submission to the local NHS Research Ethics Committee (REC) was necessary, as 
long as the research followed the ethical requirements of participant confidentiality, and 
the British Psychological Society (BPS) ethics guidelines for Internet mediated research 
(2007 & 2013), which were reviewed and adhered to thoroughly. 
 
 
5.4 Results 
The second study aimed to take a further exploration of  breast cancer patients’ experiences 
of SDM, by means of a symbolic interactionist approach to explore patient interaction, 
through examination of the conversations that take place between women within three 
online breast cancer forums. The focus of a detailed TA was to explore the relationships 
between patient online interaction and the experience of SDM for breast cancer. A 
narrative account and interpretation of the three themes that emerged from the analysis 
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follows, encompassing clear illustrative extracts from the woman’s online posts (a false 
name, post number, and line numbers will be provided for each quote in the parentheses). 
The interpretative role of the researcher played an integral part in the analysis process and, 
therefore, it is important that the narrative and description of themes are considered as a 
product of interpretative engagement with the data. Several theme-clusters emerged from 
the TA which included: patient involvement, enhancing self-esteem, access to knowledge, 
identification process, types of decision making, patient authority, and patient 
participation. Upon clustering these together, three key themes were formed which 
encapsulated the experience of SDM for participants during treatment of breast cancer. 
These themes were: 1) extending the characteristics of SDM to an online peer community, 
2) experiencing SDM online, and 3) ways to enhance SDM. Some initial descriptive 
findings were also observed in the analysis. These will be discussed prior to exploration of 
the three themes.  
 
 5.4.1 Initial descriptive findings 
Upon provisionally reviewing the data, initial descriptive findings were observed which 
revealed why and when women used the forums, during their treatment. It appeared that 
interacting within these forums had distinctive appealing characteristics for women. The 
interacting appeared to function as way for women to manage their breast cancer, and 
operated as type of coping strategy to help them through their treatment journey. Many 
women accessed these forums at various intervals of their treatment, and utilised them for 
a spectrum of benefits, such as understanding the diagnosis, finding information about 
treatments, learning about living with cancer, and gaining support from others.  
Examination of all three websites revealed that women used the forums at six specific 
times of their treatment, for specific reasons: 
Before visiting their doctor- Women came online to engage with other women or to 
acquire information, to discover the possible meaning of symptoms. This can be 
regarded as self-diagnosis period, where women try to make sense of their illness by 
themselves. 
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During tests and scans- Women used the Internet to seek reassurance from similar 
others that their doctors were doing the right tests. They also used this time online to 
help remove any feelings of distress and to prepare themselves for the test results.  
 
After the diagnosis- During this period of time, women used the forums to gather 
positive and negative information about the cancer, to make sense of their diagnosis, 
to interpret information given by health professionals, and to remove any feelings of 
distress and isolation.  
 
Decision-making about treatments- During this phase, women utilised the forums to 
acquire information about treatment options and side effects, to gain advice and 
suggestions on clinical trials and alternative or complementary treatments. Women 
also used the interaction with other to help them identify and to prepare questions to 
ask the doctors during decision-making consultations. This stage of Internet use can 
be regarded as a period of second opinion. 
 
Before treatment- The forums were used by women to find what will happen during 
treatment, what to expect in terms of side-effects of treatment, and what to expect of 
recovery. 
 
Short term follow up- Much of the conversations which took place online sought 
reassurance about symptoms, advice about diet and complementary treatments, and 
suggestions to help enhance QOL. 
 
Long term follow up- For women who were post-treatment, the forums worked as a 
space to share experience and give advice, to campaign about the condition, and to 
establish a network of friends. 
 
From these contexts of use, it can be understood that the forums served different purposes 
and benefits at each individual’s stage of treatment. Due to the voluntary use of forums, 
this meant that women could access them according to their preferential needs. Therefore, 
they could use them as much or as little as they wanted, and whenever they wanted. For 
example, some women only made a one off contribution post, whereas others were regular 
users who posted and responded every day to the forum members. The foremost reasons 
for using the forums were to acquire advice, emotional support, and health information 
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achieved through peer interaction. The motives and rewards of forum use will be explored 
further in theme one.  
 
 
5.4.2 Theme one: extending the characteristics of SDM to an online peer community 
This theme contained four theme clusters (patient involvement, enhancing self-esteem, 
access to knowledge, and identification process); all associated with what the Internet 
forums provided to women with breast cancer. Analysis of this theme revealed that the 
reasons why women engaged in online interaction with peers were similar to the 
characteristics of SDM in a clinical setting. This subsequently illustrates the presence of 
SDM characteristics, occurring within an online forum community of breast cancer 
patients. It also adds to our understanding of the processes involved for SDM. This theme 
demonstrates that women used the forums for four key reasons. These were to give women 
a sense of involvement in their cancer care; to acquire assurance, confidence and 
heightened self-esteem regarding their body, health, and treatment plan; to receive 
additional information and knowledge about their diagnosis, treatment, and recovery; and 
to establish social ties, connect, and associate with other women in similar positions. The 
extracts below illustrate each one of these four motives (theme clusters) and identify its 
similarity to the characteristics of SDM.  
 
Patient involvement: 
 
EXT 1. Alexandra. Post 100. Lines 1-7 
When I was diagnosis I felt like my whole world had collapsed. 
I found it so overwhelming to sieve through the all the 
information they gave me in order to make the right choice. But 
instead I chose to join this group, as it allowed me to be a 
part of my own cure. I found that chatting on here with others 
about my treatment choices and plan was cathartic, and 
certainly made me feel more involved in my health. It helped me 
to decide, and focused me to engage with my breast cancer and 
to fight the disease.  
 
Alexandra’s message to the forum illustrates how online membership allows women 
to feel more active and involved in their cancer care. Alexandra’s extract shows that 
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through ‘chatting’ and therefore participating in talk with others about her treatment 
choices, not only made her feel more involved in her care and treatment decision-
making, but also assisted her in having to make a decision. This similarly reflects the 
characteristics of SDM in a clinical setting. The NICE guidelines (2004 & 2012) 
define SDM as a process which involves the patient as an active member or partner 
of the medical team, who can participate in discussions about their cancer care in aid 
of choosing a preferred course of clinical care. Therefore, it can be interpreted that 
the forum interaction reflects a process of SDM, and by participating in SDM (i.e. 
participating in discussions with other forum members) this helps to enhance patient 
involvement decision-making.   
 
Enhancing self-esteem: 
 
EXT 2. Linda Post 211. Lines 12-19 
Don’t be sorry for asking loads of questions. I find these 
forums really useful, as they are a place for me to come and 
vent, but at the same time received loads of reassurance and 
hope. I remember feeling insecure about my hair too, but just 
try your best to hang in there. When we hit rock bottom the 
only way is up! My advice is just pace yourself and take the 
first cycle of chemo each day as it comes. Talk with the 
nurses, your oncologist, and share your worries, doubts, 
questions. It helped me with the healing process. There is no 
wrong or right way of dealing with the side-effects, only what 
is best for you! 
 
From Linda’s extract, it is understood that the forums were a useful place to gain 
feelings of hope and reassurance about treatment, especially regarding the side-
effects of hair loss during chemotherapy. The analysis revealed that positive 
conversations took place online, which involved motivating women and giving 
them confidence, comfort, and strength to go through their cancer journey. 
Therefore, interaction served a purpose, which was to help others increase their 
self-esteem. This is similar to the characteristic of SDM, as the concept of SDM 
aims to encourage patients to participate in health discussions and to share their 
treatment preferences. SDM is described to rely on the patient as well as the 
clinician, as “the patient is an expert on themselves, their social circumstances, 
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attitude to illness and risks, values and preferences” (The Health Foundation 2009, 
p 7). Therefore, the practice of SDM and patient-centred care is to equip patients 
with confidence to participate in their care, and to give them the self-esteem needed 
to actively interact with the clinician, and participate in the decision-making 
process. Interaction within the forums also mirrored these characteristics of SDM, 
as members shared feelings of self-belief and motivation to be involved in their 
cancer care. 
 
Access to knowledge: 
 
Ext 3. Sophie. Post 318. Lines 8-11 
I originally went into alternative therapies because the 
evidence for standard of care did not have compelling enough 
statistical proof. Even the treatment guidelines were fraught 
with disclaimers. I don't know if anybody here has read them, 
but I recommend them to those who are stuck with making a 
treatment decision and are consider rejecting conventional 
treatments.  
 
Sophie highlights that the forums are used for the purpose of information and knowledge 
acquisition. Sophie’s post is in response to another forum member’s question, asking if 
anyone could assist her with the task of making a treatment decision. Sophie’s reply is 
informative and based on her own personal experiences, views, and opinions. She guides 
the thread owner towards relevant literature, which may aid in decision-making. The 
analysis revealed that the forums acted as a useful place to exchange information, receive 
additional knowledge, and to assist other women with queries (this will be explored more 
thoroughly in the next theme). However, the process of information exchange was 
particularly evident online regarding decision-making. Therefore, the forums were 
predominantly used to acquire information which could assist women in their treatment 
decision-making dilemma. This similarly reflects the characteristic of SDM. The NICE 
guidelines (2004 & 2012) for SDM indicate the importance of medical professionals’ roles 
in giving the patient information, and support needed to make use of the information, in 
order to promote patient participation in their care. Interaction within the forums 
represented a similar process to SDM, as members would facilitate knowledge sharing, 
through a process of information exchange and two-way communication, to facilitate 
decision-making processes.  
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Identification process: 
 
Ext 4. Jenny. Post 285, Lines 20-28 
I am replying to your thread because I feel my own situation 
and diagnosis has a lot of similarity to yours, and I’m also 
trying to make a similar treatment decision to you. Those 
feelings you described sound so familiar and I understand 
your frustration. You’re not on your own and you don’t have 
to feel like this, because there are others like you 
experiencing the same thing and in the same boat. I remember 
thinking none of my friends are dealing with anything like 
what I’m going through right now. So I’m finding it good to 
talk to others on here, because I can relate to them and see 
what others have been through. Trust me, it’s not just the 
medical information aspect of these forums which are useful. 
Talking online makes you feel supported and I think it’s a 
great way to make some good friendships. 
 
Jenny’s message demonstrates one of the key functions of the forums, which is to provide 
women the opportunity to form social bonds and interactions with peers in similar 
situations. As Jenny’s account explains, interacting within these forums with women “in 
the same boat”, allowed for an experience of self association. By relating and identifying 
to similar others online, this subsequently created an online environment where everyone 
was seen as equal. Women were able to self-identify and remove feelings of isolation 
through the mutual relationships created, and the shared interactions which took place 
within these forums. This in turn, contributed in helping members to make treatment 
decisions. This reflects the process of SDM, as it is an approach which requires mutual 
doctor-patient relationships and shared interaction between the clinician and patient, in 
face of making treatment decisions (The Health Foundation, 2009). Therefore, during 
SDM, the patient is made to feel equal to the clinician (‘in the same boat’), as both are 
required to share information and accept responsibility for joint decision-making which, 
therefore, facilitates treatment decision-making. 
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5.4.3 Theme two: experiencing SDM online 
This theme encompassed a theme cluster (types of decision-making), which is associated 
with the topics of decision-making conversations. As mentioned in the initial descriptive 
findings and the above theme, women predominantly used the forums to interact over 
decision-making dilemmas they faced throughout their cancer journey. At a time of 
diagnosis or whilst undergoing treatments, women may feel vulnerable and/or show an 
inability to make complex medical and simple everyday decisions. The analysis revealed 
that during this time of difficulty, common practice for women was to participate in online 
discussions about the dilemmas they faced; and to engage in the practice of sharing views, 
knowledge, and experiences, in search for advice and information, and to seek emotional 
comfort. Participation in online interaction and sharing conversations, subsequently, 
facilitated women in their ability to solve decision-making problems. In examining the 
interactions women had about decision-making, analysis revealed more thorough insight 
about how SDM is experienced in a clinical setting, between the oncologist and patient. It 
also provided an insight into how the process of SDM can occur between peers within an 
online community. This theme will now outline the types of decision-making discussed 
through online interaction, how these relate to SDM, and how it provides an understanding 
of women’s experiences of SDM. 
 
Types of decision-making:  
Analysis initially highlighted that women were given a choice and involved by clinicians 
in the decision-making of treatment choices. Within the forums, women described their 
choices of surgery- whether to have a mastectomy or a lumpectomy. However, this only 
occupied a small percentage of decision-making which was detailed online. Instead, the 
majority of women used the forums to mostly talk about decision-making for adjuvant 
treatment, and the most frequent topic of discussion was about chemotherapy. Forum 
members predominantly interacted online to talk about whether they should consent to 
undertaking chemotherapy. For many, this decision was an important and complex one, 
which was fuelled by issues surrounding side-effects and hair loss. Therefore, the forums 
acted as a place for women to share their dilemma with similar others, in aid of receiving 
advice and support. Women made it very clear within their post about the distress and 
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emotional impact the decision-making task was having on their ability to function, and to 
make a rational decision. Extract five illustrates this further. 
EXT 5. Susan. Post 126, Lines 9-15 
After diagnosed 5 weeks ago with a grade 2 breast cancer, I've 
had it removed and all seems clear. My nodes have also been 
checked and are all clear. So I thought I would just be having 
radiotherapy and hormone treatment since I'm HER2 positive. 
Yet after seeing the oncologist this week, she told me I 
should have 8 sets of chemo, followed by 15 + 8 radiotherapy 
and a minimum of 5 years hormones. The shock of being told I 
have breast cancer still has not sunk in. Now I'm being told I 
need FEC chemo. But then I was also told the chemo was my 
choice to have or not. I have to go back next week and tell 
them. But what do I say? I have no idea why they are saying 
chemo, and what will be the long term benefits? If anyone can 
help set my mind at ease, as I know chemo is not to be taken 
lightly and there are lots of side-effects right? I don’t 
understand why they are saying I should have it, but it’s my 
choice. To me it’s either you need it or you don't. 
 
Susan illustrates an example of decision-making for adjuvant treatment that is discussed in 
forums. Her post provides an insight into her SDM experience during her consultation with 
the clinician. From her account, it is understood a conflict of interest between the 
clinician’s role and the role of SDM. For example, Susan has clarified that undergoing 
chemotherapy is her choice which, therefore, highlights the notion of SDM and patient-
centred care. However, from Susan’s account, it is also evident that she is “told” by the 
clinician that she “should have” chemotherapy which, therefore, highlights the clinicians 
expertise role. This subsequently creates a confusing situation for Susan, whereby the 
experience of SDM becomes obscured and disorganised due to the clinician’s role as a 
clinical expert. As a result of this confusing predicament, Susan, therefore, turns to the 
forum for some answers. She poses some questions online, which request advice and 
suggestions from other forum users. Interestingly, she asks two key questions, “I have no 
idea why they are saying chemo, and what will be the long term benefits?” and “there are 
lots of side-effects right?”, which signifies the lack of SDM which is experienced within 
the consultation, between herself and the clinician. For SDM to occur in a clinical setting, 
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this requires the patients to be actively involved in discussions, and to not only share their 
preferences but to also share their concerns and queries. Instead of asking the clinician 
these questions, she decides to share her concerns online with other the forum users. 
Therefore, a process of SDM is perceived, by the researcher, to be taking place online 
through two-way interaction. Susan shares her views and concerns with other members, in 
aid of others sharing their knowledge and experiences. This extract, similar to theme one, 
highlights the important of sharing information and preferences, and two-way 
communication, as characteristics of SDM. The extract also further supports the findings 
displayed in theme one, that those characteristics of SDM can take place within breast 
cancer forums. It further adds to theme one by showing that for forum members, it seems 
that SDM extends beyond the clinical setting. It is not simply a phenomenon that occurs 
between clinician and patient as it is shared in communities beyond that. Extract six further 
illustrates this finding amongst women who are faced with making decisions about 
alternative treatment therapy.  The forums revealed that many women were issued the 
additional task to consider and problem solve decisions for alternative therapies, extra 
complementary treatments, or whether to be part of clinical trials for more targeted 
treatments. The task of having to make decisions regarding new medicines or different 
treatment routes was demonstrated to be of a complex task.  
 
EXT 6. Della. Post 231, Lines 19-24 
I'm having my second chemo next week. This week my HER2 result 
finally came back - I'm HER2 positive. The breast care nurse 
said that usually patients get Herceptin after finishing 
chemo, but my particular oncologist often likes to start 
Herceptin alongside chemo. I do personally have a choice. I 
usually query him and have long conversations with him if I’m 
feeling anxious about my treatment. But so far he's been on 
the ball and I’m happy with the treatment path we have chosen 
together. Yet I'm curious as to what other people's 
experiences have been - Herceptin with or after chemo? This 
may help me decide or change my mind. 
Della’s account exemplifies her struggles in making a decision over the option given to 
have an alternative treatment path, and draws attention to patient choice. Della describes 
that she has a good relationship with her oncologist, whereby she is able to engage in 
discussions and ask questions about her treatment. She illustrates an appropriate example 
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of her previous experiences of decision-making with the clinician. Her description of a 
decision-making process is based on her active involvement and sharing of preferences, 
and a process where decisions are made jointly with the clinician, and therefore is in line 
with the concept of SDM. However, Della chose not to address her dilemma regarded 
alternative therapy through the route of SDM with her clinician. Instead she turns to the 
forum for advice on the options recommended to her. Della states that she is “curious as to 
what other people’s experiences have been”, which indicates that she prefers to make her 
decisions based upon other women’s personal experiences and views. By engaging in 
interaction with other women with breast cancer, and participating in the sharing of 
information and views, based on first-hand encounters, this constitutes towards an online 
process of SDM, which may aid Della in making a decision about treatment. Della’s extract 
ends with a direct question she poses to the forum users “Herceptin with or after chemo?” 
This mirrors the type of question she would ask the clinician if she engaged in an SDM 
consultation. However, she instead poses this question online, in aid of seeking an SDM 
process to occur between forum members. Similar to Susan’s post, this extract also draws 
attention to information sharing and knowledge acquisition, as characteristics of SDM. The 
findings emphasise that SDM is a process which can occur outside of a clinical setting 
between patients and non-medical professionals.  
 The forums highlighted that decision-making did not stop at treatment choice for 
women, but also extended into consideration of side-effects. Analysis revealed that once 
women had provided consent to their treatment path, a new genre of SDM took place. This 
includes decisions over the management of hair loss, such as choosing to wearing a wig, 
scarf, or shave it off; decisions about wearing breast prosthesis or not; and decisions over 
the management of weight, such as exercise and dieting. Making the right choice was 
regarded as important for these women, as issues of body image, self-esteem, and QOL 
were questioned and brought into the equation. The forums, therefore, became a place for 
women to interact over these dilemmas, by sharing similar stories and offering their 
experiences and advice. Extracts seven and eight further emphasise that SDM extends into 
other conceptual as well as interpersonal areas. 
 
EXT 7. Helen. Post 18, Lines 5-9 
Today my hair has started to come out, but it isn't 
noticeable to others yet. I have a wig which I chose with my 
daughter at the hospital, but I can't imagine me wearing it. 
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Think I'm more of a scarf or hat person. I’m not sure whether 
to just shave it off?! Not sure how I'll feel when it's done? 
But I know it's temporary, and who knows it may come back 
strawberry blonde with highlights and a gentle perm. Ha! 
There has to be hope in life. 
 
In Helen’s case, and the majority of forum users in the analysis, hair loss was an area of 
concern, and one which brought a task of decision-making with it. Due to the effects of 
chemotherapy, hair loss can have devastating effects on a woman’s appearance and their 
confidence. How to manage hair loss was an issue discussed within the forums, as women 
were keen to read other peoples experiences and methods of adaptation to hair loss. 
Control over body image and self-esteem was illustrated to be a key concern for women 
through the forums. From Helen’s extract, it is understood that her hair loss causes some 
dilemma, as she appears to be unsure whether the right decision is to shave it off or wear a 
scarf, as a wig is not to her preference. Discussions regarding interpersonal issues, such as 
hair/wig management, may not always be attended to at a clinical level during SDM 
consultations. Helen’s extract demonstrates that by presenting this topic to other forum 
users, this invites others to share their experiences and offer advice. Similar to Della’s post, 
Helen asks questions to other members online. These are the type of questions which 
would usually take form during conversation with the clinician, and during the process of 
SDM. However, by presenting these questions online, this opens an opportunity for a host 
of members to engage and interact on the topic matter. By reading other people’s shared 
experiences, this in turn allows Helen not only to relate to similar others, but it also equips 
her with the knowledge and information, as well as the confidence needed, to make a 
decision which is right for her. This signifies an experience of SDM, which would usually 
take place in a consultation. This extract emphasises that the forums provide a great 
opportunity for a process of SDM to take place in circumstances, or on topics, where SDM 
is not adhered to in a clinical setting. 
 Extract eight shows a similar example of the possible lack of consideration given to 
adjunct concerns in breast cancer clinics, and how SDM is a phenomenon in online 
communities which addresses such interpersonal concerns.  The analysis revealed that the 
treatment of cancer can have an impact on patients’ ability to make day to day decisions. 
For many women the diagnosis, treatments, or side-effects of cancer were demonstrated to 
cause an inability to make everyday decisions regarding QOL outside of the hospital, and 
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post-treatment. Women interacted about topics such as, deciding to go back to work, 
whether to have more children, deciding about marriage, and deciding to go on holiday, in 
aid of receiving guidance and support. 
EXT 8.Charlotte. Post 81, Lines 13-19  
I booked a beach holiday before I got diagnosis. I've paid 
half already. I'm worried that I won’t be physically able to 
keep up with my family. I want to enjoy every second with 
them, but scared of letting them down. My husband thinks we 
should cancel the holiday, but I would hate to stomp on my 
children’s’ excitement. Has anyone been on holiday whilst 
undergoing treatment or mid treatment? I just can’t seem to 
decide what the pros and cons are, and what the right decision 
should be? 
Charlotte’s post to the forum illustrates her problem over deciding to go ahead with the 
family holiday or not. As a result of her diagnosis, she is unsure whether the holiday is 
appropriate, and is torn between upsetting her husband and letting her children down. The 
decision has left her confused and, therefore, she posts on the forum in aid of addressing 
her conflict. The extract, similar to Helen’s post, once again illustrates that lack of time 
devoted in clinics to SDM conversations regarding interpersonal decisions. Both Helen’s 
and charlotte’s extract emphasise that the side-effects of cancer treatments can impose on a 
patient’s QOL, and carry the additional task of making decisions as a result of the side-
effects. It could be suggested that the process of SDM in a clinical setting only revolves 
around the topic of treatment decision-making, which subsequently results in many 
conversations about interpersonal adjunct decisions to occur within these online forums. 
Subsequently, this raises an opportunity for SDM to occur online, as supported by 
Charlotte’s extract. The experience of SDM is visible when Charlotte states “I just can’t 
seem to decide what the pros and cons are and what the right decision should be?” By 
asking this question, Charlotte is requesting forum members to collectively weigh up ‘the 
pros and cons’, and together deliberate over the appropriate decision. In a clinical setting, 
this would be regarded as SDM between patient and clinician. Therefore, it could be 
interpreted that the forum members are actively taking up the role of the clinician during 
online interaction. Consequently, this extract further adds to Susan’s, Della’s, and Helen’s 
extracts, and to the findings in theme one, by mirroring the characteristics of SDM (i.e. 
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information exchange, knowledge acquisition, sharing of preferences, and two-way 
interactions).  It supports the previous findings in this theme by showing that SDM extends 
beyond the clinical setting for patients, and is simply not a phenomenon that occurs 
between clinician and patient, as it is shared in online communities beyond that. 
 The analysis revealed that forums were not only used to aid women in making 
treatment and QOL decisions. Interaction also took place about decisions which had 
already been made and agreed upon, between patient and clinician in the clinic. For 
example, some women had already consented and decided upon a treatment with their 
clinician. However, regardless of the decision already being made, women used the forums 
to discuss and assess that decision.  A process of SDM took place online, in order to assess 
and decide whether the decision that has been made, during a SDM consultation, is 
appropriate or not. Extract nine illustrates this further. 
EXT 9. Sammy. Post 322, Lines 1-9 
Hi all, with my clinician we have decided that mastectomy 
is right form of treatment for me, given the size of the 
lump. We sat and thoroughly talked through the options 
together. However, I’m still not sure if we have made the 
right decision. I don’t really want to lose my breast. He 
has explained every to me and informed me enough to be 
able to decide why a mastectomy is the right route. But 
for some reason I still feel undecided. My breast cancer 
is a grade 2, but not travelled in my lymph nodes. Has 
anyone with a similar diagnosis to mine undergone a 
mastectomy or even a lumpectomy instead? I’m probably just 
being over cautious and I have made the right decision, 
but I just can’t help but yet question it. What do you 
think?  
Sammy highlights her indecisiveness towards the decision she has made with the clinician. 
At the start, Sammy describes her previous experiences of SDM with the clinician in the 
clinic. She makes reference to having “sat and thoroughly talked through the options 
together” with the clinician; and indicates that the clinician has “informed her enough to be 
able to decide” her treatment preference. Although an encounter of SDM took place for 
Sammy, with the clinician, for making an appropriate treatment decision, she questions her 
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encounter of SDM. The extract shows that Sammy appears to be unsure about the SDM 
process she engaged in at the clinic and, therefore, uses to the forums for a second opinion. 
Sammy engages in an online process of SDM with other forum member, by participating in 
shared discussion to gain supplementary information and advice. This subsequently allows 
her to clarify and confirm that the treatment chosen, during her clinical encounter of SDM, 
is optimal. Sammy’s extract draws awareness to the degree of trust women have in clinical 
SDM. Although SDM with a clinician enables women, like Sammy, to make patient-
centred decisions; however, as Sammy demonstrates, experience of the concept is still 
questionable. Therefore, a form of SDM appears to take place online, on a decision which 
had been formed during a SDM consultation. Women therefore choose to participate 
further in the forums by interacting with other similar members, as this enables them to 
gain further information and advice. Such acquired knowledge could supplement the 
explanations given by the clinician and, therefore, provide verification and reassurance 
about the decision that has been made. This extract illustrates that engaging in an additional 
experience of SDM online, is in aid of confirmation and support to carry out the decision. 
It could be argued that an experience of online SDM coincides and works together with an 
experience of SDM in a clinical setting, to facilitate and encourage patients to make a 
decision and adhere to it. 
 
5.4.4 Theme three: ways to enhance SDM 
The final theme includes two theme clusters (patient participation and patient authority), 
which are associated with how the concept of SDM is brought to awareness and 
encouraged amongst forum members, through interaction. In examining ‘what is said’ 
between forum members, and exploring types of advice or suggestions that are discussed 
by forum users, it became apparent that type of advice portrayed online was not medically 
related or aimed at directly providing an answer to the dilemma. Members never told one 
another what the right or wrong decision is. Instead, they offered advice, which was based 
upon guiding one another to turn to the clinician to help them with their decision-making 
dilemmas. Therefore, online interaction served a purpose, which was to facilitate the 
concept of SDM, and to encourage patient encounters of SDM in a clinical setting. The 
theme clusters patient participation and patient authority will be described in thorough 
detail, with supporting extracts. They will also be examined in relation to how the concept 
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of SDM, between patient and clinician, is spoken about online, and promoted through 
online interaction. 
 
Patient participation: 
 
In the process of interacting with other forum users online, and giving advice and 
suggestions to one another over decision-making topics, analysis of the posts revealed that 
individuals’ posts carried an underlying motive.  This motive was to encourage women to 
participate in their health care by maintaining good doctor-patient relationships and 
communication, as this facilitated decision-making.  Forum users shared their own 
personal experiences of the type of relationship they acquired with the clinician during 
decision-making. It appeared that having an established doctor-patient relationship, which 
is full of rapport, empathy, and understanding, played a facilitating role in decision-
making, and patients’ experiences of SDM. 
 
EXT 10. Tina. Post 242, lines 8-17  
It is so important to maintain a healthy relationship with 
your oncologist as it makes the decision-making process so 
much easier. My oncologist was great! He had a good sense of 
humour, listened to all my concerns and preferences, and took 
all my values into account. Equally I respected him and took 
on board all information and suggestions he gave me. We had 
such a good bond and we worked together, and because of how he 
was towards me I felt so comfortable to ask him anything. I 
felt privileged and that was all because I developed a good 
relationship with him, which was built on mutuality and trust. 
So my advice to you is to keep liaising with him and build 
good rapport, as that will get that connection going. Get 
involved and participate with your oncologist. It did me the 
world of wonders to have that established relationship during 
decision-making.  
 
Tina provides an example of how forum users were encouraged, by other members, to 
develop and sustain a healthy doctor-patient relationship throughout the course of their 
treatment. To aid decision-making, women were reminded that a strong link with the 
clinician can overcome the difficulties of decision-making. Tina’s account makes strong 
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reference to the importance of rapport as this helps her to generate trust in the clinician and 
establish mutual involvement. Arguably, through mutual involvement, both the clinician 
and the patient will be open to participation, based on the sharing of views, preferences, 
and information. These features are described by Tina to contribute towards patient 
participation and, therefore, facilitate the decision-making process. From Tina’s extract, it 
is understood that online interaction can play an important part in defining doctor-patient 
relationships, and promoting two-way interactions between patient and clinician, within a 
clinical setting. The extract shows that forums help to inform women about how to 
encounter such relationships during their treatment, and raise awareness of the benefits 
surrounding doctor-patient relationships, in respect to decision-making. More importantly, 
it illustrates awareness of SDM. Tina shows knowledge and experience of SDM in her 
account, by stating that the clinician “listened to all my concerns and preferences, and took 
all my values into account. Equally I respected him and took on board all information and 
suggestions he gave me”. This signifies a shared process of information exchange, where 
both the patient and clinician “working together”. In achieving an encounter of SDM, Tina 
reinforces the importance of maintaining a good patient relationship with the clinician. 
Tina’s post subsequently shows how online interaction defines the characteristics of SDM, 
such as mutual doctor-patient relationship, to other forum members. It also demonstrates 
how forum interaction helps to promote the benefits of SDM, and educates women on how 
to achieve SDM in a clinical setting. Extract 11 is another example of how forum users 
enhanced patient awareness and experience of SDM, by encouraging patient participation. 
However, the extract draws more specific attention to the role of knowledge acquisition in 
facilitating decision-making, and patients’ experiences of SDM. 
 
 As mentioned in theme one and two, women entered these forums to access 
knowledge of their illness, and to seek health information which could facilitate their 
treatment, or the task of decision-making. Despite of the abundance of information shared 
online between forum members, the analysis highlighted that peer to peer interaction also 
took place to encourage and give women the confidence in seeking health information 
from the medical professionals. Women were reminded that they should take a more 
‘active’ stance in their medical care, and participate in health-related decision-making with 
the clinician, by engaging in two-way discussions during clinic. It was suggested online 
that this, therefore, allowed them to develop the relevant knowledge and understanding 
needed to make informed decisions.  
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EXT 11. Diana. Post 66, Lines 5-9 
I do believe you should get as much information as you can 
from the oncologist on all of your results, any statistics, 
facts and figures, and anything that will help you decide. For 
me, knowing more about the disease and particularly about how 
it relates to my body, gave me a sense of control. It made me 
feel like I had more power, and that I played a proactive role 
in my care. 
 
Diana illustrates how support, through encouragement, is expressed to women online. This 
was a persistent feature of interaction between the forum users, as women continually 
championed one another to maintain an ‘active’ role in their treatment plan. As Diana 
explains, her engagement in conversations with the medical professionals was of valuable 
assistance to her increased knowledge of the disease. She explains that this in turn helped 
her with the decision-making process. By taking an ‘active’ stance, this gave Diana the 
ability to turn the information provided into something more personal to her and her body. 
Diana suggests that this gave her some elements of “control” and “power” over the cancer. 
The extract shows how online interaction encourages women to take decision-making out 
of the clinician’s hands, and instead turn it into a shared process, which allows them to 
work alongside the medical team to reach decisions. The level of enthusiasm and 
commitment, across all three forums, to motivate and give confidence to women to 
participate in their care was certainly highlighted. Women were reminded about the 
benefits of acquiring as much possible knowledge from the clinician, as this leads to 
greater feelings of control, decreased levels of distress, and reduced difficulties in decision-
making. Therefore, much time was devoted online to making forum users aware of the 
characteristics of SDM, such as information acquisition, and encouraging women to 
engage in these SDM characteristics, in aid of decision-making. Extract 12 is another 
example of how forums enhanced patient awareness and experience of SDM, by 
encouraging patient participation. However, the extract draws more specific attention to 
the importance of two-way conversations between medical professionals and patient in 
facilitating decision-making, and patients’ experiences of SDM. 
 EXT 12. Fiona. Post 99, Lines 1-16 
 You may want to have a consultation with an oncologist to see 
what the next step is in your treatment plan. I met with my 
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oncologist a week after I had my lumpectomy and had my 
preliminary diagnosis. The reason why you should meet with an 
oncologist is because it will allow you to ask the kind of 
questions that you are asking on here. My advice to you is to 
do your homework and prepare the questions you want to ask. 
Think about the side-effects, benefits, versus risks, and ask 
questions related to these or other topics of concern. Speak 
to your breast care nurse and oncologist as much as you can to 
arrive at a contented decision together. The best approach is 
for you to think about which treatment is most likely to give 
YOU the benefit, and a good oncologist can help guide you. You 
need to make sure your oncologist agrees with YOUR values, and 
works with you to get a treatment plan that has a reasonably 
good chance of giving you the best benefit with the lowest 
risk. That is exactly what I did and it helped me to 
eventually map out and decide the treatment plan which was 
right for me.  
Fiona starts by steering the thread owner towards interaction and engagement with the 
oncologist. Her response explains the importance of two-way communication with the 
oncologist, as this will help to address any concerns and ease the task of making a choice. 
Therefore, she is primarily enforcing the importance of patient participation. She then 
continues to elaborate on the role of the oncologist, as a medical professional, who helps 
with decision-making. This infers that decision-making is assisted by the clinician, not 
given as an instruction. The process of two-way interaction is defined by Fiona as a process 
which involves the patient sharing their values and preference, which is then weighed up 
with the clinician’s sharing of medical information. In this instance, Fiona is brings 
awareness to two-way communication, as a process and characteristic of SDM. Fiona 
indicates that by participating and engaging in discussions, this enables patients to become 
an expert in their own condition, which can contribute to facilitate decision-making. 
Therefore, this sustains the need for SDM to be experienced by patients, during a decision-
making consultation. The forums illustrated that many members, like Fiona, brought 
awareness and promoted the practice of a mutual relationship, between the doctor and 
clinician, which is based on two-way conversations. Through online interactions, members 
encouraged each other towards a collective approach to problem solving with the medical 
professional. Subsequently, these findings show that the SDM concept is understood by 
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forum users, and its characteristics, such as two-way interaction, are acknowledged and 
experienced by many women in a clinical setting. As a result of the described benefits of 
SDM in helping women make complex treatment decisions, the forums were utilised as a 
space for women to inform others about the purpose of SDM, and how it can be achieved 
during breast cancer care. Extract 13 illustrates another example of how the importance of 
doctor-patient shared conversations, were emphasised online between members. However, 
extract 13 develops further to show how forums also informed women about the content 
and structure of shared discussions they should be having, in order to facilitate encounters 
of SDM. 
 The forums served as a place for women to gain some guidance on the content of 
conversation they should be having with their clinician. Through the interactions which 
took place online, it appeared that women were presenting one another with the types of 
concerns that they should be considering and talking about to the clinician, or the type of 
questions they should be asking during a decision-making consultation.  By reading other 
women’s personal breast cancer journeys, it guided members to find the right questions to 
ask the clinician, and highlighted issues which they may have never previously thought 
about, prior to forum engagement.  It therefore appeared that online interaction helped to 
direct the women towards the types of conversations and contents of discussions they 
should be having with clinician, to facilitate decision-making and patient encounters of 
SDM. 
EXT 13. Judy. Post 155, lines 6-14  
I would list out the pros and cons of chemotherapy, so you can 
see what it is that’s actually worrying you. Many people here 
can attest that chemo is doable, but it is not without side- 
effects that could possibly affect you the rest of your life. 
Would chemo prevent a recurrence? Maybe, maybe not!? One other 
thing that many people don't think about is, if it comes back 
what is left to treat it? That's the crap shoot of it all. 
It's not a fun decision to have to be making, and one I advise 
you to share with your clinician by talking about these sorts 
of concerns and queries. Think about these sorts of questions 
and make sure to ask them. Don’t be afraid to share your views 
and preferences within your queries. I wish you peace with 
whatever you decide. 
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Judy’s intention in her post is to guide the owner of the thread towards the type of 
conversation she should be having with the clinician. Judy suggests for the patient to make 
a list of advantages and disadvantages, so they become aware of the worries and queries 
they may potentially want to ask the clinician. Judy’s action, of encouraging the patient to 
ask questions, signifies the importance of patient participation in shared interaction with 
the clinician, in aid of decision-making. Interestingly, it then appears as if Judy switches 
roles within her post, and takes on the identity of the thread owner. She begins to pose 
questions, which a patient would usually ask a clinician during a consultation. By posing 
these questions, Judy is encouraging the patient to talk with the clinician and to consider 
asking these sorts of questions, as it could help reach the right decision. The questions that 
Judy has posed are not just specific to the thread owner, as they could be acknowledged by 
other forum users who read the post. From this extract, it is understood that the forums can 
serve as guidance for women, who are unsure about the types of conversation and 
substance of discussions they should be having with their clinician, during a decision-
making consultation. This is reflected in Judy’s extract, as she raises awareness to the 
importance of patient involvement in discussions, sharing of patient views and preferences, 
and negotiation through questioning and answering, as these are characteristics which 
define SDM in a clinical setting. Therefore, similar to the posts by Sammy, Tina, Diana, 
and Fiona, this extract also shows that SDM is a process which is experienced by many 
women in a clinical setting, and a good understanding of its characteristics are known to 
breast cancer patients, as demonstrated by Judy. As a result of such awareness and 
experience of SDM, online interaction ensured to remind women of the importance of 
SDM, inform them about the characteristics of SDM and how to achieve them, and 
facilitate patients’ encounters of SDM in a clinical setting. 
 
Patient authority: 
 
Within this theme, another underlying intention of forum interaction was illustrated, which 
was to make forum members feel powerful. Analysis of interaction within the forums 
showed that much online talk was aimed at making women feel powerful in their status 
and role to participate in SDM during consultations. As mentioned in theme one, women 
continually helped one another to raise levels of confidence and self-esteem. They also 
reminded one another of the rights they had as patients during their treatments. As a result, 
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the forums appeared to generate a collective authoritarian attitude amongst their members, 
which focused on patients’ ability, influence, and entitlement to participate in their 
treatment decision-making. Subsequently, this enhanced awareness of the concept of SDM, 
and facilitated patients’ experience of SDM during clinical encounters. Extract 14 shows 
how forum members reminded one another about the importance of patient control. 
 
EXT 14. Kim. Post 8, Lines 2-6 
It’s your body, your decision! That’s what I kept reminding 
myself. You have to live with the consequences of hair loss. 
You have to live with consequences of a losing your breast. 
You have to live with the weight gain. You have to live with 
the lack of energy. These are all the things that YOUR body 
will go through. So it has to be your preferences and views 
that are taken into account during decision-making. So don’t 
think you just have to go with the flow of what your doctor 
says.   
 
Kim draws attention to the issue of changes in body image as a result of treatment side-
effects. She reminds the thread owner that the decision-making should not be taken lightly, 
and that they should stay true to their rights and preferences. Her motive is to make the 
thread owner feel in control and in charge of their body. The extract therefore suggests that 
women should not take a ‘passive’ approach towards decision-making, but to ‘actively’ 
share their views and preferences, and show interest in involvement for decision-making, 
as it is ultimately their body that will suffer. Kim’s view, subsequently, prompts the thread 
owner towards SDM. Her encouragement of self-control and ‘active’ participation supports 
and enhances SDM to take place in a clinical setting with the clinician, by reminding the 
thread owner that it is important to voice their preferences and not just “go with the flow” 
with the clinician. This highlights Kim’s awareness to the process of SDM.  Extract 15 
similarly illustrates how online interaction encourages self-control and patient authority; 
however, it demonstrates this in respect to how members encourage self-confidence to one 
another. 
EXT 15. Luisa, Post 180, Lines 3-10 
My diagnosis was just like yours and I too was told that I had 
to have a mastectomy. I was so anxious, distress and nervous. 
But most of all I felt so annoyed that I had no control over 
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what was happening what so ever. However, I remember my 
husband sitting me down one night and telling me that I have 
to try and gain some element of control back, and in doing 
that, I have to be strong, confident, and positive. That’s 
exactly what I did. It’s so important to remain assertive and 
have self-esteem during your treatment, because it gives you 
back that control you once thought you loss. I was able to 
manage and organise my treatment side-effects, and still felt 
able to talk to my clinician and be involved, despite not have 
a treatment choice.  
 
Luisa’s post draws attention to how the forums have an impact on members’ levels of self-
esteem and confidence. Luisa explains that it is important to maintain self-belief, as this 
helps to achieve self-control and feelings of capability. In her case, she was “told” her 
treatment and, therefore, had no choice or say in decision-making. This subsequently 
meant that the occurrence of SDM or perceived experience of it was hindered. However, 
Luisa continues to stress the importance of remaining ‘active’ and involved in her 
treatment plan, despite the lack of SDM, as this introduced an element of self-control, and 
enabled her to self-manage any treatment side-effects. Forum users commonly illustrated 
this practice of enhancing one another’s’ confidence, in order to motivate and support each 
other to remain ‘active’ in their care, regardless of having “no treatment choice”, or no 
option for SDM to take place.  By encouraging women to remain strong and assertive, and 
by motivating them to raise their confidence, this influenced women to maintain their role 
and ability to participate in their treatment, alongside the clinician. Therefore, Luisa’s 
extract illustrates that the ‘sharing’ component of SDM can still be enforced and take place 
in a clinical setting with the clinician, to manage other areas of the cancer journey; despite 
the lack of SDM during treatment decision-making. Subsequently, the extract illustrates 
how SDM is enhanced and maintained during forum interaction. The final extract (extract 
16), also illustrates how levels of self-efficacy are enhanced through online interaction. 
However, it shows more specifically how women are encouraged to exemplify their 
authority and confidence during decision-making with the clinician, and to remove any 
false preconceptions about the clinician’s role. 
EXT 16. Sam. Post 60, Lines 1-8  
No-one can advise you what to do. Not the women online or the 
medical team. It has to be your decision and choice entirely. 
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Just because the oncologist has offered it to you, doesn’t 
mean you have to take it, and some women don't. Don’t be 
afraid to challenge the oncologist and deliberate over your 
treatment, as it’s your right to find out all the facts and 
figures. It will help you decide. Good luck with making a 
decision. Don’t feel pressured and don’t be shy of voicing 
your view and opinion during clinic to help make that 
decision. 
Sam’s response focuses on reminding women that the decision has to be one that is 
individual and unpressured. She emphasises the importance of patient authority and patient 
preferences in decision-making, regardless of what medical professionals say. Therefore, 
this heightens the concept of patient-centred care. Sam is not only giving the thread owner 
the confidence needed to make a decision, but she is also injecting the power needed to 
participate in decision-making, and reminding her of the role she has to play alongside the 
clinician to help make a decision. Therefore, encouraging and enhancing the importance of 
SDM.  Sam explains that even though the clinician has suggested chemotherapy, this does 
not mean that the thread owner can no longer challenge the clinician’s decision. Therefore, 
this further brings awareness to importance of sharing patient values and preferences as 
characteristics of SDM, and enforces it to occur during the clinic. Sam’s extract, therefore, 
aims to diminish any feelings of compliance, and to remove any perceptions of the 
clinician’s status of expertise and professional role. Her motive, primarily, is to remind 
women of their equal status to the clinician when it comes to treatment decision-making; 
and of their mutual role in participation for decision-making. Women online were 
continually reminded by each other that ‘the treatment selected should be entirely your 
choice’ and that ‘they should have a say’. This asserts and preserves women’s battle for 
involvement in treatment choice and SDM.  Subsequently, the extract illustrates how SDM 
is enhanced and maintained during forum interaction 
 
5.5 Discussion 
A TA was conducted on three UK breast cancer online forums and identified three keys 
themes, which provide valuable information and awareness about the experience of SDM 
for breast cancer patients, from the conversations that occur online between patients. The 
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first theme addressed why women access the forums. The findings revealed that reasons 
for online peer interaction were similar to the characteristics of SDM. The second theme 
drew more specific attention to exploring the types of decisions which were discussed 
online. The findings provided an insight about SDM in a clinical setting, the extent to 
which it occurs, and about the characteristics of SDM. This theme also revealed that SDM 
is not only limited to a clinical setting, as it exist between peers during online interactions. 
The third theme showed that SDM is a concept which is brought to awareness and 
enhanced through online interactions. Findings revealed that peer to peer interaction aimed 
at educating women about SDM and to facilitate its occurrence in a clinical setting. 
Patients were continually motivated to participate in their cancer care, and encouraged to 
feel in control of their cancer care. The next section of this chapter will discuss how the 
three identified themes answer the research question- how do women with breast cancer 
experience SDM? The discussion concludes with the researcher’s personal and 
epistemological reflexivity, to outline certain issues and influences during data analysis 
and to outline how reflexivity has a place in the findings of this study. 
 The analysis primarily outlined some initial descriptive findings which supports the 
existing research on forum use. Within these findings, it was illustrated that women utilise 
the breast cancer forums during the course of their treatment, to talk about topics related to 
diagnosis, treatments and side-effects, QOL, recurrence of disease, and alternative therapy 
(Weinberg et al, 1996).  Individuals accessed the forums at various points throughout their 
entire treatment trajectories, to allow for social and emotional support (Finn, 1999; 
Braithwaite et al, 1999), and acquisition of health information (Cline, 1999; Satterlund et 
al, 2003). The forums appeared to provide a space which enabled members to exchange 
personal experiences (Sharf, 1997), and share similar stories (Bane et al, 2005), in aid of 
creating a supportive network, which provides it members with the knowledge and advice 
needed to restore emotional well-being.  
 
 The first theme, titled ‘extending the characteristics of SDM to an online peer 
community’, highlighted the reasons for breast cancer forum use in more detail. This theme 
demonstrated that the forums are an appropriate space and valuable way for women to 
receive support and information. Patient participation to the forums was largely motivated 
by the need to be informed and in control of emotional well-being. This finding mirrored 
the patients’ role in a clinical setting, as they primarily expected to be involved in their 
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health care and feel responsible for their health decisions (Emanuel, 1992). Therefore, the 
concept of patient-centred care is illustrated to be persistent not only in a clinical setting, 
but also amongst an online community. The action of posting online allowed women to 
continue to sustain their ‘active’ participatory role in their cancer care and, therefore, 
sustain characteristics of SDM outside of a clinical setting. It is, therefore, suggested that 
interactions within the forums can further promote aspects of patient-centred care and 
SDM. 
 This theme largely drew attention to the underlying characteristics of forums use, 
which reflect the characteristics of SDM in a clinical setting. SDM represents a framework 
which focuses on the equal partnership and collaboration between doctors and patients 
(NICE, 2012). Both parties are required to communicate and exchange information about 
possible attributes and consequences of options, and share their informed preferences for 
treatment in order to negotiate a mutually acceptable decision, which respects patient 
autonomy and is also desired (Charles et al, 1997; Elwyn & Charles, 2001). Similarly, this 
theme illustrates that the forums also serve a similar process to SDM, as they follow the 
same characteristics. These are that forums allow for patient participation in treatment 
discussions; allow women to exchange information and knowledge to one another; allow 
for equal relationships between peers which, therefore, enhance self-esteem; and enable 
collaborations to take place between peers.  Subsequently, it is understood from this theme 
that the interactions which take place between forum members, can transfer the 
characteristics of SDM from a clinical setting to an online community. Therefore, forum 
members are able to experience similar characteristics of SDM online, through the 
interactions they establish with other women.  As a result, this highlights the importance of 
two-way or multiple interactions online, similar to a clinical setting, to facilitate the 
occurrence of SDM. It also highlights that SDM is not just a concept which is experienced 
in a clinical setting, between patient and medical professional. In exploring this theme, an 
important question was raised:  if the characteristics of SDM are taking place within an 
online forum community, does this mean that forums members can experience SDM 
online?  
 This question was answered in the second theme titled, ‘experiencing SDM online’, 
which emphasised the topics of decision-making discussed online. The forums gave 
women the opportunity to talk to others about their concerns and difficulties in making 
medical decisions during their treatment; and to interact about a range of interpersonal 
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decision, which have to be made as a result of treatment side-effects. For instance, 
members talked to one another about complex everyday interpersonal decisions that had to 
be made regarding their treatments. For example, the issue of hair management was a topic 
of decision-making concern for many, as women suffered great difficulty in deciding how 
to control and live with their hair loss (e.g. shave it off, wear a scarf, and wear a wig). It 
can be suggested that due to the private nature of the forums and lack of face-to-face 
interactions, this allowed patients who were experiencing severe hair loss, the confidence 
to interact with others comfortably. The forum also appeared to provide an area for patients 
to interact with other patients about treatment choice. Although some discussions 
surrounding surgical treatments took place online, the most frequent topic discussed was 
about decision-making for adjuvant treatments, particularly chemotherapy. The complexity 
of chemotherapy decision-making was shown to be enhanced as a result of the issue of hair 
loss, as for many women, the concept of tampering with their body image and playing with 
their self-confidence was a factor which clouded their ability to make decisions. 
Subsequently, it can be suggested that decision-making is a topic to be shared and 
interacted with other breast cancer patients.  
 Two-way or multiple interactions about decision-making took place online, by 
members posting their concerns and experiences, and requesting, within their post, for 
other forum members to offer advice, emotional support, and to share similar experiences 
(Sharf, 1997). The process of exchanging similar experiences, and telling comparable 
stories, functioned to establish a commonality and, therefore, promoted relationship 
development between forum members (Cawyer & Smith-Dupre, 1995). Subsequently, it 
can be suggested that as a result of such rapport and established relationships online, this 
can create a united community for breast cancer patients, where decision-making could be 
shared and the process of SDM could be experienced.  
 From the interactions that took place about decision-making, a representation of 
SDM in a clinical setting was documented. It is understood that SDM is a process which is 
experienced by most women, through two-way communication and joint discussions 
between the patient and clinicians. Interactions in the forums illustrated substantial 
reference to patient encounters of SDM with the clinician. However, this theme revealed 
that SDM in a clinical setting is predominantly only for making treatment decisions, and 
excludes considerations of adjunct concerns such as interpersonal decisions (e.g. wig use 
or shaving of hair).  
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 An additional understanding of SDM, acquired from this theme, is that SDM is not 
a phenomenon which only occurs in a clinical setting between patients and medical 
professionals. SDM is also experienced in external online communities between peers, and 
in these circumstances, it took place within Internet breast cancer forums. Interpretation of 
individuals’ posts illustrated a description of how SDM occurred online. Decision-making 
online was demonstrated to take place through a shared approach, which required one 
member to share their dilemma and other members to offer advice, views, health 
information, and personal experiences, in order to facilitate decision-making. This shows 
that sharing online involves a reciprocal role of information exchange through two-way 
interactions; and it requires established  mutual relationships ,which is achieved through 
the social and emotional support provided (Housten et al, 2002; Winzelberg et al, 2003).  
 The element of two-way communication, information exchange, and mutual 
relationships during these forums, facilitate patient decision-making. It can, therefore, be 
suggested that through the process of two-way interaction and deliberations, and an 
exchange of information and preferences (patient views), the concept of SDM, which 
occurs in a clinical setting, is replicated, if not represented online. This is very similar to 
the concept for SDM which takes place between clinician and patient, as online interaction 
also involves both parties to communicate and exchange information, and share their 
preferences about possible attribute and consequences of treatment options (Elwyn & 
Charles, 2009). This finding is also supported by theme one, which illustrates how the 
characteristics of SDM in a clinical setting can be extended to an online community.  It can 
therefore be argued that a patients’ experience of SDM does not only occur in a clinical 
setting with medical professionals, but a similar symbolic representation of the concept can 
also take form through peer to peer interaction. Women are not only emotionally 
supporting one another to remove psychological distress, but they are also facilitating each 
other over the tasks of decision-making, by sharing their views, preferences, and 
knowledge (information) of breast cancer,  based on their own personal experiences. It can 
be argued that a patient’s experience of online SDM is particularly useful in instances 
where interpersonal decisions have to be made, and which are not discussed during 
clinician/patient SDM consultations. Subsequently, the interactions which take place 
within online support groups represent traits, which are consistent with the shared model of 
decision-making and the notion of SDM in a clinical setting. 
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 The theme concludes by showing that both the experience of SDM in a clinical 
setting and SDM experienced online, are important to a patient’s decision-making 
experience. Findings within this second theme showed that despite the practice of SDM in 
a clinical setting, the decision-making experience was still questioned. For example, 
women engaged in further interaction online about a decision which had already been 
confirmed during an SDM consultation with clinician. An additional online encounter of 
SDM between peers was sometimes needed to further support or facilitate the decision 
previously made in a clinic. This suggests that SDM in a clinical setting is only a subset of 
overall SDM behaviours, and should be considered to be incorporated into other SDM 
programmes outside of a clinical setting, such as SDM amongst breast cancer patients 
and/or family members. 
 
  The final theme titled ‘ways to enhance SDM’, examined how women help each 
other in the face of a decision-making dilemma. The findings revealed that decisions were 
not, in fact, reached online, as forum members were instead stirred towards an ‘active’ 
participatory role for decision-making with the clinician. The analysis revealed that women 
do not help each other to reach a decision, or tell each other what the right or wrong the 
decisions are. Instead, through the process of sharing their own personal experiences, their 
stories carried an underlying suggestion, which was to seek help from the clinician, to ease 
the decision-making process. Interaction between members online, aimed to offer methods 
which facilitate patients’ encounter of SDM and enhance its occurrence in a clinic.  
 There were two ways in which forum interactions promoted and enhanced SDM, 
between patient and clinician. This was through encouragement of patient participation and 
acquisition of patient authority during breast cancer care. In reviewing the former, women 
were encouraged to participate in decision-making to encounter an experience of SDM, 
which could help the decision-making process. Patient participation was encouraged in 
three ways. First, members encouraged one another to establish a good doctor-patient 
relationship and rapport with their clinician. To achieve this, attention focused on the 
importance of equal involvement in which both the clinician and patient shared their views, 
preferences, and information. Secondly, members encouraged one another to acquire as 
much information and knowledge as they could from their clinician. To achieve this, focus 
was given to the importance of two-way interaction and patient participation, which is 
based on an ability to ask questions and share their views. Thirdly, members encouraged 
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one another to think rationally about their involvement with the clinician, and the type of 
conversations they were going to engage in during a consultation. To achieve this, focus 
was given to the importance of structuring concerns, views, and issues to discuss with the 
clinician.  The benefits of these three techniques were continually reinforced online, as a 
means to ease decision-making dilemmas. Women advised each other on questions to ask 
the clinician and tried to boost confidence in those who were hesitant. They continually 
encouraged one another to become informed participants in their own health care, and 
taught each other how to be an ‘active’ patient who is thoroughly aware of their own case 
history and treatment risk factors.  It is important to acknowledge that these three 
suggestions are bringing awareness to the concept of SDM to members online. Patient 
participation was described online to be through a process of exchange of information; 
asking the clinician questions; and sharing patient views and preferences, all of which 
occurred through an established doctor-patient relationship, built on two-way interaction 
and rapport. Subsequently, the forums encouraged patients to be involved in their cancer 
care, to maximise positive shifts towards more equitable, or even patient-controlled, 
relationships between patient and clinician (DOH, 2001b; Graham et al, 2000; Hardey 
2001; Ferguson, 1997b).  
 As interactions within the forums are leading patients towards doctor-patient 
interaction in a health care setting (Gothill & Armstrong, 1999; Little et al, 2001), this 
subsequently heightens attention to the concept of SDM and aims to promote SDM and its 
occurrence during a treatment consultation. Members encouraged one another to 
participate in a mutual partnership with their clinician, whereby enough knowledge and 
information is exchanged through two-way conversations, in order to make an informed 
decision. This is a described characteristic of SDM (Beaver et al, 1996; Charles et al, 1997 
& 1999a; Elwyn & Charles, 2001; Towle & Godolphin, 1999). Therefore, the peer to peer 
interaction online also encourages and educates its members on how they can experience 
SDM with their clinician. By describing these three techniques for participation, forum 
users not only brought awareness about the concept of SDM and promoting its use, but 
also showed their understanding of the characteristics of SDM, based upon their own 
personal encounters of it.  This suggests that women with breast cancer can and do 
experience SDM in a clinical setting and do acquire an understanding of what SDM means, 
which is similar to the NICE guidelines (2004 & 2012) and shared model for medical 
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decision-making. Moreover, it could be suggested that breast cancer forum interaction can 
play a contributing part in facilitating patients’ experiences of SDM in a clinical setting.  
 The findings in the third theme also showed that the matter of patient authority 
emerged through online interactions, to further promote the concept of patient participation 
and SDM. The forums appeared to illustrate an overall system of support and motivation, 
which was targeted at improving and sustaining patient control and confidence, to 
participate in decision-making with the clinician. Feelings of entitlement, control, and 
power were discussed (Pitts, 2004), by reminding women of their rights and the concept of 
patient-centred care; encouraging them to remain ‘active’ in their care in order to gain self-
control; and disabling any feeling of disparity between the clinician’s and the patient’s 
status and role.  Therefore, interaction within an online community does not only raise 
awareness to patient authority, but it also instructs women how to be authoritative and in 
control of their health care; and encourages them to remain ‘active’ and involved in their 
breast cancer care. It can be suggested that by giving women the self-esteem and power to 
feel equal to the clinician, this in turn helps to sustain patient participation and draws 
attention to the importance of SDM in a clinical setting. Subsequently, the forums can act 
as campaigns for elevating the concept of SDM and enhancing experiences of SDM in a 
clinical setting. 
 
5.5.1 Reflexivity: the researcher’s voice 
As mentioned previously in this chapter (section 5.3.5- data analysis), researcher reflection 
was an integral process throughout this study, and was maintain by means of a reflexive 
diary. In having reached the findings discussed above, it is important to explore how the 
themes and interpretations of the extracts were influenced, and even shaped, by the 
researcher’s inter-subjectivity.  
 During the time of conducting the second study I was personally familiar with the 
concept and use of Internet forums for health advice. At the time, I had been diagnosed 
with a herniated spinal disc, and was given the option for surgery or to take the pain 
management path. I, therefore, turned to the Internet in search of information and advice 
from similar others. I primarily used online forums to talk to other patients about their 
similar diagnoses, and to gain an insight into the decisions they had made. For me, the 
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forums were a positive place to gain health information and advice towards treatment 
decision-making. This therefore gave me good baseline knowledge of how online forums 
operated, the type of topics which were interacted, and why patients like me used them. I 
found that my own personal engagement with online forums, subsequently, made it easier 
for me to operate the breast cancer forums. However, during data analysis, my own 
personal motives for using online forums, gave me a set of preconceptions for why breast 
cancer patients used them. In exploring the data, I asked myself questions such as, ‘why 
were the forums useful to me”’, ‘how did they help me during decision-making?’, and 
‘what topics of interaction did I engage in?’ My answers to these questions, therefore, led 
me towards examples within the data which were similar to my motives. During the stages 
of the data collection and analysis, I felt like I could personally relate to the breast cancer 
forum users, and understood the degree of complexity surrounding making treatment 
decisions. The forums were a personally valuable tool in helping me overcome some of the 
decision-making complexities. My biased view and experiences towards online forums 
resulted in me to over emphasised the benefits of forum interaction for decision-making 
and SDM. My personal engagement with forums was an empowering experience. During 
my interaction with members, it became apparent to me that forum users persisted in 
enhancing my confidence, gave me reassurance, and ensured I voiced my views to the 
doctor. For me, personally, the forums gave me the encouragement needed to stand up to 
the doctor and query his treatment preference. Furthermore, with my reading of the 
research literature on Internet use and patient empowerment, I decided to see if traits of 
empowerment were visible with the data. I acquired an assumption that if patients could 
influence each other online to question doctors, then they might encourage one another to 
engage in SDM with the doctor. This thought, therefore, drew me to extracts which 
illustrated examples of patient control, ‘active’ patient participatory roles, and the concept 
of patient-centred care in decision-making. 
 Whilst analysing the forum data, I was in regular contact with a close friend who is 
a cancer nurse. We had regular conversations about adjuvant treatment side-effects, breast 
cancer support, and the decision aids available to patients. This gave me heightened 
knowledge on topics about hair loss and body disfiguration. She also informed about the 
benefits of online forums and support groups for breast cancer patients, as a form of 
support system and coping strategy for such adverse side-effects. This subsequently 
influenced me to become drawn to data extracts about treatment side-effects above other 
Chapter Five 
180 
 
extracts. I began to question, ‘if patients come online to talk about their concerns over hair 
loss, can this impact upon their decision-making?’, and ‘how does gaining advice about 
adverse side-effects from other patients impact their experience of SDM?’ These questions 
drew me towards certain aspects of the data, and encouraged me to explore the types of 
decisions that were articulated online. I was keen to explore whether characteristics of 
SDM were evident during online interaction about adverse treatment side-effects.  
 The process of reflexivity during this second study taught me that it is a difficult 
task to put aside your own personal experiences, in the face of data collection and analysis. 
My personal experiences allowed me to create certain assumptions about why and how 
breast cancer patients interacted online, which subsequently stirred me towards certain data 
extracts. As a qualitative analyst, I have learned that research subjectivity is inevitable, 
however, must be accounted for and acknowledge during the research process, in order to 
understand the interpretations that have been made. I have therefore learnt that a researcher 
cannot completely account for their actions, nor become neutral by being reflexive, but this 
should not be the intention. Instead, the intention is to be transparent, as a researcher, and 
to describe the potential influences. 
 
 
5.6 Conclusion 
In exploring the main research question, by means of a symbolic interactionist approach, 
the three identified themes yielded some important findings about the experience of SDM 
for breast cancer patients.  The findings from this second study have demonstrated that 
women with breast cancer show knowledge and understanding of the concept of SDM, and 
about its importance for decision-making. By examining the interactions which take place 
between peers online, it is understood that women are able to characterise SDM, and show 
awareness of its meaning. Patients’ understanding of SDM and their perceived 
characteristics of SDM was shown to be based on individuals’ experiences. Therefore, this 
signifies that SDM is experienced by breast cancer patients in a clinical setting. The 
concept of SDM was symbolically characterised as a process which involved ‘active’ 
patient participation; two-way interaction between the clinician and patient, which entails 
the sharing of in information (view and preferences) and acquisition of knowledge; and 
equal relationship and division of labour, between the patient and clinician, during 
decision-making. This indicates that patient understanding of SDM is in accordance with 
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the NICE guidelines for SDM (2004 & 2012), and the shared model of medical decision-
making. 
 The findings show that an experience of SDM is highly valued and favoured by 
women, which subsequently results in women using the forums to promote, enhance, and 
educate others about the benefits of SDM during a consultation. Therefore, online support 
groups play an important role in facilitating breast cancer patients’ understanding of SDM, 
and educate patients on how the concept can be experienced during the treatment of breast 
cancer. With such awareness and promotion given to the concept of SDM, this helps to 
facilitate patient experience of SDM in a clinical setting. 
 The findings from this second study move beyond the experience of SDM in a 
clinical setting. Results showed that SDM is a concept which can occur outside of a 
consultation room, and can occur without medical professionals.  SDM can be experienced 
between patients, and Internet forums provide an opportunity for the characteristics of 
SDM to be experienced online between peers. This, therefore, suggests that decision-
making should not only be considered between the patient and clinician, as peer to peer 
interaction can also facilitate an encounter of SDM and assist decision-making for patients. 
Similar to an experience of SDM in a clinical setting, the findings show that women highly 
value and favour an SDM experience online. Subsequently, it can be concluded that 
research attention to SDM should not be confined to a clinical setting. Although patients 
showed an understanding of SDM, which corresponded to  the clinical characteristics of 
SDM between patient and clinician, the concept, should be regarded as a transferable 
process which can be experienced between patients and significant others. 
 
 In conclusion, the online forum data has revealed substantial awareness around the 
experience of SDM, from patient conversations. It has also given insight into the additional 
research questions outlined in Chapter One. For instance, it has elaborated on the meaning 
of SDM for patients, and what the characteristics of SDM are. It has provided an insight 
into the factors which influence (facilitate) patients’ encounters of SDM. The main 
discussion chapter of this thesis (Chapter Seven) will explore the findings of this study in 
relation to the implications it has on breast cancer care, further health research, and 
qualitative research. Chapter Seven will also further discuss the findings of this study, in 
more thorough detail, in relation to the literature review outlined in Chapters One and Two, 
and the overall research questions.  
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 Similar to study one (Chapter four), the findings from this study assign 
considerable importance to the role of two-way interaction and doctor-patient 
communication within a patient’s experience of SDM. The findings also highlight the role 
of mutual doctor-patient relationships, and perceived power-relations in facilitating 
patients’ experience of SDM. These outcomes raising further questions surrounding 
discourse and interactions which take place for SDM, and how this further shapes patients’ 
experiences. This subsequently warrants further exploration of the conversations which 
take place during breast cancer consultations. The next chapter introduces the rationale for 
study three, which investigates the concept and presence of SDM and doctor-patient 
communication, during breast cancer consultations. This will further examine how SDM is 
verbalised and exchanged.  
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Chapter 6 
Study 3: the presence of SDM during breast cancer consultations 
 
6.1 Introduction 
The findings from study one and two provided an insight into patients’ experience of 
SDM, from both the patients’ perspective and from the character of online interactions 
between individuals affected by breast cancer. Both of these studies provided an 
understanding into the meaning of SDM to breast cancer patients and the understood 
characteristics of SDM. The studies also provided an insight into and how patient 
experience of SDM can be influence (hinder or facilitate) by certain factors.  
 Study one (Chapter Four) highlighted the important of doctor-patient 
communication and doctor-patient imbalanced power-relations, in influencing a patient’s 
encounter with SDM. Study two (Chapter Five) revealed that characteristics of SDM can 
be experienced within peer to peer online interaction, outside of a clinical setting. The 
forums also provided an area for women to enhance their awareness of SDM, and to 
facilitate patients’ experience of SDM in a clinical setting. Subsequently, key thematic 
findings across both studies highlighted the importance of two-way communication and 
doctor-patient relationships as integral characteristics of SDM, and factors which 
influences patients’ experiences of SDM. This now warrants further exploration in the 
third study presented in this chapter.  
 This chapter focuses on how SDM is discursively formed within a breast cancer 
consultation. It explores the presence of SDM and how it might be experienced by breast 
cancer patients, through an examination of doctor-patient interaction to see how SDM is 
verbalised and exchanged. Specifically this study responds to the identified findings of 
doctor-patient two-way interaction and the issue of power differential from studies one and 
two. It maintains the theoretical framework of symbolic interactionism, through a 
qualitative audio-tape recording design, which examines the character of the conversations 
that take place during consultations about adjuvant treatment for breast cancer. This 
provides a thorough examination of how SDM is formulated through talk and how it might 
be encountered by breast cancer patients. A short literature review is provided which 
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explores the existing research surrounding doctor-patient communication and SDM, and 
applicability of using conversation analysis (CA) in exploring SDM amongst breast cancer 
patients. Following the literature review, the method is described. This is then followed by 
a detailed explanation of the findings achieved through a CA of the data. The chapter 
concludes with a discussion of the findings. 
 
6.2. Literature Review 
6.2.1 Communication skills for SDM 
Medical and health psychology literature increasingly highlights attention to good doctor-
patient communication during a consultation, as this is highly valued and fundamental to 
the delivery of high quality care, as it allows patient involvement in decision-making 
(Fallowfield & Jenkins, 1999; Katz, 1984; Simpson, 1981). Incorporating accurate and 
valuable information, by employing communication which provides appropriate 
description and explanation, has been described as an important prerequisite for a 
successful move towards increased involvement in decision-making (Brennan, 1997; Scott 
et al, 2000). Communication that stimulates patient questions has been identified as an 
important component of decision-making (Post, Cegala & Miser, 2002). Some patients 
may find it difficult to ask questions, as they feel intimidated, are concerned about using 
the doctor's time, and fear that assertiveness will jeopardise rapport (Towle, Godolphin, 
Manklow & Wiesinger, 2003). This causes many patients to attribute the process of 
question-asking mostly to the doctor. A patient’s ability to ask questions is important, as it 
can offer insight into their views and concerns. Therefore, good communication by the 
clinician, which comprises a conscientious and judicious search for patient views and 
preferences, may stimulate questions from the patient and, therefore, lead to better 
information exchange and more involvement.  
 Many studies show that patients want far more information than their doctors 
believe they do (Jenkins, Fallowfield & Saul, 2001). The vast majority of cancer patients 
want to be thoroughly informed about their illness, to allow for more involvement in their 
care (Meredith et al, 1996). Patients seek further information that is grounded in their own 
values, and want to be educated by the clinician during consultations (Greenfield et al, 
1985; Kaplan et al, 1989). According to Coulter and Ellins (2006), the delivery of high 
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quality and appropriately targeted consumer health information is central to the 
achievement of a patient’s health knowledge. Patients need access to adequate information 
and accurate knowledge given in ways, optimal to their own level of understanding, in 
order to understand the outcomes of tests and the therapeutic intent of treatments, and most 
importantly, to participate in management plans and treatment decision-making (Bruera, 
Sweeney, Calder, Palmer, & Benisch-Tolley, 2001; Buchanan et al, 1996; Coulter & 
Ellins, 2006). Nutbeam, (2000) argues that patient health knowledge acquisition is not 
simply a matter of being able to read and make sense of health information, but is also an 
essential empowerment strategy. Being able to effectively access and use health 
information is the foundation for individuals to have active and informed involvement in 
their healthcare and in decision-making relating to this (Beaver et al, 1996; Nutbeam, 
2000; Ubel & Lowenstein, 1997). This is particularly important in light of the 
government’s move towards a more formal provision of information within cancer care. 
According to the DOH (2001b & 2007), the provision of information is a key requirement 
in current cancer service standards, relating to patient empowerment and patient-
centredness in the UK. Young (2004) points out, that being empowered, informed, and 
confident leads to the most effective self-control. Therefore, by presenting appropriate 
information, this not only reassures and provides patients with realistic expectations (DOH, 
2006), but, importantly, empowers them to actively take control and responsibility for 
managing their condition, and to make further enquiries (Mettler & Kemper, 2006).  
 One of the main obstacles to patient participation is due to low acquisition of health 
information and a lack of knowledge of the subject (Katz, Jacobson, Veledar, & Kripalani, 
2007). It has been suggested that complex and poor communication can obscure the 
patient’s understanding of information about the diagnosis and prognosis of the illness 
(Epstein, Alper, & Quill, 2004); and that clinicians pay little attention to checking how 
well patients have understood the information told (Maguire & Pitceathly, 2002). The drive 
to deliver high quality consumer health information is a central component of government 
policy for the National Health Service (DOH, 1997). As a result of these policies, various 
organisations have undertaken efforts to address doctor-patient communication issues, by 
introducing series of information initiatives in aid of enhancing the provision of health 
information. For example, health professionals are encouraged to improve on their delivery 
of health information through doctor-patient communication skills training (DOH, 2004). 
Research demonstrates effectiveness of regular training on clinical practice and improved 
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patient satisfaction and well-being within cancer care (Fallowfield, Jenkins, Farewell, Saul, 
& Duffy et al, 2002; Fallowfield, Jenkins, Farewell, & Solis-Trapala, 2003). Other 
interventions focus on the development of health-related learning material and written 
information aids for patients (DOH, 2001), which show to have positive outcomes, related 
to patient anxiety, quality of life, medical knowledge, satisfaction; and on the clinicians 
communication behaviour and attitudes (Brédart, Bouleuc, & Dolbeault, 2005).  For 
example, a commitment to build on the work of the Calman-Hine Expert Advisory Group 
(NICE, 2004), includes recent developments and plans for a national information strategy, 
whereby ‘core information packages’ are established and distributed to all cancer patients. 
Informed medical decision-making occurs when patients understand both their condition, 
and the implications of the related clinical care (i.e. benefits, harms, limitations, 
alternatives, and uncertainties). This is achieved through detailed explanation and 
information from the clinician and information packs. By acquiring health information, 
this, therefore, provides patients with the confidence to engage and participate in their 
health care (Henderson, 2003).  
 The bulk of research on SDM and doctor-patient communication focuses on 
outlining the principles and tools required to improve communication skills for SDM, and 
how to involve patients in decision-making. Helping patients structure their 
communication through the use of a written tool, may improve the way patients described 
their health concerns, organise their needs and questions, and be more proactive. As a 
result, lists of competencies for involving clinicians (Box 6.1, Towle, 1997) and patients 
(Box 6.2, Towle & Godolphin, 1999) have been proposed to guide the process of SDM. 
These are stages that medical professionals may use in their discussions with patients, but 
are areas that are not covered in most communication skill training programmes for SDM 
(Elwyn et al, 1999b). The competencies listed from Towle’s framework make the process 
of doctor-patient interaction explicit. The framework should enable clinicians to identify 
patients’ preferred decision-making styles, at the start of the consultation, and to explore 
the patient’s preferred role in the decision-making. The framework also highlights the 
importance of information exchange, achieved through good doctor-patient 
communication. 
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Competencies for physicians for SDM 
 Develop a partnership with the patient 
 Establish or review the patient's preference for information—for example, amount and 
format 
 Establish or review the patient's preferences for role in decision-making 
 Ascertain and respond to patient's ideas, concerns, and expectations 
 Identify choices and evaluate the evidence from research in relation to the individual 
patient 
 Present (or direct to) evidence, taking into account the above steps, and help the patient 
reflect on and assess the impact of alternative decisions with regard to his or her values and 
lifestyle 
 Make or negotiate a decision in partnership, manage conflict 
 Agree on an action plan and complete arrangements for follow up 
Box 6.1 Towle’s competencies involved for clinicians for SDM 
 
Competencies for patients for SDM 
 Define (for oneself) the preferred doctor-patient relationship 
 Find a physician and establish, develop, and adapt a partnership 
 Articulate (for oneself) health problems, feelings, beliefs, and expectations in an objective 
and systematic manner 
 Communicate with the physician in order to understand and share relevant information 
(such as from competency 3) clearly and at the appropriate time in the medical interview 
 Access information 
 Evaluate information 
 Negotiate decisions, give feedback, resolve conflict, agree on an action plan 
 
Box 6.2 Towle’s competencies involved for patients for SDM 
 
While part of the process of SDM is to establish relationships, as illustrated by Towle 
(1997), the framework, nonetheless, aims to highlight that the concepts of SDM and two-
way interaction are not inseparable. Towle (1997) indicates that if clinicians practice the 
competencies for SDM, then this should lead to an informed agreed decision, between the 
clinician and the patient. However, if the patient is not provided with enough information 
or evidence about options, this can result in a conflict between the clinician and patient, 
and a solution needs to be negotiated. In the context of SDM, negotiation is referred to as 
back-and-forth communication which is designed to allow for an agreement, where the 
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patient and the clinician have some interests that are shared and others that are opposed 
(Fisher & Ury, 1981).  
 However, the outlined competencies of doctor-patient communication skills for 
SDM, has been the subject of debate in the literature on interpersonal communication in 
health care (Charles, Gafni & Whelan, 1999a; Elwyn, Edwards, Gywn & Grol, 1997a; 
Elwyn & Charles, 2001). SDM has been shown to be sparsely implemented and practiced 
in health care (Holmes-Rovner et al, 2000; Stevenson et al, 2000), and clinicians still lack 
the appropriate communication skills for SDM (Auerbach, 2000; Gwyn & Elwyn, 1999). 
There is some uncertainty about whether Towle’s framework can be functional in a clinical 
setting (McKinstry, 2000; Stevenson et al, 2000). There are several proposed explanations 
for this drawn from previous research. For instance, studies have shown that clinicians 
trained in some of these competences and communications skills do not devote enough 
time to two-way interaction, and/or asking the patients questions (Roter et al, 1995; 
Stewart, Brown & Weston, 1989). Time constraints were the most often cited barriers for 
implementing SDM in clinical practice. Although dedicating time to the right quantity of 
communication for an encounter of SDM may take longer, this method has been shown to 
more efficient because of improved health outcomes (Kinnersley, 1997; Roter & Hall, 
1992; Street & Voigt, 1997). According to Howie, Heaney and Maxwell (1997), providing 
patients with more time and opportunities for communication, helps to develop ‘patient 
enablement’, and allows patients to understand and cope with their health problems better. 
Similarly, Beisecker and Beisecker (1990) found that the degree to which patients sought 
information, interacted with their doctor, and participated in their health care during the 
consultation, depended on how long the consultation lasted. 
 Research on communication and SDM has been explored through systematic 
reviews (Coulter et al, 1999; Elwyn et al, 1999b; Epstein, Alper & Quill, 2004; Godolphin, 
2003; Gravel et al, 2006; Stewart, 1995; Towle & Godolphin, 1999). There is also 
evidence from some qualitative studies, including focus groups studies and semi-structured 
interviews with patients and clinicians (Edwards & Glyn, 2006; Elwyn et al, 1999a; Elwyn, 
Edwards, Kinnersley & Grol, 2000; Stevenson et al, 2000). However, understanding the 
relationship between communication skills and SDM requires new research strategies. 
Zoppi and Epstein
 
(2002) suggested that investigators should observe communication 
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behaviours, and concurrently gather participants’ objective experiences of the interaction 
to better understand about doctor-patient communication. 
 More recent research used alternative methods to examine whether the proposed 
concepts and practice of SDM for patients and clinicians are utilised, and further promoted 
SDM training in practice. More specifically, research has taken distinct turn to explore 
whether communication patterns for SDM can be identified during consultations, through a 
deeper exploration of routine clinical practice. For example, Saba et al (2006) examined 
SDM and the subjective experience of interaction, for patients and clinicians in primary 
care. Direct observations of consultations were made by videotape. Decision moments 
were coded for objective evidence of SDM, using a structured instrument, and grounded 
theory was used to identify themes. This was a useful study as it combined direct 
observation and assessment of the subjective experience of interaction. The findings 
suggested that communication behaviour did not result in a positive subjective experience 
of collaboration or partnership, and that attempts to enhance SDM needed to attend to both 
effective communication style and effective relationship dynamics.  
 Another similar study is by Elwyn et al (2008) examined the communication 
strategies of clinicians attempting to involve patients in treatment or decision-making. This 
was compared with theoretical ‘competences’ derived for SDM by Towle (1997). 
Consultations from four purposively selected clinicians, who were experienced in SDM, 
were tape-recorded and then transcribed and coded by means of CA into skill categorises  
The focus of analysis was to assess the implementation of SDM, though exploration of the 
conversations during clinical consultations. The clinical specialities conveyed from this 
study, were that the empirical data did not match the suggested theoretical framework. 
Clinicians failed to explore the views of patients about treatment possibilities, and their 
preferred role in decision-making. Interactions were initiated by a problem-defining phase, 
and the portrayal of option information was often fused with opportunities to allow patients 
to question and reflect. Significant proportions of time were shown to be for information 
exchange and patient interaction. A decision-making stage occurred consistently after 
approximately 80% of the total consultation duration .This study is useful as it 
demonstrated that some theoretical competences are not distinguishable in practice, and 
that the suggested ideal of a SDM interaction will either require more time than currently 
allocated, or alternative strategies.  
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 Both studies by Saba et al (2006) and Elwyn et al (2008) draw attention to the 
significance of qualitative methods, in exploring and evaluating the role of communication 
during SDM.  Furthermore, both of these studies are useful as they have found that a 
criterion for SDM does not ensure that the decision-making process is subjectively 
collaborative. Relationship dynamics, such as trust and power, may either influence 
patterns of communication or mediate the perception of collaboration in the decision-
making process (Saba et al, 2006). Greater efforts need to be made to enhance doctor-
patient communication and relationship dynamics. 
 
6.2.2 Exploring SDM through talk 
CA, or as it is sometimes known, the study of ‘talk-in-interaction’ is an “analytical 
orientated discipline that developed out of ethnomethodology” (Potter, 1996, p.43). 
Ethnomethodology focuses on providing a rational analysis of the structures, procedures 
and strategies that people themselves use when they are making sense of their own 
everyday world, and their actions and interactions within it. Therefore, CA investigates 
how language is put together and used in interactions. It focuses on the largely verbal 
communicative practices, which people use in interacting with one another. The analysis 
centres on first, identifying elements and structures in naturally occurring conversation, 
and then, through a detailed procedure of micro-analysis, identifying evidence for the 
models, concepts, and ideas that people use.  In a sense, CA is concerned with uncovering 
the implicit ideas and understandings people possess and use in their everyday interactions. 
The identification of sequential patterns and the practices, through which these patterns are 
generated, are distinctive to CA’s approach. In comparison to the somewhat static picture 
provided by quantitative methods, which produce statistical aggregations, CA aims to 
identify and describe the specific interactional consequences which follow from given 
verbal practices (Perakyla, 1997). The novelty and power of a CA approach is the potential 
for identifying the kinds of choices doctors and patients make, and how they design their 
turns, utterances, and sequence of talk action. CA can examine talk at various intervals of a 
consultation, whether during discussions about the patient's history, conducting a physical 
examination, delivering the diagnosis, or suggesting treatment options.  
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 CA has an established pedigree in psychological research, with specific reference to 
examining medical communication (Heritage & Maynard, 2006). CA research, in a health 
setting, compares institutional communication with everyday conversations (Drew & 
Heritage, 1992), to reveal practices which govern medical consultations. There are many 
examples of CA research in health settings, which look to explore consultation openings 
(Gafaranga & Britten, 2003); communication during physical examination (Heritage & 
Stivers, 1999); and patient explanation of their illnesses (Gill, 1998). CA has also been 
employed as a useful analytical tool to explore informed decision-making (Braddock, 
Edwards, Hasenberg, Laidley, & Levinson, 1999; Drew, Chatwin, & Collin, 2008; 
Pomerantz & Fehr, 1997); patient participation (Greenfield et al, 1985; Kettunen, 
Poskiparta & Karhila, 2003; McCabe, Health, Burns & Priebe, 2002); and doctor-patient 
relationships during clinical practice (Greenfield et al, 1988; Maynard & Heritage, 2005).  
 Regarding research in breast cancer, CA is a method which has been used to 
explore patient attitudes towards breast cancer (Wilkinson, 2000; Wilkinson & Kitzinger, 
2000); their interactions with other patients (Sharf, 1997; Winzelberg et al, 2003), partners 
and family members (Manne et al, 2006); and patient interaction with medical 
professionals (Butow, Brown, Cogar, Tattersall & Dunn, 2002; Jarret & Payne, 2000; 
Pollak et al, 2007; Robinson et al, 2008). Within the context of SDM and CA research, the 
study outlined above by Elywn et al (2008), is the only documented study. However, SDM 
and CA research is yet to be explored within breast cancer. There is also no research 
conducted using CA to examine the meaning of interaction during patient-doctor 
conversations for decision-making, to explore the concept and presence of SDM with 
breast cancer care. As CA examines ‘talk-as-action’ situated in symbolic meanings 
(Maynard & Heritage, 2005), this makes it valuable to the study of SDM and breast cancer, 
and relevant to the realm of critical health psychology and the interpretivisit perspective of 
symbolic interactionism, in which this thesis is situated within. By examining the 
enterprise of people doing the business of ‘talk-in-interaction’, CA can seek to understand 
how women with breast cancer make sense of their SDM interactions with the clinician. 
CA also enables examination of how social structures and social processes, such as the 
issue of doctor-patient power-relations highlighted in the findings from studies one and 
two, are reproduced implicitly through interaction and talk. Consequently, CA will help 
uncover the implicit experience of SDM for patients, which this thesis aims to investigate, 
through doctor-patient interactions during a breast cancer consultation. 
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 The next study aims to fill the gap in the literature by using CA to add to studies 
one and two and refine the meanings that can be applied to SDM. Similar to Elwyn, et al 
(2008), this study will employ a similar method of audio-recordings of clinical 
consultations and introduces CA as an alternative method to acquire a thorough insight into 
medical interactions for SDM. However, unlike the previous studies, which use CA to 
evaluate communication as defined by the acquisition and evaluation of skills, this study 
utilises CA in exploring doctor-patient communication to examine how breast cancer 
patients respond to the clinician’s talk in context of decision-making, to uncover the 
meanings behind interaction for SDM, and about the concept and presence of SDM.  
 
6.3 Method 
6.3.1 Study design 
With the aim to explore the research questions through a symbolic interactionist qualitative 
approach, Elywn et al’s (2008) method of audio-recording consultations was adapted and 
applied to breast cancer consultations.  The study design set to explore SDM during 
consultations for adjuvant treatment. Exploration of conversations during adjuvant 
treatment consultations was proposed for the purpose of the third study, over surgical 
consultations, as a result of the findings from study one (Chapter Four) and study two 
(Chapter Five). It was highlighted in patient interviews during study one that participants, 
who had undergone surgical treatments, stated that when it came to surgical decision-
making, patient choice and decision-making was not important. Participants obtained a 
belief that the clinical route to surgical decision-making should be to simply remove the 
cancer, as the principal aim of recovery is to remove the cells and increase chances of 
survival. Therefore, a strong attitude of ‘just get rid of it’ was found throughout the data, 
and the concept of SDM was viewed as limited. Similarly, it was revealed in study two, 
during patient online interaction, that decision-making and patients’ encounter of SDM is 
more important during the adjuvant treatment stage. Due to the side-effects of hair loss and 
weight gain, which are experienced during adjuvant treatments, patient participation and 
patient control over decision-making was regarded as essential. Therefore, the concept of 
SDM was viewed as important within the forums, and experienced largely during adjuvant 
stages of treatment. Subsequently, for the purpose of the third study, it was decided to 
explore doctor-patient communication during adjuvant consultations. CA, focused on 
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examining how SDM is verbalised and exchanged, through interpretations of language and 
discourse. Transcription used Jefferson conventions (Jefferson, 1985), which observed 
speech with all characteristics, rather than verbatim. This qualitative method of exploring 
patients’ meaning of SDM interaction is the first to be accounted for within the health 
literature for the treatment of breast cancer.  
 
6.3.2 Pre data collection preparations 
Before collecting audio-recorded data from the consultations, it was important to explore 
specific aspects of medical assessments during the adjuvant treatment stage for breast 
cancer. As with study one in reference to diagnosis and surgical discussions, it was 
essential to find out about the medical process and treatments for breast cancer during the 
adjuvant stage of treatment. Regular weekly visits were made to oncology clinics and on-
going observations took place of adjuvant treatment clinics, over a three month period. The 
observations were not intended as an independent observational study, and instead were 
utilised as an opportunity to become familiar with medical practices, clinical procedures, 
and increase awareness of terminology related to adjuvant treatments for breast cancer.  
 
6.3.2.1 Clinic observation: initial adjuvant clinic and treatment monitoring clinic   
Regular visits were made to two different types of adjuvant treatment clinics for breast 
cancer for observation. These were an initial adjuvant consultation and a treatment 
monitoring clinic. Both clinics took place at the University teaching hospital Cancer 
Centre, once a week by the same clinician who was a senior oncologist. The aim of the 
observations was to gain an extensive understanding of adjuvant treatment knowledge, and 
to observe the different types of consultations that take place during adjuvant treatments of 
chemotherapy and radiotherapy. Attendance at these consultations provided an opportunity 
to see patients talk about their illness, following surgery (either a mastectomy or a 
lumpectomy), and to perceive the clinician’s role and duties during a patient’s adjuvant 
treatment stage. The observations provided suitable insight into the phraseology, medical 
terms, procedures, and systems involved during post-surgical stages of breast cancer care. 
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 The first clinic observed was an initial adjuvant clinic, which took place weekly for 
patients who had completed surgical treatment, and were ready to start adjuvant treatments. 
Patients attended the clinic with a family member, partner, or friend for support. The initial 
adjuvant consultation began with a physical examination of the breast, and then the content 
of the consultation comprised of: review of patients’ diagnosis and surgical treatment; 
review of post-surgery test results; review of patients’ current health; discussions about 
why adjuvant treatment was necessary and which treatment was needed for the patient; 
discussion about procedure and side-effects; and outlining clinician trials which patients 
could participate in. Dialogue was mostly led by the clinician in terms of description, 
explanation, and justification. However, patients also showed some involvement by asking 
questions at the end of the consultation. Following the consultation, the oncologist left the 
room and a breast care nurse was invited inside, to spend some time with the patient. The 
nurse once more informed the patient about the treatment plan that was previously 
discussed by the clinician. This allowed them another opportunity to express any queries or 
doubts. This period of time allowed the nurse to provide the patient with all information 
packs and reading material about adjuvant treatments.  
 
 The second clinic observed was an adjuvant treatment monitoring clinic. This clinic 
took place weekly, and was designed for patients currently undergoing treatments of 
chemotherapy and/or radiotherapy, and/or required follow-up assessments. During these 
consultations a different structure of conversations took place: a review of patients’ 
adjuvant treatment plans and stages were outlined; the patients’ current health was 
reviewed; discussions about side-effects and how to manage them occurred; and a review 
of the next stage(s) of treatment was outlined. These consultations were far more patient 
led, in that they focused on reviewing the patients’ health, QOL, emotional distress, and 
any other concerns or issues with the adjuvant treatment plan. More interaction between 
the clinician and patient took place, as the patient asked frequent questions about their 
health status and treatment stages. During these consultations, a breast cancer nurse was 
present, who took medical notes and contributed to the clinicians talk, by offering further 
reassurance and health care advice through positive language. At the end of the 
consultation, patients were once again given the opportunity to spend some time alone with 
the breast care nurse, to share any queries and questions. 
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 The opportunity to observe both initial adjuvant clinics and adjuvant monitoring 
clinics, provided a better understanding of some of the medical terms, the post-surgery 
treatment stages, and how an adjuvant treatment plan  is conversed, during the adjuvant 
stage of breast cancer care. Such access to clinical practices and expansion of knowledge, 
subsequently, helped to facilitate the development of the study design and methods of data 
collection in study three. By visually witnessing how adjuvant consultations formulated 
and operated, the acquired knowledge on medical terminology and the structure of the 
consultations made listening and analysis of the audio-recordings easier to follow and 
transcribe. 
 
6.3.3 Audio-recording cassettes 
Due the sensitive and confidential nature of accessing first hand clinical observations of 
breast cancer consultations, it was, therefore, compulsory to ensure a method of data 
collection was selected which did not breach patient privacy. A technique to overcome 
direct clinical observations was for the clinician (i.e. the oncologist) to seek consent to 
record the consultations which took place. As outlined in the literature review above, 
audio-recording of clinical consultations is now a common practice, which has been used 
for a variety of health research purposes and CA studies. Of all observing techniques, 
audio-recording has been recommended as the best method for researching doctor-patient 
communication because it captures all modalities of the interaction between participants in 
a consultation (Inui & Carter, 1985). Therefore, it is a method predominantly used to 
assess patient and medical professional interactions, for teaching and training of 
communication skills. According to Coleman (2000), the ability to obtain a complete 
record of both clinicians’ and patients’ consulting behaviour has enabled researchers to 
investigate a variety of research questions, which were previously unanswerable. 
Furthermore, this method within health research has been described as high in internal 
validity, as the recordings provide a complete record of what actually happened; rather 
than participants behaving in an ‘atypical’ manner as a result of the researcher influence, 
bias, confounding variables, or chance (Gibbs, Friese & Mangabeira, 2002). 
 For the purpose of this study, audio-recordings, of initial adjuvant treatment 
consultations, made by the clinician, were used for analysis. The audio-recordings of breast 
cancer patients’ consultations were part of standard institutional practice in the Oncology 
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Department at the University teaching hospital. The method of recording was used for 
creating an information tool, which was given to the patient to take home at the end of the 
consultation. Subsequently, these cassettes acted as a means for patients to receive future 
clarification and comfort, by listening back to the conversation which took place within the 
consultation. The recordings were not used for medical or training proposes, nor were they 
stored at the hospital. As soon as the consultation ended, the tape was handed over to the 
patient and was, therefore, solely for the patients’ possession and future use. The clinician 
verbally asked patients at the start of the consultation if they agreed to their consultation 
being recorded, as a source of information for them to then take home. At the end of the 
consultation, a short self-questionnaire was completed which indicated whether the patient 
agreed to the tape recorder being switched on. The questionnaire also specified whether the 
patient decided to take the cassette home. This questionnaire was completed for the 
clinician’s own knowledge and references. For those patients who decided not to take the 
recorded cassette home, their cassette was subsequently destroyed. In order to use these 
cassette recordings for research purposes in study three, written informed consent was 
obtained from the patients, as the cassette was their property and possession. 
 
6.3.4 Participants 
Ten women aged 18 years and above, who had completed breast cancer surgery (either a 
lumpectomy or a mastectomy), consented to releasing their audio-recording cassette of 
their adjuvant treatment consultation for CA (Table 6.3 illustrates participant profiles). 
Five of the participants (50% of the sample) were aged between 50-59 years. All 10 
participants were from a white British ethnic background. The sample captured all types of 
adjuvant treatments, thus enabling a broad insight into the conversations which took place 
between clinician and patient. There was also an equal split of participants who had 
previously undergone surgical treatments of both a mastectomy and a lumpectomy. 
However, the surgical type was not an inclusion or exclusion criteria that applied.  
 
 
 
Chapter Six 
198 
 
Table 6.3  
Participant demographics 
 
 
 
 
 
 
 
 
 
 
 
 
Note: M- Mastectomy, L- Lumpectomy, C- Chemotherapy, R- Radiotherapy, H- Hormone therapy 
All women were registered patients of the Oncology Department at the University teaching 
hospital, and were seen by the same oncologist during their adjuvant treatment stage. All 
10 participants had completed their initial adjuvant consultation with their oncologist two 
months (eight weeks) prior the time of recruitment. The two year time frame was 
considered by the oncologist as an appropriate length of time for the patient to adjust to 
their treatment, and to utilise the tape for their personal use. This is an important 
consideration for ethical purposes. To maintain uniformity with studies one and two, 
patients who had opted for breast reconstruction following a mastectomy, were not 
included in the sample criteria.  Focus was maintained on only recruiting patients who had 
received a cassette recording or had agreed for recording of their consultation to take place. 
 
6.3.4.1 Participant recruitment 
Following ethical approval and access from the Research and Development (R&D) 
Department at the University teaching hospital (section 6.3.7), the senior Oncologist 
granted access to patient records and the cassette questionnaire data from the initial 
adjuvant clinic. As a log (questionnaire) was kept of patients who consented to the cassette 
P 
No’ 
Age 
 
Adjuvant 
treatment 
Surgical 
Treatment 
Other 
conditions 
Employment 
status 
Marital 
status 
1 50-59 C & H M Mental 
Health 
Unable to 
work 
Single 
2 40-49 H L None Employed Married 
3 50-59 C & H M None Self-employed Married 
4 50-59 R & H L None Employed Divorced 
5 60-69 C & R M None Employed Married 
6 50-59 C & H M None Retired Widowed 
7 40-49 R & H L Diabetes Retired Married 
8 60-69 R & H L None Employed Single 
9 50-59 R & H L Diabetes Retired Married 
10 60-69 R, C & H M None Retired Married 
Chapter Six 
199 
 
recording and had taken the cassette home, this meant that participant recruitment could be 
targeted more specifically. For the purpose of participant recruitment, the questionnaire 
was used as a means to identify which patients matched the study inclusion criteria. The 
list was filtered down to patients who had their initial consultation, with the clinician, eight 
weeks prior to the time of recruitment. Patients from the March 2012 and April 2012 clinic 
were included for recruitment. April 2012 was also included to allow for enough 
participants to be contacted and recruited. The initial adjuvant clinic was held weekly, in 
which four patients were seen during the clinic session. This, therefore, resulted in a total 
of eight clinic sessions and a total of 32 patients eligible for recruitment. However, two of 
these patients were male, two did not agree to have their consultation recorded, and one 
had since died. This left 27 eligible participants who were sent a recruitment pack. This 
included an invitation letter (appendix K), along with an information leaflet (appendix L) 
explaining the study, and an agreement form to sign (appendix M). A pre-paid envelope 
was also included in the pack for the agreement form to be returned. For ethical purposes 
participants were not contacted until their agreement letter for participation was received. 
As there was no intention to contact participants prior to acceptance, follow-up of those 
who did not respond to the initial invitation letter was avoided, and it was assumed that the 
patient had decided not to take part. From the sample of 27 contacted, 10 positively 
responded to participate, five declined, and the remaining 12 did not respond.  
 The sample size was confirmed on three reasons. The first reason pertains to the 
amount of time and effort that goes into CA text analysis at such a fine level of detail, 
relative to other qualitative analysis (Guest, Namey, & Mitchell, 2012). For example, 
compared to the TA, which was conducted in studies one and two, the item of analysis 
consisted of smaller text and the analytic action was to identify themes within that text 
segment. In contrast, linguistic-oriented approaches, such as CA, require intricate 
dissection of words, phrases, sentences, and interaction among speakers; and also take into 
account tonal inflection during the analysis. Therefore, such linguistic type of analysis 
requires far more analytic time and effort per page of text, and results in a smaller sample 
size (Guest, Namey, & Mitchell, 2012).  The second consideration is the source of data. 
Since CA is most interested with naturally occurring language, in-depth interviews or 
focus groups are not ideal data collection methods (Baker & Edwards, 2012). Therefore, 
audio-recordings or observations are required to capture the purity of the data. As breast 
cancer consultations can be arguably regarded as highly emotive or sensitive, recording 
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doctor-patient interaction during clinic may be viewed as invasive. Subsequently, with the 
population of breast cancer patients being hard to access, Baker and Edwards (2012) 
suggested that a small number of consultations or subjects, such as between six and a 
dozen, may be extremely valuable and represent adequate numbers for a research project. 
The final consideration is based on Popay, Rodgers and Williams (1998) who stated that, 
in qualitative work, “randomness and representativeness are of less concern than relevance 
[…] Does the sample produce the type of knowledge necessary to understand the structure 
and processes within which the individuals or situations are located?” (p.346). Therefore, 
the sample size (i.e. number of audio-cassettes) was made on the basis of their ability to 
provide relevant data on the area under investigation. As each tape recording was extensive 
in length and in the density of data, this provided many instances for relevant data on 
decision-making and shared doctor-patient communication to be explored. Subsequently, it 
is suggested that the number of different speakers or sample is of less relevance, than the 
number of occasions or instances in which the phenomenon (SDM) can be looked at. 
 
6.3.5 Data collection 
The method of data collection required participants to do nothing, other than to consent to 
their cassette recording being accessed by the researcher and used for research purposes. 
As mention in section 6.3.4.1 (‘participant recruitment’), participants who met inclusion 
requirements were sent a recruitment study pack, which included an invitation letter, study 
information, an agreement form, and a pre-paid envelope. Participants were informed that 
they will be contacted by telephone by the researcher to discuss the next steps only upon 
accepting to take part, and after returning the agreement form. Upon receiving the 
agreement form, a telephone conversation took place between a member of the research 
team and participant. During this telephone conversation, participants were given the 
opportunity to talk about their participation and ask questions. They were also informed 
about the next stage of data collection, whereby they were to receive additional documents 
in the post. Participants were instructed, over the phone, that they were required to sign the 
informed consent form (appendix N), complete the demographic questionnaire (appendix 
O), and send both documents back to the research team along with their audio-recorded 
cassette.  A secure postage method was set up to ensure safekeeping and confidentiality of 
cassettes. This postal service was used by participants to send their cassette to the research 
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team, and also used by the researcher to send the cassette back to the participant, upon 
completion of use. Each cassette was only in the researcher’s possession, and used for 
transcription for approximately a week and then returned. Once the cassette had been 
securely sent back to the participants, they once again received a telephone call from the 
researcher. The call was to ensure that they received their cassette, and to again allow them 
to ask further questions. Participants were informed during this second telephone 
conversation that a summary of findings will be sent to them at a future date.  
 
6.3.6 Data analysis 
Each cassette was listened to 5-6 times during transcription. The first listening was of the 
whole consultation to become familiar with the recording. The second-fourth time entailed 
micro-detailed transcription of the data, using the Jefferson system (Jefferson, 1985). This 
meant that the words were not just transcribed verbatim, but were documented as they 
were heard. The process of Jefferson transcription involves the use of symbols that denote 
emphasis, pause, inflection/deflection and overlapping speech, amongst other 
characteristics. Appendix P illustrates an example of the Jefferson system- symbols and 
their meanings- used during analysis. The process of transcription is often referred to as a 
‘noticing device’, as actually carrying out a transcription, forces the analyst to attend to 
details of the interaction that would normally escape the attention of the ordinary listener. 
According to Heath and Luff (1993):  
“The process of transcription is an important analytical tool, providing the researcher 
with an understanding of, and insights into, the participant’s conduct.  It provides the 
researcher with a way of noticing, even discovering, particular events and helps focus 
analytic attention of their socio-interactional organisation”. (p. 309). 
 
Transcription involved playing back small sections of a conversation extract repeatedly, 
and gradually writing out the words and sounds of the conversation according to the 
symbol outlined in Appendix P. Throughout the transcription process, separate notes were 
also made about aspects of the conversation which came to attention, such tone linguistic, 
intonation, tempo, and inflection. Therefore, continuous, careful, yet unmotivated, 
attention was given to the dynamic and sequential nature of the conversations. This process 
of transcription subsequently allowed attention to be drawn to aspects of the ‘talk-in-
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interaction’, which usually would not be paid attention to in everyday conversations.  The 
final listening was to ensure certainty that the orthography represented what was heard. CA 
was conducted using established frameworks and guidelines (Sacks, 1992), which focus on 
basic content, turn-taking, speech repairs and other communicative devices:  
Examining basic content - i.e. what is said. Following this, the analysis turns 
specifically to what is being done in the conversation. 
 
Turn-taking - locating when the interlocutors know when to take the conversational 
turn and what contributes to this position, e.g. the construction of turns, pauses, and 
overlaps. 
 
The sequencing of conversation- how the conversation is distributed and how 
utterances in talk are sequentially organised, e.g. how utterances are adjacent to each 
other (adjacency pairs) 
 
Expanding - examines the use of ‘filler’ words, such as “oh” (e.g. “oh, I'm not sure”), 
which in a clinical context can be useful to determine the deliberations and reasoning 
between interlocutors. 
 
Repairs - these look at how people deal with interactional ‘trouble’ during a 
conversation. They are common in naturally occurring talk, and are anticipated to be 
highly prevalent in consultation recordings. An example could be “the procedure will 
involve a... well mostly it necessitates a cut here” - an active attempt to clarify or 
emphasise a point once the speech has commenced. 
 
 Reliability checks- the research team jointly review drafts of analyses to ensure that 
the quality of analysis is high and that there is internal consistency in the linguistic 
and conceptual outcomes. 
 
Throughout the analysis there was a consistent focus on the sequential implications of 
utterances, to explore relationships between the story and subsequent talk. Therefore, the 
analysis was guided by regularly asking the question ‘why that utterance now?’ The 
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analysis was then interpreted and applied to answer the research question, which is beyond 
the focus on understanding conversational structure. In contrast to discourse analysis and 
other language focused qualitative methods, CA has a strong commitment to the idea that 
interpretations made about the data being analysed, must rest upon identifiable evidence in 
the conversations themselves. Therefore, during the analysis, specific elements in the talk, 
which supported the interpretations, were identified and illustrated by supporting extracts. 
 
 As mentioned in Chapter Four and Five, the researcher’s ability to reflect on their 
behaviour and thoughts, as well as on the phenomenon being studied, is an important 
requisite of qualitative research. Richardson (2000) refers to writing as “a method of 
inquiry, a way of finding out about yourself and your topic” (p. 923). Ellis and Bochner 
(2000) suggested that the process of written self-assessment should resemble a “personal 
tale of what went on in the backstage of doing the research” (p. 741). Therefore by keeping 
a reflexive journal during data analysis, this enabled the researcher to become aware of 
what allowed and inhibited the research’s seeing during analysis, and how the researcher’s 
personal assumptions and behaviour may be impacting the inquiry. The diaries focused on 
recording key events and habitual practices, what the researcher was feeling about the 
research, the reasons for the decisions that were made, and the researcher’s thoughts and 
attitudes towards the research itself and the information that was arising. Any 
presuppositions, choices, experiences, and actions during the research process were 
included in the diary. An evaluation of the researcher’s ability to transcribe the audio-
recordings in the Jefferson system, and engagement in CA was also recorded. In turn, the 
commentary notes in the diary were an effective way of confronting the researcher’s 
thoughts and perceptions, and to see whether they influenced the data collection process 
and analysis. The process of reflexivity will be discussed further in the discussion section 
(section 6.5.1) of this chapter 
 
 
6.3.7 Ethical submissions 
A separate ethical application was submitted for study three. Approval was granted from 
the local NHS Research Ethics Committee (REC) (appendix Qa) and the R&D department 
at the University teaching hospital (appendix Qb), from which the sample was recruited. 
The Institute for Social Sciences at Keele University, together with the supervisor team in 
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the School of Psychology certified full peer review for the study and the project as a 
whole. The researcher had clearance from the Disclosure and Barring Service (DBS), and 
was given access to patients, subject to the award of an honorary contract and research 
passport by the University teaching hospital. This was granted by the R&D Department at 
the hospital. The research also received up-to-date full Good Clinical Practice (GCP) 
training, by the NHS trust, to ensure that research was conducted to ethical and practical 
standards.  
 All ethical procedures were adhered to during the conduct, analysis, and write-up of 
data collection. As the cassette recordings were part of routine medical practice at the 
University teaching hospital, ethical permission to record doctor-patient conversations was 
not needed, and this was approved by the NHS REC. However, the committee stated that 
permission was needed of participants to access and use the cassettes for research 
purposes. Also procedures for safeguarding confidentiality were an issue of ethical concern 
raised by the committee. The methods of audio-recordings had to be understood with 
reference to issues of confidentiality, privacy, surveillance, and ownership, which were 
addressed and made reference to in the patient information leaflet. All participants 
provided their written informed consent.  Participants were also informed that they could 
request copies of the transcription, and could also receive a copy of the final report, if they 
wished. All participants and the oncologist remained anonymous, and were only given a 
number for identity. For the purpose of the thesis, where extracts are used, all participants 
are given an initial (‘P’), and the clinician (‘C’), for confidentiality reasons. 
 
6.4 Results 
The final third study, in this chapter, took a further exploration of the research questions 
and the findings raised from studies one and two, by means of a symbolic interactionist. 
Focus of the study was to gather intelligence on the concept and presence of SDM during 
breast cancer consultations, through examining of doctor-patient interaction and the 
meanings situated in actions (i.e. talk). This was subjected to a CA on the audio-
recordings. Analysis of the transcripts revealed some initial descriptive outcomes, and 
outlined three recurrent discursive practices, which took place during doctor-patient 
interaction. These were: 1) fragmented conversations, 2) territories of knowledge and 
epistemic markers, and 3) extending multi-turn utterances. The analysis also revealed 
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‘what happens when there is two-way interaction’ during an adjuvant treatment 
consultation. These findings are discussed below, accompanied by illustrative extracts 
from the audio-recording transcripts (a transcript number and line numbers will be 
provided for each quote). 
 
6.4.1 Initial descriptive findings 
Upon provisionally reviewing the transcripts, there were some trends that appeared 
prevalent across all of them. The descriptive findings helped to give a general perspective 
of the audio transcripts and the content and structure of each initial adjuvant treatment 
consultation.  These findings were also important to the rest of the analysis as they initially 
indicated the types of conversational practices which could be derived from a CA.  
 There was very little difference in content and topic of conversation which took 
place between the 10 transcripts. All 10 recordings lasted 40-45 minutes, and had a very 
strong and rigid structure to the overall consultation, including the following topics: 
1. Clinician asks the patient to explain their understanding of their diagnosis, results, 
and treatment plan 
2. Clinician providing a detailed explanation of their diagnosis and treatments 
carried out. 
3. Patient given the opportunity to ask questions about diagnosis. 
4. Clinician explaining their current status of health. 
5. Clinician explaining why further adjuvant treatment is necessary. 
6. Patient given the opportunity to ask questions. 
7. Clinician outlining the treatment plan and the processes involved. 
8. Clinician describing side-effects of treatments. 
9. Patient given the opportunity to ask questions about treatment plan. 
This template of conversation, applied to all 10 patients during the consultations. The 
scripted nature of the consultation and the rigid structure of topics discussed between the 
clinician and patient, drew attention to the importance of information exchange during 
doctor-patient interaction. For instance, the descriptive findings showed that the 
consultation time and structure of conversations were devoted to explaining, justifying, and 
describing the diagnosis, treatments, and side-effects; and delivering all of the essential 
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health information. During this time, patients were given the opportunity to share their 
concern or queries at various stages. However, there was very little patient involvement 
and interaction in conversation, unless when they were explicitly asked a direct question. 
This immediately raised questions regarding doctor-patient interaction. If opportunities for 
information exchange between the clinician and patient are structured to take place, why 
do patients choose not to contribute to interaction and participate in the conversation? Do 
patients interact beyond being directly invited and asked ‘do you have any questions?’ And 
if so, how are two-way discussions structured? These questions helped to guide the rest of 
the analysis. 
 The previous studies drew attention to the importance of two-way interaction as a 
factor which appeared to contribute towards patients’ understandings and experiences of 
SDM. Therefore, it could be questioned, if doctor-patient interaction is limited during a 
consultation, does SDM formally take place? In order to acquire a more comprehensive 
overview about patient conversations for SDM, and to answer the queries raised from the 
descriptive outcomes, it became important to scrutinise the conversations within the 
transcripts in more detail. The CA focused on identifying three particular discursive 
practices which appeared recurrent in structuring dialogue and two-way interaction, such 
as fragmented conversation; territories of knowledge and epistemic markers; and extended 
multi-turn utterances. These conversation practices will then be later interpreted in the 
discussion. 
 
6.4.2 Practice one: fragmented conversations 
The data highlighted a strong use of boundary markers and rhetorical questions during 
sections of talk within consultation, which constrained patient contribution.  Extract one 
illustrates this further. 
Ext 1. Transcript 2 
C: The:re’s a good chance you are in remission (.) because 1 
there is  nothing left- (.) and therefore you are cured↑ 2 
(2.9)  3 
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C: But- there is a sma:ll cha:nce there are micro:scopic cells 4 
left* (.) and if we did nothing they will gro:w and the cancer 5 
will come back-  6 
(2.5)  7 
C: If↑ that is the ca:se (.) what can we do n:ow to get rid of 8 
them?  9 
(3.2)  10 
C: >We can’t tell< (.) bu:t we try to build up a picture of 11 
risk-  12 
(2.8)  13 
C: S:o (0.2) we think about thre:e areas  14 
(1.0)  15 
C: We fir:st↑ think about your breast itself (.) >well< 16 
following the successful surgery (.) we know that alone is 17 
<not enough> (.) >so we want to give you radiotherapy<  18 
(2.1)  19 
C: We next think about the gland area (.) >well< there is no 20 
problem there↑ (.) >so we don’t want to do anything more<  21 
(2.0)  22 
C: Then fina:lly (.) we think about the rest of the body  23 
(0.9)  24 
C: Could (.) these cells have escaped (.) from the breast(.) 25 
and gone elsewhere?  26 
(3.4)  27 
C: We have n:o answer to that↓ >in which case< we want to give 28 
you treat:ment to get rid of it  29 
(2.8)  30 
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In the opening two lines, the clinician introduces the conversation by talking about the 
patient’s current health status. The use of the word ‘cured’, primarily invites the patient 
into a positive conversation. However, very quickly in line 4, the word ‘but’ is used to 
signify a negotiation. The negotiation is that there is a minute chance, which is illustrated 
with the use of the word ‘microscopic’, of there still being cells left. Nonetheless, the 
necessity for further adjuvant treatment is rationalised by means of a reminder to the 
patient that the ‘cancer will come back’. In line 8, a question is posed by the clinician 
about how these microscopic cells can be removed. The adjacency pair is followed by a 
long three second pause (line 10), which is heard as attributable to the patient. The silence 
indicates that the clinician has selected the patient as the next speaker in turn, and allows 
for a second pair part (SPP). The silence is interpreted as the patient not speaking. This is 
regarded as interactionally relevant, as the patient is not speaking at a time where she is 
invited to speak. Subsequently, the lack of interaction from the patient disengages her from 
the sequential turn-taking of the conversation.  
 Following on in line 11, the clinician continues the turn of talk as an attempt to 
repair the silence by providing an answer to the question posed. The question is answered 
by means of a step by step process of ‘building a picture of risk’, through story telling. The 
story opens in line 14 with a clear boundary marker (‘so’), which signifies the start of a 
new section of talk (i.e. the start of the story) and, therefore, instructs the patient to listen. 
This structural format of the story is achieved through use of time sequence connectives 
(e.g. ‘first’, ‘next’, and ‘finally’). Such connectives enable the clinician to maintain control 
over each turn construction unit (TCU), until the end of the story in line 29. This 
discourages the patient to participate, which is evident through the lack of interaction 
during the narrative.  
 Once again in line 25, another question is posed by the clinician. This again is 
followed by another extended three second pause (line 27), with no interactional response 
from the patient. Therefore, the clinician continues and responds to the question posed. In 
both instances, we can clearly see the use of questioning which does not attain an 
interaction. In both lines 8 and 25 a figure of speech, in the form of a question, is asked. 
The action consequence of the question asked is demonstrated to be no interactional 
response. This practice is arguably regarded as a form of rhetorical questioning. Thus, the 
question is not necessarily asked in order to seek information from the patient. It is instead 
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asked as a vehicle for another action, which is, to request to the patient that the clinician 
provides certain information, and in doing so, this will fill the gap in the patient knowledge 
or information state. As a result, this will facilitate the decision-making for the patient. 
There were multiple examples within all 10 transcripts, which demonstrate a systematic 
practice of rhetorical questioning during the consultations. Extract two demonstrates the 
same action by the clinician on a different occasion. 
 
Ext 2. Transcript 5 
C: Is there a benefit to chemotherapy  1 
(2.0) 2 
C: So- this is your group he:re and they have shown >percentage 3 
wise< that there is n:o benefit.  4 
(0.1)  5 
C: There m:ay be some detriment (.) >which is the side-effects<  6 
(3.8)  7 
C: S:o (.) <ho:w certain> are we of that result  8 
(2.1) 9 
C: Well the re:al result is somewhere there↓ (.) it cou:ld be that 10 
there is↑ a small benefit  11 
(0.2)  12 
C: We thi:nk there is absolutely non-↓  13 
(2.0)  14 
C: S:o  15 
(2.1)  16 
C: Right(0.8)we have to think what treat:ments do we want to do  17 
(0.5) 18 
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C: There are 2 treatments to get rid of it (1.2) first 19 
radiotherapy (1.5) secondly (.) to put you on the tablets (.) 20 
hormone therapy21 
Extract two illustrates a new focus to the action of rhetorical questioning. This extract 
reveals more about the complexity of the action being performed by the clinician. During 
the conversation, a question is stated by the clinician in line 1, as to whether there are any 
benefits to chemotherapy. The same effect is achieved, as we see no interaction (response) 
by the patient. Therefore the next TCU, in line 3, is once again taken up by the clinician. 
The clinician opens line 3 with ‘so’, as a boundary marker, which functions as a marker of 
connection to the question asked, and is used to introduce the answer to the previous 
unanswered question. It is suggested that there is ‘no benefit’ to chemotherapy, which is 
demonstrated further with the use of statistical percentages to support the claim. The 
clinician strengthens this case further in line 6, by stating that there is a ‘detriment’, a 
major loss or damage to the self, as a result of the side-effects of chemotherapy. The 
patient shows no response or retaliation, which indicates that up that point the clinician has 
put together a good argument for not having chemotherapy. We can see that the clinician 
has succeeded in this task and starts the next TCU in line 8 with the boundary marker ‘so’, 
which indicates result (at the discursive level of facts).  To add to this argument, the 
clinician assesses the decision by once again asking a question about the certainty of the 
test results (line 8). The same action by the patient is displayed, as there is no response, and 
instead the clinician provides an answer. Reiterating in lines 10-11and using the test 
results, that the benefit is small. The argument is then finally closed in line 13, as the 
clinician states, that in fact, the benefit is ‘absolutely none’. The consequences of both 
rhetorical questions, up until this stage of the conversation, enable the clinician to provide 
step by step information, explanation, and justification in slowly building the presented 
argument. This process makes transitions of talk harder for the patient, as each suggested 
line of argument gives the patient no option, but to agree to not have chemotherapy. 
Although interaction is not picked up by the patient, the action still appears to bear 
consequences, as it works as an information tool for the patient to understand and consent 
to why they do not need, and should not have chemotherapy. Furthermore, it works as a 
technique for reaching a conclusion on a decision together, by speaking for the patient 
through rhetorical questions. 
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 From line 15 there are another two clear boundary markers, starting with the word 
‘so’. However, on this occasion, the use of the word, as a stand-alone, acts as an 
interactional goal to prompt the patient to make the next relevant action.  As the two 
second TCU is not taken up by the patient, the clinician subsequently continues to talk. 
Talk, in line 17, starts with the word ‘right’, with raised intonation, which passes up 
opportunity for further talk to occur on the previous subject matter. Therefore, this informs 
both the clinician and the patient that all points have been mentioned, and that the 
argument outlined is now closed, particularly as the patient has shown no interaction. How 
the clinician chooses to introduce a new topic of conversation, is once more, presented by 
means of a rhetorical question. In asking the question in line 17, yet again, the same effect 
of a non-response is shown.  Nonetheless, the action consequence of the question is to 
structure the conversation, and to inform the patient about the next topic of discussion, i.e. 
we have decided that you are not going to have chemotherapy, so now we are going to talk 
about and decide which treatments you will need.
 Both extracts one and two, draw particular relevance to the use of rhetorical 
questioning and boundary markers, during doctor-patient interaction. The practice of 
asking the patient a rhetorical question has shown to have two effects. The first is to enable 
the clinician to guide the patient towards the next topic discussion and, therefore, structure 
the content of the consultation. By stating a rhetorical question, the clinician is then able to 
answer it himself, whilst at the same time, executing their role which is to inform the 
patient. Therefore, the practice works as a tool to facilitate the patient with appropriate 
health information needed to make an informed decision. The second effect of rhetorical 
questioning is to control interaction. In the face of a rhetorical question, the patient’s 
understanding is to listen and not respond. Therefore, the practice allows the clinician to 
hold the floor of the conversation and maintain turn-taking in dialogue. 
 The frequent use of boundary markers, during doctor-patient interaction, worked as 
a way of indicating orientation to what is happening in the discourse, particularly, at 
transitional points during the consultation. For instance, the clinician made regular use of 
the word ‘so’, and used this to signify the start of a new section of talk. This, therefore, 
instructs the patient to listen. This marker is also commonly used as a way of making a 
connection to a question just asked, and to mark the transition from the clinicians last TCU 
to the next. Therefore, although the discourse marker is syntactically independent, its 
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practice still plays a key role in notifying the patient that the turn-taking belongs to the 
clinician and, therefore, the patient should still remain inactive in communication. 
Subsequently, this practice is similar to the use of rhetorical questioning, as it prohibits the 
patient from engaging in a two-way conversation. 
 
6.4.3 Practice two: territories of knowledge and epistemic markers 
The data revealed the importance of expert knowledge and epistemic roles during doctor-
patient interaction. Practice one above, has already demonstrated how rhetorical questions 
are integrated into discussion as a way of informing the patient of the clinician’s 
professional knowledge. However, more significant and reoccurring practices were 
illustrated throughout the transcripts, which displayed territories of knowledge clearer. The 
following extracts three and four will examine this closely. 
 
Ext 3. Transcript 1 
C: With it being lobular we see e:very expectation for you to be 1 
in that group (.) we would see n:o argument for giving you 2 
chemotherapy (.) If you said you wanted it  3 
(0.9) 4 
C: But- it could be that the detriment is as bi:g as that-  5 
(2.5)  6 
C: We are al:most certain the result is in the grey area (1.3) it 7 
could ju:st be outside it (.) but (.) we are looking at that  8 
(2.3)  9 
C: >We would< suggest that we don’t give you chemo:therapy (.) 10 
>and that< we give you hormone the:rapy  11 
(1.1)  12 
Extract three demonstrates the use of an epistemic marker to signify doctor-patient roles 
and levels expertise. The use of word ‘we’ is predominantly used by the clinician 
throughout talk.  This is especially evident whilst explaining and justifying a treatment 
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choice, which this extract illustrates. Who is the clinician referring ‘we’ to? It is quite 
understandable that the patient is not going to obtain expert knowledge on breast cancer, or 
know what treatments are medically appropriate. Therefore, the term ‘we’ is unlikely to 
represent the clinician and patient. This therefore informs the patient that the term stands 
for a collaboration of experts and clinicians and, therefore, represents expert knowledge 
and professional status. The clinician opens in lines 1-3 by assuring the patient about the 
accuracy of their test results. The patient is then made aware that despite the test results, 
she still has choice about having chemotherapy. The element of patient choice, invites the 
patient into the decision-making interaction. However, the patient is very quickly 
reminded, in line 5 of the harm and negative effects of chemotherapy. The test results are 
further reinforced and elaborated in lines 7-8. Once again, reassurance is given to the 
patient, as the clinician indicates the levels of certainty assigned to the results, which have 
been further verified and confirmed by all clinicians. Subsequently, this enables the 
clinician to suggest the appropriate treatment plan needed, and finally bring the 
conversation of treatment decision making to an end.  
 The use of words such as, ‘we see’, ‘we would’, and ‘we are’, in the extract, created 
an understanding of a majority group in which the patient is excluded from. Such group 
includes members who are professionals and/or experts, who obtain superior knowledge. 
The clinician self-situates as an expert via membership to the group, and through the use of 
technical lexicon ‘we’. This, subsequently, creates a scenario where there appears to be 
clear division of power and roles, for example, the patient (the minority) versus the 
clinicians (‘the majority’ and ‘the experts’). With the clinician emphasising to the patient 
that the ‘majority’ (i.e. ‘the experts’) have all agreed with the results, and the right course 
of treatment, this subsequently constrains patient participation and interaction. This would 
be expected, as it is very unlikely for a lay person to counter-argue against a ‘majority’ of 
‘medical experts’. Extract four demonstrates another epistemic marker used to heighten 
territories of knowledge during the consultation, and create an imbalance in power-
relations between doctor and patient. 
 
Ext 4. Transcript 8
C: <so yes> we would want to give you some treatment  1 
(1.0)  2 
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C: Each treatment improves the chances that we have got rid of it 3 
completely (0.1) <if it’s gone completely> (.) then you are cured↑ 4 
(0.9)  5 
C: >Of course I don’t have a crystal ball< (.) I can’t look into 6 
the future  7 
(1.0)  8 
C: The bottom line is that it is <your choice> 9 
(3.0)  10 
C: I would <very stron:gly> advise you to have bo:th (0.5)It then 11 
makes cure the most likely thing↑  12 
(4.0)  13 
C: <I would be concerned↑ if you didn’t take the treatment (0.1) 14 
as you would not be giving yourself the most likely chance>  15 
(3.8)  16 
C: Would there be a reason that you would consider not taking it↑ 17 
(2.0) 18 
P: No (0.2) Reading about the tamoxifen, I know it’s rarely rare 19 
to get cancer elsewhere as a side-effect. 20 
(1.2) 21 
C: Yes↑ (.) and I just feel(.)in my view >so to not< take it for 22 
that risk (0.9) >so to increase< your risk of it coming back and 23 
not being cured<  24 
(2.9)  25 
C: Is there anything else that concerns you about tamoxifen 26 
(1.2) 27 
P: N:o (.) >that’s it< 28 
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Extract four opens, in line 1, with the clinician showing agreement with colleagues (‘we 
would want’), to the need for treatment. In contrast to extract three, the use of the word 
‘we’ is used for an alternative outcome. For example, in lines 1-4 the clinician links ‘we 
would want to give’ to ‘we have got rid’ and the word ‘cured’. This creates an imagery that 
the decisions made by the ‘majority’ group, lead to positive health outcomes. Therefore, by 
adhering to what the ‘majority’ suggest, results in improved health. A lack of response 
from the patient shifts the interaction back to the clinician, whereby it is mentioned in lines 
6-7 that the clinician is not psychic. The action consequence of this is to remind the patient 
that nothing is a guarantee, which then leads on to reminding the patient that clinician does 
not obtain special powers and, therefore, patient choice is still equally important. A point is 
made clear in line 9, that there is a matter of choice, and that it ultimately lies within the 
patient’s hands. Arguably, this can be interpreted as a way in which the clinician tries to 
promote the task of sharing a decision, and is attempting to invite the patient to participate 
in the conversation. Yet, the three second silence in line 10 shows that this attempt is 
unsuccessful, as there remains an interactionally inactive patient.  
 The patient’s role in decision-making becomes further marginalised, and the issue 
of imbalanced power-relations between the doctor and patient is heightened in line 11. 
There is an evident shift in positioning, as the clinician starts to detach from the context of 
‘we’ and the ‘group’, and instead starts referring to items in person. The clinician’s role 
and expertise becomes isolated from the other professionals through the context of ‘I’ 
which, therefore, enables greater bearing on the importance of the clinician’s opinions as a 
medical expert. By communicating ‘I would very strongly advise’, this highlights the 
clinician’s professional duty, as a doctor, to provide expert guidance and 
recommendations. In line 11, the use of the epistemic marker ‘I’, is once again associated 
to the positive outcome of ‘cure’. Therefore, this links professional status and expertise to 
improved health and patient reassurance.  
 Following a lack of patient interaction in line 13, shown by the four second pause, 
the clinician takes the turn-in-talk by stating concerns for not taking up the treatment. 
There is nothing to suggest why the clinician is concerned for the patient, as up until this 
point the patient has shown no interaction or disagreement with the clinician. However, by 
making a statement of concern, the clinician is, therefore, instigating for a retaliation or 
response from the patient. Yet, this technique is once again shown unsuccessful in line 16. 
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This subsequently results in a direct question being asked to the patient in line 17, in order 
to seek interaction. The question asked displays the method of a preference organisation. It 
seeks a preference for agreement to the clinician’s suggestion of taking the treatment. 
Thus, the question ‘would there be a reason that you would consider not taking it?’ is 
designed to initiate a ‘no’ response. This action is achieved in line 19, as the patient agrees 
with taking the treatment. The patient mentions about the side-effects of the treatment, 
which she has read about. The clinician displays a positive acknowledging response (lines 
22-24) to patient’s knowledge, and uses the patient’s example of a small risk to further 
stress the importance of the initial suggestion made. The use of language such as, ‘I just 
feel’, displays the clinician’s personal feelings about the patient refusing the treatment 
plan. Also, the use of terms such as, ‘in my view’ further outlines the clinician’s beliefs, to 
help build an argument. These, subsequently, put the clinician in a position that the patient 
will find difficult arguing against. Especially, as these terms are linked to the negative 
outcomes of the cancer ‘coming back’ and ‘not being cured’. There is no further 
interaction from the patient within the next TCU (line 25), which results in another direct 
question being asked to the patient, in line 26, to instigate more patient interaction again. 
By asking the patient for the second time to disclose any issues or concerns about the given 
treatment, this helps to achieve verification and approval on the treatment plan, before the 
topic of decision-making is brought to an end, and the conversation is moved to a new 
topic of discussion. 
 Extracts three and four symbolise the clinician’s level of authority and expertise. 
Through the use of epistemic markers such as, ‘we’, and ‘we think’, display an image of 
there being a ‘majority’ of clinicians versus the ‘minority’ patient. Therefore, this enhances 
the position and status of the clinician, as the leader in the decision-making process. This 
practice, subsequently, can make the patient feel excluded from conversations and 
interaction about decision-making which, therefore, result in ‘passive’ behaviours and a 
lack of two-way interaction. The use of epistemic markers such as ‘I suggest’, heightens 
the clinician’s intellectual role as a medical expert. This, therefore, signifies to the patient, 
that the clinician holds key knowledge and skills to make an appropriate decision, and 
because of that, has a duty of care to practice such acquired medical expertise to ensure 
good patient health. The patient, therefore, opts to leave the discussion about decision-
making in the clinician’s hands and control. This creates a perceived imbalance of doctor-
patient power-relations, which hinders patient involvement in during the consultation, and 
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reduces two-way interaction. As a result, it could be suggested that both of these epistemic 
markers work against the concept of patient participation and a patient-centred care 
approach, which is designed to allow patient to participate in talk. 
 
6.4.4 Practice three: extended multi-turn utterances 
Throughout the previous extracts, references have been made to long gaps or pauses 
throughout the conversation. These gaps can be seen as transitional spaces, which stretch 
the talk and, therefore, allow for transitions of turn-talking to take place. Within the data, 
there was striking evidence of long two-three second TCU’s on completion of the 
clinician’s turn. Such lengthened transitional relevant places (TRP) and the role of multi-
turn utterances, subsequently, inhibited clear projections of a relevant second pair part 
(SPP). Therefore, this left a period of silence in the talk. Extract five illustrates this.
 
Ext 5. Transcript 10 
C: We grade breast cancers into 1 (.) 2 (.) and 3  1 
(1.1)  2 
C: 3 develops quickly and 1 slowly (.) >So 2 tends to be in the 3 
middle of the road<  4 
(3.2)  5 
C: We took a margin of breast normal tissue and then we did some 6 
further test (.) >firstly< to see if it is hormone receptor 7 
sensitive or positive 8 
(1.5)  9 
C: And indeed it was stron:gely hormone receptive positive (.) 10 
>and that good< 11 
(2.8)  12 
C: That tells us hormone therapy (.) and the way tablets can be 13 
used for part of the treatment.  14 
(3.6)  15 
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C: After that(.) we tested it to see if it is over producing the 16 
protein called her2 17 
 (Further down the conversation) 18 
    19 
C: An:y questions so far on that- before we move on to any of the 20 
treatments 21 
(4.8) 22 
P: No 23 
(1.1) 24 
C: S:o  25 
(1.2) 26 
C: When we are thinking about the breast (.) we think about two 27 
areas 28 
In examining extract five, it is understood that silence occurs at the end of the each 
completed TCU by the clinician. As each one of the clinician’s statements is not a clear 
first pair part (FFP), that signals an SPP response, this suggests that either speaker could 
legitimately speak. Therefore, the silence is not attributable to any particular speaker. The 
patient is not supported to contribute at these points of silence, which is it typical of the 
clinician to continue the turn of talk.  A lack of turn-taking can also be described due to 
signs in the conversation format, which indicate to the patient that the clinician’s 
explanation is not finished yet. The clinician clearly methodically introduces a story by 
turn-taking, as the patient’s diagnosis is described. Indication of storytelling is displayed 
by the use of sequential timing words (e.g. ‘firstly’ in line 7 and ‘after that’ in line 16), 
which suggest a narrative, similar to extract one. The use of extended multi-turn utterances, 
which do not mark a clear SPP, therefore, indicate to the patient that she cannot take her 
turn until the story is complete, and, therefore, makes transitions harder.  
 Once having finished delivering information on a section of talk, the clinician asks 
the patient a direct question (line 20). As outlined in the initial descriptive findings, a 
common practice was evident at the end of every topic discussed, whereby the clinician 
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asked the patients questions and invited them to participate in a questioning and answering 
session. This subsequently marks the end of a section, and works as a means to ensure that 
patient understanding and reassurance is gained, before moving the conversation along to 
the next stage. A long gap of 4.8 seconds is illustrated in line 22, once having completed a 
TCU. However, unlike the gaps earlier in the conversation, as the four second silence has 
occurred after the spoken FPP question to the patient this, therefore, creates a TRP which 
is attributable to the patient, in which a SPP response is expected. As we can see in line 23, 
this practice is successful, as turn-taking is subsequently taken up by the patient and she 
responds minimally to the question. This example shows that the clinician’s use of direct 
questioning can generate a desired outcome of interaction from the patient. As shown in 
extract five and the previous extracts, many TRP markers are left throughout the clinician’s 
talk, in order to allow for turn-taking by the patient. However, the patient fails to recognise 
these areas of transition, and only when explicitly asked a direct FPP question, is 
interaction seen. As extracts one to five show, there is no evidence of continuers (‘mm 
hm’, ‘uh huh’, ‘yes’ or ‘right’) used by patients whilst the clinician is talking. Such 
continuers act to bridge TCU’s, and if used by the patient, would create opportunities for 
the patient to interact and “take the floor”. However, patients remain inactive, which 
signifies their understanding of the clinicians’ turn-in-process not being complete. As 
illustrated by extract five, the patient would only speak when directly asked a question at 
the end of each clinician’s topic. Therefore, at this point, the patient is aware that the 
clinician’s discussion has come to an end, making it appropriate for them to interact. 
 Following the patients minimal response, the clinician in line 25 opens the turn 
with a stretched boundary marker of ‘so’. This functions as a marker of connection to the 
patient’s response. A TCU of 1.2 seconds is provided in line 26, which now deploys a 
stand-alone ‘so’. This is used to prompt the patient to produce the next relevant action 
response, and perhaps to elaborate on their minimal response of ‘no’, or to expand further 
on the original question asked by the clinician in line 20. However, the patient shows no 
interaction, in which the term ‘so’ is now used to preface a topic beginner. This, therefore, 
moves the conversation along to introduce a new topical section, as demonstrated in line 
27. The next extract illustrates another example of attempts made to engage patients into 
the conversation.
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Ext 6. Transcript 3
C: <Do you want> under those circumstances to have chemo:therapy  1 
(1.0) 2 
C: For a small benefit  3 
(1.5)  4 
C: >When we say< there is a li:ttle benefit (.) if there was a 100 5 
of yo:u and I gave you all chemotherapy  6 
(1.0)  7 
C: There would b:e (.) a <ve:ry small percentage> (.) >probably 8 
less< than a hand full of women it would make a difference  9 
(1.0)  10 
C: A gre:at majority would make n:o difference <what so ever> 11 
(3.0)  12 
C: So in reality (0.1) we got this situation whe:re we got- to 13 
make an essential judgement (.) a decision on a <sma:ll benefit>  14 
(2.0)  15 
C: You might say right- I want chemotherapy because I want that 16 
small benefit (.)>or you might say< (.) no I DON’T even want to 17 
bother as it’s <such a small gain>  18 
(2.3)  19 
C: But we will be dealing with philosophy of how you would want to 20 
be treat:ed (.) rather than the science  21 
(2.0)  22 
C: But with this onco-type test we can actua:lly now drill down >a 23 
little bit< further↑ (0.1) we now move to the science which says 24 
that NO ONE WANTS TO do it because there is abs:olutel:y <no 25 
point>  26 
(2.0) 27 
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Extract six opens in line 1 with a direct question asked by the clinician. The question aims 
to seek information about what the patient wants to do, and to see whether the conditions 
described earlier in the conversation, have influenced the patients decision. The term 
‘under those circumstances’, makes it a qualified question, as the question is tied to the 
technical knowledge, previously given to the patient, about the side-effects of the 
treatment. Subsequently, with the question being latched on to technical knowledge, this 
requires an answer which is based on medical judgement, and may cause the patient some 
difficulty in answering. The one second TRP, indicated in line 2, is attributable to the 
patient; however, she shows no response. The clinician does not treat the lack of patient 
interaction as a means to continue the talk, but rather than a problem with the form of turn 
itself. Therefore, an increment is added in line 3, to scaffold the patient towards what the 
correct medical knowledge is. This increment subsequently converts the silence to being an 
intra-turn silence, which in a sense undoes the fact that the patient is not speaking. This is 
an example of the clinician undoing an interactional problem.  By stating ‘for a small 
benefit’, this preference organisation question changes the nature of the initial question, in 
line 1, as the clinician is now clearly stirring the patient towards the right response, by 
highlighting a small gain. The clinician then in lines 5-9, begins to expand and spell out 
what is meant by a ‘small benefit’, through statistics. This, subsequently, helps to break up 
the complexity of medical language, so that the patient is able to digest the information in 
numerical form, and understand the clinician’s explanations of risk versus the benefits.  
 The long three second TRP, in line 12, indicates that the patient chooses to remain 
inactive and provide no answer to the clinician’s initial question. The clinician follows up 
the turn in line 13, and transforms numbers into ‘reality’, by linking the numerical test 
results to everyday decision-making. The patient is made aware in line 14 about an 
‘essential judgement’, which illustrates the importance of the decision to be made. This is 
then supported with ‘we got to make a decision’. This encourages and informs the patient 
about what the essence of the consultation is about- the patient and clinician making a 
decision and weighing up the options. Up until this stage, a ‘small benefit’ has been 
mentioned three times, which again, illustrates a clear stir towards the answer the clinician 
wants from the patient. Up to this stage of the conversation, a strong argument about what 
an appropriate treatment decision should be has been presented to the patient. Several 
attempts have been demonstrated in helping the patient in making that decision. However, 
no input is shown from the patient.  
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 Due to another lack of response from the patient in line 15, more supportive 
attempts are presented by the clinician, in lines 16-18, to facilitate decision-making. In 
order to reduce the struggle and burden of decision-making from the patient, the clinician 
begins to speak on behalf of the patient. By stating ‘you might say’, this provides the 
patient with an example of the type of answer they could respond with. The patient is made 
aware that there is no right or wrong answer to the question, as the clinician presents the 
patient with two types of answers: one which shows disagreement to the question; and 
another answer which agrees with the question. The action consequence of this is to 
support patient participation, and illustrate to the patient that they should participate in 
discussions, despite a consensus or difference in opinion. However, it can also be argued 
that this practice illustrates to the patient that the clinician can play both roles (i.e. be the 
doctor and the patient), which creates a perception that the clinician knows what is going 
on inside the patients head. Therefore, this can have an effect on hindering the patient’s 
role within decision-making.  
 Regardless of all efforts made, in presenting the patient with technical medical 
information, and providing example answers, there is still a lack of interaction shown (line 
19). Consequently, in lines 20-21, the conversation turns from the concept of ‘reality’ to 
science and evidence-based decision-making, whereby clinical results and numerical 
statistics are used as a method to aid decision-making. Everything that has been done, up to 
now, to scaffold and incorporate the patient into the conversation has been unsuccessful. 
Therefore, the conversation moves toward science and raw findings, to provide the patient 
with a justifiable answer to the original question asked, back in line 1. The patient is 
presented with two extreme case formulations in lines 25-26, which state that ‘no one 
wants to’ have chemotherapy, and that there is ‘absolutely no point’ in having that 
treatment. This subsequently reinforces the argument of a ‘small benefit’, and, finally, 
provides the answer to the question, that the clinician was looking for.  
 Extracts five and six illustrate a lack of patient participation and two-way 
interaction between the patient and clinician. As shown in extract six, this is particularly 
evident when a question is asked by clinician, which is attributable to the patient to answer. 
Both extracts highlight that many instances are presented, with methods incorporated into 
talk, to encourage patient participation and integrate the patient into the discussion. For 
example, the use of a long TRP after each TCU, or prompts given by the clinician on how 
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to respond, are used to facilitate the patient’s turn in talk. However, the methods used to 
scaffold patients into two-way interaction are unrecognised by patients, and do not result in 
patient participation. As extract five shows, on certain instances, direct FPP questions need 
to be posed to patient in order to initiate an action. Subsequently, this results in a lack of 
shared interaction between the patient and clinician during decision-making 
 
6.4.5 What happens when there is two-way interaction? 
Not all patients displayed a ‘passive’ role during their consultation. Regardless of how 
little or short of a response given by patients, some interaction was evident. Therefore, it 
became important to look at what happened when the patient attempted to initiate an 
action, a topic, or secure an extended turn of talk. Extracts seven and eight examine this 
closely. 
  
Ext 7. Transcript 9:
C: A:ny other questions you want to ask about 1 
(3.2) 2 
P: When will I start the radiotherapy 3 
(0.2) 4 
C: Well- you get the tw:o visits beforehand (.) >certainly within 5 
the 2 weeks< (.) <may:be next week> (1.0) so we get going pretty 6 
quickly-  7 
(2.5) 8 
P: You just want to get on with life don’t you 9 
(0.2) 10 
C: Yes- absol:utely (.) and you should be able to↑ (.) NONE of the 11 
treatment is going to STOP you doing that. 12 
(2.9) 13 
P: I get people asking me when I am going to be cured 14 
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(0.2) 15 
C: <you’re in remission> (.) and with the treatment remission cure 16 
can only be said after time. 17 
(3.0)  18 
P: Am I going to perhaps not be in this position again 19 
(0.2) 20 
C: I mean (.) the most lik:ely thing is that you are going to be 21 
cured (.)that’s where we are trying to get everyone as close as to 22 
100%...23 
Extract seven starts in line 1, with the clinician asking a FPP question directly to the 
patient, to seek information about the patient’s concerns. This is followed by a long TRP of 
three seconds (line2), which instructs the patient to respond. A response is shown in line 3, 
and in that response, a question is asked on the practical issues. The patient’s response is 
an entirely legitimate question about their treatment plan, which is in the patient’s domain.  
The purpose of the question is to address the patient’s concerns. The clinician responds, in 
lines 5,-7 by means of four separate TCU’s, which are devised to address the patients 
query, and to outline the process of events. The first TCU (‘well you get the two visits 
beforehand’) is to inform the patient about the process of treatment. In the next TCU, a 
broad timescale is given (‘certainly within two weeks’), but then to be more specific and to 
provide the patient with information, which they see as important to their knowledge, a 
more defined timescale (‘maybe next week’) is given in the third TCU. The answer, finally, 
in the fourth TCU is supported with an assessment of the time (‘so we get going pretty 
quickly’), which orients to the patient needs of wanting to complete treatment quickly. The 
patient interacts further in line 9, with a response that acknowledges the clinician’s 
assessment, and informs the clinician about why a quick treatment duration is important. 
The patient phrases a statement in line 9 which queries her QOL, with a FPP tag question, 
which acts as a form of indicator that the patient expects a response from the clinician. 
This question differs from straightforward questions, in that the patient has cued the 
clinician to the desired response, i.e. that she should be getting on with life. Therefore, the 
tag question operates similarly to a leading question as it pushes for a certain response. 
This proves to be effective in lines 11-12, as the clinician shows an agreement with the 
patient and provides further encouragement. In a similar technique, the clinician’s response 
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to the question is once again split into several TCU’s, in which the patient’s concerns are 
addressed, and assessment of the treatment side-effects is provided. Segmenting the answer 
into sections, helps to display the answer and the information provided accurately, so that it 
is comprehensible. 
 The patient remains on the same topic of evaluating her QOL in her next FPP 
question (line 14). However, the topic of discussion now begins to focus on medical, not 
practical issues. Once again, the question asked is devised to inform the patient about the 
treatment timescale. The patient states that she has ‘people asking’, which indicates to the 
clinician the importance of answering this question as there are others, besides herself, who 
are affected by her cancer. However, use of the word ‘people’ is very broad in comparison 
to mentioning friends or family members. In response, in lines 16-17, the clinician 
provides no definite time frame, but instead provides a medically termed response 
(‘remission’), in which the next TCU expands and elaborates on its meaning, to the patient. 
The patient is advised that cure is a following result and, therefore, can only be assessed 
over a period of time. Therefore, this indicates to the patient that treatment process and re-
evaluation stages are extensive phases, and cannot be suggested specifically.  
 It is observable in line 19, that the patient is not convinced with the response she 
received, regarding her initial question in line 14. Therefore, she rephrases the question in 
a different way, which will provide her with more reassurance towards being cured. As the 
clinician’s previous response offered little confidence or assessment of her health status, by 
asking whether there is a chance of her getting cancer again this, therefore, gives way to a 
less unambiguous evaluation from the clinician. This appears to be successful, as the 
clinician, in lines 21-23, provides a noteworthy estimation of the patient’s health status. 
Line 21 is opened with ‘I mean’, which indicates clarification on the response given in 
lines 16-17. The term ‘I mean’ highlights that remission is a complex point which needs 
elaborating and, therefore, makes another attempt to explain the patient’s initial query from 
line 14. This signifies that the clinician values speaking clearly, to ensure that the patient 
fully understands her treatment and health status. Although the patient is still not provided 
with a precise timescale as to when she will be cured, she can feel more knowledgeable 
that she will be cured, and can go back and tell the people who were asking. The clinician 
uses the second TCU during the response (line 22) to add judgement, by informing the 
patient that cure is on the basis of a percentage, and the degree or percentage to which the 
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patient will be cured, is subject to further assessment. This informs the patient that 
although they are almost cured, they are still not 100 percent cancer free. 
 Extract seven shows an example of doctor-patient interaction, which is achieved 
through a series of questions and answers. The patient shows a distinct need to be informed 
about the practical issues which surround her treatment, and about the impact of the 
treatment on her QOL and future health status. The clinician, very precisely, ensures that 
the patient’s concerns are addressed, and with each answer provided, and uses turns in the 
conversation to add further information, explanation, and assessment. Following each turn 
the clinician has in the conversation, long TRP’s are provided to inform the patient that 
they still “hold the floor” of the conversation, and can ask the clinician further questions is 
they wish. Extract seven illustrates an example of two-way interaction between the patient 
and clinician, whereby conversation turn-taking is demonstrated to be effective. However, 
this was not always the case. Extract eight illustrates what happens during a consultation 
when there is slight overlap in speech, and turn constructions are left uncompleted. 
 
Ext 8. Transcript 7
P: I’m concerned about work (0.2) The doctors given me another 8 1 
weeks of work (0.5) Obviously I:= 2 
C:                         =>IF↑ you are< ke:en to work (.) <it 3 
may be possible> to work some other time (0.1) But we have to look 4 
at the working environment and how big it is.  5 
(2.0) 6 
P: >It isn’t that big really< (0.8) We work in a cro:w[d] 7 
C:                                                    [>WELL] 8 
that’s not great< 9 
(2.2) 10 
P: I don’t think↑ I’m mentally well to go (0.5) I’m [just like-]  11 
C:                                                  [>IT’S quite<] 12 
us:ual not to work (0.9) so if you didn’t work during that (.) <I 13 
don’t think> anyone would batter any eye lid (0.2) why don’t you 14 
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see how it goes↑ (0.1) stay of work at the moment (.) and then we 15 
can reassess↓ 16 
(3.0)  17 
P: I think I’ve prepared myself for the re:s[t].  18 
C:                                          [THE] treatment is 19 
being done from a <positive view point> (0.1) Though we hope you 20 
may already be cur:ed (0.1) the treatment is been given to give a 21 
better chance↑ (0.2) >so I think the treatment is the positive 22 
thing< 23 
Extract eight illustrates how reducing the transitional space, can cause overlapping in talk 
with the patient. It is understood from this extract that overlapping, between the clinician 
and the patient, is problematic and causes a break in the patient’s on-going speech. The 
patient in lines 1-2 opens, by disclosing their concern about not being able to work and 
taking time off. Before completing a possibility that she does not want that time off, the 
clinician in line 3 illustrates a collaborative turn construction, and explains a candidate 
understanding. The patient is advised, in lines 3-5, on the possibility of work at a later date, 
which is subjected to both of them assessing the workplace first. The purpose of the first 
overlap is to inform the patient, and also to introduce the notion of evaluating the issue 
raised. Therefore, this enables the clinician to structure the conversation and direct it 
towards a discussion which entails problem-solving.  
 The patient responds in line 7, exclaiming that her workplace ‘isn’t really big’, 
followed with a second TCU, which is more specific about the size. As soon as the patient 
mentions the word ‘crowd’, there is an immediate overlap of a reaction response from the 
clinician (lines 8-9), which is not positive. Following the clinicians negative reaction to the 
working environment, the patient now shows a change of heart (line 11), and demonstrates 
agreement with the clinician that perhaps working is not ideal. She draws the clinician’s 
attention to the psychological element of returning to work, in which the clinician, in line 
12, overlaps to make a persuasive suggestion, before the patient can finish a turn 
construction. The clinician opens with a suggestion in line 12-16 by stating that there is 
absolutely nothing wrong with not working, as this is the norm (‘usual’) amongst most 
women, adding that this is socially acceptable. The clinician builds on persuasive turn 
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constructions, by recommending a trial and error scenario, where the patient can stay off 
work and assess the situation throughout the treatment stages.   
 The patient stays on her same topic emotional well-being, in line 18, and provides 
further insight into her psychological health. The clinician, therefore, follows on in line 19 
to enlighten the patient that the treatment is a ‘positive’ process, and subsequently 
encourages the patient to engage in an optimistic frame of mind. The overlap in line 19 is 
unproblematic. The clinician begins to talk slightly before the patient’s possible TCU 
completion, and the overlapping begins mid-word, only two phonemes before possible 
completion. Therefore, this is not regarded as problematic as the patient’s word completion 
is projectable. The construction of the reduced transitional space is due to timing of the 
clinician’s talk and the modification of rhythm in the word ‘rest’, which reduces the 
transitional space. 
 Extract eight highlights that subtle overlap in speech is evident during doctor-
patient interaction. Such overlap was demonstrated to commonly occur at the end of the 
patient’s talk, and break into the patient’s second TCU, not the first. Therefore, the 
clinician’s initiated talk orients to the upcoming completion of talk by the patient. As 
illustrated in lines 3, 8, 12, and 19, where this happens, the overlap is not resolved by the 
patient, quickly, reaching a possible completion, but instead the overlap brings the 
patient’s talk to a stop. The purpose of the cut in speech, by the clinician, is regarded as a 
means to further educate, suggest, and support the patient about their concerns.  In the four 
instances of overlapping made by the clinician, the tone on the first overlapping word is 
raised, and speed of dialogue is increased. This is to grab the patient’s attention, and to 
ensure the patient’s talk has come to a stop. The increase in speed allows the clinician to 
swiftly get the point across, without further overlap from the patient. However, it is also 
important to acknowledge from extract eight, that long TRP’s are left in between each turn 
construction, to ensure that turn-taking remains persistent. 
 
Chapter Six 
229 
 
Both extracts seven and eight demonstrate that two-way interaction, between the 
patient and clinician, can take place during a decision-making consultation. These two 
extracts show that not all patients are ‘passive’ during the consultation, as some do respond 
to cues and, therefore, show a more ‘active’ stance in decision-making discussions with the 
clinician. The analysis revealed that when interaction did occurred; it was not consistently 
throughout the consultation. Two-way interaction only occurred during a questioning and 
answering session, which displayed evident FPP questions from the clinician and the 
patient. The questioning and answering session was allowed to be led by the patient, and 
required the clinician to provide a thorough answer. This, therefore, symbolises the 
patient’s role as a person who needs to be informed, and the clinician’s role as an expert 
who address concerns through informing and explaining. During this interaction, the 
clinician provided long TRP’s to ensure that the patient maintained their level of 
interaction and turn-taking. However, when two-way interaction did occur, it was not 
always as straight forward turn-taking. As extract eight shows, there sometimes appeared 
to be the practice of overlap in dialogue, by the clinician, through reduced transitional 
spaces. Yet, it is important to note, that these are small overlaps and not interruptions. The 
purpose of cutting into the patient’s speech, at times, was represented as a means for the 
clinician to further educate, make suggestions, and offer support to the patient, in order to 
remove any feeling of distress in relation to the patient’s concern. Subsequently, although a 
flow of interaction appeared to be taking form, it, however, was broken up by the 
clinician’s urgency to respond to a question, before the patient had finished asking it. This 
in turn, produces what seemed to be an impression of interruption. However, despite the 
overlap, focus is still maintained on ensuring that the patient’s concerns are heard and 
addressed, and that the patient has continual opportunities to interact and ask more 
questions. Subsequently, this third practice illustrates that besides the discursive methods 
shown in practices one and two, which appear to inhibit doctor-patient communication, 
there are also indications of way in to encourage patient participation and two-way 
interaction for decision-making and specifically SDM. 
 
6.5 Discussion 
A CA on audio-recorded data, from breast cancer adjuvant treatment consultations, 
identified three conversational practices. The first two practices introduced the concepts of 
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rhetorical questioning, boundary markers, and use of epistemic markers during doctor-
patient interactions. The analysis revealed that these practices discouraged patient 
participation and two-way interaction. The third practice brought attention to the use of 
multi-turn utterances and extended transitional spaces, which were embedded into doctor-
patient interaction, to invite patients to engage and participate in discussions. However, 
this practice was often not acknowledged by patients, and as a result caused periods of 
silence during the consultation. The analysis also revealed that not all patients were 
‘passive’ during their consultation with the clinician. Through the process of questioning 
and answering, a flow of two-way interaction, between the patient and clinician, was 
generated. At times, however, the flow of conversation between the patient and clinician 
was segmented, as a result of overlapping in speech. The analysis outlined and assessed the 
action consequence that these practices had on doctor-patient interaction. This section will 
discuss how these identified conversational practices relate to SDM to help answer the 
research question- how do women with breast cancer experience SDM? The discussion 
concludes with the researcher’s personal and epistemological reflexivity, to outline certain 
issues and influences during data analysis and to outline how reflexivity has a place in the 
findings of this study. 
 SDM is described as a division of labour, where there is two-way exchange of 
information, in which both the doctor and the patient reveal treatment preferences and 
agree on the treatment decision to implement (Charles et al, 1999a). However, the analysis 
revealed that this balance, for SDM, was not always sustained at an equal weight during 
doctor-patient interaction, due to conversational practices which either hindered the 
process of SDM and/or at other times facilitated it.  
 The analysis revealed that the process of SDM is not always accounted for during 
doctor-patient interaction. The concept of SDM focuses on an equal doctor-patient 
partnership, as both are required to communicate, exchange information, and share their 
informed preferences for treatment (Thompson, 2007). However, this process did not 
always take place during a consultation, which limited the presence of SDM during doctor-
patient interaction. In reviewing the discourse which took place during adjuvant treatment 
consultations, it was observed that some linguistic practices were an obstacle that blocked 
characteristics of SDM and reinforced societal assumptions of healthcare. For instance, the 
use of epistemic markers (e.g. the words ‘we’ or ‘I’) operated as a means to generate 
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territories of expertise and, therefore, played an interactional significance on the doctor-
patient relationship, which has previously been described as a competency for SDM 
(Towle, 1997). By creating territories of expertise, which heightened a perceived 
imbalance in power-relations and discrepancies in status and role, between the patient and 
clinician, this obstructed patient participation in interaction for decision-making. The use 
of such epistemic markers may have caused patients to feel inferior or inadequate in the 
decision-making process and, therefore, show little or no effort in turn-taking to negotiate, 
make suggestions, or present their views and preferences. In turn, the patients took a 
‘passive’ role during the consultation, where the responsibility of decision-making was 
handed over to the clinician. As a result, by taking a submissive stance, the concept and 
presence of SDM was restrained, and the patients’ experience of sharing decisions was 
perceived by the research to be deterred. The findings, therefore, suggest that language and 
discursive practices within doctor-patient interaction can cause patients to perceive a 
barrier that is based upon unequal power-relations, which subsequently result in a lack of 
perceived SDM. This is consistent with existing literature which demonstrates that the 
clinician’s unwillingness to share power, between doctor and patient, is a barrier to the 
implementation of SDM (Brody, 1980; Ford et al, 2003; O’Flynn & Britten, 2006). 
 The analysis further showed that little opportunity was given for patients to engage 
in a shared model of decision-making. According to Howie et al (1997), by providing 
patients with more time and opportunities for communication, this helps to develop the 
concept of ‘patient enablement’, and allows patients to participate and cope with the task 
of decision-making better. However, clear markers were displayed during interaction 
which prohibited involvement, and obstructed the presence of SDM during interaction. 
This was shown in the use of boundary markers (e.g. ‘so’ or ‘right’), rhetorical 
questioning, and sequential ordering of words (e.g. ‘first’, ‘then’, and ‘finally’) during the 
consultation. At times, there was also evidence of overlap in speech prior to the patient 
finishing speaking. The action of pushing the patient out of the two-way interaction may 
result in the patient no longer feeling comfortable to participate and, therefore, hinder the 
patient’s ability to share their views, preferences, and queries. These interactional barriers, 
subsequently, made it difficult for turn-taking between speakers to occur, and often placed 
the clinician in the driving seat of interaction. Therefore, it is suggested that this resulted in 
an inadequate process of SDM to taking place between the clinician and patient. This is 
consistent with existing research, which highlights the lack of characteristics such as, 
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‘sharing’ and ‘involving’ patients, during SDM (Charles et al, 2004). With lack of self-
efficiency to enable patient participation, this had have a negative effect on the process of 
SDM (Keefe et al, 2002; Thistlethwaite & van der Vleuten, 2004), as patients became 
repressed from the ‘sharing’ and ‘involving’ characteristics of SDM, during their adjuvant 
consultation.   
 
 However, in exploring doctor-patient conversations, it was observed that not all 
interaction was aimed at discouraging patient participation. The analysis also showed some 
instances where characteristics of SDM were present, and a possibility for doctor-patient 
SDM to occur. 
 Previous research argues that a main obstacle to patient participation is low health 
literacy and lack of subject knowledge (Coulter & Ellins, 2006). For a process of SDM to 
occur, a key goal for the clinician is to maintain a balance between information, 
explanation, and patient participation (Elwyn & Charles). The analysis revealed that 
accurate and detailed health information was an important goal of communication, as 
patients were thoroughly informed, and conveyed detailed explanations of treatments. This 
all served a purpose, which was to educate the patient at the level of the clinician, to permit 
for a two-way exchange of information to occur. This has been described as an important 
prerequisite for a successful move towards increased involvement in decision-making 
(Brennan, 1997; Scott et al, 2000), as patients cannot participate in decision-making to 
their desired extent, unless they have access to adequate and accurate health information 
(Buchanan et al, 1996). The acquisition of health information has also been described as an 
essential ingredient for SDM (Moumjid et al, 2007).  The analysis, therefore, revealed 
good practice of providing patients with the information and knowledge needed to 
participate in SDM. For instance, the use of asking rhetorical questions to the patients was 
designed to function as an information tool or decision aid. It was also an opportunity to 
provide the patient with relevant health information, which can facilitate decision-making. 
Although, a rhetorical question does not lend itself to patient interaction, the action 
appeared to bear valuable consequences, as it allowed patients to obtain the appropriate 
explanation, descriptions, and information needed to make an informed decision, or to give 
informed consent. This represents a process of SDM, and similar characteristics to that of 
SDM (Beaver et al, 1996; Elwyn & Charles, 2001; Towle & Godolphin, 1999).  
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 According to Buchanan et al (1996), patients can only participate in decision-
making if they have access to knowledge given in ways optimal to their own level of 
understanding. This was evidently reflected during the consultations, as language was 
broken down through the use of statistics, and elaborated upon through rich and detailed 
descriptions, so the patients had an accurate and precise understanding of what was being 
said. At times, where further clarity was required by patients, the use of repairs such as ‘I 
mean’, were used by the clinician to elaborate on complex explanations. It could therefore 
be suggested that this helped bring the clinician’s level of expertise down to the patient’s 
level and, therefore, remove any feelings of patient inferiority. This not only should allow 
patients to feel more comfortable and at ease to talk to the clinician, but it also means that 
patients can acquire the right knowledge and understanding needed, to confidently 
participate in discussions about decision-making (Henerson, 2003). Consequently, the use 
of uncomplicated language is an example of strategies enforced during doctor-patient 
interaction, to facilitate patient participation in decision-making, and to promote SDM 
taking place. 
 A more direct and evident example of patients being actively encouraged to 
participate in two-way exchange of information, was shown through a FPP question, 
directed at patients, ‘do you have any questions?’ It has been suggested that 
communication that stimulates patient questions is signified as an important component to 
decision-making (Post et al, 2002). Characteristics of SDM, such as two-way information 
exchange, sharing of views and preferences, knowledge acquisition, and patient 
participation were mostly illustrated through a reciprocal process of questioning and 
answering between the patient and clinician. Therefore, by asking patients questions, this 
can permit them to actively engage in a process of SDM. Many patients showed an ‘active’ 
participatory role, in the face of a direct FPP question posed at them. This window of 
opportunity was grabbed by patients, as they used it as a time to overcome any perceived 
imbalanced power-relations. It also allowed for an opportunity to actively participate in 
their care. By engaging in a shared process of questioning and answering, an equal 
encounter of doctor-patient interaction took place, through a steady turn-taking process 
where transitional spaces (TRP’s) and FFP’s were recognised by each member. The 
importance of reciprocation of dialogue has been described as an important factor for 
patient participation in SDM (Thompson, 2007). This was evident in the analysis, as the 
reciprocation of questions and answers, between the patient and clinician, lead to a distinct 
Chapter Six 
234 
 
process of sharing information, views, preferences, and beliefs, in respect to the adjuvant 
treatment, by both parties. It was during this time, that discussion about the treatment took 
place, and the patient was able to share their concerns and views. This exemplifies the 
characteristics of SDM and, therefore, such discursive practice can facilitate doctor-patient 
interactions for SDM during this stage of the consultation.  
 The characteristics of SDM were also observed, at the end of the consultation when 
the clinician would invite the patient to engage in informal and less structured talk, by 
asking the patients ‘is there anything else you want to talk about?’ During this time, 
patients showed interaction by asking the clinician questions on topics, which did not 
require clinical expertise and knowledge such as, going to work, family life, and 
relationships. This supports Thompson et al’s (1993) argument, that patients are more 
likely to be involved in decision-making that does not necessarily require medical 
knowledge, than decisions that require clinical expertise. Therefore, this draws attention to 
this issue of power-relations again, in that, patients rather hand the responsibility of 
medical decision-making over to the medical expert. Interaction over these topics, 
subsequently, allowed for a process of information exchange, views, and preferences to be 
shared between the patient and clinician, to reach a mutual decision. Although this practice 
in itself is not an experience of SDM for treatment choice, the process exerts 
characteristics of SDM, and can be a contributing factor, which works towards facilitating 
the process of SDM during the consultation for a patient to encounter with conversations. 
 From the analysis, it was understood that opportunities for SDM were created 
between doctor and patient during a consultation. Much effort was made by the clinician to 
ensure that two-way conversations took place during the consultation. However, very little 
acknowledgement to these initiating practices was shown by patients. These cues were not 
picked up by the patients which, therefore, resulted in a lack of two-way discussion about 
decision-making, and hindered the presence of SDM during doctor-patient interactions. As 
discussed above, there were many instances whereby the clinician invited patients to 
acquire information about their treatment, and to share their concerns, views, and 
preferences, by asking them a direct FPP questions. The analysis showed that this was a 
cue that patients recognised as their turn to talk. The findings showed that each time 
patients were invited to interact with the clinician, in response to a question directed at 
them, (e.g. ‘any questions so far on that?’), they did respond; however, they showed little 
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interaction, and only give single word answers (e.g. ‘yes’/‘no’). Continual attempts were 
made to invite the patient to share their queries and views at regular intervals. Yet, many 
patients remained submissive and impassive to the questions asked. In situations where the 
clinician is anticipating for a response, but yet fails to receive patient interaction, a method 
of scaffolding was used to try and stimulate patient interaction. This aimed to build an 
increment to the question asked, in order to provide the patient with further knowledge 
required, to provide a response. Another method used to push for patient interaction, was 
to use preference organisation questions. This helped to stir the patient towards the correct 
response to a topic, which they may have formerly lacked enough knowledge to respond 
to. However, patients chose not to engage in a sharing process, which involved exchanging 
any information or preferences to the clinician. According to Towle et al (2003), some 
patients may find it difficult to ask questions, as they feel intimidated, are concerned about 
using the doctor's time, and fear that assertiveness will jeopardise rapport. Alternatively, 
some patients are ‘passive’ in their participatory style, and choose not to take in decision-
making (Levinson, Kao, Kuby & Thisted, 2004). Nonetheless, the findings showed a lack 
of shared interaction about decision-making taking place. Therefore, this disengaged 
patients from the process of SDM.  
 Another example of patients’ lack of recognition to cues for SDM is through the 
lack of recognition shown to transitional spaces. Throughout the consultation, the clinician 
ensured that considerably long gaps (TRP) were evident at the end of each TCU, to allow 
invitation of interaction by patients. The period of silence should have been interpreted, by 
patients, as a sharing opportunity, a time in which the turn of talk is directed to the patient 
to either ask questions about what was outlined by the clinician, express an opinion or 
preference, or to share their understanding. The long transitional spaces gave patients 
enough time to participate and contribute, therefore, creating an opening for the process of 
SDM to occur. However, this concept of sharing failed to occur, as there was no interaction 
from some patients, or even a sign of acknowledgement through continuers (e.g. ‘mm hm’, 
‘uh huh’, ‘yes’, or ‘right’).  At times, in order to prompt patients to interact, the clinician 
used boundary markers, such as the word ‘so’, as a standalone, at the end of a TCU. The 
action consequence of this was to prompt patients to make the next relevant action, and to 
engage in the discussion. Yet the conversational aid, or cue for interaction, was shown to 
be unrecognised by patients, and in some instances, no interaction took form. Therefore, 
despite many attempts made within dialogue to try and support characteristics of SDM 
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within a consultation, such as ‘sharing’ information and preference, and ‘involving’ 
patients in discussions about decision-making. Patients, nonetheless, were at times 
unresponsive and failed to recognise such cues. Arguably, there are good indications that 
the process of SDM should and could occur if these cues were recognised by patients and 
acted upon.  
 
6.5.1 Reflexivity: the researcher’s voice 
As mention previously in this chapter (section 6.3.6- data analysis), researcher reflection 
was an integral process throughout this study, and was maintained by means of a reflexive 
diary. The researcher planned at every stage of data analysis to be reflexive and transparent 
about any potential influences. In having reached the findings discussed above, it is 
important to explore how the researcher and inter-subjective elements impinged on, and 
even transformed, these findings. 
 Besides the clinic observations made prior to data collection for this study, my 
previous research engagements, prior to the PhD, came from a background on doctor-
patient communication. My Masters Qualification required me to assess and evaluate the 
quality of oncology consultations. Therefore my existing knowledge of the literature and 
practice of doctor-patient communication within oncology was vast, prior to commencing 
this third study. I felt strongly that my experiences would play a significant and beneficial 
role within the third study, and could be used to enhance my understanding of doctor-
patient interaction for SDM. As a result, during the analysis, I was significantly aware of 
clinical barriers which inhibit doctor-patient relationship and interaction. This made me 
more prone and observant in identifying these barriers within the data. Furthermore, due to 
my previous research engagements, I found it difficult, as an analyst, to withdraw myself 
from evaluating SDM during the CA, as oppose to exploring the symbolic meanings of 
patient interaction. I was mostly drawn to data extracts which highlighted the effectiveness 
and success of SDM in increasing patient satisfaction and quality of care. However, I had 
to keep reminding myself of the research question, and kept myself focused to explore 
patients’ experiences. 
 I was also drawn to certain extracts within the data as a result of my father’s 
deteriorated health, during the time of analysis. During this time, my father had had his 
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third cardiac arrest, and was submitted to stay in hospital for three weeks. The team of 
cardiologist were trying to decide whether open bi-pass surgery was the best possible 
treatment option for him. At such a crucial time of decision making, my father had decided 
to withdraw himself from his treatment options and decision-making, and instead placed 
his trust in the hands of the multi-disciplinary team of cardiologist. I was deeply furious at 
my father, as I was aware of the process of SDM. On several occasions, I witnessed the 
cardiologist talking to my father, on the ward, about treatment decision-making. Within 
these observations, I perceived the consultant as someone who played a highly specialist 
role, who exemplified his levels of expertise by means of sharing complex medical 
information. To me, my father played the role of the question asker, while the consultant 
played the role of the expert who informs and knows all the answer. My father explained to 
me that “they know what’s best, and that they know more than he does”. From my own 
personal engagements with my father’s health, I learnt that patient participation in 
decision-making is controlled as a result of perceived power-relation, on behalf of the 
patient. I also understood that the patient and clinician can have distinct roles to play 
during decision-making, which can eliminate the process of SDM. Subsequently, what I 
had personally experienced influenced the way I looked at the CA transcripts. By carrying 
the preconception that SDM fails to occur during doctor-patient interaction, due to 
imbalanced doctor-patient power-relations, this made it very difficult for me to indentify 
the presence of SDM during doctor-patient interaction and, therefore, focus instead was on 
factors which inhibit patient encounters.  
 To facilitate me in the analysis, I therefore engaged in regular conversation with 
oncologist at the University teaching hospital, about the practice of SDM. I learnt during 
these conversations with the oncologists that SDM doesn’t necessarily have to only occur 
during formal structured talk about the treatment plan. I was informed that it mainly occurs 
during informal natural talk, for instance, during a questioning and answering session at 
the end of consultation between the patient and clinician. This reminded me of my father’s 
experience, when he played the role of the question asker and the clinician was the 
informer/answerer. From the conversations I had with the oncologists and my father 
experience, I therefore acquired this belief that the characteristics of information exchange 
and sharing of views and preferences result in a SDM process, and can facilitate doctor-
patient conversations for SDM. This assumption, therefore, stirred me towards instances 
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within the data extracts, which illustrated these characteristics during doctor-patient 
interaction.  
 Whilst undertaking the CA, I found it very difficult to only describe the ‘talk-in-
action’, and not make assumptions based upon what was spoken.  By attending several CA 
workshops and seeking aid from CA academics at Keele University, I was able to learn 
how to solely focus on the talk, and to look for patterns about the phenomena in 
interaction. Therefore, supervisory discussions were integral to the practice of CA and the 
data analysis. I was reflexive on a lower level in my diaries and personal reflections, but 
taken to a higher level of reflexivity when probed by my supervisors, to think about the 
data or ‘talk’ in different ways.  
 As a CA analyst, I have learnt that the emotions, experiences, and the thoughts that 
you carry as a research, do shape and guide your motives and interpretations during 
analysis. However, it is important that you nonetheless have the appropriate training and 
supervision, to conduct sensitive analysis accurately. The process of reflexivity, in this 
third study, has also taught me that my personal emotions and experiences can play a role 
in the way data is interpreted and understood. Although I could have undertaken this study 
from a more distanced stand point, I however feel that there would be very little gained, 
and in fact, believe it would have reduced the depth of the findings. I feel that by utilising 
my knowledge and experiences, it was possible to make the experience one of being-with, 
and to become immersed in the worlds of the participants during doctor-patient interaction. 
I believe that this involvement and being-with, allowed a depth of understanding and 
comprehension that would not be possible from a more detached standpoint. 
 
6.6 Conclusion 
In exploring the research question, through a CA on conversations during breast cancer 
adjuvant treatment consultations, the findings from the third study have provided valuable 
insight into doctor-patient communication. It has also brought awareness to the types of 
discourse which take place during a consultation, which can either inhibit or facilitate the 
characteristics of SDM, and the presence of SDM during doctor-patient interaction. The 
audio-recordings have revealed and achieved a level of realism and truth which is, 
otherwise, difficult to ascertain from participants’ accounts. On the surface when looking 
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at the data, it is initially noticeable that there was very little two-way dialogue between the 
patient and clinician about decision-making. Patients appeared to take a ‘passive’ 
participatory role, a perceived an issue of imbalanced power-relations between the 
clinician and patient. This appeared to discourage patient participation and, therefore, 
patient involvement in discussions about treatment decision-making deterred. This, 
therefore, paved little way for characteristics of SDM to take form, such as the sharing of 
information, preferences, and views in making a joint decision together. Subsequently, it 
can be suggested from these findings that there is limited presence and patient encounters 
of SDM during adjuvant treatment consultations.  
 However, once engaging in a deeper CA of the transcript, it became apparent that 
the process and presence of SDM was not totally excluded during adjuvant consultations. 
Despite certain conversational practices, which appeared to create interactional barriers 
and hinder the notion of SDM, there was also evidence of additional practices aimed to 
promote two-way discussion and patient participation for SDM. The analysis illustrated 
that there were discursive practice within doctor-patient interaction, tailored to encourage 
patient participation, and to facilitate the process of SDM. There were opportunities for a 
shared model towards medical decision-making to take place, which involved a reciprocal 
process of sharing views, preferences, and exchanging information. For some patients, the 
process of SDM was taken up and encountered during a questioning and answering session 
between the clinician and patient. Patients actively participated in two-way interaction 
about their treatment, only when been directly asked to share their views and concerns. 
During this interaction, characteristics of SDM were displayed, such as the sharing 
information and preferences, acquisition of knowledge, and patient participation.  
 However, despite the cues presented, which aimed to facilitate SDM, the findings 
also revealed that there were patients who failed to recognise the cues for SDM. This 
subsequently inhibited patients in encountering conversations for SDM with the clinician, 
despite the facilitators used in language to promote SDM. This, therefore, suggests that the 
presence of SDM in a consultation is controlled by patient participatory role, i.e. a 
‘passive’ patient will oppress the presence of SDM in comparison to an active patient who 
will broaden its presence. As a result, clinicians still require appropriate communication 
skills training with respect to the provision of SDM, to ensure that patient participation in 
decision-making is maintained, and all cues for SDM are acknowledge. Doctor-patient 
Chapter Six 
240 
 
interaction needs to be modified to patients’ individual differences, to ensure that patient 
participation in decision-making and SDM is maintained. 
 In conclusion, the CA data has revealed substantial awareness around the limited 
presence of SDM, from doctor-patient conversations. It has also revealed an insight into 
the additional questions, outlined in Chapter One. For instance, it has informed about the 
characteristics of SDM, and it has provided an insight into the factors which facilitate and 
hinder the process of SDM for patients. It has also showed that SDM for breast cancer can 
be explored qualitatively, through examination patient interactions. It is understood from 
this study that SDM is a process which is characterised by two-way interaction, where both 
the clinician and patient are required to participate in discussions and share information 
(i.e. views and preferences). The presence of SDM is understood to be influenced by 
patient participatory roles (‘passive’ or ‘active’) during interaction; and discursive 
practices, which can create unequal doctor-patient power-relations. This appears to both 
inhibit and facilitate doctor-patient conversations for SDM.  
 Similar to study one (Chapter Four) and two (Chapter Five), this final study has 
also drawn particular attention to the role of doctor-patient communication, patient 
participatory roles, and the impact of imbalanced doctor-patient power-relations on 
patients’ experience of SDM. The main discussion chapter of this thesis (Chapter Seven) 
will further explore the findings of this study in relation to the implications it has on breast 
cancer care, further health research, and qualitative research. Chapter Seven will also 
discuss the findings of this study in more thorough detail, in relation to the literature 
review outlined in Chapters One and Two, by exploring all three studies in relation to the 
research questions proposed in Chapter One. Chapter Seven will also conclude the thesis 
by outlining the limitations and implications of the research thesis as whole. 
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Chapter 7 
Advancing the understanding of SDM experience and breast cancer 
 
 
7.1 Introduction 
At the start of this thesis, the central research question was to find out how women with 
breast cancer experience SDM through their treatment journey. Additional questions that 
emerged from this central issue were: 
 What does the concept of SDM mean to women with breast cancer, and what are 
the characteristics of SDM? 
 How is the experience of SDM influenced (hindered or facilitated) for women with 
breast cancer? 
 Can SDM for breast cancer be explored qualitatively, through examining patient 
perceptions and conversations?  
Rather than looking at SDM as defined by the clinical guidelines and models of medical 
decision making (i.e. the shared model), the aim was to take a critical and interpretivist 
approach to exploring the concept of SDM from patients’ lived experiences, to gain a more 
complete and less disease orientated view. The questions above led specifically to look at 
interpreting the meanings ascribed by patients to their actions (i.e. their perceptions and 
interactions) and experiences. This was evident in Chapters Four, Five and Six, as three 
very distinct qualitative studies looked at how SDM is experienced by breast cancer 
patients, from their own perspectives and interactions/conversations with other patients and 
the clinician. By taking both theoretical frameworks of phenomenology and symbolic 
interactionism to explore the research question, the method of semi-structured interviews, 
online written comments, and audio recordings were used to access patients’ lived 
experience and advance this knowledge. This chapter discusses the main research question 
in more detail, and the three additional questions posed, using the three previous studies 
and existing literature. The chapter also discusses the contributions of the thesis, certain 
limitations, and the prospect of future research in the area within the field of health 
psychology. 
Chapter Seven 
244 
 
7.2 How do women with breast cancer experience SDM through their treatment 
journey? 
Throughout the data generated across all three studies, two main issues arose that helped to 
answer this question. The first was the definition of SDM to patients (i.e. the meaning of 
the concept and perceived characteristics of SDM). The second was the ability to trace 
SDM in patients’ lived experiences. One of the most important developments that this 
project makes in terms of discovering how breast cancer patients experience SDM, is that 
it is deliberately explored through a variety of positions within all data (i.e. patient 
perspectives and interactions).  
 
7.2.1 The meaning of SDM to breast cancer patients 
Despite the clinical guidelines outlining a medical definition of SDM by NICE (2004 & 
2012) and DOH (2006, 2007, 2010b, 2010c), the actual practice and experience of SDM is 
a less explored area. The concept of SDM has been previously researched through two 
main approaches. The first approach is through discussion of medical models of decision-
making, as outlined in Chapter Two. Such studies focus on the prototype depiction of each 
decision-making model and its components. The second approach is through examination 
of the characteristics of SDM. These studies focus on identifying the necessary criteria for 
classifying a doctor-patient decision-making interaction as SDM. Research within both of 
these approaches has explored SDM through examination of patient participatory roles, 
doctor-patient relationships, and doctor-patient communication. Studies using both 
qualitative and quantitative methods have revealed much about the explicit behaviours and 
principles of how to engage in the process of SDM, in the form of instructional guides for 
patients and clinicians. However, while a checklist approach may resonate with many 
clinicians, in terms of a clinical framework of SDM, this may not echo within patients’ 
construction of their illness experience. Furthermore, SDM is in some sense a matter of 
perception and, therefore, may be valued and recognised differently by patients and the 
clinician. Despite there already being substantial and useful groundwork in place about the 
definition and classification of SDM, there is a need for further research to explore its 
meaning from the patient’s point of view. The characteristics of SDM and the meaning of 
those characteristics need to be investigated from the perspectives, interactions, and lived 
experiences of patients during their health care.  Studies one to three achieved this, as each 
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aimed to explore SDM through an analysis of the interpretations and meanings patients 
ascribe to their situations (i.e. experiences) and actions (i.e. interactions and perspectives). 
 Across all three studies a defined meaning of SDM was illustrated, which 
outlined a process of two-way interaction, between the clinician and patient, whereby 
information exchange and the sharing of views and preferences took place. In examining 
the experience of SDM from patients’ perspectives (study one, Chapter Four), the 
interview data revealed that doctor-patient communication, and the sharing of health 
information and explanations, were important characteristics that played a constituting role 
towards SDM. For example, the study revealed that clinicians obtained the necessary 
expertise knowledge about the disease and the expected outcome of each treatment, 
compared to patients who stated they did not. Establishing a shared relationship, which 
was based on the exchange of information and knowledge acquisition, was regarded as 
important to patient participation in decision-making. These findings are similar and 
consistent with the informed decision-making model, which focuses on partnerships 
between patient and clinician, for the transfer of technical knowledge from the clinician to 
the patient. Within this decision-making model, the clinician’s role is limited to that of 
providing information and scientific knowledge to the patient (Williams, 1988; Mooney & 
Ryan, 1993). This understanding of SDM was similarly revealed in study two (Chapter 
Five), as online interactions, within breast cancer forums, highlighted the clinician as the 
‘information giver’ during consultations. However, participants’ accounts in studies one 
and two also showed that the sharing of information was not a role conducted singularly by 
the clinician, as it is also important for participants to exchange information that they 
obtained, such as their views, concerns, and preferences. This finding is consistent with the 
physician as a perfect agent model, which aims to elucidate the patient’s preferences and 
values to the clinician. Both the informed decision-making model and the physician as a 
perfect agent model, emphasis the clinician as the person who makes the final decision. 
However, the findings in both studies one and two revealed that for an encounter of SDM 
to occur, both the clinician and the patient need to make the final decision together. To 
achieve this, the findings further showed that there needs to be a process of shared 
interaction, and an opportunity to share information and knowledge between the clinician 
and patient. This highlights and supports the movement from the physician as a perfect 
agent model and informed decision-making model, to the shared model of medical 
decision-making. Both studies one and two are valuable as they not only explore the 
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characteristics and meaning of SDM from the patient perspective and interactions, but 
importantly they show that breast cancer patients show knowledge and awareness of SDM. 
In exploring patients’ lived experiences during their treatment for breast cancer, the 
findings showed that patients acquired an understanding of the concept of SDM and could 
talk about what it means to them.  
 Study three (Chapter Six) supports these findings, through its exploration of 
doctor-patient interaction during breast cancer consultations.  Within this study, 
interpretation of the conversations revealed that for doctor-patient SDM to occur, there 
needs to be two-way interaction, whereby both parties equally participate in sharing 
information and preferences. Within this study, the characteristics of SDM became more 
definite as the analysis revealed two key aspects, understood by both the clinician and 
patients: the ‘sharing of information’ (knowledge, explanations, descriptions), and the 
‘sharing of decisions’ (views and preferences). In exploring the barriers and facilitators in 
talk, which hinder and encourage SDM, it was understood, across all three studies, that 
SDM is a concept that must include both sharing of information and decisions, and both 
aspects must be practiced by both the clinician and patient (Ong et al, 1995). 
 Further findings about the meaning of SDM emerged across all three studies, 
which emphasised key characteristics such as ‘shared participation’, ‘balanced doctor-
patient relationship’, and ‘mutual interaction’. It was understood by patients that SDM is 
an equal approach towards decision-making, whereby both parties are made to feel equal.  
Importantly, these findings suggest that the meaning of SDM, in the context of breast 
cancer, is consistent with the existing literature and guidelines, which highlight SDM as a 
partnership, between doctor and patient, based on a division of labour. Both patient and 
clinician provide enough knowledge and information, and take steps together to build a 
consensus about the preferred treatment (Beaver et al, 1996; Charles et al, 1997; Elwyn & 
Charles, 2001; NICE, 2004 & 2012; Towle & Godolphin, 1999). Breast cancer patients’ 
understanding of SDM is also consistent with the shared model of medical decision-
making, which implies that SDM fundamentally relies on both the patient and clinician 
playing a reciprocal role in information exchange, deliberation of pros/cons and 
preferences, and implementation to the decision-making (Elwyn & Charles, 2009). Finally 
breast cancer patients’ understanding of SDM is consistent with the existing literature on 
doctor-patient communication, which emphasises competencies for SDM: good doctor-
Chapter Seven 
247 
 
patient partnership; provide evidence and information; establish preferences and concerns; 
and develop interaction decisions as a partnership (Towle, 1997). 
 
 In addition to determining what SDM means to breast cancer patients, the data also 
revealed that SDM can mean different things to different patients. This finding was 
reflected in study one, where a key theme within the analysis highlighted individual 
difference. In support of existing literature, the interview data illustrated that breast cancer 
patients exerted two types of participatory roles: ‘active’ and ‘passive’. These impacted on 
patient participation in medical care (Beaver et al, 1996; Bilodeau & Degner, 1996; Degner 
& Sloan, 1992; Hack, et al, 2006; Keating et al, 2002; Street & Voigt, 1997). Previous 
studies have explored how these characteristics can interplay with the efficiency of patient-
centred care (Degner & Sloan, 1992; Lerman, et al, 1990).  However, there is little context 
in analysis that tries to examine whether there are personal preconditions that are related to 
SDM, and whether these can influence a patient’s understanding of it. Where these distinct 
participatory roles have been discovered and assessed in relation to treatment success and 
satisfaction, nonetheless, very little of this understanding has been made in relation to 
breast cancer and the notion of SDM.  Study one filled this gap in the literature. The 
findings revealed that an ‘active’ participant was motivated to take part in their treatment 
decision-making, through seeking and exchanging information, and discussing treatment 
options available with the clinician. For these patients, the meaning of SDM was 
understood to be a two-way operational process, which involves sharing of information, 
views, and preferences, by both clinician and patient. This supports existing research on 
the ‘active’ patient role, which highlights that it is important for patients to work in 
collaboration with the clinician to reach a mutual and shared decision (Charles et al, 
1999b; Degner & Sloan, 1992; Frosch & Kaplan, 1999; Guadagnoli & Ward, 1998). 
Subsequently, it can be suggested that an ‘active’ patient participatory role, can facilitate 
characteristics of SDM between doctor and patient. On the contrary, a ‘passive’ participant 
avoided participation, and chose to hand the responsibility of decision-making to the 
clinician. Therefore, their understanding of SDM was demonstrated to be limited. From 
study one, it can be suggested that the meaning of SDM is shaped by patients’ actions and 
role preferences, and its meaning is not uniform amongst all breast cancer patients. 
 Study two showed that the meaning of SDM is something which is discussed 
amongst patients. Analysis of peer to peer online interaction showed that women with 
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breast cancer like to inform one another, and share their own understandings of the concept 
of SDM. The purpose of online interaction was not only to raise awareness of SDM, but to 
also promote its use in a clinical setting. Therefore, this illustrated that patients’ 
understanding and awareness of SDM is not only beneficial to their own health care, but 
that the online forums were also valuable tools for informing other patients about the 
concept of SDM. SDM is shown to be a concept which is spoken about between patients, 
and highly valued.  Great attention is given by patients to support and encourage other 
patients to encounter SDM, and increase its practice within breast cancer care. 
 
 
7.2.2 The experience of SDM for breast cancer patients 
 
The literature revealed that a patient experience of SDM is a topic which has been 
previously investigated, with a focus on evaluating clinician performance. These studies 
focused on examining the views of medical practitioners and patients, with a range of 
chronic illnesses, about the use of SDM. They also assessed the feasibility of SDM during 
medical care. Some studies used qualitative methods, such as semi-structured interviews 
and focus groups, to explore issues of doctor-patient communication, competencies for 
SDM, levels of patient involvement, and patient participatory roles (Charles, et al, 1997; 
Elwyn et al, 1999a, 1999b, 2000; Towle & Godolphin, 1999). However, more advanced 
research methods were developed to explore patient experience of SDM. This resulted in a 
growth in research, which used direct observation to assess SDM through the use of video 
and audio-recordings, to describe doctor-patient relationships/communication (Saba et al, 
2006; Elwyn et al, 2008). This highlights a shift in focus and methods, from evaluating 
competencies for SDM, to evaluating how SDM is experienced by clinicians and patients. 
Although the health psychology literature is beginning to see research on SDM from 
patients’ perspectives, however, these studies still remain focused on evaluating SDM, by 
exploring doctor-patient communication or competencies. Therefore, no research has 
aimed to explore what SDM is like for patients by studying interactions and perspectives, 
particularly within breast cancer care. Studies one to three addressed this gap in the 
literature, as each study employed a different qualitative method of enquiry to explore 
breast cancer patients’ experiences of SDM. 
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  All three studies illustrated similar described and interpreted experiences of SDM. 
Each study revealed that an experience of SDM rested upon an equal doctor-patient 
relationship which therefore resulted in opportunities to share communication, share 
information, and share views and preferences. This is similar to the discussion above about 
the meaning of SDM and implies that patients’ understanding (the meaning of SDM) and 
experiences of SDM are entwined. The findings across all three studies revealed that breast 
cancer patients’ experience of SDM was largely associated with establishing a shared 
relationship, which depends on doctor-patient knowledge acquisition, and the role of 
information transfer. This is consistent with the shared model of decision-making, as 
patient encounter of SDM is described as one which is focused on a partnership, between 
patient and clinician, for the transfer of technical knowledge and treatment preferences. In 
study one; participants explained that doctor-patient communication, which allowed for 
mutual discussions and sharing of information and preferences by both the patient and 
clinician, contributed towards an experience of SDM. In study two; in explaining how 
SDM can be achieved, forum members made each other aware, during online interaction, 
about the importance of doctor-patient relationships. This was described to be based on an 
equal division of roles and information exchange. Finally, in study three; interactions 
between patients and clinicians revealed that without doctor-patient communication, which 
permitted equal participation, sharing of preferences, and information exchange by both 
parties, the presence and process of SDM is non-existent. These findings show that breast 
cancer patients’ encounters of SDM are line with the move towards patient-centred care 
(Charles et al, 2004) and informed consent (Charles et al, 1997; Fest & Anderson, 1995). It 
also illustrates and supports the notion of a shift from in medical models of decision-
making, as the clinician is no longer the sole person who shares their knowledge and 
views, and makes the final decision. Similar to the discussion above, these findings once 
again support the existing guidelines and research about the characteristics of SDM, and 
support the shared model for medical decision-making. 
 The overall concept of SDM is based around the assumption that all patients prefer 
or want to receive information on their condition, and wish to participate in the decision-
making processes. However, this assumption is not always true, as the literature illustrated 
that a large proportion of patients do not accept the new patient role, and refused to 
participate in decision-making (Guadagnoli & Ward, 1998; Levinson et al, 2005; Strull et 
al, 1984). Therefore, a central question to the SDM paradigm is whether patients actually 
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want to experience SDM. If patient meaning and experience of SDM are interrelated, it 
could be assumed that the experience of SDM can be influenced, depending on how SDM 
is understood by patients. For instance, the discussion above outlines that SDM is 
understood in accordance to patient participatory roles (‘active’ and ‘passive’) and, 
therefore, the meaning of SDM is not viewed identically across all breast cancer patients. 
By expanding these findings to how SDM is experienced, it was illustrated that patients’ 
assumptions about SDM resulted in how they encountered it. Therefore, participants would 
use their ‘active’ or ‘passive’ attitudes and behaviours, to account for how they 
experienced SDM. For example, for an unresponsive or ‘passive’ participant, responsibility 
was seen as an unconscious emotional weight to carry (Biley, 1992; Caress, 1997), and, 
therefore, they acquired limited understanding about the concept or process of SDM. This 
resulted in them describing their experience of SDM as non-existent. However, an ‘active’ 
patient was able to outline characteristics of SDM, such as two-way interaction of 
information, views, preferences, and described having experienced SDM based on these 
characteristics. Therefore, the role of the ‘active’ patient, allows women with breast cancer 
to increase their participation (Charles et al, 1999b; Guadagnoli & Ward, 1998; Frosch & 
Kaplan, 1999) towards an experience of SDM. The findings suggest that SDM does not 
only mean different things to different breast cancer patients, but can also result in varying 
patient encounters of SDM. Patient experience of SDM is not universal across with breast 
cancer care, particularly for those who encompass ‘passive’ traits and choose not to engage 
in the characteristics of SDM. Therefore, this implies that patient experience of SDM is not 
static or desired amongst all breast cancer patients. 
 Further findings about the experience of SDM, revealed it was largely present 
regarding decision-making for adjuvant treatments, rather than surgical treatments. When 
initially diagnosed and faced with having to make surgical treatment decisions, women 
appeared less keen to participate in the decision-making process, and showed more 
urgency to accept any treatment offered. In light of the psychological implications relating 
to the discovery of breast cancer (Akechi et al, 2001; Burgess et al, 2005; Grabsch et al, 
2006), the findings in study one showed that the concept of SDM was overruled by 
patients’ fear and psychological distress of cancer, as patients’ primary concern was to 
have the cancer removed. Women were not disturbed about the prospect of losing a breast, 
or concerned about their involvement in the decision-making. However, once the lump or 
breast had been removed, and patients were then faced with having to make decisions 
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about adjuvant treatment, the practice of SDM became more. Women wanted to be 
involved in decisions about treatments which had severe implications on body image (hair 
loss and weight gain) and QOL. An experience of SDM, therefore, became imperative. 
Women wanted to voice their views and preferences, and conversely, acquire as much 
health information and knowledge possible from the clinician.  In study one, patients’ 
retrospective reflections of their experiences of SDM were only described in relation to 
decision-making for adjuvant treatment. This finding was also comparable in study two, as 
women utilised the forums to share their experiences of decision-making, predominantly 
regarding adjuvant treatment decisions, such as chemotherapy. Women would also use the 
forums to talk about decisions regarding the management of adjuvant treatment side-
effects, such as hair loss. As a result, both studies showed that there are distinct facets of 
SDM relating to adjuvant treatment, rather than surgical treatment. 
 In examining breast cancer patients’ experience of SDM, it also became evident 
that SDM is a process applicable to all conversation in which patients engage in. For 
instance, study one revealed that SDM is a process which is experienced between breast 
care nurses and other patients. This experience was described as identical to an experience 
of SDM encountered with the clinician. The breast care nurse also engaged in a two-way 
interaction with patients, by ‘sharing information’ (knowledge, explanations, and 
descriptions) with the patients, whilst also offering an opportunity for both the nurse and 
the patients to ‘share decisions’ (their views and preferences). These two characteristics 
(‘sharing information’ and ‘decisions’), which worked together, were explained by patients 
to constitute towards their experience of SDM with the nurse. Therefore, this confirms that 
the concept and practice of SDM is persistent across a multi-disciplinary team of breast 
cancer specialist (NICE, 2004). Besides conducting the practice of SDM, the breast care 
nurses also played a facilitating role, in raising awareness and encouraging the importance 
of SDM between patients and clinicians. Study one revealed that nurses promoted patients 
to participate in regular discussions with their clinician, to share their views and concerns, 
and to negotiate about treatments. Therefore, not only were the nurses facilitating SDM 
during a clinical consultation with the clinicians, but they were also contributing in defining 
the characteristics of SDM, and informing patients about what an experience of SDM 
should entail. It could, therefore, be suggested that patients’ acquired understanding and 
experience of SDM, is also shaped by the breast cancer nurses. This is a novel finding in 
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the literature on SDM, as this is the first illustration of an experience of SDM taking place, 
between the patient and breast care nurse.  
 Study two also revealed that an experience of SDM is applicable to all patient 
conversations, and does not have to solely take place in a clinical setting, with medical 
professionals. The forums highlighted that patients also experience SDM with other 
patients, through their interactions online. During online interaction about decision-
making, forum members displayed similar characteristics of SDM within their talk, as 
defined by guidelines (NICE, 2004 & 2012) and existing research (Beaver et al, 1996; 
Charles et al, 1997; Elwyn & Charles, 2001; Towle & Godolphin, 1999). Women not only 
used the forums to gain support, and to sustain healthy psychological well-being, but also 
wanted to talk to other women about their treatment choices. A process of SDM took place 
as women shared health information and knowledge based on their similar experiences; 
and shared their personal views and their preferences, in making their own decisions. 
However, patients’ experience of SDM appeared to be less structured during online 
conversations, compared to SDM in a clinical setting. The forums offered a more 
automatic and informal approach towards an experience of SDM, where patients naturally 
experienced the characteristics of SDM through naturally occurring conversations, with no 
predefined competencies for SDM. From study two, the findings illustrated a 
representation of SDM taking place online between patients. It could, therefore, be 
suggested that the forums act as an opportunity for patients to rehearse SDM, before 
undertaking the concept in a clinical setting, with medical professionals. For those who 
were ‘lurkers’ and only used the forums to read other members’ posts, by observing other 
members’ interactions, this provided useful insight into how SDM took form. These 
women could, therefore, acknowledge and learn about how SDM can be experienced with 
other patients and/or medical professionals. 
 
7.2.3 Implications and contributions of the findings 
The discussion above draws much attention to a greater understanding of how SDM is 
experienced by breast cancer patients, what the concept means to them, and how it is 
characterised. These findings have implications for breast cancer care which are worth 
discussing.  
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 First, the findings indicate that breast cancer patients’ experiences and 
understandings of SDM are in line and in accordance with the SDM guidelines (NICE, 
2004 & 2012). Women reported informed participation in their treatment decision-making, 
which aligns with the tenets of patient-centred care for breast cancer (NICE, 2006).  The 
findings raised from all three studies also serve great importance in relation to the changes 
in medical decision-making models over the years. It is evident that breast cancer patients’ 
understanding and encounters of decision-making is moving away from both the physician 
as a perfect agent model, which concentrates on the transfer of the patients’ preference 
mapping system to the clinician; and the informed decision-making model, which is 
focused on the transfer of technical knowledge from the clinician to the patient. Instead it 
is moving towards a shared model of decision-making, which is grounded in two-way 
interaction, enabling both the clinician and patient to share all stages of the decision-
making process simultaneously; both participate in the exchange of information and 
preferences, and involve complex trade-offs between risks and benefits; and finally both 
agree on a chosen treatment plan. This provides reassurance to medical professionals, that 
the competencies and guidelines outlined for SDM (Towle, 1997; Towle & Godolphin, 
1999) are viable in allowing clinicians to practice SDM, and for patients to experience 
SDM. This is of particular importance, as guidelines for SDM have been associated with 
patient satisfaction and improved health outcomes (Ashcroft Lenister, Slade, 1985; 
Deadman, Leinster, Owens, Dewey, Slade 2001; Fallowfield, Hall, Maguire 1989; Kaplan 
et al, 1989; Laine & Davidoff 1996; Morris & Ingham, 1988).  
 Secondly, the findings also illustrated that SDM is a process which occurs across a 
multi-disciplinary team within oncology. With the role of the breast care nurse highlighted 
in connection to patient experience of SDM, this emphasises the need for further research 
to evaluate and explore patient experiences of SDM with breast care nurses; an area in the 
SDM literature which has not been investigated. Moreover, by exploring SDM through 
patients’ experiences, this has provided much useful insight into how the process is 
perceived and encountered by patients. This suggests the need for further research to 
devise and evaluate methods, which medical professionals can regularly use to assess and 
monitor patient experiences of decision-making, for service quality improvements. 
Acquiring such knowledge would not only offer verification on the decision-making 
processes, but it would also indicate whether medical professionals need to take additional 
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relevant training, for services improvement, and to ensure the patient’s experiences of 
SDM is in agreement with medical guidelines and the shared model for decision-making. 
 Thirdly, the findings illustrate that an experience of SDM is not static amongst all 
breast cancer patients, and does not automatically occur within breast cancer care. SDM 
was demonstrated to have different meanings, and be encountered in different ways, by 
patients. The impact of patient participatory roles on patients’ experience and 
understanding of SDM was a novel finding. This is the first time within the health 
psychology literature, whereby the previously emerged concept of ‘passive’ and ‘active’ 
participatory roles, are brought to attention within breast cancer, and in specific relation to 
SDM. With the concept of patient-centred care being at the forefront of medical practice, it 
is important that the issue of individual differences and active and/or passive positioning is 
incorporated into training and practice. This would ensure that medical professionals are 
able to recognise the importance of patient participatory roles, and are able to detect and 
monitor a patient’s preferences for involvement. Clinicians need to show the appropriate 
skills to be able to show flexibility in applying and tailoring SDM, as and when, and in 
accordance, to the patient’s needs and traits (Rowland & Holland, 1989). For instance, the 
findings showed that ‘passive’ patients showed little understanding and no experience of 
SDM. Therefore, medical professionals need to be able to recognise such passivity, and 
create a mutual atmosphere that is conducive to the patient’s desired levels of participation 
(Coulter & Ellins, 2006; Shaller, 2007), whilst still maintaining a patient-centred approach 
and shared model of decision-making. This could be achieved through patient-focused 
interventions, which recognise the role of patients in the process of securing appropriate, 
effective, safe and responsive healthcare. Such interventions include: communication skills 
training for clinicians; patient surveys to identify role preferences; and patient satisfaction 
questions to monitor the care performance. These findings have implications for future 
research to explore how SDM can be classified and adapted to patient individual 
differences, whilst still being coherent with the shared model of decision-making.  
 However, it could be argued also that it may not be feasible to purely categorise 
patients within these two participatory roles, as patients may employ a combination of both 
roles and show differing traits during different stages of the treatment. For example, the 
findings revealed that some patients remained ‘passive’ during decision-making for 
surgical treatments, and were happy to allow the clinician to choose the decision for either 
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a mastectomy or a lumpectomy; but they showed ‘active’ traits during decisions on the 
adjuvant treatment stage. Through the Prospect Theory framework, it is understood that 
patients can assign values to health status and seemingly make rational or irrational 
treatment decisions (Treadwell & Lenert, 1999; Arthur, Werner, Olivier, 2013). Therefore, 
it could be suggested that patients are not simply assigned to one participatory role type, as 
their desire for participation, and subsequent experience of SDM, can fluctuate at various 
stages of the treatment trajectory. Subsequently, inconsistency in patient participatory roles 
and how this can affect patient experiences of SDM is an area of research, which could be 
of future interest, within the field of SDM research.  
 The findings from study two brought much attention to the experience of SDM 
online, within breast cancer forums. Previous studies have explored patient interaction 
within online forums for breast cancer (Sharf, 1997), and evaluated its impact on patient 
health outcomes (Esyenbach, 2001; Winzelberg et al, 2003). No literature has explored 
SDM for breast cancer online. Study two filled this gap in the literature, and brought 
valuable insight to the meaning, characteristics, and experience of SDM. Analysis of 
patient interaction online revealed that SDM is an approach which is applicable to all 
patient conversations, even outside of a clinical setting. Women were showed to 
experience SDM online with other breast cancer patients, within the forums. The findings 
also showed that the forums provided substantial awareness and information about SDM, 
through members sharing their own personal experiences. Members not only promoted 
SDM, but they also encouraged women to encounter SDM in a clinical setting, and 
supported women with advice as to how they could achieve such encounter. The benefits 
of online support groups in assisting patients’ understanding and experience of SDM, is an 
area worth further research. There is a long way to go to fully understand the effects and 
opportunities of SDM and virtual communities on the Internet in facilitating medical 
decision-making. The findings therefore open opportunities for future research to go 
beyond pure descriptive studies and, therefore, to develop and evaluate the opportunities 
and pitfalls of technologically mediated SDM and forum support groups in maximising 
patients’ experiences of SDM.  
 Finally, the findings emphasised the importance of patient experience of SDM in 
relation to decision-making for adjuvant, but not surgical treatment. Previous literature has 
shown that SDM has been suggested as the preferred approach to treatment decisions for 
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surgical and adjuvant therapies (NCCN, 2007). However, in exploring patients’ 
experiences of SDM, form their perspectives and interactions, the findings revealed that 
there are distinct facets of SDM relating to decision-making for adjuvant treatments, and in 
particular chemotherapy. This links to findings uncovered in study one, which 
demonstrated that women’s initial fear, from having been just diagnosed, led them to 
believe that full removal of the breast would eliminate risk and increase their survival 
chances. This acquired view, therefore, left little opportunity for SDM and patient 
participation in decision-making to take place. Participants explained that they were happy 
to place decision-making in the clinician’s hands, and undergo either a mastectomy or a 
lumpectomy, as long as it meant that the cancer was removed. However, as study two 
revealed, in the later stages of treatment, the thought of hair loss was portrayed as very 
discomforting for women, and this was significantly discussed online in respect to 
treatment decision-making. Therefore, participation in adjuvant treatment decision-making 
was of key concern to patients. This is a novel finding, and requires further research to 
explore SDM, specifically in relation to body image and self-esteem, to understand why 
patients want more ownership of decision-making for adjuvant treatments, rather than 
surgical treatment. This will, therefore, open further scope in research to explore patients’ 
experiences of SDM more closely to QOL and psychological well-being. The findings 
showed that an experience of SDM during decision-making consultations for surgical 
treatments was deemed less important. Nonetheless, this finding offers a valuable 
contribution to breast cancer care, as medical professionals can use the findings for 
assessment, training, and service development purposes, to enhance patient experiences of 
SDM during consultations with the oncology surgeon. 
 
7.3 How is the experience of SDM influenced (hindered or facilitated) for women with 
breast cancer? 
According to the shared model of decision-making, the task of treatment decision-making 
requires joint involvement from the patient and clinician. The model recognises two 
experts: the clinician is an expert in defining the clinically appropriate options, including 
the risks and benefits of each option, based on the latest medical evidence; and the patient 
is an expert in their own values, preferences and concerns (Emanuel & Emanuel, 1992). 
Both experts are required to work together to achieve an encounter for SDM (Emanuel & 
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Emanuel, 1992). Subsequently, this model outlines SDM as a bipartisan approach, which 
sits between the paternalistic model of decision-making and the consumer model of 
decision-making (informed decision-making model).  
 However, previous evaluation studies of SDM demonstrate that the concept is not a 
widely embraced approach, or prevalent in clinical practice (Holmes-Rovner et al, 2000; 
Stevenson, et al, 2000). These studies focus on assessing and evaluating barriers and 
facilitators for implementing the process of SDM in clinical practice (Auerbach, 2000; 
Butow et al, 2007; Gravel et al, 2006; Gwyn & Elwyn, 1999; Loh et al, 2006;). These 
studies of decision-making demonstrate a breakdown in the shared model, due to 
clinicians’ inability to share with patients. For example, studies of doctor-patient 
communication have consistently revealed that the characteristics of SDM, such as sharing 
information and preferences about the identified problems, and two-way interaction 
regarding treatment options, rarely occurs (Roter & Hall, 1992; Tuckett D, Boulton, Olson, 
Williams, 1985). This therefore raises concerns as to whether breast cancer patients’ 
experience of SDM is influenced by factors, which inhibit or facilitate the characteristics of 
SDM, and their subsequent encounters. This is an area in the health psychology literature 
which has not been explored.  
 
 During the investigation of patient experiences, the findings drew attention to 
factors which either facilitated or hindered patient encounters of SDM. Findings across all 
three studies began to raise an issue of a perceived imbalance in power-relations between 
the patient and clinician, which hindered the process of SDM and patients’ experiences of 
it. The interview data in study one revealed that participants appeared to have certain 
perceptions about the clinicians’ role and duty, which in turn impacted on their doctor-
patient relationship, and their subsequent experience of SDM. For many women, the 
clinician was perceived as a medical expert who attained full knowledge and responsibility 
for managing patient health, in which they trusted to deliver quality care (Emanuel & 
Emanuel, 1992). According to Pierce (1993), these patients are referred to as ‘deferrers’ in 
decision-making, as they choose not to deliberate and only accept their doctor’s 
recommendation. An authoritarian view of the clinician meant that patients believed that 
the clinician was responsible for decision-making and, therefore, an equal relationship was 
difficult to achieve. This exemplifies an issue of compliance to the clinician and possibly 
obedience to perceived authority (Milgram, 1963 & 1974). As a result, the finding sustains 
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the paternalistic model in decision-making, in which the patient passively consents to 
professional authority by agreeing to the doctor's choice of treatment (Charles et al, 1997). 
With this model of decision-making, there are no trades-off for the patient, no sharing of 
any of the decision-making steps, and a doctor-patient partnership does not exist (Caress, 
1997; Degner & Sloan, 1992).   
 Such acquired preconceptions about clinicians impacted on the patients’ experience 
of SDM. Many believed that a shared approach to decision-making was difficult to attain, 
due to the clinician’s hierarchical status and role. In support of existing literature, an 
obstacle to participation was shown to be low health literacy and lack of subject knowledge 
(Coulter & Ellins, 2006).  Women believed they lacked adequate expert knowledge, at the 
level of the clinician, in being able to share the task of decision-making and, therefore, 
chose to hand decision-making control over to the clinician. This supports previous 
literature, showing that participants were less likely to be involved in decision-making that 
requires clinical expertise (Thompson et al, 1993). The concept of SDM is to empower 
patients (Charles et al, 1997); however, a perceived discrepancy in doctor-patient power-
relations was shown, which made patients feel inferior and inadequate to participate in 
decision-making. This finding is consistent with existing research which shows that power-
relations can obstruct collaboration in the decision-making process (Saba et al, 2006) and, 
therefore, deter the implementation of SDM (Ford et al, 2003). 
 Study two strengthened the findings from study one, by also illustrating an impact 
of unequal doctor-patient power-relations on patients’ experience of SDM. In reviewing 
patients’ interactions online, it became apparent that patients believed that they must 
overcome their preconceptions of the clinician, for an experience of SDM to occur. 
Women devoted considerable time online to encourage others to maintain their role as a 
shared partner in decision-making, and to sustain control over their health care. This 
second study suggests that the issue of power is a matter recognised by breast cancer 
patients and discussed amongst them. Great focus was illustrated by patients online to 
challenge this power imbalance, as women want facilitate others in their experience of 
SDM, in order to preserve patient rights and the concept of patient-centred care. This is 
consistent with existing research, which shows that support groups can succeed in 
empowering patients (Pitts, 2004). Time was devoted online by forum members to educate 
others about the concept and characteristics of SDM, how to encounter them in a clinical 
setting, and to encourage others about the benefits of SDM in aid of making a treatment 
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decision. The findings from this study showed that forum patient interaction is important in 
raising patient awareness about factors, such as imbalanced doctor-patient power-relations, 
which can hinder patient encounters of SDM in a clinical setting. The findings also 
illustrate the benefit of online peer interaction, as a way of facilitating breast cancer 
patients’ experience of SDM. 
 
 The final study raised the issue of communication skills for SDM, as a factor 
which can inhibit the presence of SDM, and subsequent patient encounters of it. The 
findings in this study revealed that the appropriate cues to facilitate the process of SDM to 
take place, were presented during doctor-patient interaction. However, patients failed to 
recognise these cues and were unresponsive to them. It could be suggested that the lack of 
acknowledged cues for SDM are due to poor communication skills for decision-making, 
which result in a lack of ‘sharing of information’ and ‘sharing of the decision’ from 
patients (Roter & Hall, 1992; Tuckett et al, 1985). The clinician showed an ability to share 
knowledge (‘information sharing’), and also an ability to share preferences and views 
(‘sharing of decisions’). However, for there to be an SDM process between the clinician 
and patient, the patient must also be able to share both components: ‘information’ and 
‘decisions’ (Ong et al, 1995). Despite substantial efforts made during doctor-patient 
interaction to encourage both processes, these two characteristics of SDM were not 
demonstrated by the patients. This supports the literature, that there are still problems with 
respect to the provision of communication during practice (Avis, 1994; Maquire, 1999; 
Caress, 1997; Coulter et al, 1999; Fallowfield & Jenkins, 1999; Tierney, Taylor, Closs, 
1992). It could be suggested that conversations during breast cancer consultation are not 
adequately focusing on these two elements, to assist patients in an encounter of SDM.  
 Analysis of doctor-patient conversations within this study also revealed that 
SDM is hindered as result of a portrayed issue of power inequality, which inhibits patients 
from interacting. This is in support of Gafni et al (1998), who suggested that an unequal 
power dynamic within consultations may prevent a successful provision of information and 
communication. The findings demonstrated that language and discursive practices were 
used, at times, during doctor-patient interaction, such as epistemic markers, which 
enhanced and defined the clinician’s authority and level of expertise. Subsequently, a 
discrepancy in power-relations was established during decision-making conversations, 
which as a result, inhibited shared participation, and disguised any cues which had been 
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presented for SDM. This finding is consistent with existing research which has shown how 
relationship dynamics, such as power, can influence patterns of communication, and 
mediates the perception of collaboration in the decision-making process (O’Flynn & 
Britten, 2006). From the findings in study three, it could, therefore, be argued the patients’ 
equal role during SDM, in a consultation, becomes blurred as a result of being 
overwhelmed by the issue of unequal power-relations, as portrayed and perceived during 
interaction. The patient’s distorted view of their role during decision-making, blinds them 
to any facilitating efforts in conversation made for SDM to occur and, therefore, hinders 
patient participation and the process of SDM.   
 However, this study also showed that conversations for SDM during doctor-
patient interaction can be successfully facilitated during consultations. Although patient 
encounters of SDM was shown to be limited during conversations for decision-making; 
however, when patients were presented with conversations, which were less structured and 
informal in topic, patient participation and characteristics of SDM (two-way interaction, 
information and preference exchange, and patient participation) would occur. Such less 
structured conversations would take place between the clinician and patient during a 
questioning and answering session. This was an opportunity for patients to share their 
concerns, views, and preferences. The informal and less intimidating nature of two-way 
interaction between the patient and clinician lent itself to SDM. Using Henderson’s study 
(2003) to support and interpret the findings, it could be argued that when patients are faced 
with ‘problem solving situations’, which require medical expertise, they do not present 
themselves well to patient participation. However, in contrast, in ‘decision- making 
situations’, which involve the patient’s values and preferences, patients prefer to be 
involved in the latter rather than the former (Thompson et al, 1993). Study three showed 
that women simply rejected the role of ‘problem-solving’, and preferred to pass on 
decision-making to the person with the knowledge and expertise (Deber et al, 1996). 
Therefore, it could be suggested that conversations for ‘problem-solving situations’ are not 
prone to facilitate patients’ experience of SDM. This proposal and the findings from the 
third study are consistent with the findings drawn from study one and two, which showed 
that participants displayed an experience of SDM in situations where opportunities arise for 
them to share their preferences (their views, concerns, and queries). However, as study one 
demonstrated, an experience of SDM was described as unachievable during situations 
which require skills and expertise. 
Chapter Seven 
261 
 
7.3.1. Implications and contributions of the findings 
The discussion above draws much attention to how SDM is experienced by breast cancer 
patients, and how a patient’s experience of SDM can be influence (facilitate or hinder). 
These findings bear several contributions and implications to breast cancer care, as they 
provide useful insight into the views and experiences of breast cancer patients regarding 
partnership in decision-making. It is suggested that the presence of SDM is one which is 
conditioned by a perceived power imbalance regarding the clinician’s role. This perception 
is further fuelled during doctor-patient interaction, through language that further enhances 
the power imbalance. Despite the concept of SDM being designed to empower patients to 
become more involved in their health care (The Health Foundation, 2009), it appears that 
breast cancer patients’ experience of SDM is one of oppression. This is enhanced by their 
preconceptions of doctor-patient roles, and through their interactions with the clinician. 
Patients, subsequently, reduce their participation in decision-making and place greater 
responsibility for decision-making in the clinician’s hands, physically and psychologically.  
 Despite its theoretical appeal, SDM in the clinical encounter has been shown, in 
study three, to be not fully translated into practice. Breast cancer patients, in study one and 
two, show that patients are able to illustrate experiences of SDM and demonstrate an 
understanding of the concept, in accordance with the shared model of medical decision-
making. However, in assessing doctor-patient conversations, it is understood that patient 
experience of decision-making is more inline with a traditional paternalistic model, which 
upholds the practitioner as the ultimate decision maker. This model, therefore, does not 
offer the opportunities that individuals needs in becoming an ‘active’ participant in 
treatment decision-making. If health care professionals remain critical of the rhetoric of 
unbalanced power-relations, and are not prepared to identify practices that belie a shared 
model to decision-making in breast cancer care, then women with breast cancer will 
experience unmet expectations and frustration in their interactions to encounter SDM with 
practitioners. Furthermore, an uncritical adoption of the discourse may lull oncology 
professionals into a false sense of security that breast cancer patients are able to enter into 
partnerships with the clinician. Therefore, changes need to occur in the way clinicians 
communicate to patients, so that discursive cues for SDM are recognised and responded to 
by patients. Patient participation and SDM will, therefore, remain romanticised until 
communication and a shared agenda are at the forefront of the health professional-patient 
encounter.  As a result, this project promotes new insights into the development of breast 
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cancer care and SDM, as it can aid health care professionals to recognise their role in 
obstructing SDM in the treatment for breast cancer. The findings also suggest the need for 
further research to revisit the SDM guidelines, and to outline alternative competencies for 
SDM from those currently outlined in the literature, which may be more equitable and 
yield more favourable outcomes. More attention needs to be given to assessing and 
evaluating doctor-patient communication for SDM, from the patient’s perspective and told 
experiences. This will enable more adequate training of communication skills, which is 
focused on patient-centred care, for the practice and delivery of SDM within breast cancer 
care.  
 A crucial element in SDM is the nature of expectations the two people have about 
their roles, and the congruence and agreement of these role expectations. Patients and 
medical practitioners should have equal roles to play during SDM. However, breast cancer 
patients’ reality of SDM exists within a perceived issue of power imbalance, which hinder 
the SDM experience. It is within the doctor-patient interaction that this understanding is 
constructed, and then further reinforced through peer to peer interaction. Despite the 
suggestions and encouragement given to patients during online forum interaction, about 
patient authority and patient participation, an observed power imbalance between the 
patient and clinician still remains, which conflicts with patient experience of SDM. As 
shown in study three, it is only when power is shared, and both the clinician and patient 
participate in an equitable partnership, based on two-way exchange of information and 
preference, that SDM is established and experienced by patients. The challenge for medical 
professionals is to empower patients in their individual care and encounters of SDM, as 
currently the evidence from this thesis suggests that this has not been established. 
Clinicians need to be proactive in facilitating the process of empowerment in their patients, 
and showing a commitment in sharing their power, as well as the decisions to be made. By 
engaging both experts to work together, this can produce an equality of power, only if both 
roles are acknowledged, clarified, and equally valued. When patients believe they have 
power, they may feel more comfortable about exercising their right to question clinicians 
about their care, share their views and preferences, and participate in their treatment 
choice. All of these aspects have previously been described by participants in the data as 
characteristics which constitute towards patient experiences of SDM. This is not to say that 
patients should and will have more power than clinicians, but it is a question of patients 
acquiring the belief that they are of equal value to the clinician, and entitled to participate 
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during the decision-making process of treatments. Subsequently, further improvements in 
breast cancer care are required to reduce any power imbalance, and to ensure that patient 
roles in SDM are enhanced. Additional training in communication skills is required to 
remove any patient preconceptions of roles and statuses. 
 The issue of power featured as a central analytical finding across the three studies. 
Future research could focus on the power inequalities in doctor-patient consultations for 
breast cancer, and to investigate the extent to which the issue of power affects patients’ 
experience of SDM. This can be achieved by a review of the literature and a meta-analytic 
approach to locate, review, synthesise and summarise the findings, methodology, 
theoretical orientation and interpretation of qualitative research papers. This would 
ultimately identify the external influences of power on doctor-patient interaction, patient 
participation, and SDM in healthcare consultations. More training interventions are 
required to encourage health professionals to implement the shared model of decision-
making, which aims to share power and induce patient empowerment (Charles et al, 1997; 
Coulter, 1997; Elwyn et al 1999; Frosch & Kaplan, 1999; The health foundation, 2009). 
Furthermore, more qualitative research is required to solely explore breast cancer patients’ 
experiences of empowerment during SDM, as this is an unexplored area within the health 
psychology literature.  
 The issue of power also featured as an important analytical finding within the 
breast cancer forum data. The impact of power on patients’ active/passive positioning and 
involvement in decision-making is, therefore, worthy of being furthered explored amongst 
support groups. Existing literature reveals that online support groups have the potential to 
create the conditions necessary to empower patients (Sharf, 1997). Study two also revealed 
that online forum interaction promoted the presence of SDM within a clinical setting, and 
reminded members about the importance of patient authority and patient participation. It is 
unknown whether face-to-face support groups could foster the same effects and, therefore, 
it would be of value for future research to explore this issue of power further amongst 
cancer support groups, such as Macmillan cancer support or Cancer Research support. This 
could provide valuable insight as to whether face-to-face interaction, within a support 
group, should be used as an intervention to remove patients’ perceptions of an issue in 
power, and works towards a better experience of SDM for breast cancer patients. 
Subsequently the findings from this thesis and recommendations for further research offer 
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new insights and opportunities for the development of care practices for women faced with 
breast cancer. 
 
 
7.4 Can SDM for breast cancer be explored qualitatively, through examination 
patient perceptions and conversations?  
Theoretically, designing a qualitative study which is rooted in phenomenology and 
symbolic interactionism is a logical step towards answering this question. This project 
aimed to explore patients’ experience of SDM, through methods which provided detailed 
and in depth meaning and insight into patients’ experiences and understanding of SDM. 
Qualitative research can provide detailed perspectives of individuals’ experiences or 
descriptions of processes, thereby ensuring a more detailed understanding of the 
phenomenon of interest. As the focus was on patient experience of SDM, experience was 
to be captured from both theoretical frameworks of phenomenology and symbolic 
interactionism; and a triangulation of qualitative methods which focused on patients’ 
perspectives and interactions. The triangulation of methods across the three studies meant 
that patient experience could be explored using a range of qualitative research methods.  
To tackle patients’ perspectives on their experience of SDM, a semi-structured interview 
study allowed insight into how SDM was experienced during a patients’ breast cancer 
journey, and how SDM was understood as a result of their perceptions and experiences. 
The second method of capturing experience was to explore patients’ interactions, not only 
with the clinician during a consultation, but with other breast cancer patients. As access to 
direct observations were limited for ethical purposes, two separate studies took form. One 
examined patient to patient interaction, through online support forums. The other explored 
doctor-patient interaction, through audio-recordings of consultations. Both of these studies 
provided an insight into the experience of SDM, and allowed further exploration of the 
meaning, characteristics, and presence of SDM. All three studies used qualitative methods, 
which were considerably different to the traditional methods of exploring SDM, in terms of 
evaluation studies.  
 The first study chose semi-structured interviews as a means to explore patients’ 
understanding and experience of SDM from their perspectives. The interviews 
systematically examined patients’ experience of SDM chronologically, from beginning of 
diagnosis to post treatment completion. This, therefore, provided a spectrum of time points 
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in which the research questions could be explored.  The interviews were personal, but yet 
collaborative with the interviewee, which made them action orientated. The purpose of this 
study was to inform what SDM is like for patients during the whole course of their breast 
cancer journey. The study also operated at an additional level by enabling patients to make 
private reflections. This, therefore, enabled participants to describe their breast cancer and 
decision-making experiences, in ways that would not have otherwise been formulated in 
other SDM-related studies. The semi-structured nature of the interviews meant that women 
could freely talk about their lived experiences and views, during the course of their breast 
cancer care. Previous studies of chronic illness and decision-making have often utilised the 
method of interviews in an inductive way, which depersonalises the lived experience. What 
this first study has shown, by using semi-structured interviews to explore SDM, is that this 
method can reveal details of the personal experience of cancer care, whilst simultaneously 
providing insight into SDM. There was a fine balance which had to be struck in gathering 
disease related and patient satisfaction issues, and making sure that these were not at the 
forefront of the enquiry. Details on aspects of the lived experiences that surround SDM 
were encouraged. The content of these interviews were integrated with the findings of the 
other two studies, in reaching a more detailed understanding. The interview data meant that 
the research phenomena and data extracts could be examined laterally, across the whole 
data set, in an attempt to find general themes. The aim of analysis was not to generalise the 
findings, but to take an exploratory approach, to document and review individuals’ 
accounts of their experiences of SDM during breast cancer. In addition to the interviews 
identifying key emergent themes, they also provided a platform from which further 
research could extend. 
 The second study chose to explore patients’ experience of SDM from the 
interactions they have with other patients. Peer to peer interaction was examined through 
online support group forums, as this would provide a personal insight into the 
conversations which took place for women, during the course of their breast cancer care. 
The nature and benefits of Internet support groups are that they allow members to come 
online and share their views, concerns, and experiences. Therefore, this provides valuable 
data in respect to women’s lived experiences and their perspectives. As women talked 
online about multiple topics in relation to their breast cancer, this enabled SDM to be 
explored amongst experiences which were not presented in the interview data. The 
informal nature of online interaction meant that women could comfortably talk at ease, 
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without feeling embarrassed. Therefore, the online forum data emphasised issues which 
otherwise might have been too distressing for participants to talk about during an 
interview.  Similar to the interviews, the aim of analysis was not to generalise the findings, 
but take an exploratory approach, to document and review individuals’ accounts of their 
experiences of SDM during breast cancer.  The issues raised in the interviews and the 
forum data supported the need for further research to explore the conversations that take 
place during a consultation, to explore the research question further. 
 The final study adopted a more indirect observational approach to exploring patient 
encounters of SDM. This was achieved through examination of doctor-patient 
conversations, during adjuvant treatment consultations. The method was classed as 
indirect, as direct researcher observations did not take place. Instead, patient experience 
was explored through an interpretation of the meanings assigned to SDM and doctor-
patient interaction through audio-recordings of the consultations. The audio recordings 
meant that SDM could be explored during every day doctor-patient interaction for breast 
cancer. The number of recordings or clinicians used for data collection was not important, 
compared to the number of instances which showed the phenomenon (SDM) occurring 
during talk. A CA on doctor-patient interaction paid particular attention to symbolic 
meaning behind doctor-patient interaction, how SDM was verbalised and exchanged, and 
how the presence of SDM was influenced (hindered or facilitated) through talk. The audio-
recording study aimed to document the space between patient perspectives, shown in the 
interviews; and patient interactions about decision-making shown in the forum data, to 
provide a comprehensive exploration of SDM.  The third study completes the triangulation 
of methods, as it ensures that SDM has been explored from patients’ perspectives, from 
their interaction with others, and from their interaction with the clinician. Interpretation of 
the conversations provided an insight into how SDM operates, through talk, and how 
patients encounter it, through interpretation of discursive practices. By exploring how talk 
develops between clinician and patient, much is understood about the level of patient 
participation during decision-making, and the extent to which shared model for decision-
making is encountered by patients. It is important to note, that the aim within this study 
was not to evaluate doctor-patient communications skills for SDM, as this has previously 
been explored in existing literature. Instead the focus was on patients’ experiences, and to 
interpret the meanings ascribed to interactions and actions, which occur between clinicians 
and patients, for SDM during breast cancer consultations.  
Chapter Seven 
267 
 
 In conclusion, to understand how women with breast cancer experience SDM, the 
thesis highlights the need for the research question to be understood from patient 
perspectives and interactions. Much health literature on SDM still remains heavily 
quantitative in nature, as models of decision-making and patient participation are 
predominantly explored through evaluations of patient satisfaction and doctor-patient 
communication. This thesis, however, contributes to qualitative research and raises its 
profile within health related decision-making research. This thesis has extended beyond the 
traditional methods of SDM studies, which employ quantitative and qualitative methods 
for evaluation and assessment of SDM. By examining how women with breast cancer 
experience SDM, this thesis extended the boundaries of existing decision-making research 
to allow for greater understanding about the concept of SDM, as it is experienced, in the 
lived lives of breast cancer patients. A triangulation of qualitative studies has achieved an 
exploration of how SDM is experienced by breast cancer patients. The methods employed 
in each study emphasise the importance of a systematic inquiry, and understanding of 
conscious experience from the person experiencing it. The thesis also extended beyond 
SDM research, to explore the research question through alternative methods of data 
collection, such as online forums. It has sought and successfully achieved an insight into 
breast cancer patients’ experience of SDM, from their personal perspectives and their 
interactions. Finally, it has added to the growing literature on SDM, patient participation, 
doctor-patient communication, and breast cancer care.  
 The overall findings make valuable contributions to qualitative critical health 
psychology research, and provide useful recommendations for future health research. 
Further research into SDM can benefit from the methods used in this thesis, in particular 
for investigating SDM amongst other chronic illnesses. Future research could explore the 
concept of SDM in cancer care, and the identified issue of power within SDM, by means of 
other qualitative methods. For instance, through the use of participant audio-diaries, this 
would allow patients to become collaborators in the data collection, thereby shaping their 
own experience of SDM according to their breast cancer journey. This is a useful 
consideration for chronic illness and decision-making research, particularly as NHS 
initiatives aim to integrate patients into research and increase service user involvement. 
There is a need for more research to move away from focusing on the disease and 
evaluation of processes and procedures in medical care, and instead focus on experience 
and interpreted meanings of such experience.  
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7.5 Project limitations 
The self-selecting nature of the sample was a limitation. For example in study one and 
three, recruitment largely relied on individual women returning the required materials to 
the researcher, and patient good health. Similarly in study two, recruitment was largely 
based on subjective self-selection of the researcher’s ability to identify online posts, which 
met the sample inclusion criteria. This resulted in a narrow sample of participants across 
all three studies. Although the selection of sample produced relevant data to understand the 
process of SDM and patient experiences of SDM within breast cancer, the diversity of 
patients with breast cancer was limited. Participant criteria did not discriminate for other 
chronic illness and cancer diagnoses, which may have influenced patient levels of 
involvement in decision-making. The experience of younger women with breast cancer 
was not explored to detail, as the sample across all three studies represented an age of a 40 
plus population. All participants described their ethnic origin as White British. The 
inclusion of participants from other ethnic backgrounds and ages may have elicited 
different experiences and meanings of SDM, to those raised in this study. This makes the 
research findings limited to their ability to reflect experiences of SDM for other women 
with breast cancer in similar situations. There is a need for a greater exploration of the 
research question with a more diverse sample of patients. 
 Study one entailed a retrospective design, which allowed for a comprehensive view 
of patients’ perspectives and experiences of SDM from diagnosis to post treatment. 
However, for a more comprehensive insight of SDM, which does not depend on participant 
memory, there is the need for a longitudinal design to explore this topic. Such longitudinal 
exploration would allow for a more in depth review of patient experiences, and allow for 
transitions, such as from illness to good health, to be uncovered. To assist with this 
longitudinal design, qualitative methods such as audio-dairies would enable patients’ lived 
experiences to be explored throughout all stages of their illness and life, and outside of the 
hospital. Therefore, this provides a broader assessment of the issue, and a more global and 
inclusive insight into patients’ views and experiences of SDM, in and out of the hospital, 
with clinicians, and with others they interact with. By capturing experiences at all intervals 
of breast cancer treatments, certain questions raised in this thesis could be answered, such 
as why is there a perceived imbalanced of power-relations during doctor-patient decision 
making for adjuvant treatments, but not for surgical treatment decisions?  Another issue 
raised within the interview study is that interviewing largely depended upon retrieval of 
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memories. Recalling a particular distressing time can be a difficult task. Many participants 
showed difficulty in answering some of the interview questions, which may have been due 
to poor or repressed memories. This further added to the particular nature of the data 
collected. 
 The Internet forum study raises some methodological issues that need to be 
explored. Despite the advantages of online research such as, reaching a larger pool of 
potential study participants; increasing access to study sensitive issues and ‘hidden 
populations’; and decreasing data collection time, there were several methodological issues 
with online research that became apparent. As well as the sampling issues outlined above, 
the forums provided some access issues, as many of the British breast cancer support 
forums required membership as a patient in order to access the posts. This, therefore, 
limited the scope of online support groups which could be considered for data collection. 
The forum website arrangements were advanced and based on a categorisation system, 
exhibited by libraries and archives, which was beneficial to data handling. However, the 
three forums used for data collection contained large numbers of posts on a variety of 
topics, which resulted in too much data to handle and refine. The wealth of information 
available, made it difficult, at times, to not divert from the research question. The filtering 
process of online forums did not serve as a reliable means of data collection for the 
research questions, as a ‘top-down’ approach was difficult to obtain due to a large volume 
of data. Furthermore by creating a data inclusion criteria which electing to seek posts on 
decision-making, this meant that the data collection was led by the research questions and 
selected to fit the research, therefore, disabling other general topics and patterns to emerge, 
which could facilitate the overall research.  
 The analysis of conversation, through audio-recordings, also showed some 
limitations. The aim was to capture the interaction which took place between the clinician 
and patients, which was successfully achieved. However, the interaction data lacked 
physical cues, facial expressions, and body movements which could add to the analysis and 
interpretation of talk. There were particular moments of long gaps during conversation, 
which would infer patient turn-taking to take place. However, patients often failed to take 
their turn-in-talk and, therefore, it would have been of value to explore what physically 
occurs during that period of silence. This would have been particularly beneficial in 
exploring why patients often did not recognise or were unresponsive to verbal cues of 
Chapter Seven 
270 
 
SDM. Video-recordings could have provided a more precise and detailed illustration of 
both physical and verbal interaction. 
 
 
7.6 Development and summary of the thesis 
 
From the beginning, this thesis has questioned what it is like for women diagnosed with 
breast cancer to experience SDM during their treatment. To answer this question, there 
were additional questions that needed to be asked. These were: 
 What does the concept of SDM mean to women with breast cancer, and what are 
the characteristics of SDM? 
 How is the experience of SDM influenced (hindered or facilitated) for women with 
breast cancer? 
 Can SDM for breast cancer be explored qualitatively, through examining patient 
perceptions and conversations?  
 
From these questions, a subset of issues emerged with the data analysis of three distinct 
qualitative studies that followed through to the discussion outlined in this chapter. It is 
useful now to return to the initial research questions raised in Chapter One, to see how far 
this thesis has answered the main question above. When searching the literature in Chapter 
Two on SDM and breast cancer, it soon emerged that there was little evidence that 
documented patients’ lived experiences of SDM. It became clear that the literature search 
needed to be broadened to address medical decision-making as a general concern, to help 
answer the main research question.  
 
 Having consulted the literature regarding methods and methodology, in Chapter 
Three, and how best to capture patients’ experiences of decision-making, a semi-structured 
interview study was conducted, in Chapter Four, with 15 breast cancer patients, who were 
two years on from completing all treatments. The literature review at the start of the study 
drew emphasis to the importance of qualitative interviews, as a means to explore the 
research topic. This interview data provided a rich source of themes that could be explored 
further in the thesis. It also provided a valuable insight into participants’ views and 
experiences through their entire treatment trajectory, from diagnosis to post-treatment. 
Using interviews as a starting point was extremely beneficial, as the content of the data 
yielded many issues relevant to the experience of SDM for breast cancer patients. These 
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included, the individual differences in experience of SDM; aspects of doctor-patient 
interaction which constitute towards an experience of SDM; and barriers between doctor-
patient relationship which hinder experiences of SDM. These were striking accounts, not 
only about how women experienced SDM, but also about their understanding of the 
characteristics of SDM and the meaning of the concept; and about factors which can 
enhance and restrict patient encounters of SDM. 
 
 To explore patients’ experiences of SDM further, an online forum study was 
carried out and reported in Chapter Five, to capture patients’ experiences and 
understanding of SDM through the interactions they have with other patients. The 
literature review at the start of the chapter highlighted the value of the Internet as a 
medium for health research and to capture patients’ experiences of SDM; a novel method 
of exploration in the SDM literature. The Internet data allowed for considerable access to 
patient experience, and to explore the conversations, dilemmas, and concerns about 
treatment decision-making patients are faced during their cancer care. Analysis of the 
interaction yielded valuable insight that supported the interview study, and provided 
encouragement for further exploration in the thesis. The forum analysis identified many 
issues relevant to the experience of SDM for breast cancer patients. These included how 
and when the forums are used by breast cancer patients, and the types of decision-making 
topics interacted online. Other issues included awareness and encouragement given to the 
process of SDM to occur in a clinical setting, and educating others about ways to maintain 
an experience of SDM with clinicians. Considerable insight into breast cancer patients’ 
experiences and understandings of SDM, how SDM is characterised, and the factors which 
can enhance and restrict patient encounters of SDM, were obtained from this second study. 
 
 Both the interview and online forum studies show that these qualitative methods 
can be successful in terms of accessing patients’ experiences of SDM, through capturing 
patient perspectives and interactions. However, the current practice of SDM during a 
clinical encounter still needed to be explored to provide a detailed answer to the main 
research question. To demonstrate how SDM is verbalised and exchanged in a 
consultation, and to explore how the presence of SDM is hindered or facilitated during 
doctor-patient interaction, a third study was conducted and reported in Chapter Six. The 
final study aimed to explore the interactions which took place between patient and 
clinician during a decision-making consultation for adjuvant treatments. Focus was to 
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interpret the meanings ascribed to interactions which took place during doctor-patient 
communication for SDM. As the previous two studies drew awareness to importance of 
two-way communication in facilitate SDM; and a perceived issue of doctor-patient power 
discrepancy which inhibited SDM, this third study, therefore, provided an opportunity to 
further explore this issue. Analysis of conversations yielded valuable findings about how 
conversations for SDM take place between the patient and clinician. The findings showed 
that despite great efforts put forward by the clinician to exert SDM and allow for patient 
participation, there appears to be a lack of acknowledgement and response by patients to 
these displayed discursive cues. Subsequently, the concept and presence of SDM is 
demonstrated to be limited by language and conversation practices, which further 
exaggerate the perceived discrepancy of power-relations between the clinician and patient.  
The discourse, which maintains the clinician’s power, stands above and is acknowledged 
more than the discourses for SDM. This, therefore, results in a lack of two-way interaction 
and the exchange of information and preferences between clinician and patient, which 
allow for SDM to occur. Considerable insight is provided from this third study about 
patient encounters of SDM, and the factors which influence the presence of SDM during 
breast cancer consultations. 
  
 The question of ‘can SDM for breast cancer be explored qualitatively, through 
examining patient perceptions and conversations?’ was raised. Qualitative methods of 
interviews, online forum, and conversation analysis have shown to be substantial 
investigative tools. By employing the theoretical perspectives of phenomenology and 
symbolic interactionism, patient experience of SDM has been captured across all three 
studies, through examination of patient perspectives and interactions with others and the 
clinician. The thesis has not only demonstrated research with qualitative methods of 
interviews and conversation analysis, which have previously been used in existing 
literature on medical decision-making and patient participation, but it has also taken a 
novel step forward in utilising these methods in different ways. An example of this was 
using interviews post-cancer, to capture a comprehensive exploration of patient 
experiences, through their entire treatment trajectory; and by using audio-recordings to 
provide detailed insight into conversations for SDM during consultations. The thesis also 
showcases innovative qualitative methods, such as Internet written data analysis, and 
shows the applicability of this design to phenomenological and symbolic interactionist 
research and health psychology research, particularly on medical decision-making. 
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 This thesis has emphasised the importance of qualitative methods in making sense 
of SDM and understanding how it is experienced by patients. The overall message that 
thesis reveals, in terms of how patient experience of SDM can be explored, is that we must 
study SDM through patients’ lived experiences and try to understand the meanings that 
patients ascribe to those experiences. Attention should be given to how people perceive 
and interpret their encounters of SDM, and indeed with other chronic illnesses, and not 
necessarily at exploring competencies which are linked to SDM, or assessing SDM in 
relation to the disease (patient outcomes). This is because people experience their illnesses 
in many different contexts and each have personal individual differences, therefore, 
implying that patients do not always follow a treatment plan that is determined by the 
disease outcome. Removing the emphasis from evaluating SDM and extending it to other 
aspects, such as patient experiences, perspectives, and interactions is far more productive 
in producing rich and detailed data about SDM, which has not been formally documented 
in this area of research.  
 The thesis draws on the NICE (2004 & 2012) guidelines for SDM and the shared 
model of medical decision-making, and illustrates its use for the treatment of breast cancer, 
from the view of the patient’s lived experiences. The key development of the research is 
that it has contributed to the critical health psychology literature, by demonstrating how 
breast cancer patients experience SDM during their treatment, using qualitative methods 
and the theoretical perspectives of phenomenology and symbolic interactionism. Most 
importantly, it has exposed the concept and meaning of SDM from patients’ perspectives, 
interactions, and interpretations of those actions. From all three studies, the thesis has also 
suggested implications for future research, such as to further explore patient experience of 
SDM with alternative qualitative methods; to apply the methods and methodological 
practices from this thesis to explore patient experience of SDM amongst other chronic 
illnesses; to explore the impact of face-to-face support group interaction on patient 
experience of SDM; and to further explore the issue of doctor-patient power inequalities 
and SDM within breast cancer care. It is important to keep exploring patients’ lived 
experiences of SDM to add to the growing health psychology literature on decision-
making. Besides the suggestions made for future research, the thesis also offers useful 
suggestions, at a clinical level, such as, for practitioners to acknowledge patient individual 
differences and active and/or passive positioning, in order to adapt SDM to patient 
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preferred participatory roles; communication skills training for improved interaction, 
which removes discursive barriers and enables patients to recognise cues for SDM and 
patient participation during doctor-patient interaction; and the development and practice of 
methods to regularly monitor and assess patient experiences of decision-making for service 
quality improvement.  
 The thesis makes an important contribution not only to qualitative critical health 
psychology and the existing literature on SDM and patient participation, but most 
importantly to breast cancer care. It signified the relevance and importance of SDM being 
a requirement in health practice, and emphasises that something that is shared, such as 
medical decision-making, needs to be understood by all parties. It also helps to advance the 
knowledge and recognition that health care providers and services have on the concept and 
practice of SDM. It offers new insights into the development of breast cancer care, as it 
facilitates health care professionals and organisations with the appropriate knowledge and 
skills needed to ensure that the concept of SDM is experienced by all patients. The findings 
on doctor-patient power-relations will help medical professionals develop a greater 
understanding for establishing and maintaining patient-centred care, and a shared model of 
medical decision-making in the treatment for breast cancer, and for treatment of other 
cancers. This will advance services and practice to promote breast cancer patients’ health 
and well-being. 
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Glossary of breast cancer terms & abbreviations used in this 
thesis 
 
Absolute risk A measure of the risk of a certain event happening. In cancer research, an 
example of an ‘absolute risk’ can include the statistical likelihood that a cancer-free person 
of a given age will develop that cancer over a certain period of time.  
Acute Symptoms or signs that begin and worsen quickly and last for a short time; not 
chronic. 
 
Adjuvant treatment Treatment given in addition to other treatment, for example 
chemotherapy or radiotherapy given as well as surgery. 
Adverse effect An unexpected medical problem that happens during treatment with a 
medicine or other therapy. Adverse effects do not have to be caused by the medicine or 
therapy, and they may be mild, moderate or severe. Also called adverse event. 
 
Axillary clearance An operation to remove all the lymph glands from under the arm 
(axilla). 
Axillary nodes The lymph nodes (also called lymph glands) under the arm (axilla). 
Benign Not cancer 
Biopsy Removal of tissue to be looked at under a microscope. 
Breast care nurse Trained to provide information and support to anyone diagnosed with 
breast cancer. 
Breast-conserving surgery (also known as wide local excision or lumpectomy): the 
removal of the cancer with a margin (border) of normal breast tissue around it. 
Carcinoma The medical term for cancer 
Cancer A group of diseases in which malignant cells grow out of control and may spread 
to other parts of the body. 
Cells Tiny structures found in all living organisms   
Chemotherapy Treatment aimed at destroying cancer cells using anti-cancer drugs, which 
are also called cytotoxic drugs.  
Chronic An illness, disease or condition that is long lasting and generally slow to progress.  
Clinical Observation and treatment of patients. 
Clinical trials Research that aims to improve treatment or care for patients. 
Complementary therapies A varied group of therapies used alongside conventional 
medical treatments. 
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DCIS (ductal carcinoma in situ) or Intraductal: An early type of breast cancer where the 
cells have not yet developed the ability to spread outside the walls of the ducts into 
surrounding breast tissue or to other parts of the body. Sometimes called a pre-invasive, 
intraductal or non-invasive cancer.  
Drug resistance Reduced effectiveness of a drug on a disease.  
Excision Surgical removal 
FEC A combination of the chemotherapy drugs 5-flurouracil (5FU), epirubicin and 
cyclophosphamide. 
FEC-T A combination of the chemotherapy drugs 5-flurouracil (5FU), epirubicin, 
cyclophosphamide and Taxotere (docetaxel). 
Fibrocystic A benign (not cancer) breast condition when multiple cysts or lumpy areas 
develop in one or both breasts. 
Gene Stores the biological information we inherit from our parents, affecting the way we 
look and how our bodies work and grow. 
Grade The system used to classify cancer cells according to how different they are to 
normal breast cells and how quickly they are growing (1=low, 2=moderate, 3=high) 
HER2 (human epidermal growth factor receptor 2) A protein involved in the growth of 
cells. Around 20% of breast cancers have higher than normal levels of HER2 (known as 
HER2 positive) which stimulates them to grow. 
Herceptin A targeted therapy used to treat HER2 positive breast cancer, and one of a 
group of drugs called monoclonal antibodies. 
Hereditary Characteristics, conditions or illnesses that can be passed from parent to 
offspring through genes. 
Hormone receptor Involved in the growth of cells. In some breast cancers they bind to 
hormones within the cells (known as hormone receptor positive) and stimulate the cancer 
to grow. 
Hormones Chemical messengers produced in various organs of the body that regulate 
growth and reproduction. 
Hormone therapy Use of drugs to block the effect of hormones on cancer cells; only used 
if the breast cancer is hormone receptor positive. 
HRT (hormone replacement therapy) Female sex hormones, either oestrogen alone or a 
combination of oestrogen and progesterone, often used to help reduce menopausal 
symptoms. 
Invasive cancer Has the potential to spread to other parts of the body. 
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Lobular cancer (in situ/ LCIS) Non invasive cancer that begins in the lobules (milk 
glands) of the breast 
Locally advanced breast cancer Also known as regional recurrence. Breast cancer that 
has come back and spread to the tissues and lymph nodes around the chest, neck and under 
the breastbone. 
Lumpectomy An operation to remove an area of breast tissue with or without a margin of 
healthy tissue; in breast cancer may also be called wide local excision or breast-conserving 
surgery. 
Lymph nodes Also known as lymph glands. Small oval-shaped structures found in 
clusters throughout the lymphatic system, for example under the arm (axilla). 
Lymphoedema Swelling of the arm, hand or breast area caused by a build-up of lymph 
fluid in the surface tissues of the body. It can occur as a result of damage to the lymphatic 
system, for example because of surgery and/or radiotherapy to the lymph nodes under the 
arm (axilla) and surrounding area. 
Malignant In cancer, uncontrolled growth. Invasive cells that have the potential to spread 
elsewhere in the body. 
Mammogram A breast x-ray. 
Mastectomy Removal of all the breast tissue including the nipple area. 
MRI (magnetic resonance imaging): a technique whereby a computer linked to a magnet 
produces images of internal areas of the body 
Non Invasive cancer Does not have the potential to spread outside the tissue in which it 
began 
Oncologist A doctor who specialises in cancer (oncology). An oncologist may be a 
medical oncologist (cancer drugs specialist) or clinical oncologist (radiotherapy and/or 
cancer drugs specialist). 
Oncology: the study or science of cancer 
Oncoplastic surgeon A breast cancer surgeon with specific training in plastic surgery 
Palliative care Focuses on symptom control and support when an illness cannot be cured; 
usually involves a team of healthcare professionals such as specialist nurses, doctors, social 
workers and physiotherapists. 
Palliative treatment Aims to control symptoms and slow down the progress of an illness, 
rather than cure it. 
Pathology The branch of medicine that looks at how disease affects the body’s cells and 
tissues. Each time you have tissue removed a report is written by a pathologist (a doctor 
who examines the tissue). 
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Plastic surgeon A specialist surgeon trained in plastic surgery techniques such as breast 
reconstruction. 
Primary breast cancer Breast cancer that has not spread beyond the breast or the lymph 
nodes (lymph glands) under the arm (axilla) 
Prognosis The likely outlook of a disease, whether it is likely to be cured and the person’s 
life expectancy. 
Prosthesis An artificial breast form used to restore shape when all or part of the breast has 
been removed. 
Psychosocial Oncology Psychosocial Oncology is the formal study, understanding and 
treatment of the social, psychological, emotional, spiritual, quality of life and functional 
aspects of cancer across the cancer continuum, from prevention through diagnosis, 
treatment, survivorship, palliative care and bereavement. 
Radiotherapy The use of high energy x-rays to destroy cancer cells. 
Radiologist A doctor who specialises in the use of imaging (for example x-rays, 
ultrasound, CT, PET, MRI) to diagnose and treat disease. 
Reconstruction (breast) surgery rebuilds breast shape after all or part of the breast has 
been removed. 
Recurrence When a disease or condition returns. There are several types of breast cancer 
recurrence. 
Local recurrence Breast cancer that has come back in the chest/breast area or in the skin 
near the original site or scar. 
Remission when the signs and symptoms of a disease partly or completely disappear; this 
may be temporary or permanent. 
Risk factor In medicine, something that increases a person’s chance of developing an 
illness such as cancer. 
Secondary breast cancer when breast cancer cells spread from the first (primary) tumour 
in the breast through the lymphatic or blood system to other parts of the body. Also called 
metastases, advanced breast cancer, secondaries or stage 4 breast cancer. 
Sentinel node biopsy (SNB) Identifies whether or not the first lymph node (or nodes) is 
clear of cancer cells. 
Side effect Unwanted effect of treatments 
Stage The size of the cancer and how far it has spread. 
Surgical margin How close the cancer cells are to the edges of the whole area of tissue 
removed during surgery. 
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Systemic treatment Drugs that treat the whole body, for example, chemotherapy, 
hormone therapy or targeted therapy. 
Tamoxifen A hormone therapy drug. 
Targeted therapies (also know as biological therapies) A group of drugs that block the 
growth and spread of cancer by interfering with the biology of the cancer cells. They target 
specific processes in the cells that cause cancer to grow. 
Terminal illness Eventually causing death, often used when someone is approaching the 
last few weeks or days of life 
Tumour An overgrowth of cells forming a lump; may be benign (not cancer) or cancer. 
Ultrasound: a test which uses sound waves to create pictures of the tissues and internal 
organs of the body. It is helpful in determining if a breast lump is solid tissue or contains 
fluid.  
 
Wide local excision (WLE) Surgery to remove breast cancer with a margin of healthy 
tissue. Sometimes called breast-conserving surgery or lumpectomy. 
X-Ray: Low doses of high energy radiation used to diagnose disease or high doses of 
radiation used to treat cancer 
 
Abbreviations used in this thesis: 
BPS: British Psychological Society 
CA: Conversation Analysis 
DOH: Department of Health 
FPP: First Pair Parts 
HRQOL: Health-related Quality of Life 
NHS: National Health Service 
MDT: Multi-disciplinary Team 
NICE: National Institute for Health and Care Excellence 
QOL: Quality of Life 
SDM: Shared Decision-making 
R&D: Research and Development 
REC: Research Ethics Committee 
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TA: Thematic Analysis 
TCU: Turn Construction Unit 
TRP: Transitional Relevant Place 
SPP: Second Pair Parts 
 
Appendix B 
Patient invitation letter 
341 
 
IRAS Version 2  Reference 11/H1203/8  2
nd
 March 2011 
  
 
 
   Mr Narayanan 
University Hospital of North Staffordshire 
City General  
Newcastle Road 
Stoke-on-Trent 
Staffordshire 
ST4 6QG 
 
      Tel /Fax: 01782 554079 
            - / - / 2011  
Dear Patient,   
I am writing to inform you about a research project currently taking place at the Cancer 
Centre at the University Hospital of North Staffordshire.  The project aims to explore what 
are the views and experiences of shared decision making for breast cancer patients during 
treatment. We would therefore like to invite you to participate in an interview with our 
research team.  
We have enclosed some more information about the project which we would be grateful if 
you could read. If you are willing to take part in the project, please could you sign, date the 
invitation form, and return it in the FREEPOST envelope provided. 
On consent to your participation, you will be contacted by a member of the research team, 
Miss Neda Baniamer, who will be happy to arrange to meet you for an interview taking 
place at the University Hospital of North Staffordshire, at a date and time convenient for 
you.  
Finally, you do not have to take part in the project if you would prefer not to, it will not 
affect your care in any way.   
 
Yours sincerely, 
 
Mr Sankaran Narayanan 
Consultant Onco-plastic Breast Surgeon 
 
 
Keele University, Staffordshire, ST5 
5BG. Telephone: (01782) 733669 
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IRAS version 1 Reference: 2
nd
 December 2011  
 
 
 
Dr Brunt  
Mr Narayanan 
University Hospital of North Staffordshire 
City General  
Newcastle Road 
Stoke-on-Trent 
Staffordshire 
ST4 6QG 
 
Tel: 01782 679906   
Patient Information Sheet 
 
 
Project Title: Research on the views and experiences of shared decision making for 
patients during the treatment of breast cancer 
 
You are being invited to take part in a research study.  Before you decide, it is important 
for you to understand why the research is being done and what it will involve.  Please take 
time to read the following information carefully and discuss it with friends and relatives if 
you wish.  Ask us if there is anything that is not clear or if you would like more 
information.  Take time to decide whether or not you wish to take part. 
  
Part 1 Tells you the purpose of this study and what will happen to you if you take part.   
Part 2 Gives you more detailed information about the conduct of the study.  
 
PART 1- The purpose of the study / what will happen if you take part 
 
What is the purpose of the study? 
Breast cancer patients often have to face difficult decisions about their treatment. Although 
cancer management is governed by specific clinical guidelines, many decision making 
processes remain complex for patients.  Even with a choice for treatment, many feel they 
lack control or involvement in decisions to manage their health. Consequently, medical 
professionals need to be aware of the important impact of decision making processes and 
active patient participation. 
 
This research represents the first comprehensive examination of the role of shared decision 
making in the medical treatment journey and quality of life of woman with breast cancer. 
The research will help to establish guidelines for acknowledging and maintaining the 
importance of a patient’s role in shared decision making and involvement during their 
treatment of breast cancer, for use by physicians and other health professionals. Findings 
from the study will be integrated in an oncology setting and practice, and as a consequence 
will help physicians and promote breast cancer patients’ health and well-being. 
 
Keele University, Staffordshire, ST5 5BG. 
Telephone: (01782) 733669 
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Why have I been asked to take part? 
All patients who have recently completed surgery for breast cancer treatment in the last 
month, and who are currently registered under Dr Brunt’s care for treatment of radio 
therapy or chemotherapy are invited to participate. 
 
Do I have to take part? 
No. It is up to you to decide whether or not to take part once you have read this 
information sheet.  If you do, we would like you to sign the invitation form enclosed and 
send it back in the FREEPOST envelope provided. You are still free to withdraw at any 
time, even during or after the study itself, without giving a reason. A decision to withdraw 
at any time, or a decision not to take part, will not affect the standard of care you receive.  
If you change your mind after you have sent in your recorded consultation cassette, then 
please contact a member of the research team within 10 days, and we will remove your 
data accordingly. 
 
What will happen to me if I agree to take part? 
If you agree to take part in the study: 
(1) A member of the research team will contact you to thoroughly go through the 
information leaflet, give you the opportunity to discuss participation, and answer 
any questions.  
(2)  You will be then sent further documents in the post, in which you will be asked to 
provide and send back written informed consent to participate, as well as to place 
your consultation audio cassette recording into the envelop provided. 
(3) The cassette will be comprehensively analysed by a member of the research team.  
(4) You will receive your original cassette recording back to you by post, along with a 
summary of the findings. This will be accompanied by a call from the research 
team to ask if you understand the findings, as well as to talk about any questions or 
feelings you might have regarding your participation. 
 
What do I have to do? 
On acceptance of releasing your cassette for research purposes, you are required to send 
this to the research team, along with full consent.  The aim of analysis is to give us a clear 
picture of the degree of decision making, control, and patient involvement which is evident 
through the course of your consultation and treatment. 
 
Will I receive any payments or reimbursement of expenses for taking part in this 
research? 
As you are required to send documents and the cassette in the post, it will be ensured that 
all postage cost is paid for through the use of pre-paid envelopes provided. We cannot 
make additional payments for participation. 
 
What are the possible disadvantages and risks of taking part? 
There are no risks associated with this research. Your participation will not affect the 
medical care you receive in any way. 
 
What are the possible benefits of taking part? 
The research will help to develop a greater understanding for maintaining patient 
involvement in decision making processes in the treatment for breast cancer, for use by 
Appendix C 
Patient information leaflet 
344 
 
physicians and other health professionals. Therefore, it can contribute to improving the 
overall quality of life for women with breast cancer, and increasing patient satisfaction 
with the level of the care received. As a participant, you will help in achieving those goals 
 
What happens when the research study stops? 
When we have collected enough cassette recordings from patient, the research team will 
transcribe the audio cassettes and read through them carefully. This will be done at Keele 
University. They will identify key areas which worked particularly well for the patient, and 
areas which could be done differently to improve the service provided.  The results will be 
presented in the form of a report. 
 
Will my taking part in the study be kept confidential?  
Yes.  All the information about your participation in this study will be kept confidential.  
The details are included in Part 2. 
 
This completes Part 1 of the Information Sheet. 
If the information in Part 1 has interested you and you are considering participation, 
please continue to read the additional information in Part 2 before making any decision. 
 
PART 2 - Further information 
 
Is there an independent contact point where I can seek general advice about taking 
part in research? 
The Patient Advice and Liaison Services (PALS) is a hospital service, available to give 
independent advice on any queries you have about your rights as research subjects or 
information about being involved as participants in a research study. 
 
What if there is a problem? 
If you are unhappy with any aspect of this study, please tell a member of the research team 
who will contact you with and they will try to rectify the problem. Alternatively, you can 
contact a member of the research team at any other time who will do their best to answer 
your questions (see contact information below).If you remain unhappy about the research 
and/ or wish to raise a complaint about the way you have been approached or treated 
during the course of the study, please write to Nicola Leighton: Research and Governance 
Officer, Research and Enterprise Services, Dorothy Hodgkin Building, Keele University, 
ST5 5BG 
 
Will my taking part in the study be kept confidential? 
Several procedures will be carried out to safeguard you and confidentiality. These include: 
(1) Dr Brunt is aware that his patients will be contacted. However he will not know 
who participates and sends in their cassette recordings for analysis. All information 
which is collected about you during the course of the research will be kept strictly 
confidential. Only the research team will have access to hearing the cassette, and no 
one outside of the research team will have access to any of the information 
gathered. 
(2) Only the original cassette will be used for analysis. No duplications will be made of 
the cassette, and the original will be sent back to you. 
(3) Analysis of the cassette will take place in a secure confidential area at Keele 
University by the research team only. 
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(4) The transcript collected from the interview will contain no identifying features. 
You will be given an identification number only. Where data or direct quotes are 
used they will be anonymised. Any publication material arising from this research 
will contain no information identifying patients or medical staff 
(5) Computers which store the data will be password protected, and all data will be 
kept in a secure environment, at Keele University. The transcription of your 
cassette will only be read by the research team, not by Dr Brunt or any part of your 
medical team. After the feedback report has been produced, the transcripts will be 
kept as secure confidential records for a maximum of 2 years.  After this time, all 
transcripts will be destroyed.  
 
What will happen to the results of the research study? 
The research findings will be presentation to the oncology staff at the hospital. All 
participants will be presented with a written summary report, with an opportunity to 
comment on these results. The work will be submitted in fulfilment of a PhD in 
Psychology at Keele University. We may use some of the data we collect for publications 
in academic journals or for presentations at conferences.  
 
Who is organising and funding the research?   
The project is being run by Keele University (Institute of life Course Studies), Psychology 
Department. 
 
Who has reviewed the study?  
The Research and Development Department, The University of North Staffordshire, Dr 
Darren Clement, Tel: 01782 554334 
 
The Research and Development Department, Keele University, Nicola Leighton, 
Tel:01782 733306 
Staffordshire Research Ethics Committee, Redditch, Jenny Tyers, Tel: 01527 582535 
Contact Details- Research Team 
Chief Research Investigator: University Hospital of North Staffordshire, Dr Brunt- Tel: 
01782, email: Murray.Brunt@uhns.nhs.uk  
 
Principal Research Investigator: Keele University, Miss Neda Baniamer- email: 
n.baniamer@ilcs.keele.ac.uk 
 
PhD Academic Supervisor: Keele University, Dr Sally Sargeant- Tel: 01782 583387, 
email: s.j.e.sargeant@psy.keele.ac.uk.  
 
 
Thank you for taking the time to read this information sheet.  If you think you would like to 
take part, please sign and return the enclosed invitation form in the FREEPOST envelope 
provided. 
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IRAS Version 2  Reference: 11/H1203/8   2
nd
 March 2011 
 
 
 
Mr Narayanan  
University Hospital of North Staffordshire 
City General  
Newcastle Road 
Stoke-on-Trent 
Staffordshire 
ST4 6QG 
 
    INVITATION FORM 
Title of Project:  Research on the views and experiences of shared decision making for patients 
during the treatment of breast cancer 
Name of Principal Investigator:  Miss Neda Baniamer 
       Please tick 
1. I confirm that I have read and understand the information sheet dated 2
nd
 March  
      2011 (version 2) for the above study.                                      
 
2.    I have had the opportunity to consider the information, ask questions,  
       and have had these answered satisfactorily.  
 
3.    I understand that my participation is voluntary and that I am free to withdraw  
 at any time, without giving any reason, without my medical care or legal rights 
 being affected.        
                   
4. I understand that my participation in this research will have no bearing on my 
      medical treatment and will not be included in my medical notes. 
 
5.   I agree to take part in the above study.  
 
 
6. I agree to be contacted to arrange a convenient time and date for the interview  
    to take place   
 
Signed: ...........................................................................        Date: ............................................. 
 
Print Name: 
.........................................................................................................................................................
 
Keele University, Staffordshire, 
ST5 5BG. Telephone: (01782) 
733669 
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IRAS Version 1 Reference: 11/H1203/8 5
th
 January 2011 
 
Interview schedule 
 
1 Introductions and general information 
a) How long ago where you diagnosed? 
b) What treatment(s) did you undertake? 
c) How long was treatment from initial diagnosis to completion? 
(Narrative history of the patients story/background info) 
2 Knowledge of breast cancer treatments, information and communication 
 Can you describe how much you knew about breast cancer and treatments before 
you were diagnosed? 
o Friends or family? Media campaigns? 
 How did this change shortly after you were diagnosed? 
o Little? Increased your knowledge of a particular area? 
 How did this make you feel? 
 What were the main sources of information you received?  
o Written, verbal, nurse, consultant? 
o How did you find this information? 
 How did it make you feel? 
 What, if anything, did you do to find our more information for yourself? 
o Online resources, informal discussions with others, NHS Direct? 
 How did this make you feel? 
 
4 Decision-making   
a) To what extent did you feel involved in choices of treatment /care offered to you? 
o How did this make you feel? 
b) If you felt involved, what things do you think assisted this feeling? 
o (What preconditions) give examples – e.g. physical health, courage, 
personality 
o Other areas of health NHS treatment? 
c) To what extent did you want to be involved in these choices? 
d) How much control did you feel you had about your treatment choices? 
o How did this make you feel? 
e) What is your own concept of shared decision making? 
o Is it a 50/50 relationship? 
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5 After treatment  
 How would you say your life has changed since completing your treatment? 
o Increased confidence/ fear/levels of control/increased wish for involvement 
on breast cancer research or patient groups? 
 How does this make you feel? 
 What specific influence has this experience of breast cancer had on your general 
decision-making ability? And control? 
o How does this make you feel? 
 What specific influence has this experience of breast cancer had on your general 
levels of control ability? 
o How does this make you feel? 
 
6 Summary questions 
a) Looking back on everything you’ve been through, is there anything you would 
have done different or wish you had done/not done?  
b) What, if anything could have improved the overall care you received? 
c) Anything else to add before we conclude?  
 
 
Key 
Numbers: Topic in question 
Letters: Questions 
       : Prompts 
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IRAS Version 2   Reference: 11/1H203/8   2
nd
 March 2011 
 
 
 
Mr Narayanan  
University Hospital of North Staffordshire 
City General  
Newcastle Road 
Stoke-on-Trent 
Staffordshire 
ST4 6QG 
 
Tel: 01782 679906   
Patient Identification Number:   
 
CONSENT FORM 
Title of Project:   Research on the views and experiences of shared decision making for patients 
during the treatment of breast cancer 
 
Name of Principal Investigator:  Miss Neda Baniamer 
Today you will be interviewed about views and experiences of your involvement in the decision 
making processes through the course of your treatment. The interview is confidential and will take 
approximately 30 minutes. Before participating in the interview, it’s important to understand why 
the research is being conducted and what it will involve for you. So please ensure you have read 
the information leaflet carefully, and have all questions answered thoroughly. You will be given a 
copy of this information sheet and your signed form to keep. 
 
If you are interested in being interviewed, please sign below. If you are not interested, this will not 
affect your treatment in any way. 
1. I confirm that I have read and understood the information sheet. I have also had the 
opportunity to ask questions and have had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time, 
without giving any reason, without my medical care or legal rights being affected in any 
way. 
 
3. I understand that my participation in this research will have no bearing on my medical 
treatment and will not be included in my medical notes.  
 
4. I agree to the interview being audio recorded and transcribed for the researcher’s notes.  
 
 
Keele University, Staffordshire, ST5 5BG. 
Telephone: (01782) 733669 
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5. I understand that the interview is confidential, to be seen/heard only by the research team. 
 
6. I understand that relevant sections of any of my medical notes and interview   
            data collected during the study, may be looked at by responsible individuals from  
            the research team, where it is relevant to my taking part in this research.   
            I give permission for these individuals to have access to my records 
 
7. I agree to allow anonymised direct quotes to be included in the research write up. I 
understand that all data collected about me during this study will be anonymised before it 
is submitted for publication. 
 
 
.   
________________________ ________________ ____________________ 
Name of Patient  Date Signature 
   
 
 
_________________________ ________________ ____________________ 
Name of Person taking consent Date  Signature 
(if different from researcher) 
 
 
 
_________________________ ________________ ____________________ 
Researcher   Date  Signature 
 
 
 
 
 
 
 
When completed, 1 for patient; 1 for research file   
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Demographic Questionnaire 
 
Can you please complete the following demographic information. 
  
 1. What is your gender (Please tick) 
□        Male 
□        Female 
 
 
2. What is your age (Please tick) 
□  Under 22 
□  22– 29 
□  30 – 39 
□  40 – 49 
□  50 – 59 
□  60 – 69 
□  70 and over 
  
 
3. To which one of these ethnic groups would you say you belong? (Please tick ONE box 
only) 
  
a.      WHITE 
□        British 
□        Irish 
□        Any other White background 
  
b.     MIXED 
□        White and Black Caribbean 
□        White and Black African 
□        White and Asian 
□        Any other Mixed background 
  
c.      ASIAN OR ASIAN BRITISH 
□        Indian 
□        Pakistani 
□        Bangladeshi 
□        Any other Asian background 
  
d.     BLACK OR BLACK BRITISH 
□        Caribbean 
□        African 
□        Any other Black background 
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e. CHINESE OR OTHER ETHNIC GROUP 
□        Chinese 
□        Any other ethnic group 
  
 
4. Do you have any of the following long standing conditions? (Please tick all that apply) 
□        Deafness or severe hearing impairment 
□        Blindness or partially sighted 
□        A Longstanding physical disability 
□        A learning disability 
□        A mental health condition 
□        A long standing illness such as HIV, diabetes, chronic heart disease or epilepsy 
□        No, I do not have any other medical condition 
 
 
 
5.  What is your marital status (Please tick) 
□  Married 
□  Divorced 
□  Widowed 
□  Separated 
□  Never been married 
□  A member of a unmarried couple 
 
 
 
6.  What is your employment status (Please tick)  
□  Employed 
□  Self-employed 
□  Out of work 
□  A homemaker 
□  A student 
□  Retired 
□  Unable to work 
 
 
 
THANK YOU FOR YOUR HELP TODAY 
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Initial Notes/ Patterns  Lines (name) Codes Sub- Themes Provisional name Final Theme 
Engage in literature 
Ask the clinician questions 
Participate in discussion 
Want to be in control of health care 
Talking to other patients/support groups 
Must be involved in decision 
Experience SDM 
Patient involvement leads to SDM 
 
149-156 (Sarah) 
51-66, 121-124 (Judy) 
72-78, 155-156 (Elaine) 
125-139 (Katherine) 
51-58, 60-66 (Judy) 
120-132 (Sarah) 
173-185 (Katherine) 
Involved patient 
Active participatory role 
Facilitated experience of SDM 
Active and/or 
passive 
positioning 
In
d
iv
id
u
al
is
ed
 e
xp
er
ie
n
ce
s 
o
f 
SD
M
 
 
P
e
rs
o
n
al
is
in
g 
an
d
 
ad
ap
ti
n
g 
SD
M
  
 
Block learning information  
In denial over diagnosis 
Fear of increasing knowledge 
Pass responsibility of decision making 
Want no control over health care 
View that SDM doesn’t exist 
Little awareness of what SDM is 
 
69-77 (Elaine) 
24-26, 86-90, 96-99 (Debbie) 
58-62 (Sarah) 
170-182 (Lucy) 
96-99, 101-114 (Debbie) 
74-81, 92-97 (Helen) 
 
Submissive patient 
Passive participatory role 
Hindered experience of SDM 
Written information 
Verbal information 
Friendly, relaxed communication by 
doctor 
74-86 (Judy) 
60-65 (Claire) 
65-66, 137-141 (Saran) 
38-45 (Katherine) 
 
Varying types  of information 
Communication skills 
Quality of information 
Learning styles Only want to know relevant information 
Must know everything and all options 
Negative information= anxiety 
Knowing everything= little distress 
45-47 (Debbie) 
47-52, 56-61 (Louise) 
64-71, 77-79 (Lucy) 
36-42, 169-171 (Helen) 
71-74, 76-83, 112-116 (Sarah) 
 
 
Knowledge restrictions 
Quantity of information 
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Do want to talk to friends/family 
Avoid talking about with other patients 
Avoid hearing negative stories 
Do want to take anti-depressant 
Self manage own mental health 
 
117-126, 225-233 (Debbie) 
66-105 (Helen) 
127-138 (Rachel) 
95-100, 200-226 (Sarah) 
 
Isolation 
Self-support 
Distress management 
Coping 
strategies 
Talking to breast care nurses help 
Important to create social bond 
Good to relate to others patients 
Share stories, experiences, remedies 
Receive support, guidance, advice 
 
137-144 (Helen) 
72-79 (Claire) 
57-61 (Debbie) 
199-122 (Katherine) 
 
Identification process 
Support structure 
Inclusion 
 
Motivational preaching, positive QOL 255-260 (14) 
148-156 (4) 
Enhancing self esteem 
Lack of patient knowledge 
Patients have no medical skills 
Patients lack experiences of illness 
Doctor is the expert in the field 
Doctor is medically trained and knows 
what is medically appropriate 
Cant challenge doctors expertise 
Intimidated to ask questions 
Doctor knows best 
Doctor is of a higher status 
104-107 (Rachel) 
106-118, 120-124, 139-147(Claire 
126-131, 171-184 (Lucy) 
92-94 (Debbie) 
94-97 (Helen) 
162-171, 198-201 (Katherine) 
100-109 (Charlotte) 
102-108 (Louise) 
138-154 (Lucy) 
187-196 (Katherine) 
 
Patient Inferiority 
Clinician superior 
Academic discrepancy 
Obedience to doctor 
Social influence 
Conformity 
Hierarchal positions 
Doctor-patient 
knowledge 
discrepancy 
N
eg
at
iv
e 
fa
ct
o
rs
 
in
fl
u
en
ci
n
g 
SD
M
 
 P
o
w
e
r 
im
b
al
an
ce
 
an
d
 S
D
M
 
The doctor has a duty of care 
The doctor is seen as a problem solver 
Patients innate trust in doctor 
 
186-194, 203-216 (Vicky) 
89-95, 169-179 (Louise) 
162-169 (Lucy) 
102-106 (Sarah) 
         Doctor-patient roles 
Levels of responsibility 
Faith  
Assurance giver 
Roles and duties 
 
 
 
 
Appendix H 
Thematic codes and themes 
 
355 
 
84-90 (Claire) 
 
 
Patient have rights 
Patient centred care  
SDM sustains the patients roles 
 
157-163 (Sarah) 
221-236 (Judy) 
92-100 (Elaine) 
34-38(Rachel) 
 
Patient participation 
Patient centre of decision 
making 
Patient role in care 
Breast care nurses role, multidisciplinary 
team 
34-39, 264-270 (Lucy) 
78-84 (Debbie) 
201-218 (Katherine) 
Solution maker 
Balancing doctor patient roles 
Maintaining patient 
involvement 
Husbands role, children’s influence  57-74 (1) Family Proximity 
Explaining treatment options 
Justifying treatment choice 
informed consent 
Informed decision making 
Enhancing patient knowledge  
Being kept in the loop 
Doctor provides information and patient 
queries and consents 
 
198-204 (Sarah) 
97-102 (Margaret) 
126-130, 135-145 (Judy) 
66-72 74-79 (Louise) 
90-93 (Lucy) 
153-158 (Katherine) 
101-104,106-114 (Debbie) 
Clarification of details 
Rationalising treatment plans 
Involved in decisions 
Educating the patient 
Sharing information 
 
Information 
exchange 
P
at
ie
n
t 
co
n
ce
p
t 
o
f 
SD
M
 
Fe
at
u
re
s 
o
f 
 
SD
M
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Two-way conversation 
Doctor-patient discussions mutual 
feedback Question/answering sessions 
50/50 process  
Equal partnership/process 
96-107, 147-160 (Judy) 
106-111 (Elaine) 
160-162 (Katherine) 
105-115 (Judy) 
99-100 (Rachel) 
103-111, 114-118 (Helen) 
121-135 (Sarah) 
Mutual doctor-patient 
relationship 
Communication skills 
Sharing talk 
Equal control 
Patient involvement 
 
Two-way  
processes 
 
Key 
 Codes excluded and not clustered into themes due to lack of substantial extracts and data 
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Initial Notes/Patterns Lines (post N’) Initial Codes Theme Cluster Provisional name Theme 
Feel involved 1-20 (17),   2-10 (90) 
1-9 (30),     1-6 (100)    
3-12 (41),    7-9 (2) 
5-16 (176),   8-12 (130) 
12-19 (211),   1-3 (199) 
3-12 (164) 
 
4-19 (301),  1-4 (200) 
8-11 (318),  1-14 (12) 
1-7 (252),   5-17 (70) 
 
5-19 (77),   6-16 ( 1) 
1-14 (33),   4-10 (112) 
19-21 (200),  16-20 (3) 
20-28 (285) 
12-18 (152) 
Active participation 
Patient control 
Patient 
involvement 
H
o
w
 t
h
e 
p
ro
ce
ss
es
 a
n
d
 
ch
ar
ac
te
ri
st
ic
s 
o
f 
SD
M
 a
re
 
vi
si
b
le
 o
n
lin
e,
 b
et
w
ee
n
 
p
at
ie
n
ts
 
Ex
te
n
d
in
g 
th
e
 
ch
ar
ac
te
ri
st
ic
s 
o
f 
SD
M
 t
o
 
an
 o
n
lin
e
 p
e
e
r 
co
m
m
u
n
it
y Participating in the group 
Give confidence 
Scaffolding 
Enhancing self-
esteem 
Comfort and support 
Motivational preaching 
Reassurance 
Hope 
Feeling distressed 
Positive feedback 
Providing knowledge  
Informing 
Perceptions 
Experiences 
Science-based decisions 
 
Access to 
knowledge 
Views and opinions 
Help and advice 
Personal Stories 
Evidence based information 
In the same position 
Proximity 
Self association 
Mutual agreement 
Social interaction 
Social bonds 
Identification 
process  
 
Your case is similar to mine 
Relate to other patients 
Not embarrassed to talk to others 
Consensus in views 
multi-way conversation 
Social connection 
Given a choice 5-9 (18), 9-15 (126) 
5-10 (220), 13-19 (81) 
 
21-24 (261), 11-18(1) 
19-249(231), 1-14 (16) 
 
15-12 (67),  1-9 (322) 
7-19 (290), 4-16 (141) 
 
 
Treatment decision- 
making 
Types of decision-
making 
Ex
am
p
le
s 
o
f 
SD
M
 t
ak
in
g 
p
la
ce
/ 
ex
p
er
ie
n
ce
d
 
o
n
lin
e
 
 Ex
p
e
ri
e
n
ci
n
g 
SD
M
 o
n
lin
e
 I have to decide 
Treatment decisions 
Hair loss decisions Side-effect  
decision-making QOL decisions 
Can’t make up my mind 
Indecisiveness 
Problem solving 
 
Not sure if I have made the right 
choice 
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It is entirely your choice 1-12 (19),   3-10 (180) 
1-5 (300),    1-14 (64) 
5-22 (320),   2-6 (8) 
1-8 (60) 
 
1-16 (99),   1-21 (144) 
5-16 (188),   1-18 (99) 
8-17 (242),   5-10 (66) 
6-14 (155),  2-5 (5) 
 
Battle for control 
Patient influence 
Patient-centred care 
 
Patient authority 
H
o
w
 
aw
ar
en
e
ss
 t
o
 
SD
M
 a
n
d
 it
s 
p
ro
ce
ss
 a
re
 
p
ro
m
o
te
d
 
o
n
lin
e
 
W
ay
s 
to
 
e
n
h
an
ce
 
SD
M
 
You can challenge the doctor 
Patient centred care 
Patient rights 
It’s your body 
Good doctor-patient relationship  
Patient involvement 
Two-way process 
 
Patient 
participation 
Ask questions 
Two-way communication 
Engage to increase knowledge 
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IRAS Version 1 Reference: 12/NW/0140 2
nd
 December 2011 
 
 
 
        Dr M Brunt 
University Hospital of North Staffordshire 
City General  
Newcastle Road 
Stoke-on-Trent 
Staffordshire 
ST4 6QG 
 
               Tel: 01782 672565  
   
              - / - /2011  
Dear.......................,   
I am writing to inform you about a research project at the Cancer Centre of the University 
Hospital of North Staffordshire. The project aims to explore the experience of shared 
decision making during initial consultation with me. This will be achieved by examining 
the tape recordings that are part of the initial consultation with me. We would therefore 
like to invite you to participate in our research.  
We have enclosed some more information about the project and we would be grateful if 
you could read it. If you are willing to take part in the project, please could you sign and 
date the invitation form, and return it in the FREEPOST envelope provided. 
On agreeing to take part in the study, you will be contacted by a member of the research 
team, Miss Neda Baniamer, who will thoroughly go through the information leaflet and 
give you the opportunity to discuss participation and answer any questions. If you are 
willing to participate by lending us your cassette tape we will send out further 
documentation. 
Finally, you do not have to take part in the project if you would prefer not to, it will not 
affect your care in any way.   
 
Yours sincerely, 
 
Dr M Brunt  MBBS, FRCP, FRCR 
Consultant Clinical Oncologist
 
Keele University, Staffordshire, ST5 5BG. 
Telephone: (01782) 733669 
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IRAS Version 2  Reference: 12/NW/0140             18
th
 March 2012 
 
 
  
Dr M Brunt 
University Hospital of North Staffordshire 
City General  
Newcastle Road 
Stoke-on-Trent 
Staffordshire 
ST4 6QG 
 
Tel: 01782 679906   
 
Patient Information Sheet 
 
Project Title: Examining the process of shared decision making between patients and a clinician 
in initial breast cancer consultations. 
You are being invited to take part in a research study.  Before you decide, it is important 
for you to understand why the research is being done and what it will involve.  Please take 
time to read the following information carefully and discuss it with friends and relatives if 
you wish.  Ask us if there is anything that is not clear or if you would like more 
information.  Take time to decide whether or not you wish to take part. 
  
Part 1 Tells you the purpose of this study and what will happen to you if you take part.   
Part 2 Gives you more detailed information about the conduct of the study.  
 
PART 1- The purpose of the study / what will happen if you take part 
 
What is the purpose of the study? 
Patients who have surgery following a diagnosis of breast cancer often have to face 
difficult decisions about their further treatment. Although cancer management is governed 
by specific clinical guidelines, many decision making processes remain complex for 
patients.  Even with a choice of treatment, many feel they lack control or involvement in 
decisions to manage their health. Consequently, medical professionals need to be aware of 
the important impact of decision making processes and active patient participation. 
 
This research represents the first comprehensive examination of the role of shared decision 
making during a clinical consultation in the management of patients diagnosed with breast 
cancer. The research will help by providing information on the importance of a patient’s 
role in shared decision making and involvement during the management of their breast 
cancer, for use by physicians and other health professionals. Findings from the study will 
be integrated into clinical practice and as a consequence will help physicians and promote 
breast cancer patients’ health and well-being. 
 
 
 
Why have I been asked to take part? 
 
Keele University, Staffordshire, ST5 5BG. 
Telephone: (01782) 733669 
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Some patients selected randomly who have recently seen Dr Brunt to discuss management 
of breast cancer are invited to participate. 
 
Do I have to take part? 
No. It is up to you to decide whether or not to take part once you have read this 
information sheet.  If you do, we would like you to sign the invitation form enclosed and 
send it back in the FREEPOST envelope provided. You are still free to withdraw at any 
time, even during or after the study itself, without giving a reason. A decision to withdraw 
at any time, or a decision not to take part, will not affect the standard of care you receive.  
If you change your mind after you have sent in your recorded consultation cassette, then 
please contact a member of the research team within 10 days, and we will remove your 
data accordingly. 
 
What will happen to me if I agree to take part? 
If you agree to take part in the study: 
(5) A member of the research team (Neda Baniamer) will contact you to go through the 
information leaflet, give you the opportunity to discuss participation, and answer 
any questions that you may have.  
(2) You will be then sent further documents in the post which ask you to provide and 
send back written informed consent to participate. Also we ask you for your 
consultation audio cassette recording which you would need to put into the self 
addressed envelope provided.  
*Nothing else is expected from your participation (i.e. you will not need to 
travel anywhere, will not actively take part in an interview/questionnaire, 
and will not be observed during consultations) 
(3) The cassette will be analysed by the research team.  
(4) In approximately 4-6 weeks you will receive your original cassette recording back 
to you by post once the research team have completed with its transcription. A 
summary of the research findings will be sent to you when available. This will be 
accompanied by a call from the research team to ask if you understand the findings, 
as well as to talk about any questions or feelings you might have regarding your 
participation. 
 
What do I have to do? 
On acceptance of releasing your cassette for research purposes, you are required to send 
this to the research team, along with full consent.  The aim of analysis is to give us a clear 
picture of the degree of decision making, control and patient involvement which occurs 
during the consultation. 
 
Will I receive any payments or reimbursement of expenses for taking part in this 
research? 
As you are required to send documents and the cassette in the post, it will be ensured that 
all postage cost is paid for through the use of pre-paid envelopes provided. You receive no 
payment for taking part in the research. 
  
What are the possible disadvantages and risks of taking part?                                
There are no risks associated with this research. Your participation will not affect the 
medical care you receive in any way. Though it is unlikely, your audio-cassette could be 
lost e.g. in the post. 
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What are the possible benefits of taking part? 
The research will help to develop a greater understanding off patient involvement in 
decision making processes in the treatment for breast cancer, for use by physicians and 
other health professionals. Therefore, it can contribute to improving the overall quality of 
life for women with breast cancer, and increasing patient satisfaction with the level of the 
care received. As a participant, you will help in achieving those goals 
 
What happens when the research study stops? 
When we have collected enough cassette recordings from patients, the research team will 
transcribe the audio cassettes and read through them carefully. This will be done at Keele 
University. We will identify key areas which worked particularly well for the patient, and 
areas which could be done differently to improve the service provided.  The results will be 
presented in the form of a report. 
 
Will my taking part in the study be kept confidential?  
Yes.  All the information about your participation in this study will be kept confidential.  
The details are included in Part 2. 
 
This completes Part 1 of the Information Sheet. 
If the information in Part 1 has interested you and you are considering participation, 
please continue to read the additional information in Part 2 before making any decision. 
 
PART 2 - Further information 
 
Is there an independent contact point where I can seek general advice about taking 
part in research? 
The Patient Advice and Liaison Services (PALS) is a hospital service, available to give 
independent advice on any queries you have about your rights as research subjects or 
information about being involved as participants in a research study. 
 
What if there is a problem? 
If you are unhappy with any aspect of this study, please tell a member of the research team 
who will contact you and try to rectify the problem. Alternatively, you can contact a 
member of the research team at any other time who will do their best to answer your 
questions (see contact information below).If you remain unhappy about the research and/ 
or wish to raise a complaint about the way you have been approached or treated during the 
course of the study, please write to Nicola Leighton: Research and Governance Officer, 
Research and Enterprise Services, Dorothy Hodgkin Building, Keele University, ST5 5BG. 
Tel:01782 733306, Email: n.leighton@uso.keele.ac.uk 
 
Will my taking part in the study be kept confidential? 
Several procedures will be carried out to safeguard you and confidentiality. These include: 
(6) Dr Brunt is aware that some of his patients will be contacted. However he will not 
know who participates and sends in their cassette recordings for analysis. All 
information which is collected about you during the course of the research will be 
kept strictly confidential. Only the research team at Keele University will have 
access to the cassette and listen to it, and no one outside of the research team will 
have access to any of the information gathered except the report. 
(7) Only the original cassette will be used for analysis. No copies will be made of the 
cassette, and the original will be sent back to you. 
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(8) Analysis of the cassette will take place in a secure confidential area at Keele 
University by the research team only. 
(9) The transcript collected will contain no identifying features. You will be given an 
identification number only. Where data or direct quotes are used they will be 
anonymised. Any publication material arising from this research will contain no 
information identifying patients or medical staff, besides Dr Brunt as a named 
author. 
(10) Computers which store the data will be password protected, and all data will be 
kept in a secure environment, at Keele University. The transcription of your 
cassette will only be read by the research team and by Dr Brunt (though he will be 
unaware of which patients through anonymisation), not by or any other member of 
your medical team. After the feedback report has been produced, the transcripts 
will be kept as secure confidential records for a maximum of 3 years.  After this 
time, all transcripts will be destroyed.  
 
What will happen to the results of the research study? 
The research findings will be presented to the oncology staff at the University Hospital of 
North Staffordshire. All participants will be presented with a written summary report, with 
an opportunity to comment on these results. The work will be submitted in fulfilment of a 
PhD in Psychology at Keele University. We intend to publish in academic journals and 
presentations at conferences.  
 
Who is organising and funding the research?   
The project is being run by Keele University: Research Institute for Social Sciences, 
Centre for Psychological Research 
 
Who has reviewed the study?  
The Research and Development Department, The University of North Staffordshire, Dr 
Darren Clement, Tel: 01782 554334 
 
The Research and Development Department, Keele University, Nicola Leighton, 
Tel:01782 733306 
North West (Greater Manchester East) Research Ethics Committee, Elaine Hutchings, Tel: 
0161 6257820 
Contact Details- Research Team 
Chief Research Investigator: University Hospital of North Staffordshire, Dr Brunt- Tel: 
01782 672565. 
 
Principal Research Investigator: Keele University, Miss Neda Baniamer- Tel: 
07743450239, email: n.baniamer@ilcs.keele.ac.uk 
 
PhD Academic Supervisor: Keele University, Dr Sally Sargeant- Tel: 01782 733289, 
email: s.j.e.sargeant@psy.keele.ac.uk.  
 
Thank you for taking the time to read this information sheet.  If you think you would like to 
take part, please sign and return the enclosed invitation form in the FREEPOST envelope 
provided.
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IRAS Version 1  Reference 12/NW/0140         2
nd 
December 2011 
 
 
                                                                                     Dr M Brunt 
University Hospital of North Staffordshire 
City General  
Newcastle Road 
Stoke-on-Trent 
Staffordshire 
ST4 6QG 
 
Tel: 01782 672565 
 
INVITATION FORM 
Title of Project: Examining the process of shared decision making between patients and a 
clinician in initial breast cancer consultations 
 
Name of Principal Investigator:  Miss Neda Baniamer 
 
                     Please initial each statement 
 
 
 
1. I confirm that I have read and understand the information sheet dated  
    2
nd
 December  2011 (version 1) for the above study.                         
              
2. I have had the opportunity to consider the information, ask questions if needed  
    and have had these answered satisfactorily.  
 
 
3.    I understand that my participation to release my recording is voluntary and that  
       I am free to withdraw at any time, without giving any reason, without my  
       medical care or legal rights being affected.        
       
 
4. I agree to be contacted to arrange for my recording tape to be sent for research analysis  
 
 
 
Signed:..........................................................................      Date:....................................... 
 
 
Print Name: 
.............................................................................................................................................
 
Keele University, Staffordshire, ST5 5BG. 
Telephone: (01782) 733669 
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IRAS Version 2   Reference: 12/NW/0140           18
th
 March 2012 
 
 
 
        Dr M Brunt 
University Hospital of North Staffordshire 
City General  
Newcastle Road 
Stoke-on-Trent 
Staffordshire 
ST4 6QG 
 
Tel: 01782 672565   
Patient Identification Number:   
 
CONSENT FORM 
Title of Project:  Examining the process of shared decision making between patients and a 
clinician in initial breast cancer consultations 
 
Name of Principal Investigator:  Miss Neda Baniamer 
Your clinical consultation recording cassette will be analysed by the research team, 
examining your views and experiences of your involvement in the decision making 
processes through the course of your treatment. Before consenting to send in your cassette, 
it’s important to understand why the research is being conducted and what it will involve 
for you. So please ensure you have read the information leaflet carefully, and have all 
questions answered thoroughly. You will be given a copy of this information sheet and 
your signed form to keep. 
 
If you are interested in participating to release your cassette for research purposes, please 
initial next to each statement and sign below. If you are not interested, this will not 
affect your treatment in any way. 
1. I confirm that I have read and understood the information sheet. I have also had the 
opportunity to ask questions and have had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any 
time, without giving any reason, without my medical care or legal rights being 
affected in any way. 
 
3. I understand that my participation in this research will have no bearing on my 
medical treatment and will not be included in my medical notes.  
 
 
Keele University, Staffordshire, ST5 5BG. 
Telephone: (01782) 733669 
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4. I agree to my cassette being transcribed and analysed for the researcher’s notes.  
 
5. I understand that my cassette and transcription based from it is confidential, to be 
seen/heard only by the research team. 
 
6. I understand that relevant sections of any of my medical notes and data collected 
during the study, may be looked at by responsible authorities and individuals from 
the research team, where it is relevant to my taking part in this research. I give 
permission for these individuals and authorities to have access to my records. 
 
7. I agree to allow anonymised direct quotes to be included in the research write up. I 
understand that all data collected about me during this study will be anonymised 
before it is submitted for publication. 
 
8. I agree to take part in this study 
 
 
________________________ _______________         ____________________ 
Name of Patient  Date                               Signature 
   
 
 
_________________________ _______________           ____________________ 
Name of Person taking consent Date                         Signature 
(If different from patient) 
 
 
 
________________________ _______________         ____________________ 
Researcher   Date                               Signature 
 
 
 
 
When completed, 1 for patient; 1 for research file   
Appendix O 
                                                                                                                Patient demographic questionnaire   
372 
 
Demographic Questionnaire 
 
Can you please complete the following demographic information. 
  
 1. What is your gender (Please tick) 
□        Male 
□        Female 
 
 
2. What is your age (Please tick) 
□  Under 22 
□  22– 29 
□  30 – 39 
□  40 – 49 
□  50 – 59 
□  60 – 69 
□  70 and over 
 
 
3. To which one of these ethnic groups would you say you belong? (Please tick ONE box 
only) 
  
a.      WHITE 
□        British 
□        Irish 
□        Any other White background 
  
b.     MIXED 
□        White and Black Caribbean 
□        White and Black African 
□        White and Asian 
□        Any other Mixed background 
  
c.      ASIAN OR ASIAN BRITISH 
□        Indian 
□        Pakistani 
□        Bangladeshi 
□        Any other Asian background 
  
d.     BLACK OR BLACK BRITISH 
□        Caribbean 
□        African 
□        Any other Black background 
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e. CHINESE OR OTHER ETHNIC GROUP 
□        Chinese 
□        Any other ethnic group 
  
 
4. Do you have any of the following long standing conditions? (Please tick all that apply) 
□        Deafness or severe hearing impairment 
□        Blindness or partially sighted 
□        A Longstanding physical disability 
□        A learning disability 
□        A mental health condition 
□        A long standing illness such as HIV, diabetes, chronic heart disease or epilepsy 
□        No, I do not have any other medical condition 
 
 
 
5.  What is your marital status (Please tick) 
□  Married 
□  Divorced 
□  Widowed 
□  Separated 
□  Never been married 
□  A member of a unmarried couple 
 
 
 
6.  What is your employment status (Please tick)  
□  Employed 
□  Self-employed 
□  Out of work 
□  A homemaker 
□  A student 
□  Retired 
□  Unable to work 
 
 
 
THANK YOU FOR YOUR HELP TODAY 
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Jefferson transcription symbols 
 
Transcription 
Element 
     Meaning 
Transcription 
Element 
       Meaning 
 
 
 
Marked rise (or fall) in 
intonation 
 
 
 
::: 
  
 Sounds that are stretched or 
drawn out (number of :: 
indicates the length of 
stretching) 
 
 
Underlining Used for emphasis (parts of 
the utterance that are 
stressed) 
 
[  ] Overlaps, cases of 
simultaneous speech or 
interruptions.   
UPPER-
CASE 
LETTERS 
Indicate increased volume 
(note this can be combined 
with underlining) 
 
 Shown when a passage of 
talk is noticeably quieter than 
the surrounding talk 
 
.hhh A row of h’s with a dot in 
front of it indicates an in 
breath.  Without the dot an 
out breath  
 
= When there is nearly no gap 
at all between one utterance 
and another 
(comment) Analyst’s comment about 
something going on in the 
talk 
 
(.) Small pauses 
> word < Noticeably faster speech.  
 
<word> Noticeable slower speech 
 
? Rising intonation at the end 
of an utterance 
(1.4) Silences (time in secs) 
 
      , 
 
-        
 
Continuing intonation 
 
 
Sharp cut off 
 
      . 
Closing or stopping  
Intonation 
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